AU781939B2 - 6-position substituted indoline, production and use thereof as a medicament - Google Patents
6-position substituted indoline, production and use thereof as a medicament Download PDFInfo
- Publication number
- AU781939B2 AU781939B2 AU10233/01A AU1023301A AU781939B2 AU 781939 B2 AU781939 B2 AU 781939B2 AU 10233/01 A AU10233/01 A AU 10233/01A AU 1023301 A AU1023301 A AU 1023301A AU 781939 B2 AU781939 B2 AU 781939B2
- Authority
- AU
- Australia
- Prior art keywords
- group
- alkyl
- amino
- phenyl
- denotes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 238000004519 manufacturing process Methods 0.000 title claims 3
- 239000003814 drug Substances 0.000 title description 2
- 125000003387 indolinyl group Chemical class N1(CCC2=CC=CC=C12)* 0.000 title 1
- -1 C 1 -3-alkoxy Chemical group 0.000 claims description 441
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 133
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 129
- 150000001875 compounds Chemical class 0.000 claims description 122
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 87
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical class C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 claims description 85
- 125000006842 cycloalkyleneimino group Chemical group 0.000 claims description 82
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 81
- 239000000460 chlorine Substances 0.000 claims description 76
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 70
- 239000000203 mixture Substances 0.000 claims description 70
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 65
- 125000000217 alkyl group Chemical group 0.000 claims description 59
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 59
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 55
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 51
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 48
- 229910052757 nitrogen Inorganic materials 0.000 claims description 45
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 43
- 229910052801 chlorine Inorganic materials 0.000 claims description 43
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 40
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 40
- 239000001301 oxygen Substances 0.000 claims description 40
- 229910052760 oxygen Inorganic materials 0.000 claims description 40
- 150000003839 salts Chemical class 0.000 claims description 38
- 229910052731 fluorine Inorganic materials 0.000 claims description 34
- 239000011737 fluorine Substances 0.000 claims description 34
- 125000001072 heteroaryl group Chemical group 0.000 claims description 33
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 29
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 28
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 27
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 26
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 25
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 25
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims description 23
- 229910052794 bromium Inorganic materials 0.000 claims description 23
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 21
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 20
- 229910052740 iodine Inorganic materials 0.000 claims description 20
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 19
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 19
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 19
- 125000006239 protecting group Chemical group 0.000 claims description 19
- 125000003282 alkyl amino group Chemical group 0.000 claims description 18
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 18
- 125000003545 alkoxy group Chemical group 0.000 claims description 16
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims description 15
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 15
- 125000002993 cycloalkylene group Chemical group 0.000 claims description 15
- 125000001153 fluoro group Chemical group F* 0.000 claims description 15
- NALBLJLOBICXRH-UHFFFAOYSA-N dinitrogen monohydride Chemical group N=[N] NALBLJLOBICXRH-UHFFFAOYSA-N 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 14
- 125000003277 amino group Chemical group 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 13
- 239000007790 solid phase Substances 0.000 claims description 13
- 125000001424 substituent group Chemical group 0.000 claims description 13
- 125000006698 (C1-C3) dialkylamino group Chemical group 0.000 claims description 12
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 12
- 125000004744 butyloxycarbonyl group Chemical group 0.000 claims description 12
- 125000001624 naphthyl group Chemical group 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 11
- 125000006563 (C1-3) alkylaminocarbonyl group Chemical group 0.000 claims description 10
- 150000003951 lactams Chemical group 0.000 claims description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 claims description 9
- 125000002950 monocyclic group Chemical group 0.000 claims description 9
- 125000006576 di-(C1-C3-alkyl)-aminocarbonyl group Chemical group 0.000 claims description 8
- 125000002883 imidazolyl group Chemical group 0.000 claims description 8
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 8
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 8
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 7
- 125000002252 acyl group Chemical group 0.000 claims description 7
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 7
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 7
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims description 7
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 230000004663 cell proliferation Effects 0.000 claims description 6
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims description 6
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 6
- 125000006678 phenoxycarbonyl group Chemical group 0.000 claims description 6
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims description 5
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 5
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 5
- 125000001425 triazolyl group Chemical group 0.000 claims description 5
- 125000006602 (C1-C3) alkylsulfonylamino group Chemical group 0.000 claims description 4
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 4
- 230000010933 acylation Effects 0.000 claims description 4
- 238000005917 acylation reaction Methods 0.000 claims description 4
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 4
- 230000009435 amidation Effects 0.000 claims description 4
- 238000007112 amidation reaction Methods 0.000 claims description 4
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 4
- 125000001246 bromo group Chemical group Br* 0.000 claims description 4
- 150000001721 carbon Chemical group 0.000 claims description 4
- 230000032050 esterification Effects 0.000 claims description 4
- 238000005886 esterification reaction Methods 0.000 claims description 4
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000006850 spacer group Chemical group 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 3
- 125000006164 6-membered heteroaryl group Chemical group 0.000 claims description 3
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 3
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 3
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 claims description 3
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- 150000002513 isocyanates Chemical class 0.000 claims description 3
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims description 3
- 239000002243 precursor Substances 0.000 claims description 3
- 238000006722 reduction reaction Methods 0.000 claims description 3
- 238000005932 reductive alkylation reaction Methods 0.000 claims description 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- QQXQAEWRSVZPJM-UHFFFAOYSA-N ethyl 1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)OCC)=CC2=C1 QQXQAEWRSVZPJM-UHFFFAOYSA-N 0.000 claims description 2
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims description 2
- 125000002541 furyl group Chemical group 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- RWGCGSGXCAVHHS-UHFFFAOYSA-N methyl 3-[N-[4-[(dimethylamino)methyl]phenyl]-C-phenylcarbonimidoyl]-2-hydroxy-1H-indole-6-carboxylate Chemical compound CN(C)CC1=CC=C(C=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)OC)O RWGCGSGXCAVHHS-UHFFFAOYSA-N 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000002825 nitriles Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 125000002971 oxazolyl group Chemical group 0.000 claims description 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 2
- 125000000335 thiazolyl group Chemical group 0.000 claims description 2
- 125000001544 thienyl group Chemical group 0.000 claims description 2
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 claims 3
- 230000002547 anomalous effect Effects 0.000 claims 3
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 claims 2
- 125000006844 cycloalkyleneimino-C1-3-alkyl group Chemical group 0.000 claims 1
- MUAUVCXWMHWZHJ-FLWNBWAVSA-N ethyl (3z)-3-[[4-[(2,6-dimethylpiperidin-1-yl)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1C(C)CCCC1C MUAUVCXWMHWZHJ-FLWNBWAVSA-N 0.000 claims 1
- RTLQNDXPILJVLA-UHFFFAOYSA-N ethyl 2-hydroxy-3-[C-phenyl-N-[4-(piperidin-1-ylmethyl)phenyl]carbonimidoyl]-1H-indole-6-carboxylate Chemical compound CCOC(=O)C1=CC2=C(C=C1)C(=C(N2)O)C(=NC3=CC=C(C=C3)CN4CCCCC4)C5=CC=CC=C5 RTLQNDXPILJVLA-UHFFFAOYSA-N 0.000 claims 1
- XZXHXSATPCNXJR-ZIADKAODSA-N nintedanib Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(C)C(=O)CN1CCN(C)CC1 XZXHXSATPCNXJR-ZIADKAODSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 828
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 714
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 227
- 239000000741 silica gel Substances 0.000 description 223
- 229910002027 silica gel Inorganic materials 0.000 description 223
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 180
- 238000000119 electrospray ionisation mass spectrum Methods 0.000 description 165
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 156
- 229940039407 aniline Drugs 0.000 description 124
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 108
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 99
- 238000001819 mass spectrum Methods 0.000 description 99
- 229920005989 resin Polymers 0.000 description 80
- 239000011347 resin Substances 0.000 description 80
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 78
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 65
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 59
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 54
- NSLGYOTXIPMWNZ-UHFFFAOYSA-N methyl 1-acetyl-3-[ethoxy(phenyl)methylidene]-2-oxoindole-6-carboxylate Chemical compound O=C1N(C(C)=O)C2=CC(C(=O)OC)=CC=C2C1=C(OCC)C1=CC=CC=C1 NSLGYOTXIPMWNZ-UHFFFAOYSA-N 0.000 description 54
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 46
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 42
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 38
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 37
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 33
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- 229910021529 ammonia Inorganic materials 0.000 description 32
- 239000000243 solution Substances 0.000 description 30
- 239000002904 solvent Substances 0.000 description 29
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 239000002585 base Substances 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 239000013543 active substance Substances 0.000 description 18
- 229960000583 acetic acid Drugs 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 14
- 239000002253 acid Substances 0.000 description 14
- 238000002844 melting Methods 0.000 description 14
- 230000008018 melting Effects 0.000 description 14
- 239000012362 glacial acetic acid Substances 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 10
- CMKDJMDGRSJZIS-UHFFFAOYSA-N 2,3-dihydro-1h-indene-1-carbaldehyde Chemical compound C1=CC=C2C(C=O)CCC2=C1 CMKDJMDGRSJZIS-UHFFFAOYSA-N 0.000 description 10
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 10
- RRUHDUPCRXQGGL-UHFFFAOYSA-N ethyl 1-acetyl-3-[ethoxy(phenyl)methylidene]-2-oxoindole-6-carboxylate Chemical compound O=C1N(C(C)=O)C2=CC(C(=O)OCC)=CC=C2C1=C(OCC)C1=CC=CC=C1 RRUHDUPCRXQGGL-UHFFFAOYSA-N 0.000 description 10
- 239000012074 organic phase Substances 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 10
- 230000035755 proliferation Effects 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 9
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 9
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- BAGMQZQOPSFTHS-UHFFFAOYSA-N n',n'-dimethyl-n-(4-nitrophenyl)ethane-1,2-diamine Chemical compound CN(C)CCNC1=CC=C([N+]([O-])=O)C=C1 BAGMQZQOPSFTHS-UHFFFAOYSA-N 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- 239000012312 sodium hydride Substances 0.000 description 9
- 229910000104 sodium hydride Inorganic materials 0.000 description 9
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 9
- 210000002889 endothelial cell Anatomy 0.000 description 8
- YFTGUNWFFVDLNM-UHFFFAOYSA-N methyl 2-oxo-1,3-dihydroindole-6-carboxylate Chemical compound COC(=O)C1=CC=C2CC(=O)NC2=C1 YFTGUNWFFVDLNM-UHFFFAOYSA-N 0.000 description 8
- 150000007530 organic bases Chemical class 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 238000002390 rotary evaporation Methods 0.000 description 8
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 7
- XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 7
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- UXWQXBSQQHAGMG-UHFFFAOYSA-N tert-butyl n-[(4-aminophenyl)methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=C(N)C=C1 UXWQXBSQQHAGMG-UHFFFAOYSA-N 0.000 description 7
- JTSQCRJACVEMNB-UHFFFAOYSA-N 2-[2-(dimethylamino)ethyl-methylamino]-n-methyl-n-(4-nitrophenyl)acetamide Chemical compound CN(C)CCN(C)CC(=O)N(C)C1=CC=C([N+]([O-])=O)C=C1 JTSQCRJACVEMNB-UHFFFAOYSA-N 0.000 description 6
- DRYFDUUAYSVNSN-UHFFFAOYSA-N 4-(piperidin-1-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCCCC1 DRYFDUUAYSVNSN-UHFFFAOYSA-N 0.000 description 6
- RIQLJIOFWJEUCA-UHFFFAOYSA-N 4-[[benzyl(methyl)amino]methyl]aniline Chemical compound C=1C=C(N)C=CC=1CN(C)CC1=CC=CC=C1 RIQLJIOFWJEUCA-UHFFFAOYSA-N 0.000 description 6
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 6
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 6
- SDMAVFXBWFYTCI-UHFFFAOYSA-N ethyl 2-oxo-1,3-dihydroindole-6-carboxylate Chemical compound CCOC(=O)C1=CC=C2CC(=O)NC2=C1 SDMAVFXBWFYTCI-UHFFFAOYSA-N 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- LSQRHFSGOUDQDS-UHFFFAOYSA-N n-methyl-2-(4-methylpiperazin-1-yl)-n-(4-nitrophenyl)acetamide Chemical compound C=1C=C([N+]([O-])=O)C=CC=1N(C)C(=O)CN1CCN(C)CC1 LSQRHFSGOUDQDS-UHFFFAOYSA-N 0.000 description 6
- 229940002612 prodrug Drugs 0.000 description 6
- 239000000651 prodrug Chemical group 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000001117 sulphuric acid Substances 0.000 description 6
- 235000011149 sulphuric acid Nutrition 0.000 description 6
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 5
- DGHAOTHIDTUSJY-UHFFFAOYSA-N 4-(imidazol-1-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1C=NC=C1 DGHAOTHIDTUSJY-UHFFFAOYSA-N 0.000 description 5
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 5
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 5
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 description 5
- RKQPALYUCVLYGN-UHFFFAOYSA-N n-benzyl-2-[benzyl(methyl)amino]-n-(4-nitrophenyl)acetamide Chemical compound C=1C=CC=CC=1CN(C)CC(=O)N(C=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 RKQPALYUCVLYGN-UHFFFAOYSA-N 0.000 description 5
- YIEUCXDCJGYDEU-UHFFFAOYSA-N n-benzyl-n-(4-nitrophenyl)-2-piperidin-1-ylacetamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1N(C(=O)CN1CCCCC1)CC1=CC=CC=C1 YIEUCXDCJGYDEU-UHFFFAOYSA-N 0.000 description 5
- FPWNRFBIGPQPMH-UHFFFAOYSA-N n-methyl-n-(4-nitrophenyl)prop-2-enamide Chemical compound C=CC(=O)N(C)C1=CC=C([N+]([O-])=O)C=C1 FPWNRFBIGPQPMH-UHFFFAOYSA-N 0.000 description 5
- 239000007800 oxidant agent Substances 0.000 description 5
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 4
- GJKIAPNNPWBCOF-UHFFFAOYSA-N 2-(4-nitrophenyl)-1h-imidazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=NC=CN1 GJKIAPNNPWBCOF-UHFFFAOYSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- ABDMMHQWDQYLIB-UHFFFAOYSA-N 2-[(4-aminophenyl)methyl-methylamino]-n-methylacetamide Chemical compound CNC(=O)CN(C)CC1=CC=C(N)C=C1 ABDMMHQWDQYLIB-UHFFFAOYSA-N 0.000 description 4
- WOJBIBHVUSZAGS-UHFFFAOYSA-N 3-[(dimethylamino)methyl]aniline Chemical compound CN(C)CC1=CC=CC(N)=C1 WOJBIBHVUSZAGS-UHFFFAOYSA-N 0.000 description 4
- ZHOYVFPSBCXAGM-UHFFFAOYSA-N 4-(5-methyl-1h-imidazol-4-yl)aniline Chemical compound N1C=NC(C=2C=CC(N)=CC=2)=C1C ZHOYVFPSBCXAGM-UHFFFAOYSA-N 0.000 description 4
- SFEAIUCOZWDYMJ-UHFFFAOYSA-N 4-(pyrrolidin-1-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCCC1 SFEAIUCOZWDYMJ-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- RKUHAHWKUHEXCG-UHFFFAOYSA-N 4-[[benzyl(2,2,2-trifluoroethyl)amino]methyl]aniline Chemical compound C1=CC(N)=CC=C1CN(CC(F)(F)F)CC1=CC=CC=C1 RKUHAHWKUHEXCG-UHFFFAOYSA-N 0.000 description 4
- 125000006281 4-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Br)C([H])([H])* 0.000 description 4
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 4
- 108091007914 CDKs Proteins 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 102000016736 Cyclin Human genes 0.000 description 4
- 108050006400 Cyclin Proteins 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 239000001828 Gelatine Substances 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 235000019759 Maize starch Nutrition 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000012317 TBTU Substances 0.000 description 4
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 4
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 4
- 239000012346 acetyl chloride Substances 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- FPCAYZUZSJHFLE-LCUIJRPUSA-N ethyl (3z)-3-[1-[4-[acetyl-[3-(dimethylamino)propyl]amino]anilino]butylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C/1NC2=CC(C(=O)OCC)=CC=C2C\1=C(/CCC)NC1=CC=C(N(CCCN(C)C)C(C)=O)C=C1 FPCAYZUZSJHFLE-LCUIJRPUSA-N 0.000 description 4
- ZINNDPFIXNMKJZ-MBELHXAFSA-N ethyl (3z)-3-[[4-[(2,5-dioxoimidazolidin-4-ylidene)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1C=C1NC(=O)NC1=O ZINNDPFIXNMKJZ-MBELHXAFSA-N 0.000 description 4
- MHAKZTRHBLCYKV-UHFFFAOYSA-N ethyl 1h-indole-6-carboxylate Chemical compound CCOC(=O)C1=CC=C2C=CNC2=C1 MHAKZTRHBLCYKV-UHFFFAOYSA-N 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- YBGGVKMJPPALFD-DQRAZIAOSA-N methyl (3z)-3-[[4-(aminomethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN)C=C1 YBGGVKMJPPALFD-DQRAZIAOSA-N 0.000 description 4
- AYYOZKHMSABVRP-UHFFFAOYSA-N methyl 1h-indole-6-carboxylate Chemical compound COC(=O)C1=CC=C2C=CNC2=C1 AYYOZKHMSABVRP-UHFFFAOYSA-N 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 239000000829 suppository Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- 239000008215 water for injection Substances 0.000 description 4
- HDPNBNXLBDFELL-UHFFFAOYSA-N 1,1,1-trimethoxyethane Chemical compound COC(C)(OC)OC HDPNBNXLBDFELL-UHFFFAOYSA-N 0.000 description 3
- RWFPMCRAKVAYMJ-UHFFFAOYSA-N 1-[(4-aminophenyl)methyl]pyrrolidin-2-one Chemical compound C1=CC(N)=CC=C1CN1C(=O)CCC1 RWFPMCRAKVAYMJ-UHFFFAOYSA-N 0.000 description 3
- YOUQFGVYWUQFDX-UHFFFAOYSA-N 1-[(4-aminophenyl)methyl]pyrrolidin-3-ol Chemical compound C1=CC(N)=CC=C1CN1CC(O)CC1 YOUQFGVYWUQFDX-UHFFFAOYSA-N 0.000 description 3
- KBAVWAIJZRUOMZ-UHFFFAOYSA-N 2-(n-methylsulfonyl-4-nitroanilino)acetic acid Chemical compound OC(=O)CN(S(=O)(=O)C)C1=CC=C([N+]([O-])=O)C=C1 KBAVWAIJZRUOMZ-UHFFFAOYSA-N 0.000 description 3
- DVOMOWWRBXYTDR-UHFFFAOYSA-N 2-[(4-aminophenyl)methyl-methylamino]-n,n-dimethylacetamide Chemical compound CN(C)C(=O)CN(C)CC1=CC=C(N)C=C1 DVOMOWWRBXYTDR-UHFFFAOYSA-N 0.000 description 3
- WSZWBUAVTIIUOV-UHFFFAOYSA-N 2-[(4-aminophenyl)methyl-methylamino]ethanol Chemical compound OCCN(C)CC1=CC=C(N)C=C1 WSZWBUAVTIIUOV-UHFFFAOYSA-N 0.000 description 3
- BAWOCZNKJQOYRD-UHFFFAOYSA-N 2-[methyl-[(4-nitrophenyl)methyl]amino]acetic acid Chemical compound OC(=O)CN(C)CC1=CC=C([N+]([O-])=O)C=C1 BAWOCZNKJQOYRD-UHFFFAOYSA-N 0.000 description 3
- SYZRZLUNWVNNNV-UHFFFAOYSA-N 2-bromoacetyl chloride Chemical compound ClC(=O)CBr SYZRZLUNWVNNNV-UHFFFAOYSA-N 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 3
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 3
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 3
- UNNGCBLLSSNKMJ-UHFFFAOYSA-N 4-(1-ethylimidazol-2-yl)aniline Chemical compound CCN1C=CN=C1C1=CC=C(N)C=C1 UNNGCBLLSSNKMJ-UHFFFAOYSA-N 0.000 description 3
- NVNMCWWSSZFLCY-UHFFFAOYSA-N 4-(1-methylimidazol-2-yl)aniline Chemical compound CN1C=CN=C1C1=CC=C(N)C=C1 NVNMCWWSSZFLCY-UHFFFAOYSA-N 0.000 description 3
- GSBDHQDPAGRRJE-UHFFFAOYSA-N 4-(1h-imidazol-2-yl)aniline Chemical compound C1=CC(N)=CC=C1C1=NC=CN1 GSBDHQDPAGRRJE-UHFFFAOYSA-N 0.000 description 3
- CENKJXADYBDCLM-UHFFFAOYSA-N 4-(1h-imidazol-5-yl)aniline Chemical compound C1=CC(N)=CC=C1C1=CNC=N1 CENKJXADYBDCLM-UHFFFAOYSA-N 0.000 description 3
- MOZNZNKHRXRLLF-UHFFFAOYSA-N 4-(4-methylpiperazin-1-yl)aniline Chemical compound C1CN(C)CCN1C1=CC=C(N)C=C1 MOZNZNKHRXRLLF-UHFFFAOYSA-N 0.000 description 3
- MQWIENFKSMUTOO-UHFFFAOYSA-N 4-(azetidin-1-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCC1 MQWIENFKSMUTOO-UHFFFAOYSA-N 0.000 description 3
- AFHLJRYAVLIEMS-UHFFFAOYSA-N 4-(diethylaminomethyl)aniline Chemical compound CCN(CC)CC1=CC=C(N)C=C1 AFHLJRYAVLIEMS-UHFFFAOYSA-N 0.000 description 3
- WNYFVEFUHMDIRQ-UHFFFAOYSA-N 4-(morpholin-4-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCOCC1 WNYFVEFUHMDIRQ-UHFFFAOYSA-N 0.000 description 3
- WZXYYQHVDJMIFF-UHFFFAOYSA-N 4-(pyridin-4-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CC1=CC=NC=C1 WZXYYQHVDJMIFF-UHFFFAOYSA-N 0.000 description 3
- MYUXYVDWWHXMMH-UHFFFAOYSA-N 4-[(4-ethylpiperidin-1-yl)methyl]aniline Chemical compound C1CC(CC)CCN1CC1=CC=C(N)C=C1 MYUXYVDWWHXMMH-UHFFFAOYSA-N 0.000 description 3
- GQWQLBVBTIRPCU-UHFFFAOYSA-N 4-[(4-methoxypiperidin-1-yl)methyl]aniline Chemical compound C1CC(OC)CCN1CC1=CC=C(N)C=C1 GQWQLBVBTIRPCU-UHFFFAOYSA-N 0.000 description 3
- NIXCVBFXLJWUTC-UHFFFAOYSA-N 4-[(4-methylpiperazin-1-yl)methyl]aniline Chemical compound C1CN(C)CCN1CC1=CC=C(N)C=C1 NIXCVBFXLJWUTC-UHFFFAOYSA-N 0.000 description 3
- SMVDUMISDDXEAP-UHFFFAOYSA-N 4-[(7-methoxy-1,2,4,5-tetrahydro-3-benzazepin-3-yl)methyl]aniline Chemical compound C1CC2=CC(OC)=CC=C2CCN1CC1=CC=C(N)C=C1 SMVDUMISDDXEAP-UHFFFAOYSA-N 0.000 description 3
- NNCCQALFJIMRKB-UHFFFAOYSA-N 4-[(dimethylamino)methyl]aniline Chemical compound CN(C)CC1=CC=C(N)C=C1 NNCCQALFJIMRKB-UHFFFAOYSA-N 0.000 description 3
- IMMDNRXGZICMBC-UHFFFAOYSA-N 4-[2-(diethylamino)ethyl]aniline Chemical compound CCN(CC)CCC1=CC=C(N)C=C1 IMMDNRXGZICMBC-UHFFFAOYSA-N 0.000 description 3
- BWKPYQQOOFDDJS-UHFFFAOYSA-N 4-[2-amino-1-(1,3-benzodioxol-5-yl)propan-2-yl]aniline Chemical compound C=1C=C2OCOC2=CC=1CC(N)(C)C1=CC=C(N)C=C1 BWKPYQQOOFDDJS-UHFFFAOYSA-N 0.000 description 3
- LNNVDJYHQDDGSD-UHFFFAOYSA-N 4-[[methyl(propyl)amino]methyl]aniline Chemical compound CCCN(C)CC1=CC=C(N)C=C1 LNNVDJYHQDDGSD-UHFFFAOYSA-N 0.000 description 3
- HCWZFUZIQJQDJA-UHFFFAOYSA-N 4-[benzyl-[(4-nitrophenyl)methyl]amino]butanenitrile Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN(CCCC#N)CC1=CC=CC=C1 HCWZFUZIQJQDJA-UHFFFAOYSA-N 0.000 description 3
- WDTRNCFZFQIWLM-UHFFFAOYSA-N 4-benzylaniline Chemical compound C1=CC(N)=CC=C1CC1=CC=CC=C1 WDTRNCFZFQIWLM-UHFFFAOYSA-N 0.000 description 3
- VTSUWHFLMJLYKN-UHFFFAOYSA-N 4-nitro-n-propan-2-ylaniline Chemical compound CC(C)NC1=CC=C([N+]([O-])=O)C=C1 VTSUWHFLMJLYKN-UHFFFAOYSA-N 0.000 description 3
- GQGFAZFYBKYVNS-UHFFFAOYSA-N 5-[(4-aminophenyl)methylidene]imidazolidine-2,4-dione Chemical compound C1=CC(N)=CC=C1C=C1C(=O)NC(=O)N1 GQGFAZFYBKYVNS-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 239000012448 Lithium borohydride Substances 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 229960004050 aminobenzoic acid Drugs 0.000 description 3
- 230000033115 angiogenesis Effects 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- ZFQCJYHRLVIXAN-VZCXRCSSSA-N ethyl (3z)-3-[1-[4-[(dimethylamino)methyl]anilino]propylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(/CC)NC1=CC=C(CN(C)C)C=C1 ZFQCJYHRLVIXAN-VZCXRCSSSA-N 0.000 description 3
- GYBLBBSLEFEACO-QPLCGJKRSA-N ethyl (3z)-3-[[4-(1,4-diaminobutyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCCN)C=C1 GYBLBBSLEFEACO-QPLCGJKRSA-N 0.000 description 3
- BGMCJJIINYTTBD-ZIADKAODSA-N ethyl (3z)-3-[[4-(azepan-1-ylmethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCCCCC1 BGMCJJIINYTTBD-ZIADKAODSA-N 0.000 description 3
- AGICOFWZEZEPSB-RQZHXJHFSA-N ethyl (3z)-3-[[4-(morpholin-4-ylmethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCOCC1 AGICOFWZEZEPSB-RQZHXJHFSA-N 0.000 description 3
- LDLGHKOPBXJLSS-FLWNBWAVSA-N ethyl (3z)-3-[[4-[(3,5-dimethylpiperidin-1-yl)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CC(C)CC(C)C1 LDLGHKOPBXJLSS-FLWNBWAVSA-N 0.000 description 3
- UCVDESGYVWSIKY-HKWRFOASSA-N ethyl (3z)-3-[[4-[2-(dimethylamino)ethyl-methylsulfonylamino]anilino]methylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C\NC1=CC=C(N(CCN(C)C)S(C)(=O)=O)C=C1 UCVDESGYVWSIKY-HKWRFOASSA-N 0.000 description 3
- UZPJPADJORIKJY-MVJHLKBCSA-N ethyl (3z)-3-[[4-[[benzyl(ethyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN(CC)CC1=CC=CC=C1 UZPJPADJORIKJY-MVJHLKBCSA-N 0.000 description 3
- RJUIYXJUPRCXAC-RQZHXJHFSA-N ethyl (3z)-3-[[4-[acetyl-[2-(methylamino)ethyl]amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(N(CCNC)C(C)=O)C=C1 RJUIYXJUPRCXAC-RQZHXJHFSA-N 0.000 description 3
- NETCICHFVHZSSG-ZIADKAODSA-N ethyl (3z)-3-[[4-[acetyl-[3-(dimethylamino)propyl]amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(N(CCCN(C)C)C(C)=O)C=C1 NETCICHFVHZSSG-ZIADKAODSA-N 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 3
- BLJPUEQEFILIBR-UHFFFAOYSA-N n-(4-aminophenyl)-2-[2-(dimethylamino)ethyl-methylamino]-n-methylacetamide Chemical compound CN(C)CCN(C)CC(=O)N(C)C1=CC=C(N)C=C1 BLJPUEQEFILIBR-UHFFFAOYSA-N 0.000 description 3
- HNMJLMSVPJYVFA-UHFFFAOYSA-N n-(4-aminophenyl)-n-(cyanomethyl)methanesulfonamide Chemical compound N#CCN(S(=O)(=O)C)C1=CC=C(N)C=C1 HNMJLMSVPJYVFA-UHFFFAOYSA-N 0.000 description 3
- CDHPIVVFDKOCKP-UHFFFAOYSA-N n-[(4-nitrophenyl)methyl]-n-(2-phenylethyl)cyclohexanamine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN(C1CCCCC1)CCC1=CC=CC=C1 CDHPIVVFDKOCKP-UHFFFAOYSA-N 0.000 description 3
- FBNMBSWXAVZBNJ-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]methanesulfonamide Chemical compound CN(C)CCNS(C)(=O)=O FBNMBSWXAVZBNJ-UHFFFAOYSA-N 0.000 description 3
- XIFJZJPMHNUGRA-UHFFFAOYSA-N n-methyl-4-nitroaniline Chemical compound CNC1=CC=C([N+]([O-])=O)C=C1 XIFJZJPMHNUGRA-UHFFFAOYSA-N 0.000 description 3
- FWYRKLVNWYDPLY-UHFFFAOYSA-N n-methyl-n-[(4-nitrophenyl)methyl]propan-1-amine Chemical compound CCCN(C)CC1=CC=C([N+]([O-])=O)C=C1 FWYRKLVNWYDPLY-UHFFFAOYSA-N 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 125000001639 phenylmethylene group Chemical group [H]C(=*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000009518 sodium iodide Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- OOPUFXZJWLZPLC-UHFFFAOYSA-N tert-butyl 2-(4-aminophenyl)acetate Chemical compound CC(C)(C)OC(=O)CC1=CC=C(N)C=C1 OOPUFXZJWLZPLC-UHFFFAOYSA-N 0.000 description 3
- 238000007056 transamidation reaction Methods 0.000 description 3
- 108010072897 transcription factor Brn-2 Proteins 0.000 description 3
- BQFPCTXLBRVFJL-UHFFFAOYSA-N triethoxymethylbenzene Chemical compound CCOC(OCC)(OCC)C1=CC=CC=C1 BQFPCTXLBRVFJL-UHFFFAOYSA-N 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- XSGOIOAGOGRBEF-UHFFFAOYSA-N (2-amino-2-oxoethyl) 2-oxo-3H-indole-1-carboxylate Chemical compound C(N)(=O)COC(=O)N1C(CC2=CC=CC=C12)=O XSGOIOAGOGRBEF-UHFFFAOYSA-N 0.000 description 2
- QYYOBLCYPGRDDN-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl) 2-oxo-3H-indole-1-carboxylate Chemical compound C(C)OC(=O)COC(=O)N1C(CC2=CC=CC=C12)=O QYYOBLCYPGRDDN-UHFFFAOYSA-N 0.000 description 2
- OJZQOQNSUZLSMV-UHFFFAOYSA-N (3-aminophenyl)methanol Chemical compound NC1=CC=CC(CO)=C1 OJZQOQNSUZLSMV-UHFFFAOYSA-N 0.000 description 2
- KTEHHVYBDNJOOG-QPLCGJKRSA-N (3z)-2-oxo-3-[phenyl-[4-(piperidin-1-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylic acid Chemical compound O=C1NC2=CC(C(=O)O)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCCCC1 KTEHHVYBDNJOOG-QPLCGJKRSA-N 0.000 description 2
- TULRTSZXCBRSHU-VXPUYCOJSA-N (3z)-3-[(4-bromoanilino)-phenylmethylidene]-2-oxo-1h-indole-6-carboxylic acid Chemical compound O=C1NC2=CC(C(=O)O)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(Br)C=C1 TULRTSZXCBRSHU-VXPUYCOJSA-N 0.000 description 2
- VCDNZMAJMAQKPC-JLPGSUDCSA-N (3z)-3-[1-[4-[[(4-chlorophenyl)methyl-methylamino]methyl]anilino]ethylidene]-2-oxo-1h-indole-6-carboxamide Chemical compound C=1C=C(N\C(C)=C/2C3=CC=C(C=C3NC\2=O)C(N)=O)C=CC=1CN(C)CC1=CC=C(Cl)C=C1 VCDNZMAJMAQKPC-JLPGSUDCSA-N 0.000 description 2
- 125000004804 1-methylmethylene group Chemical group [H]C([H])([H])C([H])([*:2])[*:1] 0.000 description 2
- ALOCUZOKRULSAA-UHFFFAOYSA-N 1-methylpiperidin-4-amine Chemical compound CN1CCC(N)CC1 ALOCUZOKRULSAA-UHFFFAOYSA-N 0.000 description 2
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 2
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 2
- GXZTXOBCEAIHKV-UHFFFAOYSA-N 2-[(4-aminophenyl)methyl-methylamino]acetamide Chemical compound NC(=O)CN(C)CC1=CC=C(N)C=C1 GXZTXOBCEAIHKV-UHFFFAOYSA-N 0.000 description 2
- JINDOFPTXLZDEN-UHFFFAOYSA-N 2-[(4-nitrophenyl)methyl]-2,3,4,9-tetrahydro-1h-pyrazino[2,3-d]azepine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CC1NC(CC=NC=C2)=C2NC1 JINDOFPTXLZDEN-UHFFFAOYSA-N 0.000 description 2
- YCWZKMBGUJTSEI-VHXPQNKSSA-N 2-[(dimethylamino)methyl]-5-[[(z)-(6-methoxycarbonyl-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoic acid Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C)C)C(C(O)=O)=C1 YCWZKMBGUJTSEI-VHXPQNKSSA-N 0.000 description 2
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 2
- BRQCZMOFQLQZRU-UHFFFAOYSA-N 2-methoxyethyl 2-oxo-3H-indole-1-carboxylate Chemical compound COCCOC(=O)N1C(CC2=CC=CC=C12)=O BRQCZMOFQLQZRU-UHFFFAOYSA-N 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical compound NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 2
- BIJKEZLJVXXWSH-VHXPQNKSSA-N 3-amino-3-[4-[[(z)-(6-methoxycarbonyl-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]propanoic acid Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CC(O)=O)C=C1 BIJKEZLJVXXWSH-VHXPQNKSSA-N 0.000 description 2
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 2
- ZGLQVRIVLWGDNA-UHFFFAOYSA-N 4-(1,2,4-triazol-1-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1N=CN=C1 ZGLQVRIVLWGDNA-UHFFFAOYSA-N 0.000 description 2
- UBCZGCWYJYQYRA-UHFFFAOYSA-N 4-(1-benzylimidazol-2-yl)aniline Chemical compound C1=CC(N)=CC=C1C1=NC=CN1CC1=CC=CC=C1 UBCZGCWYJYQYRA-UHFFFAOYSA-N 0.000 description 2
- LLPIMIMXCXEFER-UHFFFAOYSA-N 4-(2-morpholin-4-ylethyl)aniline Chemical compound C1=CC(N)=CC=C1CCN1CCOCC1 LLPIMIMXCXEFER-UHFFFAOYSA-N 0.000 description 2
- KTPONJJKCBOJCQ-UHFFFAOYSA-N 4-(2h-tetrazol-5-yl)aniline Chemical compound C1=CC(N)=CC=C1C1=NNN=N1 KTPONJJKCBOJCQ-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- LSBRZZNINILPSU-UHFFFAOYSA-N 4-(sulfonylamino)aniline Chemical compound NC1=CC=C(N=S(=O)=O)C=C1 LSBRZZNINILPSU-UHFFFAOYSA-N 0.000 description 2
- CUSKJWJUMHRIHA-UHFFFAOYSA-N 4-(triazol-1-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1N=NC=C1 CUSKJWJUMHRIHA-UHFFFAOYSA-N 0.000 description 2
- GDIIPKWHAQGCJF-UHFFFAOYSA-N 4-Amino-2-nitrotoluene Chemical compound CC1=CC=C(N)C=C1[N+]([O-])=O GDIIPKWHAQGCJF-UHFFFAOYSA-N 0.000 description 2
- TZMCILRCGMFRJC-UHFFFAOYSA-N 4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CN1CCS(=O)(=O)CC1 TZMCILRCGMFRJC-UHFFFAOYSA-N 0.000 description 2
- MKTORDFOADPMDB-UHFFFAOYSA-N 4-[(1-oxo-1,4-thiazinan-4-yl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CN1CCS(=O)CC1 MKTORDFOADPMDB-UHFFFAOYSA-N 0.000 description 2
- OXTPGYNBWHJWOR-UHFFFAOYSA-N 4-[(2,6-dimethylpiperidin-1-yl)methyl]aniline Chemical compound CC1CCCC(C)N1CC1=CC=C(N)C=C1 OXTPGYNBWHJWOR-UHFFFAOYSA-N 0.000 description 2
- MDOWXVRXHYVFNN-UHFFFAOYSA-N 4-[(3,5-dimethylpiperidin-1-yl)methyl]aniline Chemical compound C1C(C)CC(C)CN1CC1=CC=C(N)C=C1 MDOWXVRXHYVFNN-UHFFFAOYSA-N 0.000 description 2
- ZFPNHOOYXRDLQF-UHFFFAOYSA-N 4-[(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)methyl]aniline Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CC1=CC=C(N)C=C1 ZFPNHOOYXRDLQF-UHFFFAOYSA-N 0.000 description 2
- NLPHTQCTIJOMNA-UHFFFAOYSA-N 4-[2-(1h-imidazol-5-yl)ethyl]aniline Chemical compound C1=CC(N)=CC=C1CCC1=CNC=N1 NLPHTQCTIJOMNA-UHFFFAOYSA-N 0.000 description 2
- BHAFXZJPJZZZSY-VLGSPTGOSA-N 4-[[(1z)-1-(6-ethoxycarbonyl-2-oxo-1h-indol-3-ylidene)propyl]amino]benzoic acid Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(/CC)NC1=CC=C(C(O)=O)C=C1 BHAFXZJPJZZZSY-VLGSPTGOSA-N 0.000 description 2
- OQSLGCAKMPBLQW-ICFOKQHNSA-N 4-[[(1z)-1-(6-methoxycarbonyl-2-oxo-1h-indol-3-ylidene)propyl]amino]benzoic acid Chemical compound O=C/1NC2=CC(C(=O)OC)=CC=C2C\1=C(/CC)NC1=CC=C(C(O)=O)C=C1 OQSLGCAKMPBLQW-ICFOKQHNSA-N 0.000 description 2
- VMAASPWSCKWFSL-UHFFFAOYSA-N 4-[[(4-chlorophenyl)methyl-(2,2,2-trifluoroethyl)amino]methyl]aniline Chemical compound C1=CC(N)=CC=C1CN(CC(F)(F)F)CC1=CC=C(Cl)C=C1 VMAASPWSCKWFSL-UHFFFAOYSA-N 0.000 description 2
- WCPDBKPYDDPWON-UHFFFAOYSA-N 4-[[(4-fluorophenyl)methyl-methylamino]methyl]aniline Chemical compound C=1C=C(F)C=CC=1CN(C)CC1=CC=C(N)C=C1 WCPDBKPYDDPWON-UHFFFAOYSA-N 0.000 description 2
- XMGHHOUCKIUWSR-UHFFFAOYSA-N 4-[[(4-methoxyphenyl)methyl-methylamino]methyl]aniline Chemical compound C1=CC(OC)=CC=C1CN(C)CC1=CC=C(N)C=C1 XMGHHOUCKIUWSR-UHFFFAOYSA-N 0.000 description 2
- QDDURFNKOHELFA-ZROIWOOFSA-N 4-[[(z)-(6-methoxycarbonyl-2-oxo-1h-indol-3-ylidene)methyl]amino]benzoic acid Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C\NC1=CC=C(C(O)=O)C=C1 QDDURFNKOHELFA-ZROIWOOFSA-N 0.000 description 2
- PGAQDRVMUWMODC-UHFFFAOYSA-N 4-[[2-methoxyethyl(methyl)amino]methyl]aniline Chemical compound COCCN(C)CC1=CC=C(N)C=C1 PGAQDRVMUWMODC-UHFFFAOYSA-N 0.000 description 2
- IOESAUWQNGSZCZ-UHFFFAOYSA-N 4-[[cyclohexyl(2-phenylethyl)amino]methyl]aniline Chemical compound C1=CC(N)=CC=C1CN(C1CCCCC1)CCC1=CC=CC=C1 IOESAUWQNGSZCZ-UHFFFAOYSA-N 0.000 description 2
- ICHPLZRHVCLTGA-UHFFFAOYSA-N 4-[[di(propan-2-yl)amino]methyl]aniline Chemical compound CC(C)N(C(C)C)CC1=CC=C(N)C=C1 ICHPLZRHVCLTGA-UHFFFAOYSA-N 0.000 description 2
- JBOSIXUHCCUPHD-UHFFFAOYSA-N 4-[[ethyl(methyl)amino]methyl]aniline Chemical compound CCN(C)CC1=CC=C(N)C=C1 JBOSIXUHCCUPHD-UHFFFAOYSA-N 0.000 description 2
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 2
- UZARQBVTRHEUOB-UHFFFAOYSA-N 4-n-cyclohexylbenzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1CCCCC1 UZARQBVTRHEUOB-UHFFFAOYSA-N 0.000 description 2
- VOLRSQPSJGXRNJ-UHFFFAOYSA-N 4-nitrobenzyl bromide Chemical compound [O-][N+](=O)C1=CC=C(CBr)C=C1 VOLRSQPSJGXRNJ-UHFFFAOYSA-N 0.000 description 2
- QWNDJDHFFBXOSV-UHFFFAOYSA-N 4-o-benzyl 1-o-tert-butyl 4-propan-2-ylpiperidine-1,4-dicarboxylate Chemical compound C=1C=CC=CC=1COC(=O)C1(C(C)C)CCN(C(=O)OC(C)(C)C)CC1 QWNDJDHFFBXOSV-UHFFFAOYSA-N 0.000 description 2
- 125000001318 4-trifluoromethylbenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(F)(F)F 0.000 description 2
- AHJYIHQIEHOBBE-UHFFFAOYSA-N 5-[(4-aminophenyl)methyl]imidazolidine-2,4-dione Chemical compound C1=CC(N)=CC=C1CC1C(=O)NC(=O)N1 AHJYIHQIEHOBBE-UHFFFAOYSA-N 0.000 description 2
- IMAPIOUUBNVUNN-UHFFFAOYSA-N 6-chloro-2-[(4-nitrophenyl)methyl]-3,4-dihydro-1h-isoquinoline Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CC2=CC=C(Cl)C=C2CC1 IMAPIOUUBNVUNN-UHFFFAOYSA-N 0.000 description 2
- XREGRSISJVYLJS-UHFFFAOYSA-N 7,8-dichloro-3-[(4-nitrophenyl)methyl]-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCC2=CC(Cl)=C(Cl)C=C2CC1 XREGRSISJVYLJS-UHFFFAOYSA-N 0.000 description 2
- ANMNHEIGJGZANS-UHFFFAOYSA-N 7,8-dimethoxy-3-[(4-nitrophenyl)methyl]-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1CC=2C=C(OC)C(OC)=CC=2CCN1CC1=CC=C([N+]([O-])=O)C=C1 ANMNHEIGJGZANS-UHFFFAOYSA-N 0.000 description 2
- ADVLANGIOFOPHT-UHFFFAOYSA-N 7-chloro-3-[(4-nitrophenyl)methyl]-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCC2=CC(Cl)=CC=C2CC1 ADVLANGIOFOPHT-UHFFFAOYSA-N 0.000 description 2
- BIKYQTQUVHTIPL-UHFFFAOYSA-N 7-methoxy-3-[(4-nitrophenyl)methyl]-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1CC2=CC(OC)=CC=C2CCN1CC1=CC=C([N+]([O-])=O)C=C1 BIKYQTQUVHTIPL-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 2
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 2
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 2
- 108010025454 Cyclin-Dependent Kinase 5 Proteins 0.000 description 2
- 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 2
- 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 description 2
- 101710106279 Cyclin-dependent kinase 1 Proteins 0.000 description 2
- 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 2
- 102100036329 Cyclin-dependent kinase 3 Human genes 0.000 description 2
- 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 2
- 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 2
- 102100026810 Cyclin-dependent kinase 7 Human genes 0.000 description 2
- 102100024456 Cyclin-dependent kinase 8 Human genes 0.000 description 2
- 102100024457 Cyclin-dependent kinase 9 Human genes 0.000 description 2
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 2
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 2
- 102100026805 Cyclin-dependent-like kinase 5 Human genes 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 2
- 101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 2
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 2
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 102100022623 Hepatocyte growth factor receptor Human genes 0.000 description 2
- 101000715946 Homo sapiens Cyclin-dependent kinase 3 Proteins 0.000 description 2
- 101000911952 Homo sapiens Cyclin-dependent kinase 7 Proteins 0.000 description 2
- 101000980937 Homo sapiens Cyclin-dependent kinase 8 Proteins 0.000 description 2
- 101000980930 Homo sapiens Cyclin-dependent kinase 9 Proteins 0.000 description 2
- 101000972946 Homo sapiens Hepatocyte growth factor receptor Proteins 0.000 description 2
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 2
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 125000003047 N-acetyl group Chemical group 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 206010029113 Neovascularisation Diseases 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- YQSKYNRXSXYPGI-QPLCGJKRSA-N O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCNC(C)=O)C=C1 Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCNC(C)=O)C=C1 YQSKYNRXSXYPGI-QPLCGJKRSA-N 0.000 description 2
- OCCPFUVVASGXMK-UHFFFAOYSA-N O=S1CCN(CC1)CC1=CC=C(N)C=C1.S1CCN(CC1)CC1=CC=C(N)C=C1 Chemical compound O=S1CCN(CC1)CC1=CC=C(N)C=C1.S1CCN(CC1)CC1=CC=C(N)C=C1 OCCPFUVVASGXMK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 2
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical group OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
- 239000012024 dehydrating agents Substances 0.000 description 2
- 229960004132 diethyl ether Drugs 0.000 description 2
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 2
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 2
- WJWAIQVEXSMNLI-IZHYLOQSSA-N ethyl (3z)-2-oxo-3-[phenyl-[4-(1,2,4-triazol-1-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1C=NC=N1 WJWAIQVEXSMNLI-IZHYLOQSSA-N 0.000 description 2
- GMRUCQGFMCXZCE-IZHYLOQSSA-N ethyl (3z)-2-oxo-3-[phenyl-[4-(triazol-1-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1C=CN=N1 GMRUCQGFMCXZCE-IZHYLOQSSA-N 0.000 description 2
- PXQKFKVOLJRXCJ-IZHYLOQSSA-N ethyl (3z)-2-oxo-3-[phenyl-[4-(triazol-2-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1N=CC=N1 PXQKFKVOLJRXCJ-IZHYLOQSSA-N 0.000 description 2
- MQFMJUAKVIHGAP-DQRAZIAOSA-N ethyl (3z)-3-[(4-bromoanilino)-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(Br)C=C1 MQFMJUAKVIHGAP-DQRAZIAOSA-N 0.000 description 2
- TZJRNTBXNYWUCH-IZHYLOQSSA-N ethyl (3z)-3-[[3-bromo-4-[(dimethylamino)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C)C)C(Br)=C1 TZJRNTBXNYWUCH-IZHYLOQSSA-N 0.000 description 2
- GCYBFBVHWMONRI-IZHYLOQSSA-N ethyl (3z)-3-[[3-chloro-4-[(dimethylamino)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C)C)C(Cl)=C1 GCYBFBVHWMONRI-IZHYLOQSSA-N 0.000 description 2
- AMXWKHKQGZBFAX-QPLCGJKRSA-N ethyl (3z)-3-[[4-(1-amino-3-methoxypropyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCOC)C=C1 AMXWKHKQGZBFAX-QPLCGJKRSA-N 0.000 description 2
- ANZDFYNJBOYQLG-IZHYLOQSSA-N ethyl (3z)-3-[[4-(1-methylimidazol-2-yl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1C1=NC=CN1C ANZDFYNJBOYQLG-IZHYLOQSSA-N 0.000 description 2
- MHUTVSIFRZJXLY-VHXPQNKSSA-N ethyl (3z)-3-[[4-(1h-imidazol-2-yl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1C1=NC=CN1 MHUTVSIFRZJXLY-VHXPQNKSSA-N 0.000 description 2
- MQSZSNUWQIYNCH-RQZHXJHFSA-N ethyl (3z)-3-[[4-(3-acetamido-1-aminopropyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCNC(C)=O)C=C1 MQSZSNUWQIYNCH-RQZHXJHFSA-N 0.000 description 2
- BSENHRCAKJZRCG-DQSJHHFOSA-N ethyl (3z)-3-[[4-(4-acetamido-1-aminobutyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCCNC(C)=O)C=C1 BSENHRCAKJZRCG-DQSJHHFOSA-N 0.000 description 2
- BOCNHONOUCJBRT-DQSJHHFOSA-N ethyl (3z)-3-[[4-(cyclohexanecarbonyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1C(=O)C1CCCCC1 BOCNHONOUCJBRT-DQSJHHFOSA-N 0.000 description 2
- XZMSFBYAWRFVKO-RQZHXJHFSA-N ethyl (3z)-3-[[4-(diethylaminomethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(CC)CC)C=C1 XZMSFBYAWRFVKO-RQZHXJHFSA-N 0.000 description 2
- PXEKBKUCLHQUIM-IZHYLOQSSA-N ethyl (3z)-3-[[4-[(dimethylamino)methyl]-3-fluoroanilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C)C)C(F)=C1 PXEKBKUCLHQUIM-IZHYLOQSSA-N 0.000 description 2
- FZYJUDWSHZQXIT-IZHYLOQSSA-N ethyl (3z)-3-[[4-[(dimethylamino)methyl]-3-nitroanilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C)C)C([N+]([O-])=O)=C1 FZYJUDWSHZQXIT-IZHYLOQSSA-N 0.000 description 2
- MYWHXBKARBNDFR-RQZHXJHFSA-N ethyl (3z)-3-[[4-[1-amino-3-(dimethylamino)propyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCN(C)C)C=C1 MYWHXBKARBNDFR-RQZHXJHFSA-N 0.000 description 2
- UHKVEGYQVGJASB-ZIADKAODSA-N ethyl (3z)-3-[[4-[2-(4-hydroxypiperidin-1-yl)ethyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CCN1CCC(O)CC1 UHKVEGYQVGJASB-ZIADKAODSA-N 0.000 description 2
- BKWXEEZBTJQHOJ-FLWNBWAVSA-N ethyl (3z)-3-[[4-[2-(dimethylamino)ethyl-(furan-2-carbonyl)amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(CCN(C)C)C(=O)C1=CC=CO1 BKWXEEZBTJQHOJ-FLWNBWAVSA-N 0.000 description 2
- VBFXBZFGKXGHNQ-KTMFPKCZSA-N ethyl (3z)-3-[[4-[2-(dimethylamino)ethyl-(pyridine-3-carbonyl)amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(CCN(C)C)C(=O)C1=CC=CN=C1 VBFXBZFGKXGHNQ-KTMFPKCZSA-N 0.000 description 2
- JZGMCNWSYULLGN-YHZPTAEISA-N ethyl (3z)-3-[[4-[3-[benzyl(methyl)amino]propanoyl-methylamino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(C)C(=O)CCN(C)CC1=CC=CC=C1 JZGMCNWSYULLGN-YHZPTAEISA-N 0.000 description 2
- MJUKTKWSJVXXJB-ZIADKAODSA-N ethyl (3z)-3-[[4-[[bis(2-methoxyethyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(CCOC)CCOC)C=C1 MJUKTKWSJVXXJB-ZIADKAODSA-N 0.000 description 2
- ZQWXMEXHUFYHHO-FLWNBWAVSA-N ethyl (3z)-3-[[4-[[hexyl(methyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound C1=CC(CN(C)CCCCCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(=O)OCC)C=C2NC\1=O ZQWXMEXHUFYHHO-FLWNBWAVSA-N 0.000 description 2
- FMOOGDDUNYSNGV-MVJHLKBCSA-N ethyl (3z)-3-[[4-[benzoyl-[2-(dimethylamino)ethyl]amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(CCN(C)C)C(=O)C1=CC=CC=C1 FMOOGDDUNYSNGV-MVJHLKBCSA-N 0.000 description 2
- UVUDNJXFMOTJFN-UHFFFAOYSA-N ethyl 1-[(4-aminophenyl)methyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1CC1=CC=C(N)C=C1 UVUDNJXFMOTJFN-UHFFFAOYSA-N 0.000 description 2
- MHZBFRDOUGJKFL-UHFFFAOYSA-N ethyl 2-[methyl-[(4-nitrophenyl)methyl]amino]acetate Chemical compound CCOC(=O)CN(C)CC1=CC=C([N+]([O-])=O)C=C1 MHZBFRDOUGJKFL-UHFFFAOYSA-N 0.000 description 2
- JLXBWVAKVCYKNB-UHFFFAOYSA-N ethyl 4-(2-methoxy-2-oxoethyl)-3-nitrobenzoate Chemical compound CCOC(=O)C1=CC=C(CC(=O)OC)C([N+]([O-])=O)=C1 JLXBWVAKVCYKNB-UHFFFAOYSA-N 0.000 description 2
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 201000011066 hemangioma Diseases 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 2
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- QXUAFCKBYYPTPQ-ZWKAXHIPSA-L magnesium (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol octadecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O QXUAFCKBYYPTPQ-ZWKAXHIPSA-L 0.000 description 2
- FTWGZBDWDBQXAG-MRCUWXFGSA-N methyl (3z)-2-oxo-3-[phenyl-[4-(trifluoromethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(F)(F)F)C=C1 FTWGZBDWDBQXAG-MRCUWXFGSA-N 0.000 description 2
- WLLXCGQUQRIENQ-MRCUWXFGSA-N methyl (3z)-3-[(4-fluoroanilino)-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(F)C=C1 WLLXCGQUQRIENQ-MRCUWXFGSA-N 0.000 description 2
- UQAMDWYLNNWLHK-MRCUWXFGSA-N methyl (3z)-3-[(4-nitroanilino)-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C([N+]([O-])=O)C=C1 UQAMDWYLNNWLHK-MRCUWXFGSA-N 0.000 description 2
- MWJRDTKUARDNNO-XHPQRKPJSA-N methyl (3z)-3-[1-[4-[[methyl(2-phenylethyl)amino]methyl]anilino]ethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(/C)NC(C=C1)=CC=C1CN(C)CCC1=CC=CC=C1 MWJRDTKUARDNNO-XHPQRKPJSA-N 0.000 description 2
- OOEHKUUOXWVMEJ-BZZOAKBMSA-N methyl (3z)-3-[1-[4-[acetyl-[3-(dimethylamino)propyl]amino]anilino]butylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C/1NC2=CC(C(=O)OC)=CC=C2C\1=C(/CCC)NC1=CC=C(N(CCCN(C)C)C(C)=O)C=C1 OOEHKUUOXWVMEJ-BZZOAKBMSA-N 0.000 description 2
- UTTXPPZWDJPHNM-GYHWCHFESA-N methyl (3z)-3-[1-[4-[acetyl-[3-(dimethylamino)propyl]amino]anilino]propylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C/1NC2=CC(C(=O)OC)=CC=C2C\1=C(/CC)NC1=CC=C(N(CCCN(C)C)C(C)=O)C=C1 UTTXPPZWDJPHNM-GYHWCHFESA-N 0.000 description 2
- HPNQZONFUXLKDA-VHXPQNKSSA-N methyl (3z)-3-[[3-chloro-4-[(dimethylamino)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C)C)C(Cl)=C1 HPNQZONFUXLKDA-VHXPQNKSSA-N 0.000 description 2
- CSMAMMGWSPPCFM-VHXPQNKSSA-N methyl (3z)-3-[[4-(1,3-diaminopropyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCN)C=C1 CSMAMMGWSPPCFM-VHXPQNKSSA-N 0.000 description 2
- SWAVLWARVHHEJM-QPLCGJKRSA-N methyl (3z)-3-[[4-(1-amino-3-ethoxy-3-oxopropyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound C1=CC(C(N)CC(=O)OCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(=O)OC)C=C2NC\1=O SWAVLWARVHHEJM-QPLCGJKRSA-N 0.000 description 2
- IKNSSCDVQASFBP-VHXPQNKSSA-N methyl (3z)-3-[[4-(1-amino-3-hydroxypropyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCO)C=C1 IKNSSCDVQASFBP-VHXPQNKSSA-N 0.000 description 2
- QYUVQENLWCRKLV-VHXPQNKSSA-N methyl (3z)-3-[[4-(1h-imidazol-5-yl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1C1=CNC=N1 QYUVQENLWCRKLV-VHXPQNKSSA-N 0.000 description 2
- DOOGGJTZJJJMTJ-FCQUAONHSA-N methyl (3z)-3-[[4-(2-amino-2-oxoethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CC(N)=O)C=C1 DOOGGJTZJJJMTJ-FCQUAONHSA-N 0.000 description 2
- ZRVRRMHTQYERBN-RQZHXJHFSA-N methyl (3z)-3-[[4-(4-acetamido-1-aminobutyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCCNC(C)=O)C=C1 ZRVRRMHTQYERBN-RQZHXJHFSA-N 0.000 description 2
- NQFDXCBVWXJEFE-IZHYLOQSSA-N methyl (3z)-3-[[4-[(dimethylamino)methyl]-3-methylanilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C)C)C(C)=C1 NQFDXCBVWXJEFE-IZHYLOQSSA-N 0.000 description 2
- POJVTYBLLXHLQL-QPLCGJKRSA-N methyl (3z)-3-[[4-[1-amino-3-(dimethylamino)propyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCN(C)C)C=C1 POJVTYBLLXHLQL-QPLCGJKRSA-N 0.000 description 2
- HMOGURSRJGPJER-RQZHXJHFSA-N methyl (3z)-3-[[4-[2-(diethylamino)ethyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound C1=CC(CCN(CC)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(=O)OC)C=C2NC\1=O HMOGURSRJGPJER-RQZHXJHFSA-N 0.000 description 2
- YPCNHVIKYWKTMT-IZHYLOQSSA-N methyl (3z)-3-[[4-[2-(dimethylamino)-2-oxoethyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CC(=O)N(C)C)C=C1 YPCNHVIKYWKTMT-IZHYLOQSSA-N 0.000 description 2
- UDRYCALAFSXOJU-IZHYLOQSSA-N methyl (3z)-3-[[4-[2-(dimethylamino)ethoxy]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(OCCN(C)C)C=C1 UDRYCALAFSXOJU-IZHYLOQSSA-N 0.000 description 2
- FGWGAUNAIRDVBK-IZHYLOQSSA-N methyl (3z)-3-[[4-[2-(ethylamino)ethyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound C1=CC(CCNCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(=O)OC)C=C2NC\1=O FGWGAUNAIRDVBK-IZHYLOQSSA-N 0.000 description 2
- VBLVPTZXOOSQHZ-QPLCGJKRSA-N methyl (3z)-3-[[4-[[2-(dimethylamino)acetyl]-methylamino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(N(C)C(=O)CN(C)C)C=C1 VBLVPTZXOOSQHZ-QPLCGJKRSA-N 0.000 description 2
- FKSICKKKGOVLIS-RQZHXJHFSA-N methyl (3z)-3-[[4-[[2-acetamidoethyl(methyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C)CCNC(C)=O)C=C1 FKSICKKKGOVLIS-RQZHXJHFSA-N 0.000 description 2
- RIJRLDYGGPGPOI-IZHYLOQSSA-N methyl (3z)-3-[[4-[[2-aminoethyl(methyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C)CCN)C=C1 RIJRLDYGGPGPOI-IZHYLOQSSA-N 0.000 description 2
- QFDIOUCLNGGUQP-QPLCGJKRSA-N methyl (3z)-3-[[4-[[2-methoxyethyl(methyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound C1=CC(CN(C)CCOC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(=O)OC)C=C2NC\1=O QFDIOUCLNGGUQP-QPLCGJKRSA-N 0.000 description 2
- VGFCLVZQGXFUBP-FLWNBWAVSA-N methyl (3z)-3-[[4-[[benzyl(methyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN(C)CC1=CC=CC=C1 VGFCLVZQGXFUBP-FLWNBWAVSA-N 0.000 description 2
- FQHSDNRZQHBVIC-DQSJHHFOSA-N methyl (3z)-3-[[4-[[di(propan-2-yl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C(C)C)C(C)C)C=C1 FQHSDNRZQHBVIC-DQSJHHFOSA-N 0.000 description 2
- HHZUYGKJQCTQLM-VHXPQNKSSA-N methyl (3z)-3-[[4-[acetyl(methyl)amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(N(C)C(C)=O)C=C1 HHZUYGKJQCTQLM-VHXPQNKSSA-N 0.000 description 2
- LMDQFDUMUTWWMV-DQRAZIAOSA-N methyl (3z)-3-[[4-[carbamoyl(methyl)amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(N(C)C(N)=O)C=C1 LMDQFDUMUTWWMV-DQRAZIAOSA-N 0.000 description 2
- QQJODNJZFHWZML-RQZHXJHFSA-N methyl (3z)-3-[[4-[methyl(piperidine-1-carbonyl)amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(C)C(=O)N1CCCCC1 QQJODNJZFHWZML-RQZHXJHFSA-N 0.000 description 2
- UPIPYQJPCHOZNY-UHFFFAOYSA-N methyl 1-[(4-aminophenyl)methyl]pyrrolidine-2-carboxylate Chemical compound COC(=O)C1CCCN1CC1=CC=C(N)C=C1 UPIPYQJPCHOZNY-UHFFFAOYSA-N 0.000 description 2
- DCDSLKRPXTVJSA-UHFFFAOYSA-N methyl 4-(2-methoxy-2-oxoethyl)-3-nitrobenzoate Chemical compound COC(=O)CC1=CC=C(C(=O)OC)C=C1[N+]([O-])=O DCDSLKRPXTVJSA-UHFFFAOYSA-N 0.000 description 2
- LZXXNPOYQCLXRS-UHFFFAOYSA-N methyl 4-aminobenzoate Chemical compound COC(=O)C1=CC=C(N)C=C1 LZXXNPOYQCLXRS-UHFFFAOYSA-N 0.000 description 2
- JLKRJHPQNYVSGM-UHFFFAOYSA-N methyl-(4-nitro-benzyl)-amine Chemical compound CNCC1=CC=C([N+]([O-])=O)C=C1 JLKRJHPQNYVSGM-UHFFFAOYSA-N 0.000 description 2
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- BFUKNKGBMCOSDK-UHFFFAOYSA-N n'-[(4-aminophenyl)methyl]-n,n,n'-trimethylethane-1,2-diamine Chemical compound CN(C)CCN(C)CC1=CC=C(N)C=C1 BFUKNKGBMCOSDK-UHFFFAOYSA-N 0.000 description 2
- ULDAXJQZJVUOJL-UHFFFAOYSA-N n'-[(4-aminophenyl)methyl]-n,n,n'-trimethylpropane-1,3-diamine Chemical compound CN(C)CCCN(C)CC1=CC=C(N)C=C1 ULDAXJQZJVUOJL-UHFFFAOYSA-N 0.000 description 2
- XUPVXKLPNVKACM-UHFFFAOYSA-N n-(2,4-dinitrophenyl)-n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCNC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O XUPVXKLPNVKACM-UHFFFAOYSA-N 0.000 description 2
- XRPDHTCDLNAIAX-UHFFFAOYSA-N n-(4-aminophenyl)-2-[2-methoxyethyl(methyl)amino]-n-methylacetamide Chemical compound COCCN(C)CC(=O)N(C)C1=CC=C(N)C=C1 XRPDHTCDLNAIAX-UHFFFAOYSA-N 0.000 description 2
- TXCOFUNEYLUKHR-UHFFFAOYSA-N n-(4-aminophenyl)-n-[2-(dimethylamino)ethyl]methanesulfonamide Chemical compound CN(C)CCN(S(C)(=O)=O)C1=CC=C(N)C=C1 TXCOFUNEYLUKHR-UHFFFAOYSA-N 0.000 description 2
- QFELUFGHFLYZEZ-UHFFFAOYSA-N n-(4-aminophenyl)-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC=C(N)C=C1 QFELUFGHFLYZEZ-UHFFFAOYSA-N 0.000 description 2
- CRBKFFVPLITHLR-UHFFFAOYSA-N n-[(4-nitrophenyl)methyl]ethanamine Chemical compound CCNCC1=CC=C([N+]([O-])=O)C=C1 CRBKFFVPLITHLR-UHFFFAOYSA-N 0.000 description 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 2
- QBSRKOBMKFOHOS-UHFFFAOYSA-N n-benzyl-4-nitroaniline Chemical compound C1=CC([N+](=O)[O-])=CC=C1NCC1=CC=CC=C1 QBSRKOBMKFOHOS-UHFFFAOYSA-N 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 150000004965 peroxy acids Chemical class 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 2
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- KYORUZMJUKHKFS-UHFFFAOYSA-N tert-butyl 4-aminobenzoate Chemical compound CC(C)(C)OC(=O)C1=CC=C(N)C=C1 KYORUZMJUKHKFS-UHFFFAOYSA-N 0.000 description 2
- LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- CWLNAJYDRSIKJS-UHFFFAOYSA-N triethoxymethoxyethane Chemical compound CCOC(OCC)(OCC)OCC CWLNAJYDRSIKJS-UHFFFAOYSA-N 0.000 description 2
- 239000005051 trimethylchlorosilane Substances 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- XANSQISSCAUCNJ-XGRJIHFXSA-N (3z)-2-oxo-3-[1-[4-(piperidin-1-ylmethyl)anilino]ethylidene]-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.O=C/1NC2=CC(C(N)=O)=CC=C2C\1=C(/C)NC(C=C1)=CC=C1CN1CCCCC1 XANSQISSCAUCNJ-XGRJIHFXSA-N 0.000 description 1
- DZZALUFSPSNECS-BJFQDICYSA-N (3z)-2-oxo-3-[[4-[(1-oxo-1,4-thiazinan-4-yl)methyl]anilino]-phenylmethylidene]-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.O=C1NC2=CC(C(=O)N)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCS(=O)CC1 DZZALUFSPSNECS-BJFQDICYSA-N 0.000 description 1
- UXXBTWWHJZYHMU-OQKDUQJOSA-N (3z)-2-oxo-3-[phenyl-[3-(piperidin-1-ylmethyl)anilino]methylidene]-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.O=C1NC2=CC(C(=O)N)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=1)=CC=CC=1CN1CCCCC1 UXXBTWWHJZYHMU-OQKDUQJOSA-N 0.000 description 1
- CWRTUAIHJLRNEN-QXMHVHEDSA-N (3z)-3-(1-methoxybutylidene)-2-oxo-1h-indole-6-carboxamide Chemical compound NC(=O)C1=CC=C2C(=C(OC)/CCC)\C(=O)NC2=C1 CWRTUAIHJLRNEN-QXMHVHEDSA-N 0.000 description 1
- CGEBWRUDIUVNPM-POHAHGRESA-N (3z)-3-(1-methoxyethylidene)-2-oxo-1h-indole-6-carboxamide Chemical compound NC(=O)C1=CC=C2C(=C(C)/OC)/C(=O)NC2=C1 CGEBWRUDIUVNPM-POHAHGRESA-N 0.000 description 1
- NVQYWAASJWVQFP-KHPPLWFESA-N (3z)-3-(1-methoxypropylidene)-2-oxo-1h-indole-6-carboxamide Chemical compound NC(=O)C1=CC=C2C(=C(OC)/CC)\C(=O)NC2=C1 NVQYWAASJWVQFP-KHPPLWFESA-N 0.000 description 1
- HYGMZQCLFYYMRK-TWGQIWQCSA-N (3z)-3-(ethoxymethylidene)-2-oxo-1h-indole-6-carboxamide Chemical compound NC(=O)C1=CC=C2C(=C/OCC)/C(=O)NC2=C1 HYGMZQCLFYYMRK-TWGQIWQCSA-N 0.000 description 1
- MFSPBTTUZBSNHH-DQRAZIAOSA-N (3z)-3-[(3,4-dimethoxyanilino)-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide Chemical compound C1=C(OC)C(OC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(N)=O)C=C2NC\1=O MFSPBTTUZBSNHH-DQRAZIAOSA-N 0.000 description 1
- RUVDNWVIIVCGIZ-DQRAZIAOSA-N (3z)-3-[(4-acetamidoanilino)-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(N)=O)C=C2NC\1=O RUVDNWVIIVCGIZ-DQRAZIAOSA-N 0.000 description 1
- STGZYKXKQMHPIQ-VXPUYCOJSA-N (3z)-3-[(4-bromoanilino)-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide Chemical compound O=C1NC2=CC(C(=O)N)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(Br)C=C1 STGZYKXKQMHPIQ-VXPUYCOJSA-N 0.000 description 1
- NJLNRXVIZXICAC-ICFOKQHNSA-N (3z)-3-[1-(3-chloroanilino)butylidene]-2-oxo-1h-indole-6-carboxamide Chemical compound O=C/1NC2=CC(C(N)=O)=CC=C2C\1=C(/CCC)NC1=CC=CC(Cl)=C1 NJLNRXVIZXICAC-ICFOKQHNSA-N 0.000 description 1
- BQDWMSQCELZAOX-SDXDJHTJSA-N (3z)-3-[1-(4-methyl-3-nitroanilino)butylidene]-2-oxo-1h-indole-6-carboxamide Chemical compound O=C/1NC2=CC(C(N)=O)=CC=C2C\1=C(/CCC)NC1=CC=C(C)C([N+]([O-])=O)=C1 BQDWMSQCELZAOX-SDXDJHTJSA-N 0.000 description 1
- KCHQPHRUDYPPDC-YBEGLDIGSA-N (3z)-3-[1-(4-methyl-3-nitroanilino)ethylidene]-2-oxo-1h-indole-6-carboxamide Chemical compound O=C/1NC2=CC(C(N)=O)=CC=C2C\1=C(/C)NC1=CC=C(C)C([N+]([O-])=O)=C1 KCHQPHRUDYPPDC-YBEGLDIGSA-N 0.000 description 1
- NUAYSEFEVGDTBE-GQQUDWLYSA-N (3z)-3-[1-[3-[(dimethylamino)methyl]anilino]butylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.O=C/1NC2=CC(C(N)=O)=CC=C2C\1=C(/CCC)NC1=CC=CC(CN(C)C)=C1 NUAYSEFEVGDTBE-GQQUDWLYSA-N 0.000 description 1
- AYTABIZDRYENTE-BLTQDSCZSA-N (3z)-3-[[(4-aminocyclohexyl)amino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1CC(N)CCC1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(N)=O)C=C2NC\1=O AYTABIZDRYENTE-BLTQDSCZSA-N 0.000 description 1
- GCCGOQAXJVLUGQ-BJFQDICYSA-N (3z)-3-[[3-(butylaminomethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCCCNCC1=CC=CC(N\C(=C/2C3=CC=C(C=C3NC\2=O)C(N)=O)C=2C=CC=CC=2)=C1 GCCGOQAXJVLUGQ-BJFQDICYSA-N 0.000 description 1
- ZJJNJSYFKVAZSN-BJFQDICYSA-N (3z)-3-[[3-(diethylaminomethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCN(CC)CC1=CC=CC(N\C(=C/2C3=CC=C(C=C3NC\2=O)C(N)=O)C=2C=CC=CC=2)=C1 ZJJNJSYFKVAZSN-BJFQDICYSA-N 0.000 description 1
- ZXZHUUQSESEPMV-YJACDMIVSA-N (3z)-3-[[3-[(dimethylamino)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CN(C)CC1=CC=CC(N\C(=C/2C3=CC=C(C=C3NC\2=O)C(N)=O)C=2C=CC=CC=2)=C1 ZXZHUUQSESEPMV-YJACDMIVSA-N 0.000 description 1
- DWBVFNAPFCMTPY-FJBFXRHMSA-N (3z)-3-[[3-[[benzyl(methyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=CC(N\C(=C/2C3=CC=C(C=C3NC\2=O)C(N)=O)C=2C=CC=CC=2)=CC=1CN(C)CC1=CC=CC=C1 DWBVFNAPFCMTPY-FJBFXRHMSA-N 0.000 description 1
- NDYLHUSPGSRONK-DCXSSQDFSA-N (3z)-3-[[3-[[ethyl(methyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCN(C)CC1=CC=CC(N\C(=C/2C3=CC=C(C=C3NC\2=O)C(N)=O)C=2C=CC=CC=2)=C1 NDYLHUSPGSRONK-DCXSSQDFSA-N 0.000 description 1
- ZQYUKIYTSKOCMS-CFRCJOIHSA-N (3z)-3-[[4-(aminomethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(CN)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(N)=O)C=C2NC\1=O ZQYUKIYTSKOCMS-CFRCJOIHSA-N 0.000 description 1
- MDDBUDHICHFOMF-FCQUAONHSA-N (3z)-3-[[4-(ethylaminomethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide Chemical compound C1=CC(CNCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(N)=O)C=C2NC\1=O MDDBUDHICHFOMF-FCQUAONHSA-N 0.000 description 1
- XZTQRRXQBQIJOA-LXCLTORNSA-N (3z)-3-[[4-[(2,6-dimethylpiperidin-1-yl)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1CCCC(C)N1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(N)=O)C=C2NC\1=O XZTQRRXQBQIJOA-LXCLTORNSA-N 0.000 description 1
- UELLJIISDFYUFO-LXCLTORNSA-N (3z)-3-[[4-[(benzylamino)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.O=C1NC2=CC(C(=O)N)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CNCC1=CC=CC=C1 UELLJIISDFYUFO-LXCLTORNSA-N 0.000 description 1
- QGOCRBIHJCALBD-OQKDUQJOSA-N (3z)-3-[[4-[2-(diethylamino)ethyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(CCN(CC)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(N)=O)C=C2NC\1=O QGOCRBIHJCALBD-OQKDUQJOSA-N 0.000 description 1
- DWXRNHNROVHHLU-IZHYLOQSSA-N (3z)-3-[[4-[[2-(dimethylamino)-2-oxoethyl]-methylsulfonylamino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide Chemical compound C1=CC(N(CC(=O)N(C)C)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(N)=O)C=C2NC\1=O DWXRNHNROVHHLU-IZHYLOQSSA-N 0.000 description 1
- KIWYPZHZKFZAOD-BLTQDSCZSA-N (3z)-3-[[methyl(piperidin-4-yl)amino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.O=C\1NC2=CC(C(N)=O)=CC=C2C/1=C(\C=1C=CC=CC=1)N(C)C1CCNCC1 KIWYPZHZKFZAOD-BLTQDSCZSA-N 0.000 description 1
- WRLXHEXXAWYKKR-VXPUYCOJSA-N (3z)-3-[anilino(phenyl)methylidene]-2-oxo-1h-indole-6-carboxamide Chemical compound O=C1NC2=CC(C(=O)N)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=CC=C1 WRLXHEXXAWYKKR-VXPUYCOJSA-N 0.000 description 1
- OCKDZALQQIYASP-UHFFFAOYSA-N (4-aminophenyl)-cyclohexylmethanone Chemical compound C1=CC(N)=CC=C1C(=O)C1CCCCC1 OCKDZALQQIYASP-UHFFFAOYSA-N 0.000 description 1
- 125000006597 (C1-C3) alkylcarbonylamino group Chemical group 0.000 description 1
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 description 1
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- FGWYWKIOMUZSQF-UHFFFAOYSA-N 1,1,1-triethoxypropane Chemical compound CCOC(CC)(OCC)OCC FGWYWKIOMUZSQF-UHFFFAOYSA-N 0.000 description 1
- JAFMOTJMRSZOJE-UHFFFAOYSA-N 1,1,1-trimethoxybutane Chemical compound CCCC(OC)(OC)OC JAFMOTJMRSZOJE-UHFFFAOYSA-N 0.000 description 1
- ZGMNAIODRDOMEK-UHFFFAOYSA-N 1,1,1-trimethoxypropane Chemical compound CCC(OC)(OC)OC ZGMNAIODRDOMEK-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- JIQXRLOYKOJECL-UHFFFAOYSA-N 1-(2-chloroethoxy)-2-methoxyethane Chemical compound COCCOCCCl JIQXRLOYKOJECL-UHFFFAOYSA-N 0.000 description 1
- PAMJENUKCYUKLC-UHFFFAOYSA-N 1-(4-nitrobenzyl)piperidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCCCC1 PAMJENUKCYUKLC-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- JOGOYJJLWNKJIV-UHFFFAOYSA-N 1-[(4-aminophenyl)methyl]-4-phenylpiperidin-4-ol Chemical compound C1=CC(N)=CC=C1CN1CCC(O)(C=2C=CC=CC=2)CC1 JOGOYJJLWNKJIV-UHFFFAOYSA-N 0.000 description 1
- KUYFWCXOOQDMEN-UHFFFAOYSA-N 1-[(4-nitrophenyl)methyl]-4-propan-2-ylpiperidine Chemical compound C1CC(C(C)C)CCN1CC1=CC=C([N+]([O-])=O)C=C1 KUYFWCXOOQDMEN-UHFFFAOYSA-N 0.000 description 1
- AORADOSMPZNEAL-UHFFFAOYSA-N 1-[(4-nitrophenyl)methyl]azepane Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCCCCC1 AORADOSMPZNEAL-UHFFFAOYSA-N 0.000 description 1
- GJERFMGMGRLRMD-UHFFFAOYSA-N 1-[(4-nitrophenyl)methyl]piperidin-4-ol Chemical compound C1CC(O)CCN1CC1=CC=C([N+]([O-])=O)C=C1 GJERFMGMGRLRMD-UHFFFAOYSA-N 0.000 description 1
- IRARVWPSVFZRLD-UHFFFAOYSA-N 1-[(4-nitrophenyl)methyl]triazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1N=NC=C1 IRARVWPSVFZRLD-UHFFFAOYSA-N 0.000 description 1
- FWIROFMBWVMWLB-UHFFFAOYSA-N 1-bromo-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(Br)=C1 FWIROFMBWVMWLB-UHFFFAOYSA-N 0.000 description 1
- 125000006219 1-ethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- RDCCHZDFNPOUQA-UHFFFAOYSA-N 1-methyl-2-(4-nitrophenyl)imidazole Chemical compound CN1C=CN=C1C1=CC=C([N+]([O-])=O)C=C1 RDCCHZDFNPOUQA-UHFFFAOYSA-N 0.000 description 1
- GZNDUKANJZIZOT-UHFFFAOYSA-N 1-methyl-4-(4-nitrophenyl)piperazine Chemical compound C1CN(C)CCN1C1=CC=C([N+]([O-])=O)C=C1 GZNDUKANJZIZOT-UHFFFAOYSA-N 0.000 description 1
- YBAFUECIAIDBIK-UHFFFAOYSA-N 2,2,2-trifluoro-n-[3-(n-methylsulfonyl-4-nitroanilino)propyl]acetamide Chemical compound FC(F)(F)C(=O)NCCCN(S(=O)(=O)C)C1=CC=C([N+]([O-])=O)C=C1 YBAFUECIAIDBIK-UHFFFAOYSA-N 0.000 description 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- LNSCNEJNLACZPA-UHFFFAOYSA-N 2,3-dihydroxy-2,3-bis(2-methylphenyl)butanedioic acid Chemical compound CC1=CC=CC=C1C(O)(C(O)=O)C(O)(C(O)=O)C1=CC=CC=C1C LNSCNEJNLACZPA-UHFFFAOYSA-N 0.000 description 1
- QUDBYWGIBPAZPB-UHFFFAOYSA-N 2-(2-methoxyethoxy)-n-methyl-n-[(4-nitrophenyl)methyl]ethanamine Chemical compound COCCOCCN(C)CC1=CC=C([N+]([O-])=O)C=C1 QUDBYWGIBPAZPB-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- CPSYGOZEUMFUCY-UHFFFAOYSA-N 2-(4-amino-n-methylsulfonylanilino)-n,n-dimethylacetamide Chemical compound CN(C)C(=O)CN(S(C)(=O)=O)C1=CC=C(N)C=C1 CPSYGOZEUMFUCY-UHFFFAOYSA-N 0.000 description 1
- BBTDQMDPCDWZDD-UHFFFAOYSA-N 2-(4-amino-n-methylsulfonylanilino)-n-methylacetamide Chemical compound CNC(=O)CN(S(C)(=O)=O)C1=CC=C(N)C=C1 BBTDQMDPCDWZDD-UHFFFAOYSA-N 0.000 description 1
- MTRZHSVFAGKMOA-UHFFFAOYSA-N 2-(4-nitroanilino)acetic acid Chemical compound OC(=O)CNC1=CC=C([N+]([O-])=O)C=C1 MTRZHSVFAGKMOA-UHFFFAOYSA-N 0.000 description 1
- IUEMKDAPEKIADT-UHFFFAOYSA-N 2-(dimethylamino)-n-methyl-n-(4-nitrophenyl)acetamide Chemical compound CN(C)CC(=O)N(C)C1=CC=C([N+]([O-])=O)C=C1 IUEMKDAPEKIADT-UHFFFAOYSA-N 0.000 description 1
- MPUHOVAVZQKRAW-UHFFFAOYSA-N 2-[(4-nitrophenyl)methyl]triazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1N=CC=N1 MPUHOVAVZQKRAW-UHFFFAOYSA-N 0.000 description 1
- ZDAMIXCINGRPSA-UHFFFAOYSA-N 2-amino-4-hydroxy-2-(2-hydroxyethyl)-n-methyl-n-(4-nitrophenyl)butanamide Chemical compound OCCC(N)(CCO)C(=O)N(C)C1=CC=C([N+]([O-])=O)C=C1 ZDAMIXCINGRPSA-UHFFFAOYSA-N 0.000 description 1
- LMRPYWDMPZSLDR-UHFFFAOYSA-N 2-amino-n-(4-aminophenyl)-4-methoxy-2-(2-methoxyethyl)-n-methylbutanamide Chemical compound COCCC(N)(CCOC)C(=O)N(C)C1=CC=C(N)C=C1 LMRPYWDMPZSLDR-UHFFFAOYSA-N 0.000 description 1
- KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 1
- FAWMTDSAMOCUAR-UHFFFAOYSA-N 2-bromo-1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C(Br)=C1 FAWMTDSAMOCUAR-UHFFFAOYSA-N 0.000 description 1
- XCXMDDMTHUCBCB-UHFFFAOYSA-N 2-bromo-n-(4-nitrophenyl)-n-propan-2-ylacetamide Chemical compound BrCC(=O)N(C(C)C)C1=CC=C([N+]([O-])=O)C=C1 XCXMDDMTHUCBCB-UHFFFAOYSA-N 0.000 description 1
- MHYGOCXPOWBZGK-UHFFFAOYSA-N 2-bromo-n-methyl-n-(4-nitrophenyl)acetamide Chemical compound BrCC(=O)N(C)C1=CC=C([N+]([O-])=O)C=C1 MHYGOCXPOWBZGK-UHFFFAOYSA-N 0.000 description 1
- DPHCXXYPSYMICK-UHFFFAOYSA-N 2-chloro-1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C(Cl)=C1 DPHCXXYPSYMICK-UHFFFAOYSA-N 0.000 description 1
- OFTKFKYVSBNYEC-UHFFFAOYSA-N 2-furoyl chloride Chemical compound ClC(=O)C1=CC=CO1 OFTKFKYVSBNYEC-UHFFFAOYSA-N 0.000 description 1
- RZNHSEZOLFEFGB-UHFFFAOYSA-N 2-methoxybenzoyl chloride Chemical compound COC1=CC=CC=C1C(Cl)=O RZNHSEZOLFEFGB-UHFFFAOYSA-N 0.000 description 1
- DGMOBVGABMBZSB-UHFFFAOYSA-N 2-methylpropanoyl chloride Chemical compound CC(C)C(Cl)=O DGMOBVGABMBZSB-UHFFFAOYSA-N 0.000 description 1
- IIKVTJWRBSYRSA-UHFFFAOYSA-N 2-oxo-1,3-dihydroindole-6-carboxylic acid Chemical compound OC(=O)C1=CC=C2CC(=O)NC2=C1 IIKVTJWRBSYRSA-UHFFFAOYSA-N 0.000 description 1
- ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 2-phenyl-1h-imidazole Chemical compound C1=CNC(C=2C=CC=CC=2)=N1 ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 0.000 description 1
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 1
- LGDHZCLREKIGKJ-UHFFFAOYSA-N 3,4-dimethoxyaniline Chemical compound COC1=CC=C(N)C=C1OC LGDHZCLREKIGKJ-UHFFFAOYSA-N 0.000 description 1
- YVURXDZCNLRUKR-UHFFFAOYSA-N 3-[[ethyl(methyl)amino]methyl]aniline Chemical compound CCN(C)CC1=CC=CC(N)=C1 YVURXDZCNLRUKR-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 description 1
- LUHZYXIAZMEYJC-UHFFFAOYSA-N 4-(1,3-dihydroisoindol-2-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CC2=CC=CC=C2C1 LUHZYXIAZMEYJC-UHFFFAOYSA-N 0.000 description 1
- LKKISAMEUBGGRO-UHFFFAOYSA-N 4-(1h-imidazol-5-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CC1=CNC=N1 LKKISAMEUBGGRO-UHFFFAOYSA-N 0.000 description 1
- HUXWSGQXNJKLHA-UHFFFAOYSA-N 4-(cyclohexylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CC1CCCCC1 HUXWSGQXNJKLHA-UHFFFAOYSA-N 0.000 description 1
- KCEPOOYWVQZKEV-UHFFFAOYSA-N 4-(thiomorpholin-4-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCSCC1 KCEPOOYWVQZKEV-UHFFFAOYSA-N 0.000 description 1
- NJRZJZTXQXDDMV-UHFFFAOYSA-N 4-(triazol-2-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1N=CC=N1 NJRZJZTXQXDDMV-UHFFFAOYSA-N 0.000 description 1
- CZGCEKJOLUNIFY-UHFFFAOYSA-N 4-Chloronitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1 CZGCEKJOLUNIFY-UHFFFAOYSA-N 0.000 description 1
- BUNVABGTOMIXBC-UHFFFAOYSA-N 4-[(4-aminophenyl)methyl]piperazin-2-one Chemical compound C1=CC(N)=CC=C1CN1CC(=O)NCC1 BUNVABGTOMIXBC-UHFFFAOYSA-N 0.000 description 1
- VFZNQBXHRYBIFX-UHFFFAOYSA-N 4-[(4-aminophenyl)methyl]piperazin-2-one aniline Chemical compound NC1=CC=CC=C1.O=C1CN(CCN1)CC1=CC=C(N)C=C1 VFZNQBXHRYBIFX-UHFFFAOYSA-N 0.000 description 1
- BIWGVNAYKPHYHU-UHFFFAOYSA-N 4-[(4-benzylpiperidin-1-yl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CN1CCC(CC=2C=CC=CC=2)CC1 BIWGVNAYKPHYHU-UHFFFAOYSA-N 0.000 description 1
- UJZKENORBCZXBM-UHFFFAOYSA-N 4-[(4-methylpiperidin-1-yl)methyl]aniline Chemical compound C1CC(C)CCN1CC1=CC=C(N)C=C1 UJZKENORBCZXBM-UHFFFAOYSA-N 0.000 description 1
- PFSAJWAUWMBHTP-UHFFFAOYSA-N 4-[(4-nitrophenyl)methyl]-1,4-thiazinane 1,1-dioxide Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCS(=O)(=O)CC1 PFSAJWAUWMBHTP-UHFFFAOYSA-N 0.000 description 1
- DXCVNMRMPORTSF-UHFFFAOYSA-N 4-[(4-nitrophenyl)methyl]-1,4-thiazinane 1-oxide Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCS(=O)CC1 DXCVNMRMPORTSF-UHFFFAOYSA-N 0.000 description 1
- KNTGXGBOYZAKTA-UHFFFAOYSA-N 4-[(4-nitrophenyl)methyl]morpholine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCOCC1 KNTGXGBOYZAKTA-UHFFFAOYSA-N 0.000 description 1
- FYPAVJIYVYLQGO-UHFFFAOYSA-N 4-[(4-nitrophenyl)methyl]piperazin-2-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CC(=O)NCC1 FYPAVJIYVYLQGO-UHFFFAOYSA-N 0.000 description 1
- NZEPOTOSLXJCLQ-UHFFFAOYSA-N 4-[(4-nitrophenyl)methyl]thiomorpholine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCSCC1 NZEPOTOSLXJCLQ-UHFFFAOYSA-N 0.000 description 1
- HFSSYCWTIGVIPL-UHFFFAOYSA-N 4-[(4-phenylpiperazin-1-yl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CN1CCN(C=2C=CC=CC=2)CC1 HFSSYCWTIGVIPL-UHFFFAOYSA-N 0.000 description 1
- DOHFDVQVLHRIRR-UHFFFAOYSA-N 4-[(7,8-dichloro-1,2,4,5-tetrahydro-3-benzazepin-3-yl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CN1CCC2=CC(Cl)=C(Cl)C=C2CC1 DOHFDVQVLHRIRR-UHFFFAOYSA-N 0.000 description 1
- QTTIGYUCSYDGCH-UHFFFAOYSA-N 4-[(7-chloro-1,2,4,5-tetrahydro-3-benzazepin-3-yl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CN1CCC2=CC(Cl)=CC=C2CC1 QTTIGYUCSYDGCH-UHFFFAOYSA-N 0.000 description 1
- YWLLIQINDIIEOJ-UHFFFAOYSA-N 4-[(7-methyl-1,2,4,5-tetrahydro-3-benzazepin-3-yl)methyl]aniline Chemical compound C1CC2=CC(C)=CC=C2CCN1CC1=CC=C(N)C=C1 YWLLIQINDIIEOJ-UHFFFAOYSA-N 0.000 description 1
- WITBGLGAUOJYMJ-UHFFFAOYSA-N 4-[(dipropylamino)methyl]aniline Chemical compound CCCN(CCC)CC1=CC=C(N)C=C1 WITBGLGAUOJYMJ-UHFFFAOYSA-N 0.000 description 1
- XPKKPVBDOPPWJU-UHFFFAOYSA-N 4-[2-(dimethylamino)ethyl]aniline Chemical compound CN(C)CCC1=CC=C(N)C=C1 XPKKPVBDOPPWJU-UHFFFAOYSA-N 0.000 description 1
- WQYFGQYVLZFNKB-ICFOKQHNSA-N 4-[[(1z)-1-(6-carbamoyl-2-oxo-1h-indol-3-ylidene)butyl]amino]benzoic acid Chemical compound O=C/1NC2=CC(C(N)=O)=CC=C2C\1=C(/CCC)NC1=CC=C(C(O)=O)C=C1 WQYFGQYVLZFNKB-ICFOKQHNSA-N 0.000 description 1
- DFMIGNKISJSHDR-DQRAZIAOSA-N 4-[[(z)-(6-ethoxycarbonyl-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoic acid Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(O)=O)C=C1 DFMIGNKISJSHDR-DQRAZIAOSA-N 0.000 description 1
- OPYUUWQSWMVYRP-UHFFFAOYSA-N 4-[[1,3-dioxolan-2-ylmethyl(methyl)amino]methyl]aniline Chemical compound C=1C=C(N)C=CC=1CN(C)CC1OCCO1 OPYUUWQSWMVYRP-UHFFFAOYSA-N 0.000 description 1
- ZDOLQHZWTQUMGS-UHFFFAOYSA-N 4-[[2-(2-methoxyethoxy)ethyl-methylamino]methyl]aniline Chemical compound COCCOCCN(C)CC1=CC=C(N)C=C1 ZDOLQHZWTQUMGS-UHFFFAOYSA-N 0.000 description 1
- HVPAJBSEGZAWNL-UHFFFAOYSA-N 4-[[benzyl(2-phenylethyl)amino]methyl]aniline Chemical compound C1=CC(N)=CC=C1CN(CC=1C=CC=CC=1)CCC1=CC=CC=C1 HVPAJBSEGZAWNL-UHFFFAOYSA-N 0.000 description 1
- ILBRCSYDTIZRDP-UHFFFAOYSA-N 4-[[benzyl(propan-2-yl)amino]methyl]aniline Chemical compound C=1C=C(N)C=CC=1CN(C(C)C)CC1=CC=CC=C1 ILBRCSYDTIZRDP-UHFFFAOYSA-N 0.000 description 1
- MTSGXSWIKOKTHF-UHFFFAOYSA-N 4-[[bis(2-methoxyethyl)amino]methyl]aniline Chemical compound COCCN(CCOC)CC1=CC=C(N)C=C1 MTSGXSWIKOKTHF-UHFFFAOYSA-N 0.000 description 1
- CNNPWCGDKDEKFA-UHFFFAOYSA-N 4-[[methyl(2-phenylethyl)amino]methyl]aniline Chemical compound C=1C=C(N)C=CC=1CN(C)CCC1=CC=CC=C1 CNNPWCGDKDEKFA-UHFFFAOYSA-N 0.000 description 1
- XMDDGLDGPJZGSI-UHFFFAOYSA-N 4-benzyl-1-[(4-nitrophenyl)methyl]piperidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCC(CC=2C=CC=CC=2)CC1 XMDDGLDGPJZGSI-UHFFFAOYSA-N 0.000 description 1
- WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
- BXRNOODNNYGOCY-UHFFFAOYSA-N 4-ethyl-1-[(4-nitrophenyl)methyl]piperidine Chemical compound C1CC(CC)CCN1CC1=CC=C([N+]([O-])=O)C=C1 BXRNOODNNYGOCY-UHFFFAOYSA-N 0.000 description 1
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- PHNDZBFLOPIMSM-UHFFFAOYSA-N 4-morpholin-4-ylaniline Chemical compound C1=CC(N)=CC=C1N1CCOCC1 PHNDZBFLOPIMSM-UHFFFAOYSA-N 0.000 description 1
- BXRFQSNOROATLV-UHFFFAOYSA-N 4-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C=C1 BXRFQSNOROATLV-UHFFFAOYSA-N 0.000 description 1
- FNLBIRUBMLUNQC-UHFFFAOYSA-N 5-(4-nitrophenyl)-1h-imidazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=CN=CN1 FNLBIRUBMLUNQC-UHFFFAOYSA-N 0.000 description 1
- KYKQVLBOPNFHSV-UHFFFAOYSA-N 5-methyl-4-phenyl-1h-imidazole Chemical compound N1C=NC(C=2C=CC=CC=2)=C1C KYKQVLBOPNFHSV-UHFFFAOYSA-N 0.000 description 1
- NYTQPHXLWZWBKK-UHFFFAOYSA-N 6-(ethoxymethyl)-1h-indole Chemical compound CCOCC1=CC=C2C=CNC2=C1 NYTQPHXLWZWBKK-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000003120 Angiofibroma Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OSTPFMWDJJYHPW-UHFFFAOYSA-N C1(=CC=CC=C1)C1CCN(CC1)CC1=CC=C(N)C=C1.C(C)(C)C1CCN(CC1)CC1=CC=C(N)C=C1 Chemical compound C1(=CC=CC=C1)C1CCN(CC1)CC1=CC=C(N)C=C1.C(C)(C)C1CCN(CC1)CC1=CC=C(N)C=C1 OSTPFMWDJJYHPW-UHFFFAOYSA-N 0.000 description 1
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010063209 Chronic allograft nephropathy Diseases 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000007766 Kaposi sarcoma Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- OTCCIMWXFLJLIA-UHFFFAOYSA-N N-acetyl-DL-aspartic acid Natural products CC(=O)NC(C(O)=O)CC(O)=O OTCCIMWXFLJLIA-UHFFFAOYSA-N 0.000 description 1
- OTCCIMWXFLJLIA-BYPYZUCNSA-N N-acetyl-L-aspartic acid Chemical compound CC(=O)N[C@H](C(O)=O)CC(O)=O OTCCIMWXFLJLIA-BYPYZUCNSA-N 0.000 description 1
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 1
- 206010061309 Neoplasm progression Diseases 0.000 description 1
- PKXSPUDURLLHHG-UHFFFAOYSA-N O=C1NC2=CC(C(=O)OC)=CC=C2C1=C(C=1C=CC=CC=1)NC1=CC=C(N(CC(=O)N(C)C)C(C)=O)C=C1 Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2C1=C(C=1C=CC=CC=1)NC1=CC=C(N(CC(=O)N(C)C)C(C)=O)C=C1 PKXSPUDURLLHHG-UHFFFAOYSA-N 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 101150038994 PDGFRA gene Proteins 0.000 description 1
- 102100026450 POU domain, class 3, transcription factor 4 Human genes 0.000 description 1
- 101710133389 POU domain, class 3, transcription factor 4 Proteins 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 206010038563 Reocclusion Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000008385 Urogenital Neoplasms Diseases 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- YGCODSQDUUUKIV-UHFFFAOYSA-N Zoxazolamine Chemical compound ClC1=CC=C2OC(N)=NC2=C1 YGCODSQDUUUKIV-UHFFFAOYSA-N 0.000 description 1
- SXWSAXMCGLFTAG-UHFFFAOYSA-N [1-(4-amino-n-methylanilino)piperidin-4-yl]methanol Chemical compound C=1C=C(N)C=CC=1N(C)N1CCC(CO)CC1 SXWSAXMCGLFTAG-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005236 alkanoylamino group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- NZHLHLMWAYAMGR-UHFFFAOYSA-N aniline 2-(dimethylamino)ethanol Chemical compound NC1=CC=CC=C1.CN(CCO)C NZHLHLMWAYAMGR-UHFFFAOYSA-N 0.000 description 1
- JBXPPDVWDDYUCS-UHFFFAOYSA-N aniline;2,2,2-trifluoroethanol Chemical compound OCC(F)(F)F.NC1=CC=CC=C1 JBXPPDVWDDYUCS-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000006630 butoxycarbonylamino group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- XMPZTFVPEKAKFH-UHFFFAOYSA-P ceric ammonium nitrate Chemical compound [NH4+].[NH4+].[Ce+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O XMPZTFVPEKAKFH-UHFFFAOYSA-P 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- VKIRRGRTJUUZHS-UHFFFAOYSA-N cyclohexane-1,4-diamine Chemical compound NC1CCC(N)CC1 VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 description 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000006264 diethylaminomethyl group Chemical group [H]C([H])([H])C([H])([H])N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 208000018554 digestive system carcinoma Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003534 dna topoisomerase inhibitor Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000037828 epithelial carcinoma Diseases 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- LNBFSXVABYNAAP-GYHWCHFESA-N ethyl (3z)-2-oxo-3-[1-[4-(piperidin-1-ylmethyl)anilino]propylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(/CC)NC(C=C1)=CC=C1CN1CCCCC1 LNBFSXVABYNAAP-GYHWCHFESA-N 0.000 description 1
- NWVDZWOTZGZLBZ-DQRAZIAOSA-N ethyl (3z)-2-oxo-3-[phenyl-[4-(2h-tetrazol-5-yl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1C1=NN=NN1 NWVDZWOTZGZLBZ-DQRAZIAOSA-N 0.000 description 1
- SRSFGSQMDZJKHV-DQSJHHFOSA-N ethyl (3z)-2-oxo-3-[phenyl-[4-(piperidin-1-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCCCC1 SRSFGSQMDZJKHV-DQSJHHFOSA-N 0.000 description 1
- IXLWLINBDPVBIF-QPLCGJKRSA-N ethyl (3z)-2-oxo-3-[phenyl-[4-(propylaminomethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound C1=CC(CNCCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(=O)OCC)C=C2NC\1=O IXLWLINBDPVBIF-QPLCGJKRSA-N 0.000 description 1
- KWRATKYHTNEHDF-RQZHXJHFSA-N ethyl (3z)-2-oxo-3-[phenyl-[4-(pyrrolidin-1-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCCC1 KWRATKYHTNEHDF-RQZHXJHFSA-N 0.000 description 1
- FONNKMIXGFHFRV-RQZHXJHFSA-N ethyl (3z)-2-oxo-3-[phenyl-[4-(thiomorpholin-4-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCSCC1 FONNKMIXGFHFRV-RQZHXJHFSA-N 0.000 description 1
- HULZHXOHFLVUNR-FCQUAONHSA-N ethyl (3z)-3-[(4-cyanoanilino)-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C#N)C=C1 HULZHXOHFLVUNR-FCQUAONHSA-N 0.000 description 1
- KGLGZLLAQXVHMY-IZHYLOQSSA-N ethyl (3z)-3-[[3,5-dichloro-4-[(dimethylamino)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC(Cl)=C(CN(C)C)C(Cl)=C1 KGLGZLLAQXVHMY-IZHYLOQSSA-N 0.000 description 1
- GFDYMCILCJZAAT-IZHYLOQSSA-N ethyl (3z)-3-[[3-[(dimethylamino)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=CC(CN(C)C)=C1 GFDYMCILCJZAAT-IZHYLOQSSA-N 0.000 description 1
- BBQOMPAPYHAMFE-DQSJHHFOSA-N ethyl (3z)-3-[[4-(3,6-dihydro-2h-pyridin-1-ylmethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCC=CC1 BBQOMPAPYHAMFE-DQSJHHFOSA-N 0.000 description 1
- LRKHTNZONLERKV-RQZHXJHFSA-N ethyl (3z)-3-[[4-(4-methylpiperazin-1-yl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N1CCN(C)CC1 LRKHTNZONLERKV-RQZHXJHFSA-N 0.000 description 1
- AGRUGIBTTDRWNM-RQZHXJHFSA-N ethyl (3z)-3-[[4-[(3-hydroxypyrrolidin-1-yl)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCC(O)C1 AGRUGIBTTDRWNM-RQZHXJHFSA-N 0.000 description 1
- DIWHRMJVZVOQMR-DQSJHHFOSA-N ethyl (3z)-3-[[4-[1-amino-4-(dimethylamino)butyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C(N)CCCN(C)C)C=C1 DIWHRMJVZVOQMR-DQSJHHFOSA-N 0.000 description 1
- KOVXOBIYGAPUII-QPLCGJKRSA-N ethyl (3z)-3-[[4-[[2-aminoethyl(methyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(C)CCN)C=C1 KOVXOBIYGAPUII-QPLCGJKRSA-N 0.000 description 1
- BLWGPVVOVJBMON-KTMFPKCZSA-N ethyl (3z)-3-[[4-[[benzyl(methyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN(C)CC1=CC=CC=C1 BLWGPVVOVJBMON-KTMFPKCZSA-N 0.000 description 1
- QIAFNXKHWWOBRX-MVJHLKBCSA-N ethyl (3z)-3-[[4-[[methyl(2-phenylethyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN(C)CCC1=CC=CC=C1 QIAFNXKHWWOBRX-MVJHLKBCSA-N 0.000 description 1
- FWKXTJHANITOPE-QPLCGJKRSA-N ethyl (3z)-3-[[4-[acetyl(2-aminoethyl)amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(N(CCN)C(C)=O)C=C1 FWKXTJHANITOPE-QPLCGJKRSA-N 0.000 description 1
- RDEMCYZJUBPCMK-DQRAZIAOSA-N ethyl (3z)-3-[anilino(phenyl)methylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OCC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=CC=C1 RDEMCYZJUBPCMK-DQRAZIAOSA-N 0.000 description 1
- LLEFRDNBMHFGLX-UHFFFAOYSA-N ethyl 1-(4-amino-n-methylanilino)piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1N(C)C1=CC=C(N)C=C1 LLEFRDNBMHFGLX-UHFFFAOYSA-N 0.000 description 1
- NRGBVJPPBFDBRV-UHFFFAOYSA-N ethyl 1-[(4-nitrophenyl)methyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1CC1=CC=C([N+]([O-])=O)C=C1 NRGBVJPPBFDBRV-UHFFFAOYSA-N 0.000 description 1
- RCYLCCWUDSYRNK-UHFFFAOYSA-N ethyl 1-acetyl-3-(1-ethoxypropylidene)-2-oxoindole-6-carboxylate Chemical compound CCOC(=O)C1=CC=C2C(=C(CC)OCC)C(=O)N(C(C)=O)C2=C1 RCYLCCWUDSYRNK-UHFFFAOYSA-N 0.000 description 1
- PKDYOKKJAIBJNK-UHFFFAOYSA-N ethyl 2-[(4-aminophenyl)methyl-methylamino]acetate Chemical compound CCOC(=O)CN(C)CC1=CC=C(N)C=C1 PKDYOKKJAIBJNK-UHFFFAOYSA-N 0.000 description 1
- RNSNPSMLRZWYGB-UHFFFAOYSA-N ethyl 2-oxo-3h-indole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OCC)C(=O)CC2=C1 RNSNPSMLRZWYGB-UHFFFAOYSA-N 0.000 description 1
- DPAJKWVTGGWGBI-UHFFFAOYSA-N ethyl 3-[ethoxy(phenyl)methylidene]-2-oxo-1H-indole-6-carboxylate Chemical compound C(C)OC(C1=CC=CC=C1)=C1C(NC2=CC(=CC=C12)C(=O)OCC)=O DPAJKWVTGGWGBI-UHFFFAOYSA-N 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 229960005420 etoposide Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229940116364 hard fat Drugs 0.000 description 1
- 201000003911 head and neck carcinoma Diseases 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005935 hexyloxycarbonyl group Chemical group 0.000 description 1
- 239000003667 hormone antagonist Substances 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960004873 levomenthol Drugs 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- CRAUMZAXRDXPMY-QPLCGJKRSA-N methyl (3z)-2-oxo-3-[phenyl-[4-(piperazin-1-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCNCC1 CRAUMZAXRDXPMY-QPLCGJKRSA-N 0.000 description 1
- WIBHRANONYESRM-RQZHXJHFSA-N methyl (3z)-2-oxo-3-[phenyl-[4-(pyridin-4-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CC1=CC=NC=C1 WIBHRANONYESRM-RQZHXJHFSA-N 0.000 description 1
- BTAQJYBUIQPDQB-VHXPQNKSSA-N methyl (3z)-2-oxo-3-[phenyl-[4-(triazol-1-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1C=CN=N1 BTAQJYBUIQPDQB-VHXPQNKSSA-N 0.000 description 1
- UTEHGZFZMLODQF-VHXPQNKSSA-N methyl (3z)-3-[[4-(1-methylimidazol-2-yl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1C1=NC=CN1C UTEHGZFZMLODQF-VHXPQNKSSA-N 0.000 description 1
- CTWVGZBUESYGST-VHXPQNKSSA-N methyl (3z)-3-[[4-(acetamidomethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CNC(C)=O)C=C1 CTWVGZBUESYGST-VHXPQNKSSA-N 0.000 description 1
- GUSPUPJKTCNHOJ-VHXPQNKSSA-N methyl (3z)-3-[[4-(ethylaminomethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound C1=CC(CNCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(=O)OC)C=C2NC\1=O GUSPUPJKTCNHOJ-VHXPQNKSSA-N 0.000 description 1
- BDIXPOBFDVYSJA-IZHYLOQSSA-N methyl (3z)-3-[[4-(imidazol-1-ylmethyl)anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1C=CN=C1 BDIXPOBFDVYSJA-IZHYLOQSSA-N 0.000 description 1
- BEULZLALWAJZNR-QPLCGJKRSA-N methyl (3z)-3-[[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCS(=O)(=O)CC1 BEULZLALWAJZNR-QPLCGJKRSA-N 0.000 description 1
- KHBSFMKAWOKMAX-DQRAZIAOSA-N methyl (3z)-3-[[4-[(carbamoylamino)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CNC(N)=O)C=C1 KHBSFMKAWOKMAX-DQRAZIAOSA-N 0.000 description 1
- DSVKVEZKOMOLTB-DQRAZIAOSA-N methyl (3z)-3-[[4-[(diaminomethylideneamino)methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CNC(N)=N)C=C1 DSVKVEZKOMOLTB-DQRAZIAOSA-N 0.000 description 1
- SFWYROGMRHYFHU-IZHYLOQSSA-N methyl (3z)-3-[[4-[2-(dimethylamino)ethyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CCN(C)C)C=C1 SFWYROGMRHYFHU-IZHYLOQSSA-N 0.000 description 1
- HUKMKKIFMCLRLL-IZHYLOQSSA-N methyl (3z)-3-[[4-[2-(methylamino)ethyl-methylsulfonylamino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound C1=CC(N(CCNC)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(=O)OC)C=C2NC\1=O HUKMKKIFMCLRLL-IZHYLOQSSA-N 0.000 description 1
- AFUJQLGSXUWNHA-MVJHLKBCSA-N methyl (3z)-3-[[4-[2-[benzyl(methyl)amino]ethyl-methylsulfonylamino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(S(C)(=O)=O)CCN(C)CC1=CC=CC=C1 AFUJQLGSXUWNHA-MVJHLKBCSA-N 0.000 description 1
- PFQBJQWYSLDVPT-KARKAFJISA-N methyl (3z)-3-[[4-[3-[benzyl(methyl)amino]propanoyl-methylamino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(C)C(=O)CCN(C)CC1=CC=CC=C1 PFQBJQWYSLDVPT-KARKAFJISA-N 0.000 description 1
- DPKXPQRIMHPSDV-KARKAFJISA-N methyl (3z)-3-[[4-[3-[benzyl(methyl)amino]propyl-methylsulfonylamino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(S(C)(=O)=O)CCCN(C)CC1=CC=CC=C1 DPKXPQRIMHPSDV-KARKAFJISA-N 0.000 description 1
- KULVOIVLYMLJJG-MVJHLKBCSA-N methyl (3z)-3-[[4-[[2-[benzyl(methyl)amino]acetyl]-methylamino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(C)C(=O)CN(C)CC1=CC=CC=C1 KULVOIVLYMLJJG-MVJHLKBCSA-N 0.000 description 1
- OFOIGKQPRKLLKH-QPLCGJKRSA-N methyl (3z)-3-[[4-[[bis(2-hydroxyethyl)amino]methyl]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(CN(CCO)CCO)C=C1 OFOIGKQPRKLLKH-QPLCGJKRSA-N 0.000 description 1
- CKSHKSLNZDHHFF-IZHYLOQSSA-N methyl (3z)-3-[[4-[methyl-[2-(methylamino)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound C1=CC(N(C)C(=O)CNC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(=O)OC)C=C2NC\1=O CKSHKSLNZDHHFF-IZHYLOQSSA-N 0.000 description 1
- XSPAJBFOMCBXQS-QPLCGJKRSA-N methyl (3z)-3-[[4-[methyl-[3-(methylamino)propanoyl]amino]anilino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound C1=CC(N(C)C(=O)CCNC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(=O)OC)C=C2NC\1=O XSPAJBFOMCBXQS-QPLCGJKRSA-N 0.000 description 1
- VXYDONSUAPNUAL-MRCUWXFGSA-N methyl (3z)-3-[[methyl(piperidin-4-yl)amino]-phenylmethylidene]-2-oxo-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\N(C)C1CCNCC1 VXYDONSUAPNUAL-MRCUWXFGSA-N 0.000 description 1
- YLFLCTBGQLPNCU-UHFFFAOYSA-N methyl 2-(2-methoxy-2-oxoethyl)-5-nitrobenzoate Chemical compound COC(=O)CC1=CC=C([N+]([O-])=O)C=C1C(=O)OC YLFLCTBGQLPNCU-UHFFFAOYSA-N 0.000 description 1
- QABLOFMHHSOFRJ-UHFFFAOYSA-N methyl 2-chloroacetate Chemical compound COC(=O)CCl QABLOFMHHSOFRJ-UHFFFAOYSA-N 0.000 description 1
- FPUPGTDVGVCPMU-DCXSSQDFSA-N methyl 3-amino-3-[4-[[(z)-(6-carbamoyl-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]propanoate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(C(N)CC(=O)OC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=C(C(N)=O)C=C2NC\1=O FPUPGTDVGVCPMU-DCXSSQDFSA-N 0.000 description 1
- AXLYJLKKPUICKV-UHFFFAOYSA-N methyl 3-nitrobenzoate Chemical compound COC(=O)C1=CC=CC([N+]([O-])=O)=C1 AXLYJLKKPUICKV-UHFFFAOYSA-N 0.000 description 1
- LOSQOFAVLPHCBL-YBEGLDIGSA-N methyl 4-[[(1z)-1-(6-carbamoyl-2-oxo-1h-indol-3-ylidene)ethyl]amino]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1N\C(C)=C/1C2=CC=C(C(N)=O)C=C2NC\1=O LOSQOFAVLPHCBL-YBEGLDIGSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- HJMLCGPNMFWONS-UHFFFAOYSA-N n',n'-dimethyl-n-(4-nitrophenyl)propane-1,3-diamine Chemical compound CN(C)CCCNC1=CC=C([N+]([O-])=O)C=C1 HJMLCGPNMFWONS-UHFFFAOYSA-N 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- HVOYZOQVDYHUPF-UHFFFAOYSA-N n,n',n'-trimethylethane-1,2-diamine Chemical compound CNCCN(C)C HVOYZOQVDYHUPF-UHFFFAOYSA-N 0.000 description 1
- PGIMSBPAYDNSHJ-UHFFFAOYSA-N n,n,n'-trimethyl-n'-(4-nitrophenyl)ethane-1,2-diamine Chemical compound CN(C)CCN(C)C1=CC=C([N+]([O-])=O)C=C1 PGIMSBPAYDNSHJ-UHFFFAOYSA-N 0.000 description 1
- CHKXXXQNGDVNIV-UHFFFAOYSA-N n,n-dimethyl-2-(4-nitroanilino)acetamide Chemical compound CN(C)C(=O)CNC1=CC=C([N+]([O-])=O)C=C1 CHKXXXQNGDVNIV-UHFFFAOYSA-N 0.000 description 1
- OPLUKHRHLWGKLC-UHFFFAOYSA-N n,n-dimethyl-2-(n-methylsulfonyl-4-nitroanilino)acetamide Chemical compound CN(C)C(=O)CN(S(C)(=O)=O)C1=CC=C([N+]([O-])=O)C=C1 OPLUKHRHLWGKLC-UHFFFAOYSA-N 0.000 description 1
- WTJVPDKQZPBBON-UHFFFAOYSA-N n-(2-chloro-4-nitrophenyl)-n-[2-(dimethylamino)ethyl]methanesulfonamide Chemical compound CN(C)CCN(S(C)(=O)=O)C1=CC=C([N+]([O-])=O)C=C1Cl WTJVPDKQZPBBON-UHFFFAOYSA-N 0.000 description 1
- HGHHMSZITRYJAU-UHFFFAOYSA-N n-(3-aminopropyl)-n-(4-nitrophenyl)methanesulfonamide Chemical compound NCCCN(S(=O)(=O)C)C1=CC=C([N+]([O-])=O)C=C1 HGHHMSZITRYJAU-UHFFFAOYSA-N 0.000 description 1
- HNBBGEBXTNJZOD-UHFFFAOYSA-N n-(4-amino-2-nitrophenyl)-n-[2-(dimethylamino)ethyl]methanesulfonamide Chemical compound CN(C)CCN(S(C)(=O)=O)C1=CC=C(N)C=C1[N+]([O-])=O HNBBGEBXTNJZOD-UHFFFAOYSA-N 0.000 description 1
- ZVBILJXZKYASHH-UHFFFAOYSA-N n-(4-aminophenyl)-2-(4-benzylpiperazin-1-yl)-n-methylacetamide Chemical compound C=1C=C(N)C=CC=1N(C)C(=O)CN(CC1)CCN1CC1=CC=CC=C1 ZVBILJXZKYASHH-UHFFFAOYSA-N 0.000 description 1
- FXTJCYDXMWCGAE-UHFFFAOYSA-N n-(4-aminophenyl)-2-(dimethylamino)-n-methylacetamide Chemical compound CN(C)CC(=O)N(C)C1=CC=C(N)C=C1 FXTJCYDXMWCGAE-UHFFFAOYSA-N 0.000 description 1
- BGYDAZLBPZRHCE-UHFFFAOYSA-N n-(4-aminophenyl)-2-(dimethylamino)-n-propan-2-ylacetamide Chemical compound CN(C)CC(=O)N(C(C)C)C1=CC=C(N)C=C1 BGYDAZLBPZRHCE-UHFFFAOYSA-N 0.000 description 1
- RBSORTNYVYYANP-UHFFFAOYSA-N n-(4-aminophenyl)-2-[benzyl(methyl)amino]-n-methylacetamide Chemical compound C=1C=CC=CC=1CN(C)CC(=O)N(C)C1=CC=C(N)C=C1 RBSORTNYVYYANP-UHFFFAOYSA-N 0.000 description 1
- QUOGKXIZYCADLG-UHFFFAOYSA-N n-(4-aminophenyl)-n-benzyl-2-(dimethylamino)acetamide Chemical compound C=1C=C(N)C=CC=1N(C(=O)CN(C)C)CC1=CC=CC=C1 QUOGKXIZYCADLG-UHFFFAOYSA-N 0.000 description 1
- MMRRHTBUYQOAIN-UHFFFAOYSA-N n-(4-aminophenyl)-n-benzyl-3-(dimethylamino)propanamide Chemical compound C=1C=C(N)C=CC=1N(C(=O)CCN(C)C)CC1=CC=CC=C1 MMRRHTBUYQOAIN-UHFFFAOYSA-N 0.000 description 1
- GCQFMJFKLZDMRV-UHFFFAOYSA-N n-(4-aminophenyl)-n-methyl-2-morpholin-4-ylacetamide Chemical compound C=1C=C(N)C=CC=1N(C)C(=O)CN1CCOCC1 GCQFMJFKLZDMRV-UHFFFAOYSA-N 0.000 description 1
- BTHUVPGZNFZKAQ-UHFFFAOYSA-N n-(4-aminophenyl)-n-methyl-2-piperidin-1-ylacetamide Chemical compound C=1C=C(N)C=CC=1N(C)C(=O)CN1CCCCC1 BTHUVPGZNFZKAQ-UHFFFAOYSA-N 0.000 description 1
- WZFCLDKJJMFMPI-UHFFFAOYSA-N n-(4-aminophenyl)-n-methyl-2-pyrrolidin-1-ylacetamide Chemical compound C=1C=C(N)C=CC=1N(C)C(=O)CN1CCCC1 WZFCLDKJJMFMPI-UHFFFAOYSA-N 0.000 description 1
- MGZAFDOASDXMRY-UHFFFAOYSA-N n-(4-aminophenyl)-n-methylmethanesulfonamide Chemical compound CS(=O)(=O)N(C)C1=CC=C(N)C=C1 MGZAFDOASDXMRY-UHFFFAOYSA-N 0.000 description 1
- CHMBIJAOCISYEW-UHFFFAOYSA-N n-(4-aminophenyl)acetamide Chemical compound CC(=O)NC1=CC=C(N)C=C1 CHMBIJAOCISYEW-UHFFFAOYSA-N 0.000 description 1
- GJAOBNFUBCBDCZ-UHFFFAOYSA-N n-(4-nitrobenzyl)cyclohexanamine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CNC1CCCCC1 GJAOBNFUBCBDCZ-UHFFFAOYSA-N 0.000 description 1
- IJPPOHWWAFBVHZ-UHFFFAOYSA-N n-(4-nitrophenyl)-n-propan-2-ylprop-2-enamide Chemical compound C=CC(=O)N(C(C)C)C1=CC=C([N+]([O-])=O)C=C1 IJPPOHWWAFBVHZ-UHFFFAOYSA-N 0.000 description 1
- AXEHDVUAWILBRN-UHFFFAOYSA-N n-(4-nitrophenyl)methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=C([N+]([O-])=O)C=C1 AXEHDVUAWILBRN-UHFFFAOYSA-N 0.000 description 1
- QYQYMVAVTKTFEK-UHFFFAOYSA-N n-[(4-aminophenyl)methyl]acetamide Chemical compound CC(=O)NCC1=CC=C(N)C=C1 QYQYMVAVTKTFEK-UHFFFAOYSA-N 0.000 description 1
- CTKKEBNPGLDOOO-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-1-(4-nitrophenyl)methanamine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CNCC1=CC=C(Cl)C=C1 CTKKEBNPGLDOOO-UHFFFAOYSA-N 0.000 description 1
- DNZYTQZZHUSUSC-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-1-phenylmethanesulfonamide Chemical compound CN(C)CCNS(=O)(=O)CC1=CC=CC=C1 DNZYTQZZHUSUSC-UHFFFAOYSA-N 0.000 description 1
- DMNQTXIYZKQQTC-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-n-(4-nitrophenyl)acetamide Chemical compound CN(C)CCN(C(C)=O)C1=CC=C([N+]([O-])=O)C=C1 DMNQTXIYZKQQTC-UHFFFAOYSA-N 0.000 description 1
- BUVHBNWBNIYBNA-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-n-(4-nitrophenyl)butane-1-sulfonamide Chemical compound CCCCS(=O)(=O)N(CCN(C)C)C1=CC=C([N+]([O-])=O)C=C1 BUVHBNWBNIYBNA-UHFFFAOYSA-N 0.000 description 1
- WUCLJETZBPSKOL-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-n-(4-nitrophenyl)methanesulfonamide Chemical compound CN(C)CCN(S(C)(=O)=O)C1=CC=C([N+]([O-])=O)C=C1 WUCLJETZBPSKOL-UHFFFAOYSA-N 0.000 description 1
- NQOKVBHUJJTMOW-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-n-(4-nitrophenyl)propane-1-sulfonamide Chemical compound CCCS(=O)(=O)N(CCN(C)C)C1=CC=C([N+]([O-])=O)C=C1 NQOKVBHUJJTMOW-UHFFFAOYSA-N 0.000 description 1
- NNKNJNVCSGKGJL-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]benzenesulfonamide Chemical compound CN(C)CCNS(=O)(=O)C1=CC=CC=C1 NNKNJNVCSGKGJL-UHFFFAOYSA-N 0.000 description 1
- GUWTXLFEPYROLL-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]butane-1-sulfonamide Chemical compound CCCCS(=O)(=O)NCCN(C)C GUWTXLFEPYROLL-UHFFFAOYSA-N 0.000 description 1
- CDEPIVCNUQKRLK-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]propane-1-sulfonamide Chemical compound CCCS(=O)(=O)NCCN(C)C CDEPIVCNUQKRLK-UHFFFAOYSA-N 0.000 description 1
- NUJJGFYSRFCZLJ-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]propane-2-sulfonamide Chemical compound CC(C)S(=O)(=O)NCCN(C)C NUJJGFYSRFCZLJ-UHFFFAOYSA-N 0.000 description 1
- UCWCWITUDZLYEI-UHFFFAOYSA-N n-[3-(4-amino-n-methylsulfonylanilino)propyl]-2,2,2-trifluoroacetamide Chemical compound FC(F)(F)C(=O)NCCCN(S(=O)(=O)C)C1=CC=C(N)C=C1 UCWCWITUDZLYEI-UHFFFAOYSA-N 0.000 description 1
- ACQWHSZRUMDPIU-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]-n-(4-nitrophenyl)acetamide Chemical compound CN(C)CCCN(C(C)=O)C1=CC=C([N+]([O-])=O)C=C1 ACQWHSZRUMDPIU-UHFFFAOYSA-N 0.000 description 1
- XQWDPAYBFYDFKQ-UHFFFAOYSA-N n-benzyl-2,2,2-trifluoro-n-[(4-nitrophenyl)methyl]ethanamine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN(CC(F)(F)F)CC1=CC=CC=C1 XQWDPAYBFYDFKQ-UHFFFAOYSA-N 0.000 description 1
- SLMUTYIQZCUZMY-UHFFFAOYSA-N n-benzyl-2-(dimethylamino)-n-(4-nitrophenyl)acetamide Chemical compound C=1C=C([N+]([O-])=O)C=CC=1N(C(=O)CN(C)C)CC1=CC=CC=C1 SLMUTYIQZCUZMY-UHFFFAOYSA-N 0.000 description 1
- UXHPTAGDVHUJIJ-UHFFFAOYSA-N n-benzyl-2-bromo-n-(4-nitrophenyl)acetamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1N(C(=O)CBr)CC1=CC=CC=C1 UXHPTAGDVHUJIJ-UHFFFAOYSA-N 0.000 description 1
- ZIZNSTZMWOBDGD-UHFFFAOYSA-N n-benzyl-3-(dimethylamino)-n-(4-nitrophenyl)propanamide Chemical compound C=1C=C([N+]([O-])=O)C=CC=1N(C(=O)CCN(C)C)CC1=CC=CC=C1 ZIZNSTZMWOBDGD-UHFFFAOYSA-N 0.000 description 1
- CLYMFLQESMUGIC-UHFFFAOYSA-N n-benzyl-n-(4-nitrophenyl)prop-2-enamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1N(C(=O)C=C)CC1=CC=CC=C1 CLYMFLQESMUGIC-UHFFFAOYSA-N 0.000 description 1
- XIFSKFKDFZVRLJ-UHFFFAOYSA-N n-benzyl-n-[(4-nitrophenyl)methyl]propan-2-amine Chemical compound C=1C=C([N+]([O-])=O)C=CC=1CN(C(C)C)CC1=CC=CC=C1 XIFSKFKDFZVRLJ-UHFFFAOYSA-N 0.000 description 1
- XRKQMIFKHDXFNQ-UHFFFAOYSA-N n-cyclohexyl-n-ethylcyclohexanamine Chemical compound C1CCCCC1N(CC)C1CCCCC1 XRKQMIFKHDXFNQ-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- BMFAWKLLFGEGOO-UHFFFAOYSA-N n-methyl-n-(4-nitrophenyl)-3-piperidin-1-ylpropanamide Chemical compound C=1C=C([N+]([O-])=O)C=CC=1N(C)C(=O)CCN1CCCCC1 BMFAWKLLFGEGOO-UHFFFAOYSA-N 0.000 description 1
- UZLYICXAFAPAIF-UHFFFAOYSA-N n-methyl-n-(4-nitrophenyl)methanesulfonamide Chemical compound CS(=O)(=O)N(C)C1=CC=C([N+]([O-])=O)C=C1 UZLYICXAFAPAIF-UHFFFAOYSA-N 0.000 description 1
- CPQCSJYYDADLCZ-UHFFFAOYSA-N n-methylhydroxylamine Chemical compound CNO CPQCSJYYDADLCZ-UHFFFAOYSA-N 0.000 description 1
- 201000003142 neovascular glaucoma Diseases 0.000 description 1
- 201000009925 nephrosclerosis Diseases 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 239000013034 phenoxy resin Substances 0.000 description 1
- 229920006287 phenoxy resin Polymers 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 125000005544 phthalimido group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- CBPYOHALYYGNOE-UHFFFAOYSA-M potassium;3,5-dinitrobenzoate Chemical compound [K+].[O-]C(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 CBPYOHALYYGNOE-UHFFFAOYSA-M 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- OOYIKBDYTCHVGE-ZIADKAODSA-N propan-2-yl (3z)-2-oxo-3-[phenyl-[4-(piperidin-1-ylmethyl)anilino]methylidene]-1h-indole-6-carboxylate Chemical compound O=C1NC2=CC(C(=O)OC(C)C)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCCCC1 OOYIKBDYTCHVGE-ZIADKAODSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 125000004944 pyrazin-3-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- PFPKVXJSPMPEIA-UHFFFAOYSA-N tert-butyl 4-[3-(n-methyl-4-nitroanilino)-3-oxopropyl]piperazine-1-carboxylate Chemical compound C=1C=C([N+]([O-])=O)C=CC=1N(C)C(=O)CCN1CCN(C(=O)OC(C)(C)C)CC1 PFPKVXJSPMPEIA-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 description 1
- XLSGWRGPNPPUAN-UHFFFAOYSA-N tert-butyl n-[(4-aminophenyl)methyl]-n-butylcarbamate Chemical compound CCCCN(C(=O)OC(C)(C)C)CC1=CC=C(N)C=C1 XLSGWRGPNPPUAN-UHFFFAOYSA-N 0.000 description 1
- PSBBYCGCULPBHU-UHFFFAOYSA-N tert-butyl n-[(4-aminophenyl)methyl]-n-ethylcarbamate Chemical compound CC(C)(C)OC(=O)N(CC)CC1=CC=C(N)C=C1 PSBBYCGCULPBHU-UHFFFAOYSA-N 0.000 description 1
- OIJFDQGSKLIZTO-UHFFFAOYSA-N tert-butyl n-[(4-aminophenyl)methyl]-n-propylcarbamate Chemical compound CC(C)(C)OC(=O)N(CCC)CC1=CC=C(N)C=C1 OIJFDQGSKLIZTO-UHFFFAOYSA-N 0.000 description 1
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229940044693 topoisomerase inhibitor Drugs 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 125000003652 trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- XVOGWGAMGKHTDC-UHFFFAOYSA-M triphenyl-[(1-tritylimidazol-4-yl)methyl]phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)CC(N=C1)=CN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 XVOGWGAMGKHTDC-UHFFFAOYSA-M 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 208000037964 urogenital cancer Diseases 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
71488pct.203 Boehringer Ingelheim Pharma KG Case 5/1275-Ro D-55216 INGELHEIM Foreign filing text Indolinones substituted in the 6-position, the preparation thereof and their use as pharmaceutical compositions The present invention relates to new indolinones of general formula
R
3 R 4
-N
N N R
R
2 i
R
substituted in the 6 position, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof which have valuable properties.
The above compounds of general formula I wherein R 1 denotes a hydrogen atom or a prodrug group have valuable pharmacological properties, in particular an inhibiting effect on various kinases, especially receptor tyrosine kinases such as VEGFR2, PDGFRc, PDGFRP, FGFR1, FGFR3, EGFR, HER2, IGF1R and HGFR, as well as complexes of CDK's (Cyclin Dependent Kinases) such as CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9 with their specific cyclins Bl, B2, C, D1, D2, D3, E, F, Gl, G2, H, I and K) and to viral cyclin (cf. L. Mengtao in J.
Virology 71(3), 1984-1991 (1997)), and on the proliferation of cultivated human cells, in particular endothelial cells, e.g.
in angiogenesis, but also on the proliferation of other cells, in particular tumour cells.
2 The other compounds of the above general formula I wherein R, does not denote a hydrogen atom or a prodrug group are valuable intermediate products for preparing the abovementioned compounds.
The present invention thus relates to the above compounds of general formula I, whereby those compounds wherein R 1 denotes a hydrogen atom or a prodrug group have valuable pharmacological properties, pharmaceutical compositions containing the pharmacologically active compounds, the use thereof and processes for preparing them.
In the above general formula I X denotes an oxygen or sulphur atom,
R
I denotes a hydrogen atom or a prodrug group such as a
C.
4 -alkoxycarbonyl or C, 4 -alkanoyl group,
R
2 denotes a carboxy group, a straight-chain or branched
C
1 6 -alkoxy-carbonyl group, a C 4 ,_-cycloalkoxy-carbonyl or an aryloxycarbonyl group, a straight-chain or branched C 1 6 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C,~-alkoxy-carbonyl, aminocarbonyl,
C
1 3 -alkylamino-carbonyl or di-(C,- 3 -alkyl)-aminocarbonyl group, a straight-chain or branched C2-6-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, CI.3-alkoxy, amino, C1-3-alkylamino or di-(CI.3-alkyl)-amino group, -3an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C,-3-alkoxy group or; if does not denoto an aminosulphony 1-phenyl or N- (Cl- 5 -alkyl) -C,,-alkylaminocarbonyl-phenyl group, it may also denote a di-(Cl- 2 -alkyl) -aminocarbonyl group,
R
3 denotes a hydrogen atom, a C 16 -alkyl, C 3 cycloalkyl, trifluoromethyl or heteroaryl group, a phenyl or naphthyl group, a phenyl or naphthyl group monoor disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, Cl-,-alkyl or C 1 3 -alkoxy group, whilst in the event of disubstitution the substituents may be identical or different and wherein the abovementioned unsubstituted as well as the mono- and disubstituted phenyl and naphthyl groups may additionally be substituted by a hydroxy, hydroxy-C 1 3 -alkyl or C,--alkoxy-Cl 1 3 -alkyl group, by a cyano, carboxy, carboxy-C 1 3 -alkyl,
C,-
3 -alkoxycarbonyl, aminocarbonyl, C 1 alkylamino-carbonyl or di- (Cl- 3 -alkyl) -aminocarbonyl group, by a nitro group, by an amino, CI- 3 -alkylamino, di-(C 1 3 ,-alkyl) -amino or amino-C- 3 -alkyl group, by a C.
3 -alkylcarbonylamino, N-(C 1 3 -alkyl) -Cl- 3 -alkylcarbonylamino, Cl 1 3 -alkylcarbonylamino-C alkyl, N- (C, 3 -alkyl) -C 1 3 -alkylcarbonylamino-Cl 1 3 -alkyl, Cl- 3 -alkylsuiphonylamino, Cl 1 3 -alkylsulphonylamino-Cl.
3 -alkyl, N- (Cl 3 -alkyl) -Cl- 3 -alkylsulphonylamino-Cl, -alkyl or aryl-C- 3 -alkylsulphonylamino group, 4 by a cycloalkylamino, cycloalkyleneimino, cycloalkyleneiminocarbonyl, cycloalkyleneimino-C, 3 -alkyl, cycloalkyleneiminocarbonyl-C, 3 -aky or cycloalkyleneiminosulphonyl-C 3 -alkyl group having 4 to 7 ring members in each case, whilst in each case the methylene group in position 4 of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, b' a sulphinyl, sulphonyl, -NH or -N(Cl- 3 -alkyl) group, or by a heteroaryl or heteroaryl-C,3-alkyl group,
R
4 denotes a C 3 ,-cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7membered cycloalkyl group may be substituted by an amino, Cl- 3 -alkylamino or di-(C, 3 -alkyl)-amino group or replaced by an -NH or -N(C 1 3 -alkyl) group, or a phenyl group substituted by the group which may additionally be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C 1 5 -alkyl, trifluoromethyl, hydroxy, CI-3-alkoxy, carboxy, C 1 -3-alkoxycarbonyl, amino, acetylamino, C, 3 -alkyl-sulphonylamino, aminocarbonyl, Cl_ 3 -alkyl-aminocarbonyl, di-(C 1 3 -alkyl)-aminocarbonyl, aminosulphonyl, C,- 3 -alkyl-aminosulphonyl, di-(C 1 3 -alkyl)-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different and wherein R, denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, amino, Cl_ 5 -alkyl, C 3 _,-cycloalkyl, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group, the group of formula 0
XNH
H 0 wherein the hydrogen atoms bound to a nitrogen atom may in each case be replaced independently of one another by a Cl- 3 -al kyl group,, a C- 3 -alkoxy group, a C,-,-alkoxy-C 1 3 -alkoxy, phenyl-C 1 3 -alkoxy, amino -C 2 3 -alkoxy, CI-3-a lkylamino-C 2 3 -alkoxy, di- (Cl- 3 -alkyl) -amino -C 2 -1-alkoxy, phenyl-Cl- 3 -alkylamino-
C
2 3 -alkoxy, N- (CI- 3 -alkyl) -phenyl-C,-,-alkylamino-C 2 3 -alkoxy, C,-,-cycloalkyleneimino-C 2 3 -alkoxy or kylmercapto group, a carboxy, C, 4 -alkoxycarbonyl, aminocarbonyl, Cl 1 3 -alkylamino-carbonyl, N- (C 1 5 -alkyl) -C- 3 -alkylaminocarbonyl, phenyl-Cl- 3 -alkylamino-carbonyl, N- (Cl 3 -alkyl) -phenyl-CI- 3 -alkylamino-carbonyl, piperazinocarbonyl or N- (Cl 1 3 -alkyl) -pipe ra zinocarbonyl group, a C- 3 -alkylaminocarbonyl or N- (C 1 5 ,-alkyl) Cl- 3 -alkylaminocarbonyl group wherein an alkyl moiety is substituted by a carboxy or cl-,-alkoxycarbonyl group or in the 2 or 3 position by a di- (C 1 3 -alkyl) -amino, piperazino, N-(Cl- 3 -alkyl)-piperazino or a 4- to 7-membered cycloalkyleneimino group, a C 3 7 -cycloalkyl-carbonyl group, wherein the methylene group in the 4 position of the 6- or 7-membered cycloalkyl moiety may be substituted by an amino, Cl- 3 -alkylamino or di- (Cl 1 3 -alkyl) -amino group or replaced by an -NH or -N(C 1 3 -alkyl) group, 6 a 4- to 7-membered cycloalkyleneimino group wherein a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or the cycloalkylene moiety may be fused to a phenyl ring or one or two hydrogen atoms may each be replaced by a alkyl group and/or in each case the methylene group in the 4 position of a 6or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C 1 l 3 -alkoxycarbonyl, aminocarbonyl,
C
1 _3-alkylaminocarbonyl, di-(C 1 3 -alkyl)-aminocarbonyl, phenyl-C 1 3 -alkylamino or N-(C 1 _3-alkyl)phenyl-C_ 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl), -N(phenyl), -N(C_.3-alkyl-carbonyl) or -N(benzoyl) group, a C 1 .4-alkyl group substituted by the group wherein
R
7 denotes a C 3 _,-cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be substituted by an amino, C 1 3 -alkylamino or di- (C_3-alkyl)-amino group or replaced by an -NH or -N(C.3-alkyl) group or in a 5- to 7-membered cycloalkyl group a -(CH 2 group may be replaced by a -CO-NH group, a -(CH 2 3 group may be replaced by a -NH-CO-NH or -CO-NH-CO group or a
-(CH
2 4 group may be replaced by a -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 -alkyl group, -7 an aryl or heteroaryl group, 11 IhYd'roxy or C, -aikuxy group, an amino, C 1 7 -alkylamino, di- (C 17 -alkyl) -amino, phenylamino, N-phenyl -C,-,-alkyl -amino, phenyl-C,-,-alkylamino, N- (C 13 -alkyl) -phenyl-C 1 3 -alkylamino or di- (phenyl-C,- 3 -alky1) -amino group, an co-hydroxy-C,-,-alkyl -amino, N- (C,-,-alkyl) -co-hydroxy-
C
2 3 -alkyl-amino, di- (o-hydroxy-C 23 alkyl) -amino, di- (co- (Cl- 3 -alkoxy) -C 2 3 -alkyl) -amino or N-(dioxolan- 2-yl)-CI- -alkyl-amino group, a C 1-3 -alkylcarbonylamino-C,-,-alkyl -amino or
C-
3 -alkylcarbonylamino-C 2 3 -alkyl-N- (Cl 13 -alkyl) -amino group, a Cl- 3 -alkylsulphonylamino, N- (Cl 13 -alkyl) -C 1 3 -alkylsuiphonylamino, Cl- 3 -akylsulphonylamino-C 2 3 -alky1-amino or
C-
3 -alkylsulphonylamino-C 2 3 -alky1-N- (C 13 -alkyl) -amino group, a hydroxycarbonyl-Cl- 3 -alkylamino or N- (C 13 -alkyl) hydroxycarbonyl-C 1 3 -alkyl -amino group, a guanidino group wherein one or two hydrogen atoms may each be replaced by a C 1 3 -alkyl group, a group of formula
N(R
8
)VCO-(CH
2 )n-R 9
(II),
wherein 8 R, denotes a hydrogen atom or a C, 1 3-alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and
R
9 denotes an amino, C 1 4 -alkylamino, di-(C 1 4 -alkyl)-amino, phenylamino,
N-(C
1 _4-alkyl)-phenylamino, benzylamino,
N-(C
1 4 -alkyl)-benzylamino or C 1 4 -alkoxy group, a 4- to 7-membered cycloalkyleneimino group, whilst in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 3 -alkyl), -N(phenyl), -N(C 1 3-alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula
-N(R
1 0 )-(CH2)m-(CO)o-R 1
(III),
wherein Ri 0 denotes a hydrogen atom, a C 1--alkyl group, a
C_
3 -alkylcarbonyl, arylcarbonyl, phenyl-C 1 3 -alkylcarbonyl, C 1 3 -alkylsulphonyl, arylsulphonyl or phenyl-C. 3-alkylsulphonyl group, m denotes one of the numbers 1, 2, 3 or 4, o denotes the number 1 or, if m denotes one of the numbers 2, 3 or 4, o may also denote the number 0 and
R
11 denotes an amino, C 1 4 -alkylamino, di-(Cl_ 4 -alkyl)-amino, phenylamino, 4 -alkyl)-phenylamino, benzylamino, N- (C,_-alkyl) -benzylamino, C 1 _4-alkoxy or 9
C
1 3 -alkoxy-C, 3 -alkoxy group, a di-(C 1 _-alkyl)-amino-Ci_3alkylamino group optionally substituted in the 1 position by a C 1 _-alkyl group or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH,
-N(C
1 3 -alkyl)', -N(phenyl), -N(C 1 3 -alkyl-carbonyl) or -N(benzoyl) group, a C4_,-cycloalkylamino, C4_,-cycloalkyl-C_-3-alkylamino or
C
4 7 ,-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a Cs.,-cycloalkyl,
C
2 -4-alkenyl or C 1 4 -alkyl group, a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C 1 3 -alkyl, CI- 3 -alkoxy or amino group, and/or one or two hydrogen atoms may each be replaced by a
C
1 3 -alkyl, Cs,.-cycloalkyl or phenyl group and/or the methylene group in the 3 position of a cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-Ci_ 3 -alkyl, C,_3-alkoxy or
C,_
3 -alkoxy-C, 1 3 -alkyl group, the methylene group in the 3 or 4 position of a 6- or 7-membered cycloalkyleneimino group may in each case be 0 -10 substituted by a hydroxy, hydroxy-C,-,-alkyl, C1- 3 -alkoxy, Cl-,-alkoxy- C 1 3 -alkyl, carboxy, Cl- 4 -alkoxycarbonyl, aminocarbonyl, cl'3-a1lkmlai..ca--ny, di- tC 1-aikyi) -aminocarbonvi, phenyl-Cl- 3 -alkylamino or N- (C 13 -alkyl) -phenyl-C 1 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, siilphonyl, -NH, 3 -alkyl-), -N(phenyl), -N(phenyl-C- 3 -alkyl-), -N(C 13 -alkyl-carbonyl-), -N(Cl- 4 -hydroxy-carbonyl-), -N(Cl 14 -alkoxy-carbonyl-), -N(benzoyl-) or -N(phenyl-C 1 3 -alkyl-carbonyl-) group, wherein a methylene group linked to an iminonitrogen atom of the cycloalkylendimino group may be replaced by a carbonyl or sulphonyl group or in a to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the iminonitrogen atom may each be replaced by a carbonyl group, or R 6 denotes a C 14 -alkyl group which is substituted by a carboxy, C 13 -alkoxycarbonyl, aminocarbonyl,
C
1 3 -alkylaminocarbonyl or di- (Cl 13 -alkyl) -aminocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group, an N-(C 1 3 -alkyl) -C 2 4 -al kanoylamino group which is additionally substituted in the alkyl moiety by a carboxy or 1,3-akxcroy group, a group of formula -N(Rl 2 -Go-(CH 2 R1 3 (IV) 11 wherein
R
12 denotes a hydrogen atom, a C 16 -alkyl or C 3 7 -cycloalkyl group or a C 3 aky group t inally susituted by a phenyl, heteroaryl, trifluoromethyl, hydroxy, C_.3-alkoxy, aminocarbonyl, C-_4-alkylamino-carbonyl, di-(C-_4-alkyl)amino-carbonyl, C 1 -3-alkyl-carbonyl, C_ 3 -alkyl-sulphonylamino, N-(C 13 -alkyl)-C 1 3 -alkyl-sulphonylamino,
C,_
3 -alkyl-aminodulphonyl or di- (C 1 .3-alkyl)-aminosulphonyl group and p denotes one of the numbers 0, 1, 2 or 3 and assumes the meanings of the abovementioned group R,, or, if p denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula
-N(R
1 4 )-(CH2)q-(CO)-R5 wherein
R
14 denotes a hydrogen atom, a C-_4-alkyl group, a C .3-alkylcarbonyl, arylcarbonyl, phenyl-Cl3-alkylcarbonyl, heteroarylcarbonyl, heteroaryl-C 1 3 -alkylcarbonyl,
C
1 4 -alkylsulphonyl, arylsulphonyl, phenyl-C 1 3 -alkylsulphonyl, heteroarylsulphonyl or heteroaryl-Cl_ 3 -alkyl-sulphonyl group, q denotes one of the numbers 1, 2, 3 or 4, r denotes the number 1 or, if q is one of the numbers 2, 3 or 4, it may also denote the number 0 and R1s assumes the meanings of the abovementioned group R,, 12 a group of formula
-N(R
16 )-S0 2
-R
17
(VI),
wherein R,6 denotes a hydrogen atom or a C, 1 -alkyl group optionally terminally substituted by a cyano, trifluoromethyl-carbonylamino or
N-(C
13 -alkyl)-trifluoromethyl-carbonyl-amino group and
R
17 denotes a C,-3-alkyl group, an amino group substituted by a di-(Ci.
3 -alkyl)amino-C 3 -alkyl-carbonyl or di-(C 1 3 -alkyl)amino-C 1 3 -alkyl-sulphonyl group and a di-(C 13 -alkyl)aminocarbonyl-C_ 3 -alkyl group, or an N-(C_.3-alkyl)-C-_s-alkylsulphonylamino or
N-(C
1 3 -alkyl)-phenylsulphonylamino group wherein the alkyl moiety is additionally substituted by a cyano or carboxy group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R, may be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C 1 _-alkyl, trifluoromethyl, hydroxy, C_ 3 -alkoxy, carboxy, C_- 3 -alkoxycarbonyl, aminocarbonyl,
C
1 -4-alkylamino-carbonyl, di- (C, 4 -alkyl) -amino carbonyl, aminosulphonyl, C 1 .3-alkyl-aminosulphonyl, di-(Cl- 3 -alkyl) -aminosulphonyl, C 1 3 -alkyl-sulphonylamino, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, 13 and R, denotes a hydrogen atom or a C -alkyl group, wherein by an aryl group is meant a phenyl or naphthyl group optionally mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a cyano, trifluoromethyl, nitro, carboxy, aminocarbohyl, C 1 3 -alkyl or C 1 3 -alkoxy group and by a heteroaryl group is meant .a monocyclic 5- or 6-membered heteroaryl group optionally substituted by a C 1 _3-alkyl group in the carbon skeleton, wherein the 6-membered heteroaryl group contains one, two or three nitrogen atoms and the 5-membered heteroaryl group contains an imino group optionally substituted by a C 1 _3-alkyl or phenyl-C 1 3 -alkyl group, an oxygen or sulphur atom or an imino group optionally substituted by a C_ 3 -alkyl or phenyl-C_ 3 -alkyl group or an oxygen or sulphur atom and additionally a nitrogen atom or an imino group optionally substituted by a Ci 3 -alkyl or phenyl-C, 3 -alkyl group and two nitrogen atoms, and moreover a phenyl ring may be fused to the abovementioned monocyclic heterocyclic groups via two adjacent carbon atoms and the bonding takes place via a nitrogen atom or via a carbon atom of the heterocyclic moiety or a fused phenyl ring, some or all of the hydrogen atoms in the abovementioned alkyl and alkoxy groups or in the alkyl moieties contained in the 14 above-defined groups of formula I optionally being replaced by fluorine atoms, the saturated alkyl and alkoxy moieties with more Lhan 2 carbon atoms which are present in the groups defined hereinbefore also include the branched isomers thereof, such as for example the isopropyl, tert.butyl, isobutyl group, unless otherwise stated, and additionally the hydrogen atom of any carboxy group present or a hydrogen atom bound to a nitrogen atom, e.g. a hydrogen atom of an amino, alkylamino or imino group or a saturated Nheterocycle such as the piperidinyl group, may each be replaced by a group which can be cleaved in vivo.
By a group which can be cleaved in vivo from an imino or amino group is meant, for example, a hydroxy group, an acyl group such as the benzoyl or pyridinoyl group or a C,, 6 -alkanoyl group such as the formyl, acetyl, propionyl, butanoyl, pentanoyl or hexanoyl group, an allyloxycarbonyl group, a C,_,,-alkoxycarbonyl group such as the methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, tert.butoxycarbonyl, pentoxycarbonyl, hexyloxycarbonyl, octyloxycarbonyl, nonyloxycarbonyl, decyloxycarbonyl, undecyloxycarbonyl, dodecyloxycarbonyl or hexadecyloxycarbonyl group, a phenyl-C,- -alkoxycarbonyl group such as the benzyloxycarbonyl, phenylethoxycarbonyl or phenylpropoxycarbonyl group, a C 1 3-alkylsulphonyl-
C
2 4 -alkoxycarbonyl, C, 1 3 -alkoxy-C 2 4 -alkoxy-C 2 4 -alkoxycarbonyl or ReCO-O-(RfCR,)-O-CO group wherein Re denotes a C, -alkyl, C,_-cycloalkyl, phenyl or phenyl- C_ 3-alkyl group, 15 R, denotes a hydrogen atom, a C 1 3 -alkyl, C.,-cycloalkyl or phenyl group and R, denotes a hydrogen atom, a C 1 -alkyl or ReCO-O- (RCRg)group wherein Re to R, are as hereinbefore defined, wherein additionally the amino group may be a phthalimido group, whilst the abovementioned ester groups may also be used as a group which cap be converted in vivo into a carboxy group.
One sub-group of compounds of general formula I which deserves special mention comprises those wherein X, Ri and R 3 to R 5 are as hereinbefore defined and
R
2 denotes a straight-chain or branched C 6 -alkoxy-carbonyl group, a C4_,-cycloalkoxycarbonyl or a aryloxycarbonyl group, a straight-chain or branched Cl._-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C 1 3 -alkoxycarbonyl, aminocarbonyl, C,.3-alkylaminocarbonyl or di-(C.
3 -alkyl)-aminocarbonyl group, a straight-chain or branched C2-6-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, C 1 3 -alkoxy, amino, Ci.
3 -alkylamino or di-(C,_ 3 -alkyl)-amino group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
A second sub-group of compounds of general formula I which deserves special mention comprises those wherein 16 X, R i and R 3 to R 5 are as hereinbefore defined and
R
2 denotes an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C 3 -alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or N-(C,.s-alkyl)-C 1 .3-alkylaminocarbonyl-phenyl group, R, may also denote a di-(C 1 -2-alkyl)-aminocarbonyl group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
A third sub-group of compounds of general formula I which deserves special mention comprises those wherein X, Ri to R 3 and R. are as hereinbefore defined and
R
4 denotes an R,-(C 1 ,_-alkyl)-phenyl group, wherein R, denotes an amino, C- 7 _-alkylamino, di-(C 1 _,-alkyl) -amino, phenylamino, N-phenyl-C 1 3 -alkyl-amino, phenyl-C 1 3 -alkylamino, N-(Cl_ 3 -alkyl)-phenyl-C 1 3 -alkylamino or di-(phenyl-C_3-alkyl)-amino group, or a phenyl group substituted by the group of formula
-N(R
1 2
)-CO-(CH
2 )p-R13 (IV), wherein R 12 p and R 13 are as hereinbefore defined, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
Preferred compounds of general formula I are those wherein 17 R, and R 3 are as hereinbefore defined and X denotes an oxygen atom,
R
2 denotes a carboxy group, a straight-chain or branched C,1_-alkoxy-carbonyl group, a Cs,_-cycloalkoxycarbonyl or a phenoxycarbonyl group, a straight-chain or branched C 1 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C 1 3 -alkoxycarbonyl, aminocarbonyl, C,.3-alkylaminocarbonyl or di- (C 13 -alkyl) -aminocarbonyl group, a straight-chain or branched C 2 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom, by a hydroxy, C 1 -_-alkoxy, amino, C, 3 -alkylamino or di- (C_.3-alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C -3-alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or
N-(C
1 is-alkyl)-C, 3 -alkylaminocarbonyl-phenyl group, it may also denote a di-(C_ 2 -alkyl)-aminocarbonyl group,
R
4 denotes a C 3 ,--cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7membered cycloalkyl group may be substituted by an amino,
C
1 3 -alkylamino or di-(Cl_ 3 -alkyl)-amino group or replaced by an -NH or -N(C 1 -3-alkyl) group, or a phenyl group substituted by the group which may additionally be mono- or disubstituted by fluorine, chlorine or bromine atoms, by CI.3-alkyl, trifluoromethyl, hydroxy, 18
C
13 -alkoxy, carboxy, Cl- 3 -alkoxycarbonyl, amino, acetylamino, aminocarboiyl, C- 3 -alkyl-aminocarbonyl, di- (C, 13 -alkyl) -aminocarbonyl, nitro or cyano groups, wherein the substitiuents may be identical dr iffeen and wherein R. denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, amino, C,-,-alkyl, C 3 7 -cycloalkyl, trifluoromethyl, phenyl, tetrazolyl'or heteroaryl group, the group of formula 0
NH
wherein a hydrogen atom bound to the nitrogen atom may be replaced by a C--a lkyl group, a C 1 3 -alkoxy group, an amino- C- 3 alkoxy, Cl-,-alkylamino-
C
2 3 -alkoxy, di (C 1 3 alkyl) amino-C 2 3 alkoxy, phenyl- Cl- 3 -alkylamino-C 2 -alkoxy, N- (Cl 1 3 -alkyl) -phenyl-
C,-
3 -alkylamino-C 2 -alkoxy, pyrrolidino-C 2 3 alkoxy, piperidino-C 2 3 -alkoxy or C 1 3 -alkylmercapto group, a carboxy, C,- 4 -alkoxycarbonyl, aminocarbonyl, C,- 3 -alkylamino-carbonyl, phenyl-C- 3 -alkylamino-carbonyl or N- (Cl- 3 -alkyl) -phenyl-C 1 3 -alkylamino-carbonyl group, a C 3 7 -cycloalkyl-carbonyl group, wherein the methylene group in the 4 position of the 6- or 7-membered cycloalkyl moiety may be replaced by an -NH or
-N(C
1 3 -alkyl) group, 19 a 4- to 7-membered cycloalkyleneimino group, wherein a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or one or two hydrogen atoms may each be replaced by a C1_3-alkyl group and/or in each case thO methylene group in the 4 position of a 6or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C _3-alkoxycarbonyl, aminocarbonyl, C, 3-alkylaminocarbonyl, di- (C, 3 -alkyl) -aminocarbonyl, phenyl-Ci_ 3 -alkylamino or N-(C,_-alkyl)phenyl-C,.3-alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or -N(C, 1 ,-alkyl) group, a C,_4-alkyl group terminally substituted by the group R,, wherein
R
7 denotes a C 5 .,-cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be replaced by an -NH or -N(C 3 -alkyl) group or in a 5- to 7-membered cycloalkyl group a -(CH 2 2 group may be replaced by a -CO-NH group, a -(CH 2 3 group may be replaced by a -NH-CO-NH- or a -(CH 2 4 group may be replaced by a -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 alkyl group, a phenyl or heteroaryl group, 20 a hydroxy or C 13 -al koxy group, an amino, C, 1 6 -alkylamino, di- (Cl- 6 -alkyl) -amino, phenylaimino, N-pfheriyi-C, -a-Lkyi aio pheny1-C,-,-alkylamino, N- (C,-,-alkyl) -pheny1-C,-,-alkylamino or di- (phenyl-C 1 3 ,-alkyl) -amino group, a o-hydroxy-C 2 -alkyl -amino, N- (C,-,-alkyl) -zo-hydroxyikyl -amino, di- (ao-hydroxy-C 2 3 -alkyl) -amino, di- (co- (Cl- 3 -alkoxy) -C 2 -alkyl) -amino or N- (dioxolan-2-yl) -Cl- -alkyl-amino group, a CI- 3 -alkylcarbonylamino-C 2 3 -alkyl -amino or
C-
3 -alkylcarbonylamino-C 2 3 -alkyl-N- (C 1 3 -alkyl) -amino group, a CI al kyl suiphonyl amino, N- (C 1 3 -alkyl)
C-
3 -al kylsuiphonylamino, C- 3 -alkylsuiphonylamino-
-C
2 3 -a ikyl -amino or C,-,-alkylsulphonylamino-C 2 3 -alkyl- (Cl- 3 -alkyl) -amino group, a hydroxycarbonyl-C 1 3 -alkylamino or N- (CI- 3 -alkyl) -hydroxycarbonyl -C 1 3 -alkyl -amino group a guanidino group wherein a hydrogen atom may be replaced by a C 1 3 -alkyl group, a group of formula
N(R
8 )-C0(CH 2 )n-R 9 wherein R. denotes a hydrogen atom or a C 1 3 alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and 21
R
9 denotes an amino, C 1 _-alkylamino, di-(C 1 3 -alkyl)amino, phenylamino, benzylamino or C.-,-alkoxy group, a to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH, -N(C 1 .3-alkyl), -N(phenyl), -N(C 1 3 -alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2'or 3, it may also denote a hydrogen atom, a group of formula -N(Rio)-(CH 2 )m-(CO)o-R 11
(III),
wherein Rio denotes a hydrogen atom, a C 13 -alkyl group, a
C
1 3 -alkylcarbonyl or Ci.3-alkylsulphonyl group, m denotes one of the numbers 1, 2 or 3, o denotes the number 1 or, if m is one of the numbers 2 or 3, o may also denote the number 0 and
R
11 denotes an amino, C 1 3 -alkylamino, di-(C_3-alkyl)-amino, C-.
4 -alkoxy or
C,.
3 -alkoxy-C..
3 -alkoxy group or a 5- to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH, -N(Ci.
3 -alkyl), -N(phenyl), -N(C 1 alkyl-carbonyl) or -N(benzoyl) group, a C, 4 7 -cycloalkylamino or C 4 ,-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond, 22 a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or one or two hydrogen atoms may each be replaced by a
C
1 3 -alkyl group and/or the methylene group in position 3 of the pyrrolidino group may be substituted by a hydroxy or C 1 3 -alkoxy group, in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl,
C
1 3-alkoxy, carboxy, Ci.
3 -alkoxycarbonyl, aminocarbonyl, C_-3-alkylaminocarbonyl, di-(C,~ 3 -alkyl) -aminocarbonyl, phenyl-C_3-alkylamino or N- 3 -alkyl) -phenyl-C, 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 -3-alkyl) -N(phenyl), -N(phenyl-C_3-alkyl) -N(C, 3 -alkyl-carbonyl), -N(C_.4-alkoxy-carbonyl), -N(benzoyl) or -N(phenyl-Cl_ 3 -alkyl-carbonyl) group, wherein a methylene group linked to an iminonitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a to 6-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the iminonitrogen atom may each be replaced by a carbonyl group, 23 or R 6 denotes a C 1 4 ,-alkyl group which is terminally substituted by a carboxy, Cl_3-alkoxycarbonyl, aminocarbonyl, -alkylaminocarbonyl or di-(C -alky)-a inocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group, a group of formula -N(R~2)-CO-(CH2)p-RI3 (IV), wherein
R
12 denotes a hydrogen atom, a C 1 alkyl, Cs 7 ,-cycloalkyl, phenyl-C_3-alkyl or heteroaryl-C 1 3 -alkyl group and p denotes one of the numbers 0, 1, 2 or 3 and
R,
3 assumes the meanings of the abovementioned group R,, or, if p denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula -N(Rl 4 )-(CH2)q-(CO)r-R5 wherein
R,
4 denotes a hydrogen atom, a C 1 4 -alkyl group, a C_3-alkylcarbonyl, phenylcarbonyl, phenyl-C 3 -alkylcarbonyl, heteroarylcarbonyl, heteroaryl-C 3 -alkylcarbonyl, C,_ 4 -alkylsulphonyl, phenylsulphonyl, phenyl-C 1 3 -alkylsulphonylheteroarylsulphonyl or heteroaryl-C 1 3 -alkyl-sulphonyl group, q denotes one of the numbers 1, 2, 3 or 4, 24 r denotes the number 1 or, if q is one of the numbers 2, 3 or 4, it may also denote the number 0 and
R
1 assumes the meanings of the abovementioned group R,, a group of formula -7 (R 1 6 )-S0 2
-R
1 7
(VI),
wherein
R
16 denotes a hydrogen atom or a C_-4-alkyl group optionally terminally substituted by a cyano, trifluoromethylcarbonylamino or N- 3 -alkyl) -trifluoromethyl- -carbonyl-amino group and
R
17 denotes a Cl_ 3 -alkyl group, an amino group substituted by a di- (C 1 3 -alkyl)amino-C 3 -alkyl-carbonyl or di- (Ci_3-alkyl)amino-C 1 3 -alkyl-sulphonyl group and a di-(C 1 3 -alkyl)aminocarbonyl-C,~ 3 -alkyl group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R, may be monoor disubstituted by fluorine, chlorine or bromine atoms, by C 1 3 -alkyl, trifluoromethyl, hydroxy,
C_.
3 -alkoxy, carboxy, C 1 3 -alkoxycarbonyl, aminocarbonyl,
C
1 3 -alkyl-aminocarbonyl, aminosulphonyl,
C.
3 -alkyl-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, and R, denotes a hydrogen atom or a C,3-alkyl group, 25 whilst by a heteroaryl group as mentioned above is meant a pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, pyrrolyl, furyl, thienyl, oxazolyl, thiazolyl, pyrazolyl, imidazolyl or triazoly; group optionally substituted in Lhe carbon skeleton by a C,.3-alkyl group wherein a hydrogen atom bound to a nitrogen atom may be replaced by a C.3-alkyl or phenyl-C 1 .,-alkyl group and wherein the 5-membered heteroaryl groups containing at least one imino group are bound via a carbon or nitrogen atom, a hydrogen atom bound to a nitrogen atom in the abovementioned groups may be replaced by a group which can be cleaved in vivo, particularly by an acetyl or tert.butoxycarbonyl group, the carboxy groups contained in the abovementioned groups may each be substituted by a group which can be cleaved in vivo and may occur, for example, in the form of the tert.butoxycarbonyl group, some or all of the hydrogen atoms in the abovementioned alkyl and alkoxy groups or in the alkyl moieties contained in the above-defined groups of formula I optionally being replaced by fluorine atoms and the saturated alkyl and alkoxy moieties contained in the abovementioned groups, which contain more than 2 carbon atoms, may be straight-chain or branched, unless otherwise stated, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
One subgroup of preferred compounds of general formula I deserving special mention comprises those wherein X, R, and R 3 to R s are as hereinbefore defined and 26
R
2 denotes a straight-chain or branched C 1 6 -alkoxy-carbonyl group, a C_,--cycloalkoxycarbonyl or a phenoxycarbonyl group, a straight-chain or branched C, 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenylcarboxy, C -3-alkoxycarbonyl, aminocarbonyl,
C,
3 -alkylaminocarbonyl or di-(C.3-alkyl)-aminocarbonyl group, a straight-chain or branched C 2 _,-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a hydroxy,
C,_
3 -alkoxy, amino, Cl.
3 -alkylamino or di-(C 1 3 -alkyl)-amino group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
A second sub-group of preferred compounds of general formula I deserving special mention comprises those wherein X, Ri and R 3 to R 5 are as hereinbefore defined and
R
2 denotes an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C., 3 -alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or
N-(C
1 _.-alkyl)-C_.
3 -alkylaminocarbonyl-phenyl group, R 2 may also denote a di-(C 1 -2-alkyl)-aminocarbonyl group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
A third sub-group of preferred compounds of general formula I deserving special mention comprises those wherein X, RI to R 3 and R 5 are as hereinbefore defined and 27
R
4 denotes an R,-(n-CI, 4 -alkyl)-phenyl group, wherein R, denotes an amino, C, -alkylamino, di-(C -aiky)-amino, phenylamino, N-phenyl-C,_3-alkyl-amino, phenyl-Ci 3-alkylamino, 3 -alkyl) -phenyl-CI_3-alkylamino or di-(phenyl- C,_3-alkyl)-amino group, or a phenyl group substituted by the group of formula -N(RI2)-CO-(CH2)p-R13 (IV), wherein R1 2 p and are as hereinbefore defined, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
Particularly preferred compounds of general formula I are those wherein X denotes an oxygen atom, R, denotes a hydrogen atom,
R
2 denotes a carboxy group, a straight-chain or branched C _4-alkoxycarbonyl group or a phenoxycarbonyl group, a straight-chain or branched Cl 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, carboxy, C,.
3 -alkoxycarbonyl, aminocarbonyl, Ci,3-alkylaminocarbonyl or di-(CI_3-alkyl)-aminocarbonyl group, a straight-chain or branched C2-,-alkoxy-carbonyl group which is terminally substituted in the alkyl moiety by a hydroxy, 28 C,.3-alkoxy, amino, C 1 3 -alkylamino or di-(C 1 3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C -3-alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or
N-(C_
5 -alkyl)-Cl.
3 -alkylaminocarbonyl-phenyl group, it may also denote a di-(C- 2 -alkyl)-aminocarbonyl group,
R
3 denotes a C 1 4 -alkyl group or a phenyl group which may be substituted by a fluorine, chlorine or bromine atom, by a trifluoromethyl, C 1 3 -alkyl, hydroxy or C 1 .3-alkoxy group,
R
4 denotes a C 5 6 -cycloalkyl group, wherein the methylene group in position 4 of the cyclohexyl group may be substituted by an amino,
C
1 3 -alkylamino or di-(C 1 -3-alkyl)-amino group or replaced by an -NH or -N(C_ 3 -alkyl) group, a phenyl group, a phenyl group disubstituted by C 1 3 -alkyl,
C
1 3 -alkoxy or nitro groups, wherein the substituents may be identical or different, or a phenyl group substituted by the group which may additionally be substituted by a fluorine, chlorine or bromine atom or by an amino or nitro group, wherein
R
6 denotes a fluorine, chlorine or bromine atom, a C 1 3 -alkyl, C 1 3 -alkoxy, nitro, amino or Cs_ 6 -cycloalkyl group, a pyrrolyl, pyrazolyl, imidazolyl, triazolyl or tetrazolyl group bound via a carbon atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be 29 substituted by a C 3-alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 -alkyl or phenyl-C 1 3 -alkyl group, the group of formula 0
CNH
CH
N
H
a carboxy, C,.4-alkoxycarbonyl, phenyl-C-_ -alkylamino-carbonyl or C 5 7 -cycloalkyl-carbonyl group, a 5 or 6-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH or
-N(C
1 .3-alkyl) group, an unbranched C 1 .3-alkyl group terminally substituted by the group wherein
R
7 denotes a C 5 _-cycloalkyl group, wherein in a 5 or 6-membered cycloalkyl group a group may be replaced by a -CO-NH group, a -(CH 2 3 group may be replaced by an -NH-CO-NH- or a -(CH 2 4 group may be replaced by an -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 -alkyl group, a phenyl or pyridinyl group or a pyrrolyl, pyrazolyl, imidazolyl or triazolyl group bound via a carbon or nitrogen atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be substituted by a 30
C
1 3 -alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a -al kyl group, a hydroxy or C, ,-alkoxy group, an amino, Cl- 6 -alkylamino, di- (C 1 6 -alkyl) -amino, phenylamino, N-phenyl-C,- 3 -alkylamino, phenyl-C,-,-alkylamino or N- (C 1 3 -alkyl) -phenyl- Cl- 3 ikylamino group, a o-hydroxy-C 2 3 -alkyl -amino, N- (CI- 3 -alkyl) -w-hydroxy-C,,-alkylamino, di- (wo-hydroxy-C 2 3 -alkyl) -amino or di- (Cl- 3 -alkoxy) -C 2 3 -alkyl) -amino group, a Cl- 3 -alkylcarbonylamino-C- 3 -alkyl-amino or Cl- 3 -alkylcarbonylamino-C 2 3 -alkyl-N- (C 1 3 -alkyl) -amino group, a Cl- 3 -alkylsulphonylamino, N- (C 1 3 -alkyl)
C-
3 -alkylsuiphonylamino, Cl-3-alkylsuiphonylamino-
-C
2 3 -alkylamino or C- 3 -alkylsuiphonylamino-
-C
2 3 -alkyi-N- (C 1 3 -aikyi) -amino group, a hydroxycarbonyl-CI-3-alkylamino or N- (Cl 3 -alkyl) -hydroxycarbonyl-Cl- 3 -alkyl-amino group, a guanidino group wherein a hydrogen atom may be replaced by a C 1 3 -alkyl group, a group of formula
N(R
8
)VCOI(CH
2 )n-R 9
(II),
wherein 31 R, denotes a hydrogen atom or a CI_3-alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and
R
9 denotes an amino, C 1 3 -alkylamino, di-(C 1 .3-alkyl)-amino or C 4-alkoxy group, a 5- or 6membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH, -N(C _--alkyl) or
-N(C
1 3 -alkyl-carbonyl) group, or, if n denotes one of the numbers 1, 2 or 3, R 9 may also denote a hydrogen atom, a group of formula -N(Rio)-(CH 2 )m-(CO)o-R11 (III), wherein
R
10 denotes a hydrogen atom or a C -3-alkyl group, m denotes one of the numbers 1, 2 or 3, o denotes the number 1 or, if m is one of the numbers 2 or 3, o may also denote the number 0 and
R
1 denotes an amino, C 1 .3-alkylamino, di-(C 1 .3-alkyl)-amino, C-,4-alkoxy or methoxy-C 1 ~,-alkoxy group or a 5- or 6-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH,
-N(C
1 3 -alkyl) or -N(Cl--alkyl-carbonyl) group, an azetidino, pyrrolidino, piperidino, 2,6-dimethyl-piperidino, 3,5-dimethyl-piperidino or azepino group, wherein 32 the methylene group in position 3 of the pyrrolidino group may be substituted by a hydroxy group, the methylene group in position 4 of the piperidino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl or C, 3 -alkoxy group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl) -N(C- 3 -alkylcarbonyl), -N(benzoyl) or -N(phenyl-C 1 3 -alkyl-carbonyl) group, wherein a methylene group linked to an iminonitrogen atom of the pyrrolidino, piperidino or piperazino group may be replaced by a carbonyl group, or R 6 denotes a straight-chain C 1 _3-alkyl group which is terminally substituted by a carboxy or C,.3-alkoxy-carbonyl group, a group of formula -N(RI2)-CO-(CH2)p-R13 (IV), wherein
R
12 denotes a hydrogen atom, a C, 3 -alkyl or phenyl-C 1 3 alkyl group, p denotes one of the numbers 0, 1 or 2 and
R
13 denotes an amino, C 1 _4-alkylamino, di-(C 1 _4-alkyl)-amino, benzylamino, N-(C_ 3 -alkyl)-benzylamino,
CI.
3 -alkoxy-Cl_ 3 -alkylamino, N- (C, 3 -alkyl)- 33 Cl 3 -alkoxy-C 1 3 -alkylamino, di- (2-methoxy-ethyl) -amino, di- (-hydroxy-C 2 3 -alkyl) -amino or aminocarbonyl-methyl-N- (methyl)-amino group, a pyrrolyl, pyrazolyl or imidazolyl group bound via a nitrogen atom and optionally substituted by a C- 3 -alkyl group, a pyrrolidino, iperidino, morpholino, thiomorpholino or a piperazino group optionally substituted in the 4 position by a C- 3 -alkyl, phenyl-Cl- 3 -alkyl, C 1 3 -alkylcarbonyl or
C,-
4 -alkoxycarbonyl group or, if n denotes the number 1 or 2, it may also denote a hydrogen atom, a group of formula
-N(R
1 4 (CH2)q(CO)r-Rl5 (V) wherein
R
14 denotes a hydrogen atom, a C,-,-alkyl, C,-,-alkylcarbonyl, phenylcarbonyl, phenyl-C 13 -alkylcarbonyl, furylcarbonyl, pyridinyl-carbonyl, furyl-CI- 3 -alkylcarbonyl, pyridinyl-C 1 3 -alkylcarbonyl, C 1 4 -alkylsulphonyl, phenylsuiphonyl or phenyl-C 1 3 -alkylsulphonyl group, q denotes one of the numbers 1, 2 or 3, r denotes the number 1 or, if q is one of the numbers 2 or 3, it may also denote the number 0 and R. denotes an amino, C 1 4 -alkylamino, di-(C 1 4 ,-alkyl) -amino, phenylamino, N-(C 1 4 ,-alkyl) -phenylamino, benzylamino or N- (C 14 -alkyl) -benzylamino group, 34 or a group of formula
-N(R
1 6 )-S0 2
-R
17
(VI),
wherein
R
16 denotes a hydrogen atom or a C 3-alkyl group optionally terminally substituted by a cyano, trifluoromethyl-carbonylamino or
N-(C
1 3 -alkyl)-trifluoromethyl-carbonyl-amino group and
R,
7 denotes a CI3-alkyl group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R 6 may be substituted by a fluorine, chlorine or bromine atom, by a methyl, trifluoromethyl, methoxy, nitro or cyano group and Rs denotes a hydrogen atom, wherein a hydrogen atom bound to a nitrogen atom in the abovementioned groups may be replaced by an acetyl or tert.butoxycarbonyl group, the carboxy groups contained in the abovementioned groups may also be present in the form of the tert.butoxycarbonyl precursor group and the saturated alkyl and alkoxy moieties contained in the abovementioned groups, which contain more than 2 carbon atoms, may be straight-chain or branched, unless otherwise stated, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
35 One subgroup of particularly preferred compounds of general formula I deserving special mention comprises those wherein X, R, and R, are as hereinbefore defined,
R
2 denotes a straight-chain or branched C.4,-alkoxycarbonyl group or a phenoxycarbonyl group, a straight-chain orbranched C 1 3 -alkoxycarbonyl group, which is terminally substituted in the alkyl moiety by a phenylcarboxy, C -3-alkoxycarbonyl, aminocarbonyl,
C
1 3 -alkylaminocarbonyl or di-(C 1 3 -alkyl)-aminocarbonyl group, or a straight-chain or branched C 2 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a hydroxy,
C
1 .3-alkoxy, amino, C 3 3-alkylamino or di-(C 1 3 -alkyl)-amino group, and
R
4 denotes an R,-(n-C_3-alkyl)-phenyl group, wherein R, denotes an amino, C,_--alkylamino, di-(C-_ 4 -alkyl) -amino, o-hydroxy-C 2 -3-alkyl-amino, N- (C_ 3 -alkyl) -o-hydroxy-C 2 -3-alkyl-amino, di- (o-hydroxy-C 2 3 -alkyl)-amino or di- (C,_--alkoxy)-C2-3-alkyl)-amino group, or a phenyl group substituted by the group of formula -N(RI2)-CO-(CH2)p-R13 (IV), wherein R 12 p and R 13 are as hereinbefore defined, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
36 A second subgroup of particularly preferred compounds of general formula I deserving special mention comprises those wherein X, R 3 and R. are as hereinbefore defined,
R
2 denotes an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C 1 3 -alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or N-(Cis-alkyl)-C 1 3 -alkylaminocarbonyl-phenyl group, R 2 may also denote a di-(C 1 -2-alkyl)-aminocarbonyl group and
R
4 denotes a R,-(n-C 1 3 -alkyl)-phenyl group, wherein
R
7 denotes an amino, C 1 6 -alkylamino, di-(C 1 4 -alkyl)-amino, )-hydroxy-C2- 3 -alkyl-amino, N- (C 1 3 -alkyl) -o-hydroxy- -C2-3-alkyl-amino, di-((o-hydroxy-C2-3-alkyl)-amino or di- (CI_ 3 -alkoxy)-C2- 3 -alkyl)-amino group, or a phenyl group substituted by the group of formula -N(RI2)-CO-(CH2)p-RI3 (IV), wherein R 12 p and R 13 are as hereinbefore defined, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
Most particularly preferred compounds of general formula I are those wherein X denotes an oxygen atom, 37 R and R, each denote a hydrogen atom,
R
2 denotes a methoxycarbonyl, ethoxycarbonyl or aminocarbonyl group,
R
3 denotes a phenyl group and
R
4 denotes a phenyl group monosubstituted by the group R 6 wherein
R
6 denotes an N-methyl-imidazol-2-yl group, an unbranched C 1 .3-alkyl group which is terminally substituted by a C,4-alkylamino, di-(C-_4-alkyl) -amino, piperidino or 2,6-dimethyl-piperidino group, a group of formula
-N(R
1 2
)-CO-(CH
2 )p-R1 3
(IV),
wherein
R
12 denotes a Cl -alkyl group, p denotes one of the numbers 1 or 2 and
R
13 denotes a di-(C- 3 _-alkyl)-amino group, or a group of formula -N(R14)-(CH2)q-(CO)r-R1 5 wherein R,4 denotes a C-_ 3 -alkyl-carbonyl or C,_-alkylsulphonyl group, 38 q denotes one of the numbers 1, 2 or 3, r denotes the number 1 or, if q is one of the numbers 2 or 3, r may also denote the number 0 and
R
15 denotes a di-(C, 3 -alkyl)-amino group, wherein the saturated alkyl moieties contained in the abovementioned groups which contain more than 2 carbon atoms may be straight-chain or branched, unless otherwise stated, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
A subgroup of most particularly preferred compounds of general formula I deserving special mention comprises those wherein X, R, and R s are as hereinbefore defined,
R
2 denotes a methoxycarbonyl or ethoxycarbonyl group and
R
4 denotes a di-(C.3-alkyl)-amino-C 1 3 -alkylphenyl group or a phenyl group substituted by the group of formula -N(RI2)-CO-(CH2)p-R13 (IV), wherein R 12 p and R 13 are as hereinbefore defined, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
The following are mentioned as examples of particularly preferred compounds: 39 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylenel -6-ethoxycarbonyl-2-indolinone, -I PL e e-ii A- '34 -Y 'I ni±'-1Ij -i-p -leilylmethylene] -6-carbamoyl-2-indolinone, 3-Z-[1-C4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene] -6 -methoxycarbonyl indolinone, 3-Z- [1-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] ethoxycarbonyl indolinone, 3-Z-[l-(4-((2,6-dimethyl-piperidin-1-yl)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- CN-(2-dimethylamino-ethyl)-N-acetyl-amino)-ani- 1mo) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- (3-dimethylamino-propyl) -N-acetyl-amino)-ani- 1mo) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, Ch) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indolinone, Wi 3-Z- [l-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, 3-Z- (N-acetyl-N-dimethylaminocarbonylmethyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, Ck) 3-Z- [1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene] 6 -methoxycarbonyl -2-indol inone, 3-Z-[1-(4-(1-methyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, 0 -40 (in) 3-Z- (N-dimethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone, 3-Z- (3dimethylamino-propyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinoie, 3-Z- (N-dimethylaminocarbonylmethyl-Nmethylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6met hoxycarbonyl indol inane, 3-Z- ((2-dimethylamino-ethyl) -carbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inane, 3-Z- (2-dimethylamino-ethyl)-N-acetyl-amino)-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone and 3-Z- (1-(4-methylaminomethyl-anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indolinone the tautomers, the mixtures and the salts thereof.
Another subgroup of compounds of general formula I comprises those wherein X denotes an oxygen or sulphur atom, R. denotes a hydrogen atom or a prodrug group such as a c 4 -alkoxycarbonyl or C 24 -alkanoyl group, 41 R2 denotes a carboxy group, a straight-chain or branched -alkoxycarbonyl group, a C,-,-cycloalkoxycarbonyl or phenyl- C,-3-alkoxycarbonyl group, an aminocarbonyl or C,-7-alkylaminocarbonyl grouip or, if R 4 does not denct- an aminosuiphonyl-phenyl or N- (C 1 5 ,-alkyl)-C-,-alkylaminocarbonylphenyl group, a di-(Cl 1 2 -alkyl)-aminocarbonyl group,
R
3 denotes a hydrogen atom, a C-6-alkyl, C,-,-cycloalkyl, trifluoromethyl or heteroaryl group, a phenyl or naphthyl group, a phenyl or naphthyl group monoor disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, C,-,-alkyl or C- 3 -alkoxy group, whilst in the event of disubstitution the substituents may be identical or different and wherein the abovementioned unsubstituted as well as the mono- and disubstituted phenyl and naphthyl groups may additionally be substituted by a hydroxy, hydroxy-C 1 3 ,-alkyl or C 1 alkoxy-C 1 alkyl group, by a cyano, carboxy, carboxy-Cl 1 3 -alkyl, C-3-alkoxycarbonyl, aminocarbonyl, C 1 alkylamino-carbonyl or di-(Cl- 3 -alkyl) -aminocarbonyl group, by a nitro group, by an amino, C-3-alkylamino, di-(Cl 1 3 -alkyl) -amino or amino-C 1 3 -alkyl group, by a C 1 3 -alkylcarbonylamino, N-(C 1 3 -alkyl) -C 1 3 -alkylcarbonylamino, C- 3 alkylcarbonylamino-C alkyl, N- (Cl- 3 -alkyl) -Cl- 3 -alkylcarbonylamino-C- 3 -alkyl, Cl- 3 -alkylsulphonylamino, Cl 1 3 -alkylsulphonylamino-C al kyl, N- (CI- 3 -alkyl) -Cl- 3 -alkylsulphonylamino-C 1 3 -alkyl or aryl-Cl- -alkylsulphonylamino group, 42 by a cycloalkylamino, cycloalkyleneimino, cycloalkyleneiminocarbonyl, cycloalkyleneimino-C, 3 -alkyl, cycloalkyleneiminocarbonyl-C-_3-alkyl or cycloalkyleneiminosulphonyl-C 1 3 -alkyl group having 4 to 7 ring members in each case, whilst in each case the methylene group in position 4 of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or
-N(CI_
3 -alkyl) group, or by a heteroaryl or heteroaryl-C_3-alkyl group,
R
4 denotes a C3.
7 -cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7membered cycloalkyl group may be substituted by an amino, C1 3-alkylamino or di-(C_ 3 -alkyl)-amino group or replaced by an -NH or -N(C_ 3 -alkyl) group, or a phenyl group substituted by the group which may additionally be substituted by a fluorine, chlorine, bromine or iodine atom, by a Cl_-alkyl, trifluoromethyl, C_ 3 -alkoxy, carboxy, C_.
3 -alkoxycarbonyl, aminosulphonyl, nitro or cyano group, wherein R, denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, C,_s-alkyl, C 3 _7-cycloalkyl, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group, a C-.3-alkoxy group optionally sunstituted by 1 to 3 fluorine atoms, a C-.3-alkoxy-Ci_ 3 -alkoxy, phenyl-Cl.
3 -alkoxy, amino-C2- -alkoxy, C_- 3 -alkylamino-C_ 3 -alkoxy, di-(C 3 -alkyl) -amino-C_ 3 -alkoxy, phenyl-C.
3 -alkylamino- 43
C
2 3 -alkoxy, N- (C,-,-alkvl) -phenyl-CI--alkvlamino-C2- alkoxy, cycloalkyleneimino-C 2 3 -alkoxy or C,-,-alkylmercapto group, -a ca-rboxy, C r inc c b -onyl amino-carbonyl, N- (C,-,-alkyl) -C alkylaminocarbonyl, phenyl-C 1 3 -alkylamino-carbonyl, N- (Cl 3 -alkyl) -phenyl-C 1 3 -alkylamino-carbonyl, piperazinocarbonyl or N- (Cl 1 3 -alkyl) -piperazinocarbonyl group, a C 1 3 -alkylaminocarbonyl or N-(C 1 5 ,-alkyl)- Cl- 3 -alkylaminocarbonyl group wherein an alkyl moiety is substituted by a carboxy or C 1 3 -alkoxycarbonyl group or is substituted in the 2 or 3 position by a di-(C 1 3 -alkyl)-amino, piperazino, N-(C 1 3 -alkyl) -piperazino or a 4- to 7-membered cycloalkyleneimino group, a 4- to 7-membered cycloalkyleneimino group, wherein a methylene group linked to the imino group may be replaced by a carbonyl or suiphonyl group or the cycloalkylene moiety may be fused to a phenyl ring or one or two hydrogen atoms may each be replaced by a CI-3-aikyl group and/or in each case the methylene group in the 4 position of a 6or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C- 3 -alkoxycarbonyl, aminocarbonyl,
C-
3 -alkylaminocarbonyl, di-(C 13 ,-alkyl)-aminocarbonyl, phenyl-C.
3 -aikylamino or N- (Cl 1 3 -alkyl)phenyl-C 1 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl) -N(phenyl),
-N(C
1 3 ,-alkyl-carbonyl) or -N(benzoyl) group, 44 a C 1 _4-alkyl group which may be substituted _y a ydroxy or C, -al'Aoxy group, by an amino, Cl_,-alkylamino, di-(C 1 7 -alkyl)-amino, di-N-(C,~ 3 -alkyl) -amino-C 2 3 -alkylamino, tri-N,N,N' (C- 3 -alkyl) -amino-C 2 3 -alkylamino, phenylamino, N-phenyl-C_ 3 -alkyl-amino, phenyl-C 3-alkylamino, N-(C_.3-alkyl)-phenyl-C, 3 alkylamino or di- (phenyl-C_3-alkyl)-amino group, by a Ci_ 3 -alkylcarbonylamino, N-(Ci.
3 -alkyl)-
C
1 3-alkylcarbonylamino, C, 3 alkoxycarbonyl-C, 3 -alkylamino or N-(C_3-alkyl)-C-.
3 -alkoxycarbonyl-C_ 3 -alkylamino group, by a C_,-cycloalkylamino, C 4 7 -cycloalkyl-CI _-alkylamino or
C
4 ,_-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a C 1 3 -alkyl group wherein some or all of the hydrogen atoms are replaced by fluorine atoms, by a CI-cycloalkyl, C 2 _4-alkenyl or C 1 _4-alkyl group, by a 4- to 7-membered cycloalkyleneimino group, wherein a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C,_ 3 -alkyl, C, 3 alkoxy or amino group or 45 one or two hydrogen atoms may each be replaced by a
C,
1 -alkyl, Cs,-cycloalkyl or phenyl group and/or in each case the methylenc group in the 4 posiLion of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, carboxy, C, 4 -alkoxycarbonyl, aminocarbonyl, C.
3 ,-alkylaminocarbonyl, di-(C 1 3 -alkyl)-aminocarbonyl, phenyl-C 1 3 -alkylamino or
N-(C
1 3 -alkyl)'-phenyl-Ci- 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl), -N(phenyl), -N(C_.3-alkyl-carbonyl) or -N(benzoyl) group, by a carboxy, C,_--alkoxycarbonyl, aminocarbonyl,
C,.
3 -alkylaminocarbonyl or di-(C 1 .3-alkyl)-aminocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group, an amino, pyrrolidino, piperidino, morpholino, benzoylamino or
N-(C_
3 -alkyl)-benzoylamino group, an N-(C_.3-alkyl)-C, 4 alkanoylamino group which is additionally substituted in the alkyl moiety by a carboxy or C,_3-alkoxycarbonyl group, a group of formula
-N(R
8
)-CO-(CH
2 )n-R 9
(II),
wherein R, denotes a hydrogen atom or a Ci.3-alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and 46-
R
9 denotes an amino, C 1 -4-alkylamino, phenylamino, N-(Cl.
4 -alkyl)-phenylamino, benzylamino, N-(Ci- 4 -alky])-benzylamino or di-(Ci.,-alkyl)-amino group, a 4- to 7-membered cycloalkyleneimino group, whilst in each case the methylene group in the 4 position of a 6- or 7membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH,
-N(C
1 _3-alkyl), -N(phenyl), -N(CI_ 3 -alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula
-N(R
10
)-(CH
2 )m-(CO)o-R 1
(III),
wherein Rio denotes a hydrogen atom, a C 1 3 -alkyl group, a
C
1 3 -alkylcarbonyl, arylcarbonyl, phenyl-C 1 3 -alkylcarbonyl,
C
1 3 -alkylsulphonyl, arylsulphonyl or phenyl-C~.3-alkylsulphonyl group, m denotes one of the numbers 1, 2, 3 or 4, o denotes one of the numbers 0 or 1 and
R
1 denotes an amino, Cl,4-alkylamino, phenylamino,
N-(C
1 4 -alkyl)-phenylamino, benzylamino,
N-(C-
4 -alkyl)-benzylamino or di-(Ci.
4 -alkyl)-amino group, a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, 3 -alkyl), -N(phenyl), -N(C,.3-alkyl-carbonyl) or 47 -N(benzoyl) group, a C 1 _3-alkoxy group or a di- (C, 4 -alkyl) -amino-C 1 3 -alkylamino group optionally substituted in the 1 position by a C~ 3-alkyl group, or an N-(C _3-alkyl) 5 -alkylsulphonylamino or
N-(C
1 3 -alkyl)-phenylsulphonylamino group wherein the alkyl moiety is additionally substituted by a cyano or carboxy group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R 6 may be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C.,-alkyl, trifluoromethyl, C_ 3 -alkoxy, carboxy, Cl_ 3 -alkoxycarbonyl, aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, and Rs denotes a hydrogen atom or a C 1 3 -alkyl group, wherein by an aryl group is meant a phenyl or naphthyl group optionally mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, C 1 .3-alkyl or Cl_--alkoxy group and by a heteroaryl group is meant a monocyclic 5- or 6-membered heteroaryl group optionally substituted by a C 1 3 -alkyl group, wherein the 6-membered heteroaryl group contains one, two or three nitrogen atoms and the 5-membered heteroaryl group contains an imino group optionally substituted by a C_13-alkyl group, an oxygen or sulphur atom or an imino group optionally substituted by a C 1 3 -alkyl group and an oxygen or sulphur atom or one or two nitrogen atoms, and moreover a phenyl ring may 48be fused to the abovementioned monocyclic heterocyclic groups via two adjacent carbon atoms, the saturated alkyl and alkoxy moieties present in the groups defined above which contain more than 2 carbon atoms also include the branched isomers thereof such as, for example, the isopropyl, tert.butyl or isobutyl group, unless otherwise stated, and additionally any carboxy, amino or imino group present may be substituted by a group which can be cleaved in vivo, the isomers and the salts thereof.
According to the invention the new compounds are obtained, for example, by the following methods known in principle from the literature: a. reacting a compound of general formula R3 X
(VII),
N
R
2
I
R18 wherein X and R 3 are as hereinbefore defined,
R
2 has the meanings given for R 2 hereinbefore,
R,
1 denotes a hydrogen atom or a protecting group for the nitrogen atom of the lactam group, wherein one of the groups
R
2 and Ri, may also denote a bond to a solid phase optionally formed via a spacer and the other one of the groups and R,, 49 has the abovementioned meanings, and Z, denotes a halogen atom, a hydroxy, alkoxy or aryl-alkoxy group, e.g. a chlorine or bromine atom, a methoxy, ethoxy or benzyloxy group, with an amine of general formula /Rs H N (VIII), R4 wherein
R
4 and R s are as hereinbefore defined, and if necessary subsequently cleaving any protecting group used for the nitrogen atom of the lactam group or cleaving from a solid phase.
The protecting group for the nitrogen atom of the lactam group may be, for example, an acetyl, benzoyl, ethoxycarbonyl, tert.butyloxycarbonyl or benzyloxycarbonyl group and the solid phase may be a resin such as a 4-(2',4'-dimethoxyphenylaminomethyl)-phenoxy resin, the bond preferably being formed via the amino group, or a pbenzyloxybenzyl alcohol resin, wherein the bond is conveniently formed via an intermediate member such as a dimethoxy-4-hydroxy-benzyl derivative.
The reaction is conveniently carried out in a solvent such as dimethylformamide, toluene, acetonitrile, tetrahydrofuran, dimethylsulphoxide, methylene chloride or mixtures thereof, optionally in the presence of an inert base such as triethylamine, N-ethyl-diisopropylamine or sodium hydrogen carbonate at temperatures between 20 and 175 0 C, whilst any protecting group used can be cleaved at the same time by transamidation.
50 If Z in a compound of general formula VII denotes a halogen atom, the reaction is preferably carried out in the presence of an inert base at temperatures of between 20 and 1200C.
If Z 1 in a compound of general formula VII denotes a hydroxy, alkoxy or arylalkoxy group, the reaction is preferably carried out at temperatures between 20 and 200 0
C.
If a protecting group used subsequently has to be cleaved, this is conveniently done either hydrolytically in an aqueous or alcoholic solvent, e.g. in methanol/water, ethanol/water, isopropanol/water, tetrahydrofuran/water, dioxan/water, dimethylformamide/water, methanol or ethanol in the presence of an alkali metal base such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures between 0 and 100 0 C, preferably at temperatures between 10 and 50 0
C,
or advantageously by transamidation with an organic base such as ammonia, butylamine, dimethylamine or piperidine in a solvent such as methanol, ethanol, dimethylformamide and the mixtures thereof or in an excess of the amine used, at temperatures between 0 and 100 0 C, preferably at temperatures between 10 and 50 0
C.
Cleaving from any solid phase used is preferably carried out using trifluoroacetic acid and water at temperatures between 0 and 35 0 C, preferably at ambient temperature.
b. In order to prepare a compound of general formula I wherein
R
2 has the meanings given hereinbefore, with the exception of the carboxy group: reacting a compound of general formula 51 R3 R1 0
(IX),
HOOC
I
RI
Ri wherein Ri and R 3 to R s are as hereinbefore defined, or the reactive derivatives thereof, with a compound of general formula H R 19 wherein
R
19 denotes a C 1 6 -alkanol, a C 4 7 -cycloalkanol or an aromatic alcohol, a C 1 .6-alkanol which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C_ 3 -alkoxy-carbonyl, aminocarbonyl, C 3-alkylamino-carbonyl or di-(C 1 .3-alkyl)-aminocarbonyl group, a C 2 6 -alkanol which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, C_.3-alkoxy, amino,
C,.
3 -alkylamino or di-(CI_3-alkyl)-amino group, an amino or methylamino group, an ethylamino group optionally substituted in the 2 position of the ethyl group by a hydroxy or C 1 -3-alkoxy group or a di-(C 1 -2-alkyl)-amino group.
The esterification or amidation is preferably carried out in a solvent such as methylene chloride, diethylether, tetrahydrofuran, toluene, dioxan, acetonitrile, dimethylsulphoxide or dimethylformamide, optionally in the presence of an inorganic or a tertiary organic base, 52 preferably at temperatures between 20 0 C and the boiling temperature of the solvent used. The reaction with a corresponding acid is preferably carried out in the presence of a dehydrating agent, e.g. in the presence of isobutyl chloroformate, tetraethyl orthocarbonate, trimethyl orthoacetate, 2,2-dimethoxypropane, tetramethoxysilane, thionylchloride, trimethylchlorosilane, phosphorus trichloride, phosphorus pentoxide, N,N'-dicyclohexylcarbodiimide, N,N'-dicyclohexylcarbodiimide/N-hydroxysuccinimide, N,N'-dicyclohexylcarbodiimide/1-hydroxy-benzotriazole, 2-(1H-benzotriazol-lyl)-1,1,3,3-tetramethyluronium-tetrafluoroborate, 2-(1Hbenzotriazol-l-yl)-1,1,3,3-tetramethyluroniumtetrafluoroborate/l-hydroxy-benzotriazole, N,N'-carbonyldiimidazole or triphenylphosphine/carbon tetrachloride, and optionally with the addition of a base such as pyridine, 4-dimethylaminopyridine, N-methyl-morpholine or triethylamine, conveniently at temperatures between 0 and 150 0 C, preferably at temperatures between 0 and 100 0 C, and the acylation with a corresponding reactive compound such as an anhydride, ester, imidazolide or halide thereof, is optionally carried out in the presence of a tertiary organic base such as triethylamine, N-ethyl-diisopropylamine or N-methyl-morpholine at temperatures between 0 and 150 0 C, preferably at temperatures between 50 and 100 0
C.
c. In order to prepare a compound of general formula I, wherein R 4 denotes a C 1 4 -alkyl group substituted by the group
R
7 wherein R, denotes an amino, C 1 _,-alkylamino, di-(C 1 ,-alkyl)-amino, phenylamino, N-phenyl-C_ 3 -alkyl-amino, phenyl-C 1 3 -alkylamino, N-(C_ 3 -alkyl)-phenyl-C_ 3 -alkylamino or di-(phenyl-C,_ 3 -alkyl)-amino group, 53 a ow-hydroxy-C,-,-alkyl -amino, N- (C 1 3 -alkyl) -w-hydroxy-C,_,-alkyl -amino, di- (wo-hydroxy-C,_,-alkyl) -amino, di- (Cl- 3 -alkoxy) -C,-,-alkyl) -amino or N- (dioxolan-2-yl) -C- 3 -alkyl-amino group, a C 1 3 -alkylcarbonylamino-C 2 -alkyl -amino or
C
3 -alkylcarbonylamirio-C 2 3 -alkyl-N- (C,-,-alkyl) -amino group, a C 1 3 -alkylsulphonylamino, N- (C,-,-alkyl)
C-
3 -a lkylsulphonylamino,
C-
3 -alkylsulphonylamino-C 2 3 -alky1 -amino or Cl- 3 -alkylsulphonylamino-C 2 3 -alky1-N- (C,-,-alkyl) -amino group, a group of formula N(RjO)-(CH 2 )m-4CO)o-Rjj (III), wherein Rio denotes a hydrogen atom, a C 1 3 -alkyl group, a
C
1 3 -alkylcarbonyl, arylcarbonyl, phenyl-Cl- 3 -alkylcarbonyl, Cl-3-al kylsuiphonyl, arylsuiphonyl or phenyl- C- alkylsuiphonyl group, m denotes one of the numbers 1, 2, 3 or 4, o denotes the number 1 and
R
11 denotes an amino, C,-,-alkylamino, di- (Cl- 4 -alkyl) -amino, phenylamino, N- (Cl 4 -alkyl) -phenylamino, benzylamino, N- (C 1 4 -alkyl) -benzylamino, C 1 4 -alkoxy or
C-
3 -alkoxy-C 1 3 -alkoxy group, a di- (C,-,-alkyl) -amino-C- 3 54 alkylamino group optionally substituted in the 1 position by a C 1 3 alkyl group, or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiet may b fused to a phenyl ring or in ach case the methylene group in the 4 position of a 6- or 7membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH,
-N(C
1 3 -alkyl), -N(phenyl), -N(C_ 3 -alkyl-carbonyl) or -N(benzoyl) group, a C 4 7 -cycloalkylamino, C 4 ,_-cycloalkyl-C-,-alkylamino or C4-7-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a Cs.,-cycloalkyl,
C
2 -4-alkenyl or C_ -alkyl group, or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C_3-alkyl, C1_3-alkoxy or amino group, and/or one or two hydrogen atoms may each be replaced by a C,.3-alkyl, Cs,_-cycloalkyl or phenyl group and/or the methylene group in the 3 position of a cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl, C_ 3 -alkoxy or C,.3-alkoxy-Ci_ 3 -alkyl group, in each case the methylene group in the 3 or 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C,_ 3 -alkyl, 55 Ci.3-alkoxy, C 1 _3-alkoxy-C 1 .3-alkyl, C-_4-alkoxycarbonyl, aminocarbonyl, CI_--alkylaminocarbonyl, di-(C 3 -alkyl)aminocarbonyl, phenyl-C- 3 -alkylamino or N-(C 3 -alkyl)phienyl -a-i-y-Llamjino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl-), -N(phenyl), -N(phenyl-C,_ 3 -alkyl-) -N(C- 3 -alkyl-carbonyl-), -N(Cl_ 4 -alkoxy-carbonyl-), -N(benzoyl-) or -N(phenyl-C. 3-alkyl-carbonyl-) group, wherein a methylene group linked to an iminonitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the iminonitrogen atom may each be replaced by a carbonyl group: reacting a compound of general formula
R
3 Rs I A- Z2
N
x
(XI),
N
R2'
RI
wherein
R
3
R
5 and X are as hereinbefore defined,
R
2 has the meanings given for R 2 hereinbefore, Ri 8 denotes a hydrogen atom or a protecting group for the nitrogen atom of the lactam group, wherein one of the groups
R
2 and R 8 may also denote a bond to a solid phase optionally 56 formed via a spacer and the other one of the groups R 2 and R,, has the abovementioned meanings, A denotes a C,-4-alkyl group and Z 2 denotes a leaving group, for example an alkyl or arysulphonyloxy group such as the methysulphonyloxy, ethylsulphonyloxy, p-toluenesulphonyloxy or trifluoromethanesulphonyloxy group, with an amine of general formula
(XII),
wherein R has the meanings given for R, hereinbefore, and subsequently, if necessary, cleaving any protecting group used for the nitrogen atom of the lactam group, or cleaving from a solid phase.
The reaction is conveniently carried out in a solvent such as methylene chloride, tetrahydrofuran, 1,4-dioxan, toluene, acetonitrile, dimethylsulphoxide, dimethylformamide, dimethylacetamide, N-methylpyrrolidone or the mixtures thereof, optionally with the addition of water as a co-solvent and/or with the addition of an inert auxiliary base, e.g. sodium hydrogen carbonate, pyridine, 2,4,6-trimethylpyridine, quinoline, triethylamine, N-ethyldiisopropylamine, N-ethyldicyclohexylamine, 1,4-diazabicyclo[2,2,2]octane or 1,8diazabicyclo[5,4,0]undec-7-ene, at temperatures between -50 0
C
and +100 0 C, preferably between -10 0 C and +50 0 C, while any protecting group used may be cleaved at the same time by transamidation.
If any protecting group used for the nitrogen atom of the lactam group has to be removed or if the compound has to be cleaved from a solid phase this is carried out as described under method above.
57 If according to the invention a compound of general formula I is obtained which contains an alkoxycarbonyl group, this may be converted by hydrolysi into a corresponding carboxy compound, or if a compound of general formula I is obtained which contains an amino or alkylamino group, this may be converted by reductive alkylation into a corresponding alkylamino or dialkylamino compound, or if a compound of general formula I is obtained which contains an amino or alkylamino group, this may be converted by acylation or sulphonation into a corresponding acyl or sulphonyl compound, or if a compound of general formula I is obtained which contains a carboxy group, this may be converted by esterification or amidation into a corresponding ester or aminocarbonyl compound, or if a compound of general formula I is obtained which contains a cycloalkyleneimino group wherein a methylene group is replaced by a sulphur atom, this may be converted by oxidation into a corresponding sulphinyl or sulphonyl compound, or if a compound of general formula I is obtained which contains a nitro group, this may be converted by reduction into a corresponding amino compound, or if a compound of general formula I is obtained wherein R 4 denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group, this may subsequently be converted, by reaction with a corresponding cyanate, isocyanate or carbamoyl halide, into a corresponding urea compound of general formula I, or 58 if a compound of general formula I is obtained wherein R 4 denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group, this may subsequently be converted, by reaction with a corresponding compound which transfers the amidino group or by reaction with a corresponding nitrile, into a corresponding guanidino compound of general formula I.
The subsequent hydrolysis is preferably carried out in an aqueous solvent, e.g. in water, methanol/water, ethanol/water, isopropanol/water, tetrahydrofuran/water or dioxan/water, in the presence of an acid such as trifluoroacetic acid, hydrochloric acid or sulphuric acid or in the presence of an alkali metal base such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures between 0 and 100 0
C,
preferably at temperatures between 10 and 50 0
C.
The subsequent reductive alkylation is preferably carried out in a suitable solvent such as methanol, methanol/water, methanol/water/ammonia, ethanol, ether, tetrahydrofuran, dioxan or dimethylformamide, optionally with the addition of an acid such as hydrochloric acid in the presence of catalytically activated hydrogen, e.g. hydrogen in the presence of Raney nickel, platinum or palladium/charcoal, or in the presence of a metal hydride such as sodium borohydride, lithium borohydride, sodium cyanoborohydride or lithium aluminium hydride at temperatures between 0 and 100 0
C,
preferably at temperatures between 20 and 80 0
C.
The subsequent acylation or sulphonylation is preferably carried out with the corresponding free acid or a corresponding reactive compound such as the anhydride, ester, imidazolide or halide thereof, preferably in a solvent such as methylene chloride, diethylether, tetrahydrofuran, toluene, dioxan, acetonitrile, dimethylsulphoxide or dimethylformamide, 59 optionally in the presence of an inorganic or tertiary organic base at temperatures between -20 and 200°C, preferably at temperatures between 200C and boiling temperature of the solvent used. The reaction with the free acid may optionally be carried out in the presence of an acid-activating agent or a dehydrating agent, e.g. in the presence of isobutyl chloroformate, tetraethyl orthocarbonate, trimethyl orthoacetate, 2,2-dimethoxypropane, tetramethoxysilane, thionyl chloride, trimethylchlorosilane, phosphorus trichloride, phosphorus pentoxide, N,N'-dicyclohexylcarbodiimide, N,N'-dicyclohexylcarbodiimide/N-hydroxysuccinimide, N,N'-dicyclohexylcarbodiimide/l-hydroxy-benzotriazole, 2-(1H-benzotriazol-l-yl)-1,1,3,3-tetramethyluroniumtetrafluoroborate, 2-(1H-benzotriazol-l-yl)-1,1,3,3tetramethyluronium-tetrafluoroborate/1-hydroxy-benzotriazole, N,N'-carbonyldiimidazole or triphenylphosphine/carbon tetrachloride, and optionally with the addition of a base such as pyridine, 4-dimethylamino-pyridine, N-methyl-morpholine or triethylamine, conveniently at temperatures between 0 and 1500C, preferably at temperatures between 0 and 100 0 C. The reaction with a corresponding reactive compound may optionally be carried out in the presence of a tertiary organic base such as triethylamine, N-ethyl-diisopropylamine, N-methylmorpholine or pyridine or by using an anhydride in the presence of the corresponding acid at temperatures between 0 and 1500C, preferably at temperatures between 50 and 100 0
C.
The subsequent esterification or amidation is conveniently carried out by reacting a corresponding reactive carboxylic acid derivative with a corresponding alcohol or amine as described hereinbefore.
The subsequent oxidation of the sulphur atom is preferably carried out in a solvent or mixture of solvents, e.g. in water, water/pyridine, acetone, methylene chloride, acetic 60 acid, acetic acid/acetic anhydride, dilute sulphuric acid or trifluoroacetic acid, usefully at temperatures of between and 100 0 C depending on the oxidising agent used.
In order to prepare a corresponding sulphinyl compound of general formula I the oxidation is expediently carried out with one equivalent of the oxidising agent used, e.g. with hydrogen peroxide in glacial acetic acid, trifluoroacetic acid or formic acid at 0 to 20 0 C or in acetone at 0 to 60 0 C, with a peracid such as performic acid in glacial acetic acid or trifluoroacetic acid at 0 to 50 0 C or with m-chloroperbenzoic acid in methylene chloride, chloroform or dioxan at -20 to 0 C, with sodium metaperiodate in aqueous methanol or ethanol at -15 to 25 0 C, with bromine in glacial acetic acid or aqueous acetic acid optionally in the presence of a weak base such as sodium acetate, with N-bromosuccinimide in ethanol, with tert.butyl hypochlorite in methanol at -80 to -30 0 C, with iodobenzodichloride in aqueous pyridine at 0 to 50 0 C, with nitric acid in glacial acetic acid at 0 to 20 0 C, with chromic acid in glacial acetic acid or in acetone at 0 to 20 0 C and with sulphuryl chloride in methylene chloride at -70 0 C, the resulting thioether-chlorine complex is expediently hydrolysed with aqueous ethanol.
In order to prepare a sulphonyl compound of general formula I the oxidation is expediently carried out starting from a corresponding sulphinyl compound with one or more equivalents of the oxidising agent used or starting from a corresponding mercapto compound, expediently with two or more equivalents of the oxidising agent used, e.g. with hydrogen peroxide in glacial acetic acid/acetic anhydride, trifluoroacetic acid or in formic acid at 20 to 100 0 C or in acetone at 0 to 60 0 C, with a peracid such as performic acid or m-chloroperbenzoic acid in glacial acetic acid, trifluoroacetic acid, methylene chloride or chloroform at temperatures between 0 and 60 0 C, with nitric acid in glacial acetic acid at 0 to 20 0 C, with chromic acid, 61 sodium periodate or potassium permanganate in acetic acid, water/sulphuric acid or in acetone at 0 to 20 0
C.
The subsequent reduction of a nitro group is preferably carried out by hydrogenolysis, e.g. with hydrogen in the presence of a catalyst such as palladium/charcoal or Raney nickel in a solvent such as methanol, ethanol, ethyl acetate, dimethylformamide, dimethylformamide/acetone or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid or glacial acetic acid at temperatures of between 0 and 50 0 C, but preferably at ambient temperature, and at a hydrogen pressure of 1 to 7 bar, but preferably 3 to bar.
The subsequent preparation of a corresponding urea compound of general formula I is conveniently carried out with an inorganic cyanate or a corresponding isocyanate or carbamoylchloride, preferably in a solvent such as dimethylformamide and optionally in the presence of a tertiary organic base such as triethylamine at temperatures between 0 and 50 0 C, preferably at ambient.
The subsequent preparation of a corresponding guanidino compound of general formula I is conveniently carried out by reacting with a compound which transfers the amidino group such as 3,5-dimethylpyrazole-l-carboxylic acid amidine, preferably in a solvent such as dimethylformamide and optionally in the presence of a tertiary organic base such as triethylamine at temperatures of between 0 and 50 0
C,
preferably at ambient temperature.
In the reactions described hereinbefore, any reactive groups present such as carboxy, hydroxy, amino, alkylamino or imino groups may be protected during the reaction by conventional protecting groups which are cleaved again after the reaction.
62 For example, a protecting group for a carboxyl group may be a trimethylsilyl, methyl, ethyl, tert.butyl, benzyl or tetrahydropyranyl group and protecting groups for a hydroxy, amino, alkylamino or imino group may be an acetyl, trifluoroacetyl, benzoyl, ethoxycarbonyl, tert.butoxycarbonyl, benzyloxycarbonyl, benzyl, methoxybenzyl or 2,4-dimethoxybenzyl group and additionally, for the amino group, a phthalyl group.
Any protecting group used is optionally subsequently cleaved for example by hydrolysis in an aqueous solvent, e.g. in water, isopropanol/water, tetrahydrofuran/water or dioxan/water, in the presence of a acid such as trifluoroacetic acid, hydrochloric acid or sulphuric acid or in the presence of an alkali metal base such as lithium hydroxide, sodium hydroxide or potassium hydroxide, at temperatures between 0 and 100 0 C, preferably at temperatures between 10 and 50 0
C.
However, a benzyl, methoxybenzyl or benzyloxycarbonyl group is cleaved, for example, hydrogenolytically, e.g. with hydrogen in the presence of a catalyst such as palladium/charcoal in a solvent such as methanol, ethanol, ethyl acetate, dimethylformamide, dimethylformamide/acetone or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid or glacial acetic acid at temperatures between 0 and 500C, but preferably at ambient temperature, and at a hydrogen pressure of 1 to 7 bar, but preferably 3 to bar.
A methoxybenzyl group may also be cleaved in the presence of an oxidising agent such as cerium(IV)ammonium nitrate in a solvent such as methylene chloride, acetonitrile or 63 acetonitrile/water at temperatures of between 0 and 50 0 C, but preferably at ambient temperature.
A 2,4-dimethoxybenzyl group, however, is preferably cleaved in trifluoroacetic acid in the presence of anisole.
A tert.butyl or tert.butyloxycarbonyl group is preferably cleaved by treating with an acid such as trifluoroacetic acid or hydrochloric acid, optionally using a solvent such as methylene chloride, dioxan, ethyl acetate or ether.
A phthalyl group is preferably cleaved in the presence of hydrazine or a primary amine such as methylamine, ethylamine or n-butylamine in a solvent such as methanol, ethanol, isopropanol, toluene/water or dioxan at temperatures between and 50 0
C.
Moreover, chiral compounds of general formula I obtained may be resolved into their enantiomers and/or diastereomers.
Thus, for example, the compounds of general formula I obtained which occur as racemates may be separated by methods known per se (cf. Allinger N. L. and Eliel E. L. in "Topics in Stereochemistry", Vol. 6, Wiley Interscience, 1971) into their optical antipodes and compounds of general formula I with at least 2 asymmetric carbon atoms may be resolved into their diastereomers on the basis of their physical-chemical differences using methods known per se, e.g. by chromatography and/or fractional crystallisation, and, if these compounds are obtained in racemic form, they may subsequently be resolved into the enantiomers as mentioned above.
The enantiomers are preferably separated by column separation on chiral phases or by recrystallisation from an optically active solvent or by reacting with an optically active 64 substance which forms salts or derivatives such as e.g. esters or amides with the racemic compound, particularly acids and the activated derivatives or alcohols thereof, and separating the mixture of diasLereomeric salts or derivatives thus obtained, e.g. on the basis of their differences in solubility, whilst the free antipodes may be released from the pure diastereomeric salts or derivatives by the action of suitable agents. Optically active acids in common use are e.g.
the D- and L-forms of tartaric acid or dibenzoyltartaric acid, di-o-tolyltartaric acid, malic acid, mandelic acid, camphorsulphonic acid, glutamic acid, N-acetylglutamic acid, aspartic acid, N-acetylaspartic acid or quinic acid. An optically active alcohol may be for example or (-)-menthol and an optically active acyl group in amides, for example, may be a or (-)-menthyloxycarbonyl group.
Furthermore, the compounds of formula I obtained may be converted into the salts thereof, particularly for pharmaceutical use into the physiologically acceptable salts with inorganic or organic acids. Acids which may be used for this purpose include for example hydrochloric acid, hydrobromic acid, sulphuric acid, phosphoric acid, fumaric acid, succinic acid, lactic acid, citric acid, tartaric acid, maleic acid or methanesulphonic acid.
Moreover, if the new compounds of formula I thus obtained contain a carboxy group, they may subsequently, if desired, be converted into the salts thereof with inorganic or organic bases, particularly for pharmaceutical use into the physiologically acceptable salts thereof. Suitable bases for this purpose include for example sodium hydroxide, potassium hydroxide, cyclohexylamine, ethanolamine, diethanolamine and triethanolamine.
The compounds of general formulae VII to XII used as starting materials are known from the literature in some cases or may 65 be obtained by methods known from the literature or may be obtained by the methods described hereinbefore and in the Examples. For example, the compounds of general formula VI are described in German Patent Application 198 24 922.5.
Moreover, the compounds of general formula XI may be obtained from the compounds of general formula I wherein R 4 denotes a
C
1 4 -alkyl-phenyl group substituted in the alkyl moiety by a hydroxy group, for example, by reacting with alkyl- or arylsulphonyl chlorides.
As already mentioned, the new compounds of general formula I wherein R 1 denotes a hydrogen atom or a prodrug group have valuable pharmacological properties, particularly inhibitory effects on various kinases, especially on receptor-tyrosine kinases such as VEGFR2, PDGFRa, PDGFRP, FGFR1, FGFR3, EGFR, HER2, IGF1R and HGFR, as well as on complexes of CDK's (Cyclin Dependent Kinases) such as CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9 with their specific cyclins Bl, B2, C, D1, D2, D3, E, F, Gl, G2, H, I and K) and on viral cyclin, on the proliferation of cultivated human cells, particularly endothelial cells, e.g. in angiogenesis, but also on the proliferation of other cells, particularly tumour cells.
The biological properties of the new compounds were tested by the following standard procedure, as follows: Human umbilical endothelial cells (HUVEC) were cultivated in IMDM (Gibco BRL), supplemented with 10 foetal calf serum (FBS) (Sigma), 50 AM of I-mercaptoethanol (Fluka), standard antibiotics, 15 Ag/ml of endothelial cell growth factor (ECGS, Collaborative Biomedical Products) and 100 Ag/ml of heparin (Sigma) on gelatine-coated culture dishes (0.2 gelatine, Sigma) at 37 0 C, under 5 CO 2 in a water-saturated atmosphere.
66 In order to investigate the inhibitory activity of the compounds according to the invention the cells were starved for 16 hours, i.e. kept in culture medium without growth factors (ECGS heparin). The cells were detached from the culture dishes using trypsin/EDTA and washed once in serumcontaining medium. Then they were seeded out in amounts of x 10 3 cells per well.
The proliferation of the cells was stimulated with 5 ng/ml of
VEGF
16 5 (vascular endothelial growth factor; H. Weich, GBF Braunschweig) and 10 gg/ml of heparin. As a control, 6 wells in each dish were not stimulated.
The compounds according to the invention were dissolved in 100% dimethylsulphoxide and added to the cultures in various dilutions in triplicate, the maximum dimethyl sulphoxide concentration being 0.3 The cells were incubated for 76 hours at 37 0 C, then for a further 16 hours 3 H-thymidine (0.1 A Ci/well, Amersham) was added in order to determine the DNA synthesis. Then the radioactively labelled cells were immobilised on filter mats and the radioactivity incorporated was measured in a 6counter. In order to determine the inhibitory activity of the compounds according to the invention the mean value of the non-stimulated cells was subtracted from the mean value of the factor-stimulated cells (in the presence or absence of the compounds according to the invention).
The relative cell proliferation was calculated as a percentage of the control (HUVEC without inhibitor) and the concentration of active substance which inhibits the proliferation of the cells by 50 (IC 5 0 was determined.
S -67 The test results of the following compounds to of general formula I are given by way of example: methy-7ene] -6-etAoyIarbonyl-2-indolinone, Ib Z-[(L-(4Itpiperidi -1-yl-methyl) -ai Lio-penl methylene] -6-carbxayl-2-indolinone, 3-Z- [1-(4-(piperidin-1-yl-methyl)-anilino)--phenylmethylene] -6 -methaoyaboy-indolinone, 3-Z- (1-(4-(dimethylinoymethyl)-anilino) phenylmethylene] -6-methoxycarbonyl-2-indolinone, 3-Z-[l-(4-((2,6-dilmty-ppri-1y)methyl)-anilino)-i-hnl 1-hlmethylene -6-ethoxycarbonyl-2-indolinone, 3-Z- [1-(4-(N(2-dimethylaminoethinyl)-aetyl-ai) alo-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- [l-(4-(N-(3-dimethylamino-proyl)-N-acetyl-amino)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indolinone, 3-Z- [l-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] -6 -methoxycarbonyl -2-indolinone, 3-Z- (N-acetyl-N-dimethylaminocarbonylmethyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- [1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone, 68 3-Z-[1-(4-C1-methyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, Cm) 3-Z-[li- CN-dimethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- [1-(4-(N-(2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2ndol inone, 3-Z- (3-dimethylamina-prapyl) -N-methylsulphanylamino) -anilina) -1-phenyl-methylene] -6-methoxycarbanyl-2indalinane, 3-Z- Ii- (N-dimethylaminocarbonylmethyl-Nmethylsuiphanyl-amino) -anilina) -1-phenyl-methylene] -6methaxycarbanyl-2 -indal inane, 3-Z- ((2-dimethylamina-ethyl) -carbanyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indalinone, 3-Z- (N-(2-dimethylamino-ethyl)-N-acetyl-amina)anilina) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone and 3-Z- [1-C4-methylaminomethyl-anilina) -l-phenyl-methylene] 6-methoxycarbonyl-2-indolinone.
69 The following Table contains the results found: Compound IC50 [im] 0.04 0.35 0.01 0.02 0.05 0.01 0.003 0.01 0.03 0.02 0.03 0.1 0.02 0.02 0.01 0.02 0.02 0.01 0.04 In view of their inhibitory effect on the proliferation of cells, particularly endothelial cells and tumour cells, the compounds of general formula I are suitable for treating diseases in which the proliferation of cells, particularly endothelial cells, plays a part.
Thus, for example, the proliferation of endothelial cells and the concomitant neovascularisation constitute a crucial stage in tumour progression (Folkman J. et al., Nature 339, 58-61, (1989); Hanahan D. and Folkman Cell 86, 353-365, (1996)).
Furthermore, the proliferation of endothelial cells is also 70 important in haemangiomas, in metastasisation, rheumatoid arthritis, psoriasis and ocular neovascularisation (Folkman Nature Med. 1, 27-31, (1995)). The therapeutic usefulness of inhibitors of endothelial cell proliferation was demonstrated in the animal model for example by O'Reilly et al. and Parangi et al. (O'Reilly M.S. et al., Cell 88, 277- 285, (1997); Parangi S. et al., Proc Natl Acad Sci USA 93, 2002-2007, (1996)).
The compounds of general formula I, their tautomers, their stereoisomers or the physiologically acceptable salts thereof are thus suitable, for example, for treating tumours (e.g.
plate epithelial carcinoma, astrocytoma, Kaposi's sarcoma, glioblastoma, lung cancer, bladder cancer, carcinoma of the neck, melanoma, ovarian cancer, prostate cancer, breast cancer, small-cell lung cancer, glioma, colorectal carcinoma, urogenital cancer and gastrointestinal carcinoma as well as haematological cancers, such as multiple myeloma), psoriasis, arthritis rheumatoid arthritis), haemangioma, angiofibroma, eye diseases diabetic retinopathy), neovascular glaucoma, kidney diseases (e.g.
glomerulonephritis), diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy, fibrotic diseases cirrhosis of the liver), mesangial cell proliferative diseases, arteriosclerosis and damage to the nerve tissue and also for inhibiting the reocclusion of blood vessels after treatment with a balloon catheter, in vascular prosthetics or after the insertion of mechanical devices for keeping blood vessels open stents), or other diseases in which cell proliferation or angiogenesis are involved.
By reason of their biological properties the compounds according to the invention may be used on their own or in conjunction with other pharmacologically active compounds, for example in tumour therapy, in monotherapy or in conjunction 71 with other anti-tumour therapeutic agents, for example in combination with topoisomerase inhibitors etoposide), mitosis inhibitors vinblastin, taxol), compounds which interact with nucleic acids cis-platin, cyclophosphamide, adriamycin), hormone antagonists (e.g.
tamoxifen), inhibitors of metabolic processes etc.), cytokines interferons), kinase inhibitors, antibodies, or in conjunction with radiotherapy, etc. These combinations may be'administered either simultaneously or sequentially.
For pharmaceutical use the compounds according to the invention are generally used for warm-blooded vertebrates, particularly humans, in doses of 0.01-100 mg/kg of body weight, preferably 0.1-20 mg/kg. For administration they are formulated with one or more conventional inert carriers and/or diluents, e.g. with corn starch, lactose, glucose, microcrystalline cellulose, magnesium stearate, polyvinylpyrrolidone, citric acid, tartaric acid, water, water/ethanol, water/glycerol, water/sorbitol, water/polyethylene glycol, propylene glycol, stearyl alcohol, carboxymethylcellulose or fatty substances such as hard fat or suitable mixtures thereof in conventional galenic preparations such as plain or coated tablets, capsules, powders, injectable solutions, ampoules, suspensions, solutions, sprays or suppositories.
72 The Examples which follow are intended to illustrate the invention: Abbreviations used: FMOC 9-fluorenylmethoxycarbonyl HOBt l-hydroxy'lH-benzotriazole TBTU O-benzotriazol-l-yl-N,N,N',N'-tetramethyluroniumtetrafluoroborate DBU 1,8-diazabicyclo[5.4.0]undec-7-ene Preparation of the starting compounds: Solid phase Example I g of Rink resin (MBHA resin, made by Messrs Novabiochem) are left to swell in 30 ml of dimethylformamide. Then 40 ml of piperidine in dimethylformamide are added and the mixture is shaken for 7 minutes to cleave the FMOC protecting group.
The resin is then washed repeatedly with dimethylformamide.
Then 0.4 g of 2-indolinone-6-carboxylic acid (prepared analogously to Langenbeck et al., Justus Liebigs Ann. Chem.
499, 201-208 (1932)), 297 mg HOBt, 706 mg TBTU and 0.9 ml of N-ethyl-diisopropylamine in 30 ml of dimethylformamide are added and the mixture is shaken for 1 hour. Then the solution is suction filtered and the resin is washed five times with ml of dimethylformamide and three times with 30 ml of methylene chloride. To dry it, nitrogen is blown through the resin.
Yield: 1.9 g of charged resin 73 Solid phase example II 1.9 g of the resin obtained in Example I are stirred with 6 ml of acetic anhydride and 6 mi of triethyl orthobenzoate for 3 hours at 110 0 C. Then the mixture is left to cool and the resin is washed with dimethylformamide and subsequently with methylene chloride.
Yield: 1.9 g of moist resin The following charged resins are prepared analogously to Example II: resin charged with 3-Z-(1-ethoxy-methylene)-6-carbamoyl-2indolinone Prepared by reacting the resin obtained according to Example I with triethyl orthoformate resin charged with 3-Z-(1-methoxy-l-methyl-methylene)-6carbamoyl-2-indolinone Prepared by reacting the resin obtained according to Example I with trimethyl orthoacetate resin charged with 3-Z-(l-methoxy-l-ethyl-methylene)-6carbamoyl-2-indolinone Prepared by reacting the resin obtained according to Example I with trimethyl orthopropionate resin charged with 3-Z-(l-methoxy-l-propyl-methylene)-6carbamoyl-2-indolinone Prepared by reacting the product of Example I and trimethyl orthobutyrate 74 Example III N-(4-nitrophenyl)-N-methyl-methanesulphonamide g of N-methyl-4-nitroaniline are dissolved in 20 mi ot pyridine and 2.4 g of methanesulphonic acid chloride added dropwise at room temperature. The mixture is stirred for 12 hours at room temperature. After this time the mixture is poured onto water, the precipitate formed is filtered off and dried at 50°C in vabuo.
Yield: 4.0 g (87 of theory), Rf value: 0.5 (silica gel, ethyl acetate/toluene 7:3) Melting point: 107-108 °C Example IV N-(2-dimethylamino-ethyl)-N-methylsulphonyl-4-nitroaniline 38.9 g of N-methylsulphonyl-4-nitroaniline are dissolved in 1 of acetone, 51.9 g of l-chloro-2-dimethylamino-ethane, 77.4 g of potassium carbonate and 5.0 g of sodium iodide are added and the mixture is stirred for a total of 4 days at 500C, while after 12 hours a further 25.9 g of l-chloro-2dimethylamino-ethane, 49.8 g of potassium carbonate and 5.0 g of sodium iodide in 500 ml of acetone are added and after 36 hours another 26.0 g of l-chloro-2-dimethylamino-ethane, 50.0 g of potassium carbonate and 5.0 g of sodium iodide in 100 ml of acetone are added. After this time the mixture is filtered and the filtrate evaporated down. The residue is stirred with ether, suction filtered and dried at 400C.
Yield: 25.3 g (49 of theory), Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia 9:1:0.1) CI HN4S ESI mass spectrum: m/z 288 75 The following compounds are prepared analogously to Example
IV:
4-LN-(3-dimethylamino-propyl)-N-methylsulphonyl-amino]nitrobenzene N-carboxymethyl-N-methylsulphonyl-4-nitroaniline N-cyanomethyl-N.methylsulphonyl-p-phenylenediamine 4-[N-(2-(N-benzyl-N-methyl-amino)-ethyl)-Nmethylsulphonyl-amino]-nitrobenzene 4-[N-(3-phthalimido-2-yl-propyl)-N-methylsulphonyl-amino]nitrobenzene 4-[N-(3-(N-benzyl-N-methyl-amino)-propyl)-Nmethylsulphonyl-amino]-nitrobenzene Example V N-(dimethylaminocarbonyl-methyl)-N-methylsulphonyl-4nitroaniline g of N-carboxymethyl-N-methylsulphonyl-4-nitroaniline, g of dimethylamine hydrochloride, 8.1 g of TBTU and 3.9 g of HOBT are dissolved in 125 ml of dimethylformamide and at 0 C 17.6 ml of N-ethyl-diisopropylamine are added. The mixture is stirred for 4 hours at room temperature, diluted with 1 1 of water and the precipitate formed is suction filtered. After washing with water, ethanol and ether the residue is dried at 0 C in vacuo.
Yield: 5.3 g (69 of theory), Rf value: 0.40 (silica gel, methylene chloride/methanol 9:1)
C
1
H
15 N0OsS ESI mass spectrum: m/z 300 76 The following compounds are prepared analogously to Example V: 4-[(N-dimethylaminocarbonylmethyl)-amino]-nitrobenzene prepared from 4-(N-carboxymethyl-amino)-nitrobenzene and dimethylamine hydrochloride 4-(N-methylaminocarbonylmethyl-N-methylsulphonyl-amino)nitrobenzene Prepared from N-carboxymethyl-N-methylsulphonyl-4-nitroaniline and methylamine hydrochloride 4-[(N-(methylcarbamoyl-methyl)-N-methyl-amino)-methyl]nitrobenzene Prepared from 4-[(N-carboxymethyl-N-methyl-amino)-methyl]nitrobenzene and methylamine hydrochloride 4-[(N-(dimethylcarbamoyl-methyl)-N-methyl-amino)-methyl]nitrobenzene Prepared from 4-[(N-carboxymethyl-N-methyl-amino)-methyl]nitrobenzene and dimethylamine hydrochloride Example VI 4-[N-(2-dimethylamino-ethyl)-N-acetyl-amino]-nitrobenzene 3.6 g of 4-(2-dimethylamino-ethylamino)-nitrobenzene (according to Gabbay et al., J. Am. Chem. Soc. 91, 5136 (1969)) are dissolved in 50 ml of methylene chloride and ml of triethylamine are added. 1.3 ml of acetyl chloride are slowly added dropwise to this mixture at room temperature and the mixture is stirred for 2 hours at room temperature. After this time another 5.0 ml of triethylamine and 1.3 ml of acetylchloride are added and the mixture is refluxed for another 2 hours. The solvent is removed, the residue is taken up in ethyl acetate and the organic phase is extracted twice 77 with water. After drying over MgSO, the solvent is removed and the residue dried in vacuo.
Yield: 2.0 g (45 of theory), R, value: 0.55 (silica gel, methylene chloride/methanol/ammonia 9:1:0.1)
C
12 HIN303 ESI mass spectrum: m/z 252 The following compounds are prepared analogously to Example
VI:
4-[N-(3-dimethylamino-propyl)-N-acetyl-amino]-nitrobenzene Prepared from 4-(3-dimethylamino-propylamino)-nitrobenzene (according to Gabbay et al., J. Am. Chem. Soc. 91, 5136 (1969) and acetyl chloride 4-[N-(2-dimethylamino-ethyl)-N-propionyl-amino]nitrobenzene Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and propionyl chloride 4- [N-acetyl-N-(dimethylaminocarbonylmethyl)-amino]nitrobenzene Prepared from 4-[N-(dimethylaminocarbonylmethyl)-amino]nitrobenzene and acetyl chloride 4-[N-(2-dimethylamino-ethyl)-N-butyryl-amino]-nitrobenzene Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and butyryl chloride 4-[N-(2-dimethylamino-ethyl)-N-isobutyryl-amino]nitrobenzene Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and isobutyryl chloride 78 4-E[N- (2 -dimethylamino- ethyl) -N-benzoyl -amino] nitrobenzene Prepared from 4- (2-dimethylamino-ethylamino) -nitrobenzene and benzoyl chloride 4- [N-(2-dimethylamino-ethyl)-N-acetyl-amino] -1,3dinitrobenzene Prepared from 4- (2-dimethylamino-ethyl-amino) -1,3dinitrobenzene and acetyl chloride 4- (2-dimethylamino-ethyl) (furan-2-carbonyl) -amino] nitrobenzene Prepared from 4- (2-dimethylamino-ethylamino) -nitrobenzene and furan-2-carbonyl chloride 4 IN- (2 -dimethylamino- ethyl) (2 -methoxy-benzoyl) amino]nitrobenzene Prepared from 4- (2-dimethylamino-ethylamino) -nitrobenzene and 2-methoxy-benzoyl chloride 4-IN- (2-dimethylamino-ethyl) (pyridine-3-carbonyl) amino] -nitrobenzene Prepared from 4- (2 -dimethylamino -ethyl amino) -nitrobenzene and nicotinic acid chloride (11) 4 -IN- (2 -dimethylamino -ethyl) (phenyl -acetyl) amino] nitrobenzene Prepared from 4- (2-dimethylamino-ethylamino) -nitrobenzene and phenylacetyl -chloride (12) 4-I[N- (2 -dimethylamino-ethyl) -N-acetyl -amino] 3-bromonitrobenzene Prepared from 4-E(N- (2 -dimethylamino- ethyl) -amino] -3-bromonitrobenzene and acetyl chloride (13) N-acryloyl-N-methyl-4-nitro-aniline 79 Prepared from 4-methylamino-nitrobenzene and acrylic acid chloride (14) N-acroyoyl-N-isopropyl-4-nitro-aniline Prepared from 4-isopropylamino-nitrobenzene and acrylic acid chloride N-acryloyl-N-benzyl-4-nitro-aniline Prepared from 4-bentylamino-nitrobenzene and acrylic acid chloride (16) N-bromoacetyl-N-methyl-4-nitro-aniline Prepared from 4-methylamino-nitrobenzene and bromoacetyl chloride (17) N-bromoacetyl-N-isopropyl-4-nitro-aniline Prepared from 4-isopropylamino-nitrobenzene and bromoacetyl chloride (18) N-bromoacetyl-N-benzyl-4-nitro-aniline Prepared from 4-benzylamino-nitrobenzene and bromoacetyl chloride Example VII N-(dimethylaminomethylcarbonyl)-N-methyl-4-nitro-aniline 1.8 g of dimethylamine hydrochloride and 5.5 g of potassium carbonate are placed in 80 ml of acetone and 4.2 g of Nbromoacetyl-N-methyl-4-nitroaniline are added in three batches at room temperature. The mixture is stirred for 12 hours at room temperature. After this time the mixture is filtered and the filtrate is evaporated down. The residue is dissolved in ethyl acetate, washed twice with water, dried over sodium sulphate and finally concentrated by rotary evaporation.
Yield: 2.8 g (79 of theory), R, value: 0.5 (silica gel, ethyl acetate/methanol 7:3) 80 Melting point: 121-122 0
C
The following compounds are prepared analogously to Example
VII:
N- (piperidin-l-yl-methylcarbonyl) -N-methyl-4-nitroaniline N- (morpholin-4-yl-methylcarbonyl) -N-methyl-4-nitroaniline N- [(4-benzyl-piperazin-l-yl) -methylcarbonyl] -N-methyl-4nitroaniline N- (pyrrolidin-l-yl-methylcarbonyl) -N-methyl-4-nitroaniline N-tI(N-aminocarbonylmethyl-N-methyl-amino) -methylcarbonyl] N-methyl -4 -nitroaniline N- [(N-benzyl-N-methyl-amino) -methylcarbonyl] -N-methyl-4nitroaniline N- [di- (2-methoxyethyl) -amiino-methylcarbonyl] -N-methyl-4nitroaniline N- (dimethylaminomethylcarbonyl) -N-isopropyl-4-nitroaniline N- (piperidin-l-yl-methylcarbonyl) -N-isopropyl-4-nitroaniline N- [(4-tert.butoxycarbonyl-piperazin-l-yl) methylcarbonyl] -N-isopropyl-4-nitro-aniline (11) N- [(N-benzyl-N-methyl-amino) -methylcarbonyl] -N-benzyl-4nitro-aniline (12) N- (dimethylaminomethylcarbonyl) -N-benzyl-4-nitro-aniline 81 (13) N-(piperidin-1-yl-methylcarbonyl)-N-benzyl-4-nitroaniline (14) N-[di-(2-hydroxyethyl)-amino-methylcarbonyl]-N-methyl-4nitroaniline N-[(N-(2-methoxyethyl)-N-methyl-amino)-methylcarbonyl]-Nmethyl-4-nitroanilife (16) N-[(N-(2-dimethylamino-ethyl)-N-methyl-amino)methylcarbonyl]-N-methyl-4-nitroaniline (17) N-[(4-methyl-piperazin-l-yl)-methylcarbonyl]-N-methyl-4nitroaniline (18) N-((imidazol-1-yl)-methylcarbonyll-N-methyl-4nitroaniline (19) N-[(phthalimido-2-yl)-methylcarbonyl]-N-methyl-4nitroaniline Example VIII N-[(2-dimethylamino-ethyl)-carbonyl]-N-benzvl-4-nitro-aniline g of dimethylamine hydrochloride, 1.1 ml of triethylamine and 1.2 g of N-acryloyl-N-benzyl-4-nitro-aniline are dissolved in 50 ml of methanol and stirred for 24 hours at room temperature. After this time the mixture is evaporated down.
The residue is purified over an aluminium oxide column (activity 2-3) with methylene chloride/ethanol 50:1 as eluant.
Yield: 1.4 g (98 of theory), Rf value: 0.8 (aluminium oxide, methylene chloride/ethanol 20:1) Melting point: 73 0
C
82 The following compounds are prepared analogously to Example
VIII:
N- (2-dinethylamin ethyl) 4-carbony -N-isopropyl -4 -nitroaniline Prepared from N-acryloyl-N-isopropyl-4-nitro-aniline and dimethylamine hydrochloride N-[(2-dimethylartino-ethyl)-carbonyl]-N-methyl-4-nitroaniline Prepared from N-acryloyl-N-methyl-4-nitro-aniline and dimethylamine hydrochloride N-[(2-(4-tert.butoxycarbonyl-piperazin-1-yl)-ethyl)carbonyl]-N-methyl-4-nitro-aniline Prepared from N-acryloyl-N-methyl-4-nitro-aniline and N-tert.butoxycarbonyl-piperazine N-[(2-(piperidin-1-yl)-ethyl)-carbonyl] -N-methyl-4-nitroaniline Prepared from N-acryloyl-N-methyl-4-nitro-aniline and piperidine N-[(2-(N-benzyl-N-methyl-amino)-ethyl)-carbonyl]-N-methyl- 4-nitro-aniline Prepared from N-acryloyl-N-methyl-4-nitro-aniline and N-benzyl-N-methyl-amine Example IX 4-(4-methyl-piperazine-l-yl)-nitrobenzene 31.5 g of 4-chloro-l-nitrobenzene and 44.4 ml of 1methylpiperazine are combined and stirred for 18 hours at 0 C. Then the solution is poured onto ice water and the precipitate formed is suction filtered, washed with water and -83 recrystallised from ethanol/water 1:1. The residue is dried in vacuo at 75 0
C.
Yield: 44.0 g (99 of theory), Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1) Melting point: 108-112 0
C
The following compounds are prepared analogously to Example
IX:
N- (2-dimethylaminoethyl) -N-methyl-4-nitroaniline Prepared from 1-fluoro-4-nitrobenzene and 1-dimethylamino-2methylamino-ethane N- (3-dimethylaminopropyl) -N-methyl-4-nitroaniline Prepared from 1-fluoro-4-nitrobenzene and 1-dimethylamino-3methylamino-propane 4- (N-carboxymethyl-amino) -nitrobenzene Prepared from 1-f luoro-4-nitrobenzene and glycine N-cyclohexyl -p-phenylenediamine Prepared from IL-fluoro-4*-nitrobenzene and cyclohexylamine 6- (2-dimethylamino-ethyl) -N-methylsulphonyl-amino] -3phthalimido-2 -yl-nitrobenzene Prepared from 2-nitro-4-phthalimido-2-yl-fluorobenzene, N- (2-dimethylamino-ethyl) -methanesulphonamide and sodium hydride as base 6- (2-dimethylamino-ethyl) -N-methylsulphonyl-amino] -1,3dinitrobenzene Prepared from 2,4-dinitro-chlorobenzene, N- (2-dimethylaminoethyl) -methanesulphonamide and sodium hydride as base 84 4-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-3chloro-nitrobenzene Prepared from 2-fluoro-5-nitro-chlorobenzene, N-(2-dimethylamino-ethyl)-methanesuiphonamide and sodium hydride as base 4-(2-dimethylamino-ethyl-amino)-1,3-dinitrobenzene Prepared from l-chloro-2,4-dinitro-benzene and N,N-dimethylethylenediamine 4-[N-(2-dimethylamino-ethyl)-N-(ethylsuiphonyl)-amino]nitrobenzene Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-ethanesuiphonamide and sodium hydride as base 4-[N-(2-dimethylamino-ethyl)-N-(propylsulphonyl)-amino]nitrobenzene Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-propanesulphonamide and sodium hydride as base (11) 4-[N-(2-dimethylamino-ethyl)-N-(butylsulphonyl)-amino]nitrobenzene Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-butanesulphonamide and sodium hydride as base (12) 4-EN-(2-dimethylamino-ethyl)-N-(benzylsulphonyl)-amino]nitrobenzene Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-C-phenylmethanesulphonamide and sodium hydride as base (13) 4-EN-(2-dimethylamino-ethyl)-N-(phenylsulphonyl)-amino]nitrobenzene Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-benzenesulphonamide and sodium hydride as base (14) 4-EN-(2-dimethylamino-ethyl)-N-(isopropylsulphonyl)amino]-nitrobenzene 85 Prepared from l-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-isopropylsulphonamide and sodium hydride as base 4- (2--dimeLhylaiiiino-eLhyl) -aminoj -3-bromo-nitrobenzene Prepared from 2-bromo-l-fluoro-4-nitro-benzene and N,Ndimethyl-ethylenediamine (16) 4-isopropylamino-nitrobenzene Prepared from l-flu6ro-4-nitrobenzene and isopropylamine (17) 4-benzylamino-nitrobenzene Prepared from l-fluoro-4-nitrobenzene and benzylamine Example X 4-(imidazol-4-vl)-nitrobenzene g of 2-phenylimidazole are carefully dissolved in 50 ml of concentrated sulphuric acid and 5.8 g of ammonium nitrate are added to this solution at 0°C. After a further 60 minutes stirring at 0°C the mixture is poured onto ice water, made basic with ammonia water and the precipitate formed is suction filtered and recrystallised from ethanol.
Yield: 8.0 g (64 of theory), R, value: 0.6 (silica gel, ethyl acetate/ethanol 10:1)
C
9
HN
3 0 2 Mass spectrum: m/z 189 The following compounds are prepared analogously to Example X: 4-(imidazol-2-yl)-nitrobenzene Prepared from 4-(imidazol-2-yl)-benzene 4-(5-methyl-imidazol-4-yl)-nitrobenzene Prepared from 4-methyl-5-phenyl-imidazole Heterocycl.
Chem. 1983, 20, 1277-1281) 86 Example XI 4-(2-(imidazol-4-yl)-ethylene)-nitrobenzene g of 4-nitrobenzaldehyde and 7.45 g of (N-trityl-imidazol- 4-yl-methyl)-triphenylphosphonium chloride are dissolved in ml of tetrahydrofuran and to this solution 3.0 ml of DBU are added dropwise at room temperature. After a further 120 minutes stirring at room temperature the mixture is poured onto water and the precipitate formed is suction filtered. The product is taken up in 25 ml of 1N hydrochloric acid and refluxed for 4 hours. After this time it is neutralised with ammoniacal water, extracted with ethyl acetate and the organic phase is washed with water, dried over sodium sulphate and evaporated down. The residue is purified over a silica gel column with methylene chloride/methanol 10:1 as eluant.
Yield: 1.0 g of (47 of theory), Rf value: 0.6 (silica gel, ethyl acetate/ethanol 10:1) Melting point: 185-188 0
C
Example XII 4-(Diperidin-l-vl-methyl)-nitrobenzene 40.0 g of 4-nitrobenzyl bromide are dissolved in 500 ml of methylene chloride, 51.5 ml of triethylamine are added and 18.3 ml of piperidine are carefully added dropwise. After the end of the exothermic reaction the mixture is refluxed for another 30 minutes. After cooling it is washed with water and the organic phase is dried over sodium sulphate. Finally, the organic phase is evaporated down.
Yield: 36.3 g of (89 of theory), R, value: 0.6 (silica gel, methylene chloride/methanol 9:1)
C
12 Hi 6 N202 Mass spectrum: m/z 221 [M
S
87 The following compounds are prepared analogously to Example
XII:
4- [(2,6-dimethyl-piperidin-l-yl) -methyl] -nitrobenzene 3- (N,N-dimethyl-aminomethyl) -nitrobenzene 4- (N,N-dimethyl-aminomethyl) -nitrobenzene 4- (2-dimethylamino-ethyl) -nitrobenzene 4- (2-diethylamino-ethyl) -nitrobenzene 4- (diethylamino-methyl) -nitrobenzene 4- (N-benzyl-N-methyl-aminomethyl) -nitrobenzene 4- (N-ethyl-N-methyl-aminomethyl) -nitrobenzene 4- (n-hexyl) -N-methyl-aminomethyl] -nitrobenzene 4- (thiomorpholii-4--rl -rrethyl) -nitrcbenzene (11) 4- [(4-methyl-piperazine-l-yl) -methyl] -nitrobenzene (12) 4- (imidazol-l-yl-methyl) -nitrobenzene (13) 4- (4-hydroxy-piperidin-1-yl) -ethyl-amino] -nitrobenzene (14) 4- [(3-hydroxy-pyrrolidin-l-yl) -methyl] -nitrobenzene 4- (l,2,4-triazol-l-yl-methyl) -nitrobenzene (16) 4- (1,2,3-triazol-2-yl-methyl) -nitrobenzene (17) 4-(l,2,3-triazol-l-yl-methyl)-nitrobenzene 88 (18) 4- [(N-ethoxycarbonylmethyl-N-methyl-amino) -methyl] nitrobenzene (19) 4-[I(N-aminocarbonylmethyl-N-methyl-amino) -methyl] nitrobenzene 4- (azetidin-l-yl-methyl) -nitrobenzene (21) 4- (2-methoxy-ethyl) -amino) -methyl] -nitrobenzene (22) 4- (N-tert.butoxycarbonyl-3-amino-propyl) -N-methylaminomethyl] -nitrobenzene (23) 4- [(N-propyl-N-methyl-amino) -methyl] -nitrobenzene (24) 4- (2-dimethylamino-ethyl) -N-methyl-amino) -methyl] nitrobenzene 4- (3-dimethylamino-propyl) -N-methyl-amino) -methyl] nitrobenzene (26) 4- (2-methoxy-ethyl) -N-methyl-amino) -methyl] nitrobenzene (27) 4- (2-hydroxy-ethyl) -N-methyl-amino) -methyl] nitrobenzene (28) 4- (dioxolan-2-yl-methyl) -N-methyl-amino) -methyl] nitrobenzene (29) 4- (3-oxo-piperazine-1-yl-methyl) -nitrobenzene 89 Example XIII 4-[(N-carboxymethyl-N-methyl-amino)-methyl]-nitrobenzene 7.33 of 4 (N-ehoxycarbonylmethyl-N- meLhy l-amino) -methyl] nitrobenzene are dissolved in 140 ml of ethanol, 34.0 ml of IN sodium hydroxide solution are added and the mixture is stirred for half an hour at room temperature. After this time the mixture is neutralised with 34 ml of IN hydrochloric acid, the solvent removed, the residue taken up in methylene chloride and extracted with water. The aqueous phase is evaporated down and the residue is recrystallised from methylene chloride.
Yield: 5.43 g (84 of theory), Rf value: 0.4 (silica gel, methylene chloride/methanol 2:1) CIoHi2N,04 Mass spectrum: m/z 223 Example XIV 4-(N-ethyl-aminomethyl)-nitrobenzene g of 4-nitrobenzyl bromide are dissolved in 25 ml of ethanol, combined with 25 ml of 10% ethanolic ethylamine solution and refluxed for 2 hours. Then the solution is concentrated by rotary evaporation, the residue is taken up with methylene chloride and washed with dilute sodium hydroxide solution. Finally the organic phase is evaporated down.
Yield: 2.3 g (46 of theory), R, value: 0.2 (silica gel, methylene chloride/methanol 9:1)
CHIN
2 0 2 ESI mass spectrum: m/z 179 The following compounds are prepared analogously to Example
XIV:
4-[N-(4-chlorobenzyl)-aminomethyl]-nitrobenzene 90 4- (N-cyclohexyl-aminomethyl) -nitrobenzene A _nlIr- _nz-n (4N4 (-Lspropyl-aminomethyl) -nitrobenzene 4- (N-methyl-aminomethyl) -nitrobenzene 4- (N-butyl-amixomethyl) -nitrobenzene 4- (N-methoxycarboraylmethyl-aminomethyl) -nitrobenzene 4- (N-benzyl-aminomethyl) -nitrobenzene 4- (aminomethyl) -nitrobenzene 4- (pyrrolidin-1-yl-methyl) -nitrobenzene (11) 4- (morpholin-4-yl-methyl) -nitrobenzene (12) 4- (hexamethyleneiminomethyl) -nitrobenzene (13) 4- (4-hydroxy-piperidin-1-yl-methyl) -nitrobenzene (14) 4- (4-methoxy-piperidin-1-yl-methyl) -nitrobenzene 4- (4-methyl-piperidin-1-yl-methyl) -nitrobenzene (16) 4- (4-ethyl-piperidin-1-yl-methyl) -nitrobenzene (17) 4- (4-isopropyl-piperidin-1-yl-methyl) -nitrobenzene (18) 4- (4-phenyl-piperidin-1-y1-methyl) -nitrobenzene (19) 4- (4-benzyl-piperidin-1-yl-methyl) -nitrobenzene 91 4- (4-ethoxycarbonyl-piperidin-l-yl-methyl) -nitrobenzene '12 ,'prpy.-aLn1~Li-eL1 -IiiLrobenzene (22) 4- (4-tert.butoxycarbonyl-piperazin-1-yl-methyl) nitrobenzene (23) 4- (2-morpholin-4-y1-ethyl) -nitrobenzene (24) 4- (2-pyrrolidin-1-yl-ethyl) -nitrobenzene 4- (2-piperidin-1-yl-ethyl) -nitrobenzene (26) 4- (N-ethyl-N-benzyl-aminomethyl) -nitrobenzene (27) 4- (N-propyl-N-benzyl-aminomethyl) -nitrobenzene (28) 4- [N-methyl-N- (4-chlorobenzyl) -aminomethyl] -nitrobenzene (29) 4- [N-methyl-N- (4-bromobenzyl) -aminomethyl] -nitrobenzene 4- [N-methyl-N- (4-f luorobenzyl) -aminomethyl] -nitrobenzene (31) 4- [N-methyl-N- (4-methylbenzyl) -aminomethyl] -nitrobenzene (32) 4- [N-methyl-N- (3-chlorobenzyl) -aminomethyl] -nitrobenzene (33) 4- [N-methyl-N- (3,4-dimethoxybenzyl) -aminomethyl] nitrobenzene (34) 4- [N-methyl-N- (4-methoxybenzyl) -aminomethyl] -nitrobenzene 4- (N-2,2,2-trifluoroethyl-N-benzyl-aminomethyl) nitrobenzene 0 -92- (36) 4- [N-2,2,2-trifluoroethyl-N- (4-chlorobenzyl) aminomethyl] -nitrobenzene (37) 4- (Lhliororpholin-4-yi-methyl) -nitrobenzene (38) 4- (azetidion-1-yl-methyl) -nitrobenzene (39) 4- (3,4-dihydropyrrolidin-1-yl-methyl) -nitroberizene 4- (3,4-dihydropiperidin-1-yl-methyl) -nitrobenzene (41) 4- (2-methoxycarbonyl-pyrrolidin-1-yl-methyl) -nitrobenzene (42) 4- (3,5-dimethyl-piperidin-1-yl-methyl) -nitrobenzene (43) 4- (4-phenyl-piperazin-1-yl-methyl) -nitrobenzene (44) 4- (4-phenyl-4-hydroxy-piperidin-1-yl-methyl) -nitrobenzene 4- (3,4,5-trimethoxybenzyl-N-methyl-aminomethyl) nitrobenzene (46) 4-EN- (3,4-dimethoxybenzyl) -N-ethyl-aminomethyl] nitrobenzene (47) 4-EN- (2,6-dichlorobenzyl) -N-methyl) -aminomethyl] nitrobenzene (48) 4-EN- (4-trifluoromethylbenzyl) -N-methyl) -aminomethyl] nitrobenzene (49) 4- (N-benzyl-N-isopropyl-aminomethyl) -nitrobenzene 4- (N-benzyl-N-tert.butyl-aminomethyl) -nitrobenzeie (51) 4- (N,N-diisopropyl-aminomethyl) -nitrobenzene 0 -93 (52) 4- (N,N-diisobutyl-aminomethyl) -nitrobenzene (53) 4- (2,3,4,5-tetrahydro-benzo(d)azepin-3-y1-methyi)nitrobenzene (54) 4- (2,3-dihydro-isoindol-2-yl-methyl) -nitrobenzene 4-(6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -nitrobenzeie (56) 4-(1,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) nitrobenzene (57) 4- (2-hydroxyethyl) -N-benzyl-aminomethyl] -nitrobenzene (58) 4-EN- (1-ethyl-pentyl) (pyridin-2-yl-methyl) aminomethyl] -nitrobenzene (59) 4- (piperin-1-yl-methyl) -1,3-dinitrobenzene 4- (N-phenethyl-N-methyl-aminomethyl) -nitrobenzene (61) 4- (3,4-dihydroxy-phenethyl) -N-methyl-aminomethyl] nitrobenzene (62) 4-EN- (3,4,5-trimethoxy-phenethyl) -N-methyl-aminomethyl] nitrobenzene (63) 4-EN- (3,4-dimethoxy-phenethyl) -N-methyl-aminomethyl] nitrobenzene (64) 4-EN- (3,4-dimethoxy-benzyl) -N-methyl-aminomethyl] nitrobenzene 4- (4-chloro-benzyl) -N-methyl-aminomethyl] -nitrobenzene 0 -94 (66) 4- (4-bromo-benzyl) -N-methyl-aminomethyl] -nitrobenzene A .rM TI b A Phl-iinoehl -nIoez LIMk-, Luoo-eiizyl) -N-ei y-mioehl -ntoezn (68) 4- (4-methyl-benzyl) -N-methyl-aminomethyl] -nitrobenzene (69) 4- (4-nitro-phenethyl) -N-methyl-aminomethyl] nitrobenzene 4- (N-phenethyl-N-benzyl-aminomethyl) -nitrobenzene (71) 4- (N-phenethyl-N-cyclohexyl-aminomethyl) -nitrobenzene (72) 4- (pyridin-2-yl) -ethyl) -N-methyl-aminomethyl] nitrobenzene (73) 4- (pyridin-4-yl) -ethyl) -N-methyl-aminomethylJ nitrobenzene (74) 4- (pyridin-4-yl-methyl) -N-methyl-aminomethyl] nitrobenzene 4- (N,N-dibenzyl-aminomethyl) -nitrobenzene (76) 4- (4-nitro-phenethyl) -N-propyl-aminomethyl] nitrobenzene (77) 4- (N-benzyl-N- (3-cyano-propyl) -aminomethyl) -nitrobenzene (78) 4- (N-berzyl-N-allyl-aminomethyl) -nitrobenzene (79) 4- [N-benzyl-N- (2,2,2-trifluoroethyl) -aminomethyl] nitrobenzene 95 4-[N-(2-benzo(1,3)dioxol-5-yl-methyl)-N-methylaminomethyl] -nitrobenzene (81) 4-(7-chloro-2,3,4,5-tetrahydro--benzo(d)azepin-3-ylmethyl) -nitrobenzene (82) 4-(7,8-dichloro-2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -nitrobenzene (83) 4-(7-methoxy-2,3,4,5-tetrahydro--benzo(d)azepin-3-ylmethyl) -nitrobenzene (84) 4-(7-methyl-2,3,4,5-tetrahydro-benzo~d)azepin-3-ylmethyl) -nitrobenzene 4-(7,8-dimethoxy--2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -nit robenzene (86) 4-(6,7-dichloro-l,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -nitrobenzene (87) 4-(6,7-dimethvl-l,2,3,4-tetrahvdro-isoquinolin-2-vlmethyl) -nitrobenzene (88) 4-(6-chloro-1,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)nitrobenzene (89) 4-(7-chloro-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)nitrobenzene 4-(6-methoxy-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)nitrobenzene (91) 4- (7-methoxy-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) nitrobenzene 96 (92) 4-[(2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3-yl)methyl] -nitrobenzene (93) -[(7/-amit-no-2 ,3,4,5-tetrahydro-azepin-o(4,5-b)pyrazin-3yl) -methyl] -nitrobenzene (94) 4-[(2-amino-5,6,7,8-tetrahydro-azepino(4,5-d)thiazol-6yl) -methyl] -nitrobenzene 4-[(5,6,7,8-tetrahydro-azepino(4,5-d)thiazol-6-yl)methyl] -nitrobenzene Example XV 4- (1,1-dioxo-thiomorpholin-4-vl-methyl) -nitrobenzene g of 4-(thiomorpholin-4-yl-methyl)-nitrobenzene are dissolved in 100 ml of methylene chloride and 10.3 g of metachloroperbenzoic acid are slowly added. After a further 3 hours stirring at room temperature the precipitate obtained is filtered off.
Yield: 6.2 g (91 of theory) Rf value: 0.5 (silica gel, methylene chloride/methanol 1:1)
C
1
IH
14 N04S Mass spectrum: m/z 270 The following compound is prepared analogously to Example XV: 4- (l-oxo-thiomorpholin-4-yl-methyl) -nitrobenzene Example XVI 4- (3-amino-propyl) -N-methvlsulphonvl-aminol -nitrobenzene g of 4- (3-phthalimido-2-yl-propyl) -N-methylsulphonylamino] -nitrobenzene are dissolved in 200 ml of ethanol, 11.5 ml of hydrazine hydrate are added and the mixture is stirred for 1.5 hours at 50 OC. After cooling the residue is largely -97 evaporated down, water is added and the solution is extracted with methylene chloride. The organic phase is dried, evaporated down and purified over a silica gel column with methylene chloride/methanol/ammonia 9:1:0.1.
Yield: 2.5 g (39 of theory) R, value: 0.2 (silica gel, methylene chloride/methanol 9:1) ESI mass spectrum: m/z 272 The following compound is prepared analogously to Example XVI: 6-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-3amino-nitrobenzene Prepared from 6-[N-(2-dimethylamino-ethyl)-N-methylsulphonylamino]-3-phthalimido-2-yl-nitrobenzene Example XVII 4-(1-methyl-imidazol-2-vl)-nitrobenzene g of 4-(imidazol-2-yl)-nitrobenzene are dissolved in 50 ml of dimethylsulphoxide and at 0°C 5.0 g of potassium tert.butoxide are added. After one hour of stirring at room temperature 2.6 ml of methyl iodide are added dropwise and the mixture is stirred for one hour at room temperature. After this time the residue is poured onto ice water and the precipitate formed is suction filtered, washed with water and dried.
Yield: 6.1 g (76 of theory) Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1) Melting point: 186-187°C 98 The following compounds are prepared analogously to Example
XVII:
1) 4- 1 -ety-i miazol y-nitrobenzene Prepared from 4-(imidazol-2-yl)-nitrobenzene and ethyl iodide 4-(l-benzyl-imidazol-2-yl)-nitrobenzene Prepared from 4-(imidazol-2-yl)-nitrobenzene and benzyl bromide Example XVIII 4-[(N-(2-(2-methoxy-ethoxy)-ethyl)-N-methyl-amino)-methyl]nitrobenzene g of 4-methylaminomethyl-nitrobenzene are dissolved in ml of dimethylformamide and 4.6 g of 2-(2-methoxy-ethoxy)ethyl chloride are added. After six hours' stirring at 100 0
C
the solvent is removed and the residue is taken up in ethyl acetate. The organic phase is washed with water and dried over sodium sulphate. After the elimination of the solvent the residue is purified over an aluminium oxide column (activity 2-3) with toluene/ethyl acetate 5:1 as eluant.
Yield: 2.3 g (29 of theory) Rf value: 0.5 (aluminium oxide, toluene/ethyl acetate 5:1)
C
13
H
20
N
2 0 4 ESI mass spectrum: m/z 267 Example XIX 4-(N-ethyl-N-tert.butoxycarbonyl-aminomethyl)-nitrobenzene 2.2 g of 4-(ethylaminomethyl)-nitrobenzene are dissolved in ml of ethyl acetate and stirred with 2.6 g of di-tert-butyl.
dicarbonate (tert.butoxycarbonyl-anhydride) for 30 minutes at room temperature. Then the solution is washed with water and evaporated down.
Yield: 3.4 g of theory 99 Rf value: 0.3 (silica gel, methylene chloride/methanol 50:1) Melting point: 85 OC The following compounds are prepared analogously to Example
XIX:
4- (4-chlorophenyl-methyl) -N-tert.butoxycarbonylaminomethyl] -nitrobenzene 4- (N-tert .butoxycarbonyl-aminomethyl) -nitrobenzene 4- (N-cyclohexyl-N-tert.butoxycarbonyl-aminomethyl) nitrobenzene 4- (N-isopropyl-N-tert.butoxycarbonyl-aminomethyl) nitrobenzene 4- (N-methyl-N-tert.butoxycarbonyl-aminomethyl) nitrobenzene 4- (N-propyl-N-tert.butoxycarbonyl-aminomethyl) nitrobenzene 4- (N-butyl-N-tert.butoxycarbonyl-aminomethyl) -nitrobenzene 4- (N-methoxycarbonylmethyl-N-tert .butoxycarbonylaminomethyl) -nitrobenzene 4- (N-benzyl-N-tert.butoxycarbonyl-aminomethyl) nitrobenzene 100 4-[N-(3-trifluoroacetylamino-propyl)-N-methylsulphonylamino]-nitrobenzene Prepared from 4-[N-(3-amino-propyl)-N-methylsulphonyl-amino]nitrobenzene and trifluoroacetic acid anhydride (11) 4-[(4-tert.butoxycarbonyl-piperazin-1-yl)-methyl]nitrobenzene Example XX 4-(piperidin-l-yl-methyl)-aniline 37.0 g of 4-(piperidin-l-yl-methyl)-nitrobenzene are dissolved in 300 ml of methanol, 8.0 g of Raney nickel are added and the mixture is hydrogenated for 85 minutes with 3 bars of hydrogen at room temperature. The catalyst is filtered off and the filtrate is evaporated down.
Yield: 24.0 g (75 of theory), R, value: 0.4 (silica gel, methylene chloride/methanol 9:1)
C
12 Hs 1
N
2 ESI mass spectrum: m/z 191 The following compounds are prepared analogously to Example
VIII:
4-[(2,6-dimethyl-piperidin-l-yl)-methyl]-aniline N-(2-dimethylamino-ethyl)-N-methylsulphonyl-pphenylenediamine 3-(dimethylaminomethyl)-aniline 4-(dimethylaminomethyl)-aniline 4-(2-dimethylamino-ethyl)-aniline 4-[N-(2-dimethylamino-ethyl)-N-acetyl-amino]-aniline 101 4- (3-dimethylamino-propyl) -N-acetyl-amino] -aniline 8) 4- ti--dimethylamino-ethyl) -N-benzoyl-aminol -aniline 4- (2-dimethylamino-ethyl) -N-propionyl-aminol -aniline 4- (2-dimethylamino-ethyl) -N-butyryl-amino] -aniline (11) 4- (2-dimethylamino-ethyl) -N-isobutyryl-amino] -aniline (12) 4- (N-tert.butoxycarbonyl-aminomethyl) -aniline (13) 4- (N-ethyl-N-tert.butoxycarbonyl-aminomethyl) -aniline (14) 4-EN- (4-chlorophenyl-methyl) -N-tert.butoxycarbonylaminomethyl] -aniline 4- (N-cyclohexyl-N-tert.butoxycarbonyl-aminomethyl) aniline (16) 4- (N-isopropyl-N-tert .butoxycarbonyl-aminomethyl) -ani line (17) 4- (N-propyl-N-tert.butoxycarbonyl-aminomethyl) -aniline (18) 4- (N-methyl-N-tert.butoxycarbonyl-aminomethyl) -aniline (19) 4- (N-butyl-N-tert.butoxycarbonyl-aminomethyl) -aniline 4- (N-methoxycarbonyl-methyl-N-tert.butoxycarbonylaminomethyl) -aniline (21) 4- (N-benzyl-N-tert.butoxycarbonyl-aminomethyl) -aniline (22) 4- (pyrrolidin-l-yl-methyl) -aniline 102 (23) 4- (morpholin-4-yl -methyl) -aniline (24) 4- (hexamethyleneiminomethyl) -aniline 4- (4-hydroxy-piperidin-l-yl-methyl) -aniline (26) 4- (4-methoxy-piperidin-1-yl-methyl) -aniline (27) 4- (4-methyl-piperidin-1-yl-methyl) -aniline (28) 4- (4-ethyl-piperidin-l-yl-methyl) -aniline (29) 4- (4-isopropyl-piperidin-l-yl-methyl) -aniline 4- (4-phenyl-piperidin-l-yl-methyl) -aniline (31) 4- (4-benzyl-piperidin-1-yl-methyl) -aniline (32) 4- (4-ethoxycarbonyl-piperidin-1-yl-methyl) -aniline (33) 4- (N,N-dipropyl-aminomethyl) -aniline (34) 4- (4-tert.butoxycarbonyl-piperazin-l-yl-methyl) -aniline 4- (2-morpholin-4-yl-ethyl) -aniline (36) 4-(2-pyrrolidin-l-yl-ethyl)-aniline (37) 4- (2-piperidin-1-yl-ethyl) -aniline (38) 4- (N-propyl-N-benzyl-aminomethyl) -aniline (39) 4-EN- (n-hexyl) -N-methyl-aminomethyl] -aniline 4-EN-methyl-N- (4-chlorobenzyl) -aminomethyl] -aniline 103 (41) 4- (N-methyl-N- (4-bromobenzyl) -aminomethyl] -aniline (42) 4- (N-methyl-N- (4-methylbenzyl) -aminomethyl] -aniline (43) 4- [N-methyl-N- (4-f luorobenzyl) -aminomethyl] -aniline (44) 4- [N-methyl-N- (3-chlorobenzyl) -aminomethyl] -aniline 4- [N-methyl-N- (3,4-dimethoxybenzyl) -aminomethyl] -aniline (46) 4- [N-methyl-N- (4-methoxybenzyl) -aminomethyl] -aniline (47) 4- (N-2,2,2-trifluoroethyl-N-benzyl-aminomethyl) -aniline (48) 4-[N-2,2,2-trifluoroethyl-N-(4-chlorobenzyl)aminomethyl] -aniline (49) 4- (thiomorpholin-4-yl-methyl) -aniline 4- (l-oxo-thiomorpholin-4-yl-methyl) -aniline (51) 4- (l,1-dioxo-thiomorpholin-4-yl-methyl) -aniline (52) 4- (azetidion-1-yl-methyl) -aniline (53) 4- (3,4-dihydropyrrolidin-l-yl-methyl) -aniline (54) 4- (3.4-dihydropiperidin-l-yl-methyl) -aniline 4- (2-methoxycarbonyl-pyrrolidin-l-yl-methyl) -aniline (56) 4- (3,5-dimethyl-piperidin-1-yl-methyl) -aniline (57) 4- (4-phenyl-piperazin-l-yl-methyl) -aniline (58) 4- (4-phenyl-4-hydroxy-piperidin-1-yl-methyl) -aniline 104 (59) 4-EN- 5-trimethoxy-benzyl) -N-methyl-aminomethyl] aniline 4- (3,4-dimethoxy-benzyl) -N-ethyl-aminomethyl] -aniline (61) 4- (N-benzyl-N-ethyl-aminomethyl) -aniline (62) 4-E[N- 6-dichlorobenzyl) -N-methyl-aminomethyll -aniline (63) 4-EN- (4-trifluoromethylbenzyl) -N-methyl-aminomethyll aniline (64) 4- (N-benzyl-N-isopropyl-aminomethyl) -aniline 4- (N-benzyl-N-tert.butyl-aminomethyl) -aniline (66) 4- (diethylamino-methyl) -aniline (67) 4- (2-diethylamino-ethyl) -aniline (68) 4- (N,N-diisopropyl-aminomethyl) -aniline (69) 4- (N,N-diisobutyl-aminomethyl) -aniline 4- (2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl) -aniline (71) 4- (2,3-dihydro-isoindol-2-yl-methyl) -aniline (72) 4-(6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline (73) 4 4-tetrahydro-isoquinolin-2-yl-methyl) -aniline (74) 4-E[N- (2-hydroxy-ethyl) -N-benzyl-aminomethyl] -aniline 0 105 4- Ci-ethyl-pentyl) (pyridin-2-yl-methyl) aminomethyll -aniline (76) 4-('piperidin-1-yi-methyl) -3-nitro-aniline (77) 4- (piperidin-1-yl-methyl) -3-amino-aniline (78) 4- (N-benzyl-N-methyl-aminomethyl) -aniline (79) 4- (N-ethyl-N-methyl-aminomethyl) -aniline 4- (N-phenethyl-N-methyl-aminomethyl) -aniline (81) 4- (3,4-dihydroxy-phenethyl) -N-methyl-aminomethyl] aniline (82) 4- (3,4,5-trimethoxy-phenethyl) -N-methyl-aminomethyll aniline (83) 4- (3,4-dimethoxy-phenethyl) -N-methyl-aminomethyllaniline (84) 4- (3,4-dimethoxy-benzyl) -N-methyl-aminomethyl] -aniline 4- (4-chloro-benzyl) -N-methyl-aminomethyl] -aniline- (86) 4- (4-bromo-benzyl) -N-methyl-aminomethyl] -aniline (87) 4- (4-f luoro-benzyl) -N-methyl-aminomethyl] -aniline (88) 4- (4-methyl-benzyl) -N-methyl-aminomethyl] -aniline (89) 4-EN- (4-nitro-phenethyl) -N-methyl-aminomethyll -aniline 4- (N-phenethyl-N-benzyl-aminomethyl) -aniline 106 (91) 4- (N-phenethyl-N-cyclohexyl-aminomethyl) -aniline (92) 4- (pyridin-2-yl) -ethyl) -N-methyl-aminomethyl] a- 11 1 4 (93) 4- (pyridin-4-yl) -ethyl) -N-methyl-aminomethyl] aniline (94) 4- (pyridin-4-yl-methyl) -N-methyl-aminomethyll -aniline 4- (N,N-dibenzylaminomethyl) -aniline (96) 4- (4-nitro-benzyl) -N-propyl-aminomethyl] -aniline (97) 4- fN-benzyl-N- (3-cyano-propyl) -aminomethyl] -aniline (98) 4- (N-benzyl-N-allyl-aminomethyl) -aniline (99) 4- [N-benzyl-N- (2,2,2-trifluoroethyl) -aminomethyl] -aniline (100) 4- [(benzo(l,3)dioxol-5-yl-methyl) -methyl-aminomethyl] aniline (101) 4-(7-chloro-2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -aniline (102) 4-(7,8-dichloro-2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -aniline (103) 4- (7-methoxy-2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -aniline (104) 4-(7-methyl-2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -aniline 107 (105) 4-(7,8-dimethoxy-2,3,4..5-tetrahydro-benzo(d)azepin-3-ylmethyl) -aniline (106) 4-(6,'/-dichloro-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline (107) 4-(6,7-dimethyl-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline (108) 4-(6-chloro-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)aniline (109) 4- (7-chloro-1.2,3,4-tetrahydro-isoquinolin-2-yl-methyl) aniline (110) 4-(6-methoxy-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline (111) 4- (7-methoxy-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline (112) 4-(2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3-ylmethyl) -aniline (113) 4- (7-amino-2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3yl-methyl) -aniline (114) 4-(2-amino-5,6,7,8-tetrahydro-azepino(4,5-d)thiazol-6y1-methyl) -aniline (115) 4-(5,6,7,8-tetrahydro-azepino(4,5-d)thiazol-6-ylmethyl) -aniline (116) 4-(4-methyl-piperazin-1-yl)-aniline (117) 4- (2-dimethylamino-ethyl) -N-methyl-amino] -aniline 108 (118) 4- (3-dimethylamino-propyl) -N-methyl-amino] -aniline -119 "3-d"iethylamino-propyl) -N-methylsulphonyl -pphenylenediamine (120) 4- [(N-dimethylaminocarbonylmethyl-N-methylsulphonyl) amino] -aniline (121) N- (4-aminophenyl) -N-methyl-methanesulphonamide (122) 4- (imidazol-4-yl) -aniline (123) 4- (tetrazol-5-yl) -aniline (124) 4 (2 -dimethylamino-ethyl) -N-propionyl -amino] -aniline (125) N- (dimethylaminomethylcarbonyl) -N-methyl-pphenylenediamine (126) N- [(2-dimethylamino-ethyl) -carbonyl] -N-methyl-pphenylenediamine (127) 4- (N-acetyl-N-dimethylaminocarbonylmethyl) -amino) aniline (128) N-methylaminocarbonylmethyl-N-methylsulphonyl-pphenylenediamine (129) N-aminocarbonylmethyl-N-methylsulphonyl-pphenylenediamine (130) 4- (imidazolidin-2,4-dion-5-ylidene-methyl) -aniline (131) 4-(imidazolidin-2,4-dion-5-yl-methyl)-aniline -109 (132) 4-(2-oxo-pyrrolidin-l-yl-methyl) -aniline (133) N-cyanomethyl-N-methylsulphonyl-p-phenylenediamine (134) 4-[2-(imidazol-4-yl)-ethyl]-aniline (135) 4- [(4-methyl-piperazin-1-yl) -methyl] -aniline (136) 4-[IN-(2-(N-behzyl-N-methyl-amino)-ethyl)-Nmethylsulphonyl-amino] -aniline (137) 4- (N-benzyl-N-methyl-amino) -propyl) -Nmethylsulphonyl-amino] -aniline (138) N- cyclohexyl -p-phenylenediamine (139) 4- (pyridin-4-yl-methyl) -aniline (140) 4-(imidazol-1-yl-methyl)-aniline (141) 4-benzyl-aniline (142) N- (3-trifluoroacetylamino-propyl) -N-methylsulphonyl-pphenylenediamine (143) tert .butyl 4-amino-phenylacetate (144) 4- (imidazol-2-yl) -aniline (145) 4-(1-methyl-imidazol-2-yl)-aniline (146) 4- (l-ethyl-imidazol-2-yl) -aniline (147) 4-(1-benzyl-imidazol-2-yl)-aniline 110 (148) 4- (2-dimethylamino-ethyl) -N-methylsulphonyl-amino] -3amino-aniline (149) 4- (2-dimethylamino-ethyl) -N-methylsulphonyl-amino] -3chioro-aniline (150) 4-EN- (2-dimethylamino-ethyl) -N-acetyl-amino] -3-aminoaniline (151) 4- (2-dimethylamino-ethyl) -N-acetyl-amino] -3-bromoaniline (152) 4- (4-hydroxy-piperidin-1-yl) -ethyl-amino] -aniline (153) N- (2-dimethylamino-ethyl) -N-ethylsulphonyl-pphenylenediamine (154) N- (2-dimethylamino-ethyl) -N-propylsulphonyl-pphenylenediamine (155) N- (2-dimethylamino-ethyl) -N-isopropylsulphonyl-pphenylenediamine (156) N- (2-dimethylamino-ethyl) -N-butylsulphonyl-pphenylenediamine (157) N- (2-dimethylamino-ethyl) -N-benzylsulphonyl-pphenylenediamine (158) N- (2-dimethylamino-ethyl) -N-phenylsulphonyl-pphenylenediamine (159) 4- ((3-hydroxy-pyrrolidin-1-yl) -methyl) -aniline (160) 4-EN- (2-dimethylamino-ethyl) (furan-2-carbonyl) amino] -aniline (161) 4- (2-dimethylamino-ethyl) (2-methoxy-benzoyl) amino] -aniline (162) 4- (2-dimethylamino-ethyl) (pyridine-3-carbonyl) amino] -aniline (163) 4- (2-dimethylamino-ethyl) (phenyl-acetyl) -amino] aniline (164) N- (piperidin-1-yl-methylcarbonyl) -N-methyl-pphenylenediamine (165) N- (morpholin-4-yl-methylcarbonyl) -N-methyl-pphenylenediamine (166) N- [(4-benzyl-piperazin-1-y1) -methylcarbonyl] -N-methyl-pphenylenediamine (167) N- (pyrrolidin-l-yl-methylcarbonyl) -N-methyl-pphenylenediamine (168) 4-(5-methyl-imidazol-4-yl)-aniline (169) N-f (2-dimethylamino-ethyl) -carbonyl] -N-isopropyl-pphenylenediamine (170) N- [(2-dimethylamino-ethyl) -carbonyl] -N-benzyl-pphenylenediamine (171) N- (N-aminocarbonylmethyl-N-methyl-amino) methylcarbonyl) -N-methyl -p-phenylenediamine (172) N- [(N-benzyl-N-methyl-amino) -methylcarbonyl] -N-methyl-pphenyl enediamine 112 (173) N- [di- (2-methoxyethyl) -amino-methylcarbonyl] -N-methyl-pphenylenediamine (1-74 A ITtr~uxoroilpieai--i ehl carbonyl] -N-methyl -p-phenylenediamine (175) N- t(2-(piperidin-l-yl)-ethyl)-carbonyl] -N-methyl-pphenylenediamine (176) N- (N-benzyl-N-methyl-amino) -ethyl) -carbonyl] -Nmethyl -p-phenylenediamine (177) N- (dimethylaminomethylcarbonyl) -N-isopropyl-pphenylenediamine (178) N- (piperidin-l-yl-methylcarbonyl) -N-isopropyl-pphenylenediamine (179) N- [(4-tert.butoxycarbonyl-piperazin-l-yl) methylcarbonyl] -N-isopropyl-p-phenylenediamine (180) N- [(N-benzyl-N-methyl-amino) -methylcarbonyl] -N-benzyl-pphenylenediamine (181) N- (dimethylaminomethylcarbonyl) -N-benzyl-pphenylenediamine (182) N- (piperidin-l-yl-methylcarbonyl) -N-benzyl-pphenylenediamine (183) 4-(l,2,4-triazol-l-yl-methyl)-aniline (184) 4-(1,2,3-triazol-2-yl-methyl)-anilile (185) 4-(1,2,3-triazol-l-yl-methyl)-aniline -113 (186) 4-[(N-ethoxycarbonylmethyl-N-methyl-amino)-methyl]aniline (187) 4-[(N-aminocarbonylmethyl-N-methyl-amino)-methyl]aniline (188) 4-(azetidin-l-yl-methyl)-aniline (189) 4-[(di-(2-methoxy-ethyl)-amino)-methyl]-aniline (190) 4-[(N-(2-(2-methoxy-ethoxy)-ethyl)-N-methyl-amino)methyl]-aniline (191) 4-[N-(N-tert.butoxycarbonyl-3-amino-propyl)-N-methylaminomethyl]-aniline (192) 4-[(N-(methylcarbamoyl-methyl)-N-methyl-amino)-methyl]aniline (193) 4-[(N-(dimethylcarbamoyl-methyl)-N-methyl-amino)methyl]-aniline (194) 4-[(N-propyl-N-methyl-amino)-methyl]-aniline (195) 4-[(N-(2-dimethylamino-ethyl)-N-methyl-amino)-methyl]aniline (196) 4-[(N-(3-dimethylamino-propyl)-N-methyl-amino)-methyl]aniline (197) 4-[(N-(2-methoxy-ethyl)-N-methyl-amino)-methyl]-aniline (198) 4-[(N-(2-hydroxy-ethyl)-N-methyl-amino)-methyl]-aniline (199) 4-[(N-(dioxolan-2-yl-methyl)-N-methyl-amino)-methyl]aniline 114 (200) 4-(3-oxo-piperazin-l-yl-methyl)-aniline 201) N-T di-(2-hydroxyethyl)-amino-methylcarbonyl]-N-methyl-pphenylenediamine (202) N-[(N-(2-methoxyethyl)-N-methyl-amino)-methylcarbonyl]- N-methyl-p-phenylenediamine (203) N-[(N-(2-dimethylamino-ethyl)-N-methyl-amino)methylcarbonyl]-N-methyl-p-phenylenediamine (204) N-[(4-methyl-piperazin-l-yl)-methylcarbonyl]-N-methyl-pphenylenediamine (205) N-[(imidazol-1-yl)-methylcarbonyl]-N-methyl-pphenylenediamine (206) N-[(phthalimido-2-yl)-methylcarbonyl]-N-methyl-pphenylenediamine Example XXI 4-(4-hydroxvmethvl-piperidin-l-yl-methyl-amino)-aniline 1.1 g of 4-(4-ethoxycarbonyl-piperidin-l-yl-methyl-amino)aniline are suspended in 15 ml of tetrahydrofuran. 175 mg of lithium borohydride are added at room temperature, stirred for 24 h, another 175 mg of lithium borohydride are added and after a further 7.5 hours 15 ml of water are added and the mixture is stirred for 10 minutes. It is extracted three times with 15 ml of ethyl acetate. The combined organic phases are washed with water and saturated saline solution, dried over sodium sulphate and concentrated by rotary evaporation. The residue is purified over a silica gel column with methylene chloride/methanol/ammonia 4:1:0.01 as eluant.
Yield: 200 mg (27 of theory) 115 Rf value: 0.4 (silica gel, methylene chloride/methanol/ammonia 4:1:0.01) Melting point: 1570C Example XXII methyl 4-methoxycarbonylmethyl-3-nitro-benzoate 54.3 g of methyl 3-nitro-benzoate and 29.0 g of methyl chloroacetate are dissolved in 100 ml of dimethylformamide and this solution is added dropwise at -10 0 C to a solution of 78.5 g of potassium-tert. butoxide in 500 ml of dimethylformamide.
The mixture is stirred for another 10 minutes at room temperature and after this time the solution is poured onto 350 ml of concentrated hydrochloric acid in 2 1 of ice water.
The solution is stirred for 0.5 hours, the precipitate obtained is suction filtered and washed with water. The product is recrystallised from 150 ml of methanol and dried at in vacuo.
Yield: 48.3 g of (51 of theory), contains about 20 of methyl 6-methoxycarbonylmethyl-3-nitro-benzoate R, value: 0.7 (silica gel, petroleum ether/ethyl acetate 1:1) Melting point: 65-73 °C The following compound is prepared analogously to Example
XXII:
ethyl 4-methoxycarbonylmethyl-3-nitro-benzoate Prepared from ethyl 4-thoxycarbonylmethyl-3-nitro-benzoate Example XXIII methyl 2-indolinone-6-carboxylate 48.3 g of methyl 4-methoxycarbonylmethyl-3-nitro-benzoate are dissolved in 800 ml of concentrated acetic acid, 5.0 g of 116 palladium on carbon are added and the solution is hydrogenated for 2.5 hours at room temperature and 50 psi. The catalyst is filtered off and the filtrate is evaporated down.
The residue is taken up in 150 ml of tert.-butylmethyl ether, filtered again and dried in vacuo at 100 0
C.
Yield: 28.6 g (98 of theory), R, value: 0.4 (silica gel, methylene chloride/methanol 10:1) Melting point: 208-211 °C The following compound is prepared analogously to Example
XXIII:
ethyl 2-indolinone-6-carboxylate Prepared from ethyl 4-methoxycarbonylmethyl-3-nitro-benzoate Example XXIV l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6-ethoxycarbonyl- 2-indolinone 15.0 g of ethyl 2-indolinone-6-carboxylate, 49.6 ml of triethyl orthobenzoate and 150 ml of acetic anhydride are stirred for 4 hours at 110 0 C. After this time the solvent is removed, the residue is recrystallised from petroleum ether and dried in vacuo at 50 0
C.
Yield: 16.9 g (61 of theory), Rf value: 0.5 (silica gel, petroleum ether/methylene chloride/ethyl acetate 5:4:1) Melting point: 98-100 0
C
C
22
H
21
NO,
The following compounds are prepared analogously to Example
XXIV:
l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl- 2-indolinone -117 Prepared from methyl 2-indolinone-6-carboxylate, triethyl orthobenzoate and acetic anhydride 1 -ace tyl 3- (1i-eLioxy-i1-ethyl -methylene) 6- ethoxycarbonyl 2 -indolinone Prepared from ethyl 2-indolinone-6-carboxylate, triethyl orthopropionate and acetic anhydride 118 Preparation of the final compounds: Example 1 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene]- 6 -carbamoyl-2-indolinone-trifluoroacetate 300 mg of resin obtained according to Example II are suspended in 3 ml of dimethylformamide and shaken with 0.2 g of 4- (piperidin-1-yl-methyl)-aniline for 22 hours at 70 0 C. Then it is filtered off and the resin is washed several times with methylene chloride, methanol and dimethylformamide. Then 1 ml of methanolic ammonia is added for 2 hours in order to eliminate the acetyl group. Then after further washing 4 ml of trifluoroacetic acid in methylene chloride are added during another 60 minutes, the resin is separated off and the solution is evaporated down.
Yield: 69 mg Rf value: 0.1 (silica gel, methylene chloride/methanol 9:1)
C
28
H
28
N
4 0 2 Mass spectrum: m/z 452 The following compounds are prepared analogously to Example 1: 3-Z-(l-Anilino-l-phenyl-methylene)-6-carbamoyl-2indolinone Prepared from the resin obtained according to Example II and aniline
C
22
HI
7N 3 02 Mass spectrum: m/z 355 3-Z-[l-(4-dimethylaminomethyl-anilino)-l-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-dimethylaminomethyl-aniline
C
2 5H 24
N
4 02 Mass spectrum: m/z 412 119 3-Z-[1-(4-(2-diethylamino-ethyl)-anilino)-l-phenylmethylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared fromt Lhe resin obtained according to Example II and 4- (2-diethylamino-ethyl) -aniline
C
2 8 3 0 2 mass spectrum: m/z 454 3-Z-E1-(4-(morpholin-4-yl-methyl)-anilino)-1-phenylmethylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4- (morpholin-4-yl-methyl) -aniline Rf value: 0.50 (silica gel, methylene chloride/methanol 4:1)
C
2 7H 26
N
4
O
3 mass spectrum: m/z 454 3-Z-[1-(4-(1-oxo-thiomorpholin-4-yl-methyl)-anilino)- 1-phenyl-methylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4- (l-oxo-thiomorpholin-4-yl-methyl) -aniline Rf value: 0.30 (silica gel, methylene chloride/methanol 9:1)
C
27
H
26
N
4 0 3
S
Mass spectrum: m/z 486 3-Z-[l-(4-(1,1-dioxo-thiomorpholin-4-yl-methyl)-anilino)- 1-phenyl-methylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4- (1,l1-dioxo-thiomorpholin-4-yl-methyl) -aniline Rf value: 0.30 (silica gel, methylene chloride/methanol 9:1)
C
2 7H 26
N
4 0 4
S
Mass spectrum: m/z 502 3-Z- [1-(4-(benzylaminomethyl)-anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone-trifluoroacetate 120 Prepared from the resin obtained according to Example II and 4-[N-(phenyl-methyl)-N-tert.butoxycarbonyl-aminomethyl]aniline Rf value: 0.40 (silica gel, methylene chloride/methanol 4:1)
C
30
H
26
N
4 02 Mass spectrum: m/z 474 3-Z-[1-(4-(amino-methyl)-anilino)-l-phenyl-methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-(N-tert.butoxycarbonyl-aminomethyl)-aniline Rf value: 0.10 (silica gel, methylene chloride/methanol 4:1)
C
23
H
2 0N40 2 Mass spectrum: m/z 384 3-Z-[1-(4-(2,6-dimethylpiperidin-l-yl-methyl)-anilino)- 1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-(2,6-dimethylpiperidin-l-yl-methyl)-aniline Rf value: 0.45 (silica gel, methylene chloride/methanol 4:1)
C
30
H
32
N
4 0 2 Mass spectrum: m/z 480 (m) 3-Z-[l-(4-(pyrrolidin-l-yl-methyl)-anilino)-1-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-(pyrrolidin-l-yl-methyl)-aniline R, value: 0.15 (silica gel, methylene chloride/methanol 4:1)
C
2 7H26N402 Mass spectrum: m/z 438 (m) (11) 3-Z-[1-(3-(dimethylaminomethyl)-anilino)-1-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 3-dimethylaminomethyl-aniline R, value: 0.23 (silica gel, methylene chloride/methanol 4:1) 121
C
25
H
24
N
4 02 Mass spectrum: m/z 412 (12) 3-Z-[1-(3-(N-methyl-N-ethyl-aminomethyl)-anilino)- 1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 3-(N-methyl-N-ethyl-aminomethyl)-aniline R, value: 0.23 (silica gel, methylene chloride/methanol 4:1)
C
26
H
26 N402 Mass spectrum: m/z 426 (m (13) 3-Z-[l-(3-(methylaminomethyl)-anilino)-l-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-(N-tert.butoxycarbonyl-N-methyl-aminomethyl)-aniline Rf value: 0.06 (silica gel, methylene chloride/methanol 4:1) C24H 22
N
4 02 Mass spectrum: m/z 399 (14) 3-Z-[l-(3-hydroxymethyl-anilino)-l-phenyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 3-amino-benzyl alcohol Rf value: 0.7 (silica gel, methylene chloride/methanol 4:1)
C
23
HIN
3
O,
Mass spectrum: m/z 385 3-Z-[1-(4-(methoxycarbonylmethyl-aminomethyl)-anilino)- 1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-(N-methoxycarbonylmethyl-N-tert.butoxycarbonyl-aminomethyl)aniline Rf value: 0.40 (silica gel, methylene chloride/methanol 9:1)
C
26
H
24
N
4 0 4 Mass spectrum: m/z 457 122 (16) 3-Z-[1-(4-(N-methylsulphonyl-N-(dimethylaminocarbonylmethyl)-amino)-anilino)-1-phenyl-methylene]-6-carbamoyl- 2-indolinone Prepared from the resin obtained according to Example II and 4-(N-methylsulphonyl-N-(dimethylaminocarbonylmethyl)-amino)aniline Rf value: 0.40 (silica gel, methylene chloride/methanol 9:1)
C
27
H
27
N
5 OsS Mass spectrum: m/z 533 (17) 3-Z-[l-(4-(N-acetyl-aminomethyl)-anilino)-l-phenylmethylene]-6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 4-(N-acetyl-aminomethyl)-aniline Rf value: 0.70 (silica gel, methylene chloride/methanol 4:1)
C
2
H
22
N
4 03 Mass spectrum: m/z 426 (18) 3-Z-[1-(3,4-dimethoxy-anilino)-l-phenyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 3,4-dimethoxy-aniline R, value: 0.40 (silica gel, methylene chloride/methanol 9:1)
C
24
H
21
N
3 0 4 Mass spectrum: m/z 415 (19) 3-Z-[l-(4-(morpholin-4-yl)-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-morpholin-4-yl-aniline R, value: 0.20 (silica gel, methylene chloride/methanol 9:1)
C
26
H
24 N403 Mass spectrum: m/z 440 3-Z-[1-(4-acetylamino-anilino)-l-phenyl-methylene]- 6-carbamoyl-2-indolinone 123 Prepared from the resin obtained according to Example II and 4-acetylamino-aniline R, value: 0.25 (silica gel, methylene chloride/methanol 9:1) C24H2 0
N
4 0 3 Mass spectrum: m/z 412 (21) 3-Z-[l-(4-amino-anilino)-1-phenyl-methylene]-6-carbamoyl- 2-indolinone Prepared from the resin obtained according to Example II and 4-amino-aniline R, value: 0.40 (silica gel, methylene chloride/methanol 9:1)
C
22 H1N402 Mass spectrum: m/z 370 (22) 3-Z-[1-(4-N-methyl-N-acetyl-amino-anilino)-1-phenylmethylene]-6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 4-(N-methyl-N-acetyl-amino)-aniline
C
2 sH 22
N
4 0 3 Mass spectrum: m/z 426 (23) 3-Z-[l-(4-ethoxycarbonyl-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and ethyl 4-amino-benzoate
C
2 5H 21 N30 4 Mass spectrum: m/z 427 (24) 3-Z-[l-(4-carboxy-anilino)-l-phenyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 4-amino-benzoic acid Rf value: 0.11 (silica gel, methylene chloride/methanol 9:1)
C
23
H
17 N304 Mass spectrum: m/z 398 124 3-Z-[l-(4-benzylcarbamoyl-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 4-amino-benzoic acid-bcnzylamide R, value: 0.21 (silica gel, methylene chloride/methanol 9:1)
C
30
H
24 N40 3 Mass spectrum: m/z 488 (26) 3-Z-[l-(cyclohexyl-amino)-1-phenyl-methylene]-6carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and cyclohexylamine R, value: 0.60 (silica gel, methylene chloride/methanol 9:1)
C
22
H
23 N302 Mass spectrum: m/z 361 (m) (27) 3-Z-[1-(4-amino-cyclohexyl-amino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-amino-cyclohexylamine
C
22
H
24 N402 Mass spectrum: m/z 376 (28) 3-Z-[1-(N-methyl-piperidine-4-yl-amino)-1-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-amino-l-methyl-piperidine R, value: 0.15 (silica gel, methylene chloride/methanol 4:1)
C
22
H
24 N402 Mass spectrum: m/z 376 (m (29) 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-methylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(2) and 4-(piperidin-l-yl-methyl)-aniline R, value: 0.30 (silica gel, methylene chloride/methanol 4:1) 0 125
C
2 3H 2 6
N
4 02 Mass spectrum: m/z 390 (3 7- r I -Ii A4 me h lamome 1 L..nL Ilyl methylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(2) and 3-dimethylaminomethyl-aniline Rf value: 0.51 (silica gel, methylene chloride/methanol 4:1)
C
2 0 2 2 4 2 Mass spectrum: m/z 351 (31) 3-Z- [l-(4-(N-methyl-N-benzyl-aminomethyl)-anilino) 1-methyl-methylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(2) and 4- (N-methyl-N-benzyl-aminomethyl) -aniline Rf value: 0.73 (silica gel, methylene chloride/methanol 4:1)
C
2 6
H
2 6 4 2 Mass spectrum: m/z 426 (32) 3-Z-[li- (N-methylsulphonyl-N- (2-dimethylamino-ethyl) amino) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinonetrifluoroacetate Prepared from the resin obtained according to Example 11(2) and 4- (N-methylsulphonyl-N- (2-dimethylamino-ethyl) -amino) aniline
C
22
H
2 7 N04S mass spectrum: m/z 458 (m+H2) (33) 3-Z- [l-(4-chloro-anilino)-1-methyl-methylene]-6carbamoyl indolinone Prepared from the resin obtained according to Example 11(2) and 4-chloro-aniline Rf value: 0.10 (silica gel, methylene chloride/methanol 9:1)
C
17 H 14 ClN 3 0 2 Mass spectrum: m/z 327/329 126 (34) 3-Z-[l-(3-chloro-anilino)-l-methyl-methylene]-6carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(2) and 3-chloro-aniline R, value: 0.11 (silica gel, methylene chloride/methanol 9:1)
C
1
,H
7 1 C1N O, Mass spectrum: m/z 327/329 (m 3-Z-[1-(4-methoxycarbonyl-anilino)-1-methyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II(2) and methyl 4-amino-benzoate R, value: 0.11 (silica gel, methylene chloride/methanol 9:1)
C
19 H ,N 3 0 4 Mass spectrum: m/z 351 (36) 3-Z-[l-(4-carboxy-anilino)-l-methyl-methylene]-6carbamoyl-2-indolinone Prepared from the resin obtained according to Example II(2) and 4-amino-benzoic acid CisHiN O,4 Mass spectrum: m/z 336 (37) 3-Z-[1-(4-methyl-3-nitro-anilino)-1-methyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II(2) and 4-methyl-3-nitro-aniline Rf value: 0.82 (silica gel, methylene chloride/methanol 4:1)
C
18
H
16
N
4 0 4 Mass spectrum: m/z 352 (38) 3-Z-[l-(4-(piperidin-l-yl-methyl)-anilino)-1-propylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(4) and 4-(piperidin-l-yl-methyl)-aniline Rf value: 0.37 (silica gel, methylene chloride/methanol 4:1) 127
C
25
H
30
N
4 0 2 Mass spectrum: m/z 418 (39) 3-Z-[1-(3-dimethylaminomethyl-anilino)-1-propylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(4) and 3-dimethylaminomethyl-aniline R, value: 0.42 (silica gel, methylene chloride/methanol 4:1)
C
22
H
26
N
4 0 2 Mass spectrum: m/z 378 3-Z-[l-(4-(N-methyl-N-benzyl-aminomethyl)-anilino)-1-propyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(4) and 4-(N-methyl-N-benzyl-aminomethyl)-aniline Rf value: 0.81 (silica gel, methylene chloride/methanol 4:1)
C
28 H30N40, Mass spectrum: m/z 454 (41) 3-Z-[1-(4-(N-methylsulphonyl-N-(2-dimethylamino-ethyl)amino)-anilino)-1-propyl-methylene]-6-carbamoyl-2-indolinonetrifluoroacetate Prepared from the resin obtained according to Example 11(4) and 4-(N-methylsulphonyl-N-(2-dimethylamino-ethyl)-amino)aniline Rf value: 0.59 (silica gel, methylene chloride/methanol 4:1)
C
24
H
31 N0O 4S Mass spectrum: m/z 486 (42) 3-Z-[l-(4-chloro-anilino)-l-propyl-methylene]-6carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(4) and 4-chloro-aniline R, value: 0.17 (silica gel, methylene chloride/methanol 9:1)
C
19 ,HC1N 3 02 Mass spectrum: m/z 355/357 128 (43) 3-Z-[1-(3-chloro-anilino)-1-propyl-methylene]-6carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(4) and 3-chloro-aniline R, value: 0.12 (silica gel, methylene chloride/methanol 9:1)
C
19 ,,HC1N302 Mass spectrum: m/z 355/357 (44) 3-Z-[l-(4-methoxycarbonyl-anilino)-1-propyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(4) and methyl 4-amino-benzoate R, value: 0.8 (silica gel, methylene chloride/methanol 4:1)
C
21
H
21
N
3 0 4 Mass spectrum: m/z 379 (mf) 3-Z-[1-(4-carboxy-anilino)-1-propyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(4) and 4-amino-benzoic acid
C
20
H
19 N30 4 Mass spectrum: m/z 364 (46) 3-Z-[1-(4-methyl-3-nitro-anilino)-1-propyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(4) and 4-methyl-3-nitro-aniline R, value: 0.86 (silica gel, methylene chloride/methanol 4:1)
C
20
H
20
N
4 0 4 Mass spectrum: m/z 380 (mf) 129 Example 2 3-Z-[1-(3-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene]-6-carbamoyl-2-indolinone-tritluoroacetate g of resin obtained according to Example II are reacted analogously to Example 1 with 2.0 g of 3-aminobenzyl alcohol in 20 ml of dimethylformamide for 22 hours at 700C. Then the solvent is suction filtered and the resin is washed several times with dimethylformamide and methylene chloride. Then 200 mg of the moist charged resin are suspended in 2 ml of methylene chloride and left to stand with 0.2 ml of methanesulphonic acid chloride and 0.1 ml of triethylamine for 2 hours at room temperature. Then the resin is washed several times with methylene chloride, suspended in 2 ml of methylene chloride and combined with 0.2 ml of piperidine. After 1 hour the resin is washed with methylene chloride and dimethylformamide and then treated with trifluoroacetic acid analogously to Example 1.
Yield: 15 mg Rf value: 0.30 (silica gel, methylene chloride/methanol 4:1)
C
28
H
28
N
4 0 2 Mass spectrum: m/z 452 The following compounds are prepared analogously to Example 2: 3-Z-[1-(3-(diethylaminomethyl)-anilino)-1-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and diethylamine R, value: 0.80 (silica gel, methylene chloride/methanol 4:1)
C
27
H
28 N402 Mass spectrum: m/z 440 3-Z-[l-(3-(benzylaminomethyl)-anilino)-l-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate 130 Prepared from the resin obtained according to Example II and benzylamine R, value: 0.80 (silica gel, methylene chloride/methanol 4:1) 26
N
4 02 Mass spectrum: m/z 474 3-Z-[1-(3-(N-methyl-N-benzyl-aminomethyl)-anilino)- 1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and N-methyl-benzylamine Rf value: 0.80 (silica gel, methylene chloride/methanol 4:1)
C
31
H
28
N
4 0 2 Mass spectrum: m/z 488 3-Z-[1-(3-(butylaminomethyl)-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and butylamine R, value: 0.40 (silica gel, methylene chloride/methanol 4:1)
C
27
H
28
N
4 0 2 Mass spectrum: m/z 440 3-Z-[l-(3-(aminomethyl)-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and ammonia
C
23
H
20
N
4 0 2 Mass spectrum: m/z 385 3-Z-[1-(3-(N-(3-dimethylaminopropyl)-N-methyl-aminomethyl)-anilino)-1-phenyl-methylene]-6-carbamoyl-2-indolinonetrifluoroacetate Prepared from the resin obtained according to Example II and l-dimethylamino-3-methylaminopropane R, value: 0.67 (silica gel, methylene chloride/methanol 4:1) C2 9
H
33 NsO2 131 Mass spectrum: m/z 484 3-Z-[1-(3-(N-(2-dimethylaminoethyl)-N-methyl-aminomethyl)anilino) -1-phenyl-miiethyiene -6-carbamoyi-2-indolinonetrifluoroacetate Prepared from the resin obtained according to Example II and 1-dimethylamino-2-methylaminoethane R, value: 0.40 (silica gel, methylene chloride/methanol 4:1) C28H31N5O2 Mass spectrum: m/z 470 Example 3 3-Z-[1-(4-(piperidin-l-yl-methyl)-anilino)-1-phenylmethylene]-6-ethoxycarbonyl-2-indolinone g of l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6ethoxycarbonyl-2-indolinone and 1.1 g of 4-(piperidin-1-ylmethyl)-aniline are dissolved in 15 ml of dimethylformamide and stirred for 45 minutes at 100 0 C. After cooling 5.0 ml of piperidine are added and the mixture is stirred for another 3 hours at room temperature. The solvent is removed and the residue purified over an aluminium oxide column (activity: 2-3) with methylene chloride/ethanol (100:3) as eluant.
Yield: 1.1 g (58% of theory), R, value: 0.5 (aluminium oxide, methylene chloride/ethanol 100:3)
C
3 oH 31
N
3 03 Mass spectrum: m/z 481 [M] The following compounds are prepared analogously to Example 3: 3-Z-[1-(4-bromo-anilino)-l-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6ethoxycarbonyl-2-indolinone and 4-bromoaniline R, value: 0.4 (silica gel, toluene/ethyl acetate 5:1) 132
C
24
H
19 BrN 2 03 Mass spectrum: m/z 462/464 2) 3-Z- Li-(3-(dimethylaminomethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l--phenylmethylene) -6ethoxycarbonyl-2-indolinone and 3- (dimethylaminomethyl) aniline Rf value: 0.5 (aluml'nium oxide, methylene chloride/ethanol= 30:1)
C
2 7
H
2 7N 3 0 3 ESI mass spectrum: m/z 442 iM+H~] 3-Z- (dimethylaminomethyl)-anilino)-l-phenylmethylene] -6-ethoxycarbonyl-2 -indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (dimethylaminomethyl) aniline Rf value: 0.7 (aluminium oxide, ethyl acetate/ethanol 20:1)
C
2 7
H
2 7
N
3 03 ESI mass spectrum: m/z 442 [M+H]1 3-Z-[l-(4-[(2,6-dimethyl-piperidin-1-yl)-methyl]-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4-1(2, 6-dimethyl-piperidin-1yl) -methyl] -aniline Rf value: 0.6 (silica gel, methylene chloride/ethanol 5:1)
C
32
H
3 5
N
3 03 Mass spectrum: m/z 509 [M'1 3-Z- [l-(4-(2-dimethylamino-ethyl)-anilino)-l-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) aniline -133 Rf value: 0.2 (silica gel, methylene chloride/ethanol =5:1)
C
2 8 2 9 3 Mass spectrum: m/z 455 [M'1 3-Z- (2-dimethylamino-ethyl) -N-acetyl-amino)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy--l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-acetyl-amino) -aniline Rf value: 0.4 (aluminium oxide, methylene chloride/ethanol= 20:1)
C
3 0 3 2 4 mass spectrum: m/z 512 [WI1 3-Z- [l-(4-tert.butyloxycarbonyl-anilino)-l-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4-tert .butyloxycarbonylaniline Rf value: 0.4 (aluminium oxide, methylene chloride/ethanol 40:1)
C
29
H
28
N
2 Mass spectrum: m/z 484 [M]1 3-Z- [l-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (3-dimethylamino-propyl) N-acetyl-amino) -aniline Rf value: 0.2 (aluminium oxide, methylene chloride/ethanol 40:1)
C
3 1 3 4 4 Mass spectrum: m/z 526 [M]1 -134 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone Prepared from 1-acetyi-3- (1-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nmethylsuiphonyl -p-phenylenediamine Rf value: 0.3 (aluminium oxide, methylene chloride/ethanol 40:1)
C
29
H
32
N
4 0 5
S
Mass spectrum: m/z =548 3-Z-[1-(4-(4-methyl-piperazin-1-yl)-anilino)-l-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (4-methyl-piperazin-1-yl) aniline Rf value: 0.3 (aluminium oxide, ethyl acetate)
C
29
H
30
N
4 0 3 ESI mass spectrum: m/z 483 IM+H]l (11) 3-Z-[lI-(4-(N-(2-dimethylamino-ethyl)-N-methyl-amino)anilino) -1-phenyl-methylene] -6-ethoxvcarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-methyl-amino) -aniline Rf value: 0.5 (aluminium oxide, methylene chloride/ethanol 20:1)
C
29
H
32
N
4 0 3 ESI mass spectrum: m/z 485 [M+H]1 (12) 3-Z- (3-dimethylamino-propyl) -N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (3-dimethylamino-propyl) N-methyl-amino) -aniline Rf value: 0.5 (aluminium oxide, ethyl acetate) 135
C
30 H 34
N
4 0 3 ESI mass spectrum: m/z 499 iM+H]1 (13) 3-Z-[l-(4-(N-methyl-acetylamino)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl--2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4-amino-N-methyl-acetanilide Rf value: 0.3 (silica gel, methylene chloride/ethanol 15:1)
C
2 7
H
2 5N 3 04 Mass spectrum: m/z 455 (14) 3-Z- (N-methyl-methylsulphonylamino) -anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and N- (4-aminophenyl) -N-methylmet hanesulphonamide Rf value: 0.8 (aluminium oxide, ethyl acetate)
C
26
H
25
N
3 0 5
S
Mass spectrum: m/z 491 [M'1 3-Z- (3-dimethylamino-propyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and N- (3-dimethylamino-propyl) -Nmethyl suiphonyl -p-phenylenediamine Rf value: 0.6 (silica gel, methylene chloride/ethanol/ammonia 5:2:0.01)
C
3 0
H
34
N
4 0 5
S
ESI mass spectrum: m/z 563 [M+H]1 (16) 3-Z- (N-dimethylaminocarbonylmethyl-Nmethylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone -13G Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (Ndimethylaminocarbonylmethyl-N-methylsulphonyl) -amino) -aniline Rf value: 0.6 (silica gel, methylene chloride/ethanol 10:1)
C
29
H
30
N
4 0 6
S
ESI mass spectrum: m/z 561 EM-Hi1 (17) 3-Z-[1-(4-(imidazol-4-yl)-anilino)-l-phenyl-methylene]-6ethoxycarbonyl iniol inone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (imidazol-4-yl) -aniline Rf value: 0.5 (silica gel, methylene chloride/ethanol/ammonia 10:1:0.01)
C
27
H
22
N
4 0 3 Mass spectrum: m/z 450 [M*i (18) 3-Z-[1-(4-(tetrazol-5-yl)-anilino)-l-phenyl-methylene]-6ethoxycarbonyl indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (tetrazol-5-yl) -aniline Rf value: 0.5 (silica gel, methylene chloride/ethanol 5:1) C, H, 0 NF 0, ESI mass spectrum: m/z 451 [M-HA1 (19) 3-Z- [l-(4-(N-benzyl-N-methyl-aminomethyl)-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (N-benzyl-N-methylaminomethyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/ethanol 10:1)
C
3 3 3 1 3 ESI mass spectrum: m/z 516 [M-Hi1 3-Z- [l-(4-(N-(2-dimethylamino-ethyl) -N-propionyl-amino) aniline) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -137 Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-propionyl-aminol -aniline Rf value: 0.2 (silica gel, methylene chloride/ethanol 5:1)
C
3
H
34 4 ESI mass spectrum: m/z 525 [M-H]1 (21) 3-Z-[1-(4-(pyrrolidin-1-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (pyrrolidin-1-yl-methyl) aniline Rf value: 0.1 (silica gel, methylene chloride/ethanol 5:1)
C
2 9 2 9 3 ESI mass spectrum: m/z 466 [M-HA] (22) 3-Z- [1-(4-(N-methyl-N-phenethyl-aminomethyl)-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (N-phenethyl-N-methylaminomethyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/ethanol 10:1)
C
3 4 3 3 3 ESI mass spectrum: m/z 530 [M-Hi1 (23) 3 [1 (4 (N-dimethylaminomethylcarbonyl -N-methyl -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl -2-indolinone and N-dimethylaminomethylcarbonyl- N-methyl -p-phenylenediamine Rf value: 0.1 (silica gel, methylene chloride/ethanol 10:1) C2 9
H
3
N
0 4 EST mass spectrum: m/z 497 EM-Hi1 138 (24) 3-Z- El-(4-(N-(2-dimethylamino-ethyl)-N-ethylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone Prepared fron. 1--acetL-y'l (1-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nethylsuiphonyl -p-phenylenediamine R, value: 0. 6 (silica gel, methylene chloride /ethanol 5: 1)
C
3 0H 34
N
4 ESI mass spectrum: rh/z 561 [M-H-1 3-Z- (N-tert.butoxycarbonyl-N-ethyl-aminomethyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (N-tert .butoxycarbonyl-Nethyl-aminonethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride /methanol 10:1)
C
32
H
3 5N 3 ESI mass spectrum: m/z 540 [M-Hi1 (26) 3-Z-[1-(4-(piperidin-l-yl-methyl)-anilino)-l-ethylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-ethyl-methylene) -6ethoxycarbonyl-2-indolinone and 4- (piperidin-l-yl-methyl) aniline Rf value: 0.9 (silica gel, methylene chloride/ethanol 5:1)
C
26
H
3 1
N
3 03 ESI mass spectrum: m/z 432 EM-Hi1 (27) 3-Z-[11- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-ethyl-methylene] -6-ethoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-l-ethyl-methylene) -6ethoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nmethyl sulphonyl -p-phenylenediamine Rf value: 0.3 (silica gel, methylene chloride/ethanol 5:1)
C
25
H
32
N
4 139 ESI mass spectrum: m/z 499 [M-Hi1 (28) 3-Z- [l-(4-(dimethylaminomethyl)-anilino) -1-phenylmethylenel -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (dimethylaminomethyl) aniline R, value: 0.6 (silica gel, methylene chloride/methanol 5:1)
C
26
H
25 N303 ESI mass spectrum: m/z 428 [M+H]l (29) 3-Z-tl-(4-[(2,6-dimethyl-piperidin-1-yl)-methyl]anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- 6-dimethyl-piperidin-1yl) -methyl] -aniline Rf value: 0.5 (RP 8, methanol/five percent saline solution= 4:1)
C
3 13 3
N
3 03 ESI mass spectrum: m/z 496 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nmethylsulphonyl -p-phenylenediamine R, value: 0.6 (silica gel, methylene chloride/methanol 5:1)
C
28
H
3 0
N
4 ESI mass spectrum: m/z 533 [M-HA1 (31) 3-Z-[Il- (3-dimethylamino-propyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone 140 Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (3-dimethylamino-propyl) -Nmethyl suiphonyl -p-phenylenediamine R, value: 0. 5 (aluminium oxide, methylene chloride/methanol 30:1)
C
29
H
32
N
4 0 5
S
ESI mass spectrum: m/z 547 EM-Hi1 (32) 3-Z- El- (N-dimethylaminocarbonylmethyl-Nmethylsulphonyl -amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl indol inone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-dimethylaminocarbonylmethyl-N-methylsulphonyl) -amino) -aniline Rf value: 0. 5 (aluminium oxide, methylene chloride /methanol 20:1)
C
28
H
28
N
4 0 6
S
ESI mass spectrum: m/z 547 EM-Hi1 (33) 3 [1 (4 (N-acetyl -N-dimethylaminocarbonylmethyl -amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxv-l-phenvlmethvlene)-6methoxycarbonyl-2-indolinone and 4- (N-acetyl -Ndimethylaminocarbonylmethyl) -amino) -aniline Rf value: 0. 6 (silica gel, methylene chloride /methanol 10: 1)
C
29
H
28
N
4 0 ESI mass spectrum: m/z 511 EM-Hi1 (34) 3-Z- (N-dimethylaminocarbonylmethyl -amino) -anilino) 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-dimethylaminocarbonylmethyl) -amino) -aniline Rf value: 0.6 (aluminium oxide, methylene chloride /methanol 30:1)
C
2 7H 26
N
4 0 4 -141 ESI mass spectrum: m/z 469 EM-Hi1 3-Z- (3-dimethylamino-propyl) -N-acetyl-amino) no J-lnl mLeLI: hyl ene -,Cmtreioxycarbuiiyi iridolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (3-dimethylamino-propyl) -Nacetyl -p-phenylenediamine Rf value: 0.5 (aluminium oxide, methylene chloride/methanol= 20:1)
C
30
H
32
N
4 0 4 ESI mass spectrum: m/z 511 [M-Hi1 (36) 3-Z- (N-methylaminocarbonylmethyl-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl indolinone and N-methylaminocarbonylmethyl N-methylsulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
2 7
H
26
N
4 0 6
S
ESI mass spectrum: m/z 533 [M-Hi1 (37) 3-Z-[l-(4-((imidazolidin-2,4-dion-5-ylidene)-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((imidazolidin-2,4-dion-5ylidene) -methyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
27
H
20
N
4 ESI mass spectrum: m/z 479 [M-Hi1 (38) 3-Z- (2-dimethylamino-ethyl)-carbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone -142 Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N-C (2-dimethylamino-ethyl) carbonyl) -N-methyl -p-phenylenediamine Rf value: 0.5 (aluminium oxide, methylene chloride/methanol 20:1)
C
29
H
30
N
4 0 4 ESI mass spectrum: m/z 497 EM-Hi1 (39) 3-Z-[l-(4-(N-t~rt.butoxycarbony1-aminomethyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-tert .butoxycarbonylaminomethyl) -aniline Rf value: 0.3 (aluminium oxide, methylene chloride/methanol= 20:1)
C
29
H
29
N
3 0 EST mass spectrum: m/z 498 [M-Hi1 3-Z-(l-(4-(2-oxo-pyrrolidin-l-yl-methyl)-anilino)-lphenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-oxo-pyrrolidin-l-ylmethyl) -aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 20:1)
C
28
H
25
N
3 04 ESI mass spectrum: m/z 466 IM-Hi1 (41) (N-aminocarbonylmethyl-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl -2 -indolinone and N-aminocarbonylmethyl-Nmethylsulphonyl -p-phenylenediamine Rf value: 0.7 (silica gel, methylene chloride/methanol 5:1)
C
26
H
24
N
4 0 6
S
ESI mass spectrum: m/z 519 EM-Hi1 -143 (42) 3-Z-[l-(4-(thiomorpholin-4-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (thiomorpholin-4-ylmethyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 15:1)
C
28
H
2 7 N03S ESI mass spectrum: m/z 484 [M-Hi1 (43) 3-Z-[1-(4-(l,1-dioxo-thiomorpholin-4-yl-methyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- 1-dioxo-thiomorpholin-4yl-methyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
28
H
27 ESI mass spectrum: m/z 516 IM-Hi1 (44) 3-Z- (N-cyanomethyl-N-methylsulphonyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N-cyanomethyl-N-methylsulphonyl -p-phenylenediamine Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1)
C
26 H22N405S ESI mass spectrum: m/z 501 fM-H-i 3-Z- (N-tert.butoxycarbonyl-ethylaminomethyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-ethyl-Ntert .butoxycarbonyl-aminomethyl) -aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1) ESI mass spectrum: m/z 526 EM-Hi) -144 (46) 3-Z- [1-(4-(N-benzyl-N-methyl-aminomethyl) -anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared front l-acetyi-3- (1-ethoxy-i-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-benzyl-N-methylaminomethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
32
H
2 9
N
3 03 ESI mass spectrum: th/z 502 [M-Hi1 (47) 3-Z-[l-(4-(l-oxo-thiomorpholin-4-yl-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (l-oxo-thiomorpholin-4-ylmethyl) -aniline Rf value: 0.7 (silica gel, methylene chloride/methanol 10:1)
C
28
H
27
N
3 0 4
S
ESI mass spectrum: m/z 500 EM-Hi1 (48) 3-Z-[l-(4-(2-(imidazol-4-yl)-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (imidazol-4-yl) -ethyl) aniline Rf value: 0.4. (silica gel, methylene chloride/methanol 5:1)
C
28
H
24
N
4 0 3 ESI mass spectrum: m/z 463 EM-Hi1 (49) 3-Z-[l-(4-(morpholin-4-yl-methyl)-anilino)-l-phenylmethylenel -6 -methoxycarbonyl indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (morpholin-4-yl-methyl) aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
28
H
27
N
3 04 ESI mass spectrum: m/z 468 EM-Hi1 145 3-Z-t1-(4-((4-methyl-piperazin-l-yl)-methyl)-anilino)-iphenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((4-methyl-piperazin-l-yl) methyl) -aniline R, value: 0.4 (silica gel, methylene chloride/methanol 5:1)
C
2 9 3 0 3 EST mass spectrum: m/z 481 tM-Hi1 (51) 3-Z-t1-(4-((2-(N-benzyl-N-methyl-amino)-ethyl)-Nmethylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6met hoxycarbonyl indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-benzyl-N-methylamino) -ethyl) -N-methylsulphonyl-amino) -aniline Rf value: 0.7 (silica gel, methylene chloride/methanol 10:1)
C
34
H
34 ESI mass spectrum: m/z 609 EM-Hi1 (52) 3-Z- (l-(4-cyclohexylamino-anilino)-l-phenyl-methylene -6methoxycarbonyl -2 -indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N-cyclohexyl-pphenylenediamine Rf value: 0.8 (silica gel, methylene chloride/methanol 10:1)
C
29
H
28 2 3 ESI mass spectrum: m/z 451 IM-Hi1 (53) 3-Z-[1-(4-(pyridin-4-yl-methyl)-anilino)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (pyridin-4-yl-methyl) aniline Rf value: 0.6 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01) 146
C
29 H 2 3
N
3 0 3 ESI mass spectrum: m/z 460 EM-Hi1 (54) 3-Z-[1-(4-(imidazol-l-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (imidazol-1-yl-methyl) aniline Rf value: 0.4 (silida gel, methylene chloride /methanol /ammonia 10:1:0.01)
C
27 H 2 2
N
4 0 3 ESI mass spectrum: m/z 449 EM-Hi1 3-Z-[l-(4-(imidazol-1-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (imidazol-1-yl-methyl) aniline Rf value: 0.4 (silica gel, methylene chloride /methanol /ammonia 10:1:0.01)
C
2 7 2 2 4 3 ES! mass spectrum: m/z 449 [M-Hi1 (56) 3-Z- [1-(N-methyl-piperidine-4-yl-amino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4-amino-1-methyl-piperidine Rf value: 0.3 (silica gel, methylene chloride/methanol 5:1)
C
2 3
H
2 5
N
3 0 3 EST mass spectrum: m/z 390 EM-Hi1 (57) 3-Z-[l-(4-(imidazol-4-yl-methyl)-anilirlo)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (imidazol-4-yl-methyl) aniline -147 R, value: 0.2 (silica gel, methylene chloride/methanol 5:1)
C
27
H
22
N
4 03 ESI mass spectrum: m/z 449 [M-Hi1 (58) 3-Z-[l-(4-((4-hydroxy-piperidin-l-yl)-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((4-hydroxy-piperidin-lyl) -methyl) -aniline Rf value: 0.1 (silica gel, methylene chloride/methanol 10:1)
C
2 9 2 9 3 ESI mass spectrum: m/z 482 [M-Hi1 (59) 3-Z-[1-(4-((4-methoxy-piperidin-1-yl)-methyl)-anilino)-1phenyl-methylenel -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((4-methoxy-piperidin-1yl) -methyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1) ESI mass spectrum: m/z 496 tM-Hi1 3-Z- [l-(4-benzyl-anilino)-l-phenyl-methylenel-6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (i-ethoxy-i-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4-benzyl-aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1)
C
30 H 24
N
2 0 3 Melting point: 224 0
C
(61) 3-Z-[1-(4-(N-(3-trifluoroacetylamilo-propyl)
-N-
methylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (3-trifluoroacetylaminopropyl) -N-methylsulphonyl-p-phenylenediamine 148 Rf value: 0.5 (aluminium oxide, methylene chloride/methanol 20:1)
C
2
,H
27
F
3
N
4 0 6
S
EST mass~ spectrum: -m/Z 615r (62) 3-Z- [1-(4-tert.butoxycarbonylmethyl-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and tert.butyl 4aminophenylacetate Rf value: 0.5 (aluminium oxide, ethyl acetate)
C
3 0
H
30
N
2 ESI mass spectrum: m/z 497 EM-Hi1 (63) 3-Z-[1-(4-tert.butoxycarbonyl-anilino)-1-ethylmethylene] -6 -ethoxycarbonyl -2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-ethylmethylen) -6ethoxycarbonyl-2-indolinone and 4-tert .butoxycarbonyl-aniline Rf value: 0.4 (aluminium oxide, methylene chloride/ethanol= 20:1)
C
2 5
H
2 8
N
2 0 ESI mass spectrum: m/z 435 EM-Hi1 (64) 3-Z-[lI-(4-(4-tert.butoxycarbonyl-piperazin-1-yl-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (4-tert .butoxycarbonylpiperazin-i-yl-methyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
33
H
36
N
4 0 ESI mass spectrum: m/z 567 [M-Hi1 3-Z-[l-(4-(1-methyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone 149 Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (l-methyl-imidazol-2-yl) aniline R, value: 0.6 (silica gel.. methylene chloride/methanol1 5:111
C
2 7 2 2 4 3 EST mass spectrum: m/z 449 EM-Hi1 (66) (2-dimethylamino-ethyl) -N-methylsulphonylamino) -3-nitro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone Prepared from l-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 6- (2-dimethylamino-ethyl) N-methylsulphonyl-amino) -3-amino-nitrobenzene Rf value: 0.6 (silica gel, methylene chloride/methanol 5:1)
C
28
H
29
N
5 0 7
S
ESI mass spectrum: m/z 578 [M-Hi1 (67) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -3-amino-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indol inone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-methylsulphonyl-amino) -3-amino-aniline Rf value: 0.5 (aluminium oxide, methylene chloride/methanol= 20:1)
C
2 8H 31
NSO
5
S
ESI mass spectrum: m/z 548 EM-Hi1 (68) 3-Z- (N-benzyl-N-methyl-amino) -propyl) -N-methylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-benzyl-N-methylamino) -propyl) -N-methylsulphonyl-amino) -aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1)
C
35
H
36
N
4 0 5
S
150 ESI mass spectrum: m/z 623 [M-Hi1 (69) 3 Z- 1- (4 (2 -dimethylamino- ethyl) -N-methylsulphonyl ;qminr)-I3-rhlor-ilno-1 -phenyl-methylene]-cmethoxycarbonyl indol inane Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2 -dime thylamino -ethyl) N-methylsulphonyl-amino) -3-chioro-aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
28
H
2 9 C N 4 EST mass spectrum: m/z 567/569 [M-Hi1 3-Z- (N-dimethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl indol inone and Ndimethylaminomethylcarbonyl -N-methyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
28
H
2 8N 4 0 4 ESI mass spectrum: m/z 483 jM-Hi1 (71) 3 (4 (2 -dimethylamino-ethyl) -N-acetyl -amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2 -dimethylamino- ethyl) N-acetyl-amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
2 9
H
3
N
0 4 ESI mass spectrum: m/z 497 [M-Hi1 (72) 3 [1l- (4 (2 -dimethylamino-ethyl) -N-propionyl -amino) anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2 -dimethylamino- ethyl) N-propionyl-amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1) 151
C
30 H32N404 ESI mass spectrum: m/z 511 [M-H-J (73) 3-Z- (2 -dime thylamcino -ethyl) -N-butyryl -amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-butyryl-amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3
H
34
N
4 04 ESI mass spectrum: m/z 525 EM-Hi1 (74) 3-Z-[li- (4-(N-(2-dimethylamino-ethyl) -N-isobutyryl-amino) anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-isobutyryl-amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 1 3 4 4 ESI mass spectrum: m/z 525 EM-Hi1 3-Z-[Il- (2-dimethylamino-ethyl) -N-benzovl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-benzoyl-amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
34
H
3 2
N
4 04 ESI mass spectrum: m/z 559 EM-Hi1 (76) 3-Z-[l-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-3amino-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-acetyl-amino) -3-amino-aniline 152 Rf value: 0.5 (aluminium oxide, methylene chloride/methanol 20:1)
C
29
H
31
N
5 0 4 ESI mass spectrum: m/z 512 EM-Hi1 (77) 3-Z-[l-(4-(4-hydroxymethyl-piperidin-l-yl-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-iidolinone and 4- (4-hydroxymethyl-piperidin- 1-yl-methyl-amino) -aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 5:1)
C
30
H
31
N
3 0 4 ESI mass spectrum: m/z 496 [M-Hi1 (78) 3-Z-[l-(4-(2-(4-hydroxy-piperidin-1-yl)-ethyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (4-hydroxy-piperidin-lyl) -ethyl-amino) -aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 5:1)
C
3 0
H
31
N
3 04 ESI mass spectrum: m/z 496 EM-HF] (79) 3-Z- (2-dimethylamino-ethyl) -N-propylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Npropylsulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
30
H
3 4 ESI mass spectrum: m/z 561 EM-Hi1 3-Z- El- (2-dimethylamino-ethyl) -N-butylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone 153 Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nbutylsuiphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 1 3 6 ESI mass spectrum: m/z 575 EM-Hi1 (81) 3-Z- (2-dimethylamino-ethyl) -N-phenylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nphenylsulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
33
H
32 ESI mass spectrum: m/z 595 [M-Hi1 (82) 3-Z- (2-dimethylamino-ethyl) -N-benzylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nbenzylsulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
34
H
34
N
4 0 5
S
ESI mass spectrum: m/z 609 (M-Hi1 (83) 3-Z- (2-dimethylamino-ethyl)-N-ethylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nethyl sulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
29
H
32
N
4 ESI mass spectrum: m/z 547 [M-H-i -154 (84) 3-Z-[l-(4-((imidazolidin-2,4-dion-5-yl)-methyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((imidazolidin-2,4-dion-5yl) -methyl) -aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 5:1)
C
27
H
22
N
4 0 ESI mass spectrum: r'n/z 481 [M-Hi1 3-Z-[1-(4-((3-hydroxy-pyrrolidin-1-yl)-methyl)-anilino)- 1-phenyl-methylenel -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((3-hydroxy-pyrrolidin-1yl) -methyl) -aniline Rf value: 0.1 (silica gel, methylene chloride/methanol 10:1)
C
2 8 2 7 3 4 ESI mass spectrum: m/z 468 IM-HA1 (86) 3-Z- (cyclohexylyl-methyl) -anilino) -1-phenylmethylenel -6 -methoxycarbonyl indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (cyclohexyl-methyl) -aniline (Eur. J. Med. Chem. Chim. Ther. 1992, 27, 537-544) Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1)
C
30 H 30 N 2 0 3 ESI mass spectrum: m/z 465 [M-HWI (87) 3-Z- fl-(4-(cyclohexyl-carbonyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (cyclohexyl-carbonyl) aniline R, value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
30
H
28 4 ESI mass spectrum: m/z 479 EM-Hi1 -155 (88) 3-Z-(1-(4-diethylaminomethyl-anilino)-1-phenylmethylene] -6-rethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (diethylamino-methyl) aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
28 H 29
N
3 0 3 ESI mass spectrum: m/z 454 [M-HA1 (89) 3-Z-[l-(4-(N-(n-hexyl)-N-methyl-aminomethyl)-anilino)-lphenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (n-hexyl) -N-methylaminomethyl) -aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1)
C
31
H
35
N
3 0 3 ESI mass spectrum: m/z 496 tM-Hi1 3-Z- f1-(4-(N-(2-dimethylamino-ethyl)-N-(furan-2carbonyl) -amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N- (furan-2-carbonyl) -amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 2
H
3 0
N
4 ESI mass spectrum: m/z 549 [M-Hi1 (91) (2-dimethylamino-ethyl)-N-(2-methoxybenzoyl) -amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N- (2-methoxy-benzoyl) -amino) -aniline Rf value: 0.5 (silica gel,. methylene chloride/methanol 9:1) 156
C
3 5
H
34
N
4 ESI mass spectrum: m/z 589 [M-H-i (92) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N- (pyridine-3carbonyl) -amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N- (pyridine-3-carbohyl) -amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
33
H
31 NS0 4 ESI mass spectrum: m/z 560 [M-Hi1 (93) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl) (phenyl-acetyl)amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N- (phenyl-acetyl) -amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 5 3 4 4 ESI mass spectrum: m/z 573 jM-Hi1 (94) 3-Z-[l-(4-(N-ethyl-N-methyl-aminomethyl)-anilino)-1phenyl-methylene] -6 -methoxycarbonyl-2 -indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-ethyl-N-methylaminomethyl) -aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 10:1)
C
27
H
27 N 03 ESI mass spectrum: m/z 440 EM-Hi1 3-Z- [l-(4-(imidazol-2-yl)-anilino)-l-phenyl-methylene] -6methoxycarbonyl indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (imidazol-2-yl) -aniline 157 R, value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
26 H 20
N
4 0 3 ESI mass spectrum: m/z 435 EM-Wi1 (96) 3-Z-[1-(4-(l-ethyl-imidazol-2-yl)-alililo)-1-phelylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (l-ethyl-imidazol-2-yl) aniline R, value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
28
H
24
N
4 0 3 ESI mass spectrum: m/z 463 tM-Hi1 (97) 3-Z-t1-(4-(1-benzyl-imidazol-2-yl)-anililo)--phelylmethylene] -6 -methoxycarbonyl -2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (i-benzyl-imidazol-2-yl) aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 20:1)
C
3 3 2 6 4 3 ESI mass spectrum: m/z 525 EM-WI1 (98) 3-Z-[l-(4-(N-(2-dimethylamino-ethyl)-Nisopropylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nisopropylsulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
30
H
34
N
4 ESI mass spectrum: m/z 561 EM-Hi1 (99) 3-Z- (piperidin-l-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2indol inone 158 Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (piperidin-l-ylmethylcarbonyl) -N-methyl-p-phenylenediamine rf value: 0.5 (si±±Ud gel, methylene chloride/methanol 9:1)
C
31
H
32
N
4 0 4 ESI mass spectrum: m/z 523 [M-FV] (100) 3-Z- (morpholin-4-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phienyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (morpholin-4-ylmethylcarbonyl) -N-methyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 0H 3
ON
4 0 ESI mass spectrum: m/z 525 [M-Hi1 (101) 3-Z- (4-benzyl-piperazin-l-yl) -methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- ((4-benzyl-piperazin-1-yl) methylcarbonyl) -N-methyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 7
H
3 7N 5
O
4 ESI mass spectrum: m/z 614 [M-Hi1 (102) 3-Z- (pyrrolidin-l-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (pyrrolidin-l-ylmethylcarbonyl) -N-methyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 0
H
3 0
N
4 0 4 ESI mass spectrum: m/z 509 [M-Hi1 -159 (103) 3-Z- (2 -dimethylamino- ethyl) -N-acetyl -amino) -3bromo-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-acetyl-amino) -3-bromo-aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 5:1)
C
29
H
29 BrN 4
O
4 ESI mass spectrum: m/z 575/577 EM-WI1 (104) 3-Z-[l-(4-(5-methyl-imidazol-4-yl)-anilino)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (5-methyl-imidazol-4-yl) aniline R, value: 0.5 (silica gel, methylene chloride /methanol /ammonia 10:1:0.01)
C
2 7 2 2 4 3 ESI mass spectrum: m/z 449 EM-WI1 (105) 3-Z- (2-dimethylamino-ethyl) -carbonyl) -Nisopropyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- ((2-dimethylamino-ethyl) carbonyl) isopropyl -p-phenylenediamine Rf value: 0.1 (silica gel, methylene chloride /methanol 10:1)
C
3
H
34 4 ESI mass spectrum: m/z 525 EM-Hi1 (106) 3-Z-El-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-Nbenzyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indolinone 160 Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- ((2-dimethylamino-ethyl) carbonyl) -N-benzyl -p-phenylenediamine value: 0.1 (silica ael- meithy-le-ne chlor--*-ide/lmeth-1-ano-l 1:1
C
3 1
H
34
N
4 04 ESI mass spectrum: m/z 525 EM-If] (107) 3-Z- Ii- (N-butyl-N-tert.butoxycarbonyl-aminomethyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-butyl-Ntert .butoxycarbonyl-aminomethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 3
H
37
N
3 0 ESI mass spectrum: m/z 554 EM-Hi1 (108) 3-Z- ((N-aminocarbonylmethyl-N-methyl-amino) methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (N-aminocarbonylmethyl -Nmethyl-amino) -methylcarbonyl) -N-methyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
29
H
29
N
5 ESI mass spectrum: m/z 526 EM-Hi1 (109) 3-Z- ((N-benzyl-N-methyl-amino) -methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6met hoxycarbonyl indol inone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- ((N-benzyl-N-methyl-amino) methylcarbonyl) -N-methyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
34
H
32
N
4 0 4 ESI mass spectrum: m/z 559 EM-Hi1 S 161 (110) 3-Z-E1- (4-(N-(di-(2-methoxyethyl)-amino-methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from l-acetyl-3- (1-ethoxy-i--phenylrnethylene) -6methoxycarbonyl-2-indolinone and N- (di- (2-methoxyethyl) -aminomethylcarbonyl) -N-methyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
32
H
36
N
4 0 6 ESI mass spectrum: m/z 571 EM-Hi1 (111) 3-Z-[1-(4-(N-((2-(4-tert.butoxycarbonyl-piperazin-l-yl)ethyl) -carbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6-me thoxycarbonyl indol inone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (4-tert .butoxycarbonylpiperazin-l-yl) -ethyl) -carbonyl) -N-methyl-p-phenylenediamine Rf value: 0.8 (silica gel, methylene chloride/methanol 5:1)
C
36 41 5 6 ESI mass spectrum: m/z 638 EM-Hi1 (112) 3-Z-[l-(4-(N-((2-(piperidin-1-yl)-ethyl)-carbonyl)-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indol inone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (piperidin-1-yl) ethyl) -carbonyl) -N-methyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 5:1)
C
32
H
34
N
4 0 4 EST mass spectrum: m/z 537 EM-Hi1 (113) 3-Z-E1-(4-(N-((2-(N-benzyl-N-methyl-amino)-ethyl)carbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (N-benzyl-N-methylamino) -ethyl) -carbonyl) -N-methyl-p-phenylenediamine 0 162 Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
35
H
34
N
4 0 4 ESI mass spectrum: m/z 573 EM-Hi1 (114) 3-Z- (N-dimethylaminomethylcarbonyl-N-isopropylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-iridolinone and N- (dimethylaminomethylcarbonyl) -N-isopropyl-p-phenylenediamine R, value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 0 3 2 4 ESI mass spectrum: m/z 511 EM-Hi1 (115) 3-Z- il- (4-(N-(piperidin-1-yl-methylcarbonyl)-Nisopropyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (piperidin-1-ylmethylcarbonyl) isopropyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 3 3 6 4 ESI mass spectrum: m/z 551 EM-Hi1 (116) 3-Z-E1-(4-(N-((4-tert.butoxycarbonyl-piperazin-1-yl)methylcarbonyl) -N-isopropyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from i-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- ((4-tert .butoxycarbonylpiperazin-1-yl) -methylcarbonyl) -N-isopropyl-p-phenylenediamine R, value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 7 4 3 5 6 EST mass spectrum: m/z 652 EM-Hi1 163 (117) 3-Z- (N-benzyl-N-methyl-amino) -methylcarbonyl) N-benzyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N-C (N-benzyl-N-methyl-amino) methylcarbonyl) -N-benzyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
4 0 3 6 4 ESI mass spectrum: m/z 635 EM-Hi1 (118) 3-Z- (N-dimethylaminomethylcarbonyl-N-benzylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (dimethylaminomethylcarbonyl) -N-benzyl-p-phenylenediamine R, value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
34
H
32
N
4 04 ESI mass spectrum: m/z 559 EM-Hi1 (119) 3-Z- (piperidin-l-yl-methylcarbonyl) -N-benzylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (5-methyl-imidazol-4-yl) aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3
?H
36
N
4
O
4 ESI mass spectrum: m/z 559 EM-Hi1 (120) 3-Z-[l-(4-(l,2,4-triazol-2-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (l.2,4-triazol-l-ylmethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride /methanol 10:1) 0 164-
C
26
H
21
N
5 0 3 ESI mass spectrum: m/z 450 [M-Hi1 (121) 3-Z-E1-(4-(1,2,3-triazol-2-yl-methyl.)-anilino)-1-phenvlmethylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (1,2,3-triazol-2-ylmethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol =20:1)
C
26
H
2
IN
5 0 3 ESI mass spectrum: m/z 450 EM-Hi1 (122) 3-Z-[1-(4-(l,2,3-triazol-l-yl-methyl)-anilino)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (l,2,3-triazol-1-ylmethyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 9:1)
C
2 6
H
2 1
N
5 0 3 ES1 mass spectrum: m/z 450 EM-Hi1 (123) 3-Z- ((N-aminocarbonylmethyl-N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((N-aminocarbonylmethyl-Nmethyl-amino) -methyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
27
H
2 6
N
4 04 ES1 mass spectrum: m/z 469 EM-Hi1 (124) 3-Z-(1-(4-((di-(2-methoxy-ethyl)-amino)-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-methoxy-ethyl) amino) -methyl) -aniline 165 R, value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
30 H 33
N
3 0 ESI mass spectrum: m/z 514 [M-Hi1 (125) 3-Z-E1-(4-(pyrrolidin-l-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (pyrrolidin-1-yl-methyl) aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
28
H
2 7N 3
O
3 ESI mass spectrum: m/z 452 EM-Hi) (126) 3-Z-[1-(4-((di-(2-hydroxy-ethyl)-amino)-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-hydroxy-ethyl) amino) -methyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
2 8 2 9 3 ESI mass spectrum: m/z 486 EM-Hi] (127) 3-Z- ((N-ethoxycarbonylmethyl-N-methyl-amino) methyl) -anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((N-ethoxycarbonylmethyl-Nmethyl-amino) -methyl) -aniline Rf value: 0.5 (aluminium oxide, methylene chloride/ethanol= 40:1)
C
2 9
H
2 9
N
3 ESI mass spectrum: m/z 498 EM-Hi1 (128) 3-Z-[l-(4-(azetidin-1-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone 0 166 Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (azetidin-1-yl-methyl) aniline Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia 9:1:0.5)
C
27
H
25 3 ESI mass spectrum: m/z 438 EM-Hi) (129) 3-Z- El- (N-propyl-N-tert.butoxycarbonyl-aminomethyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-propyl-Ntert .butoxycarbonyl-aminomethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
32
H
3 5
N
3 ESI mass spectrum: m/z 540 EM-Hi1 (130) 3-Z-[l-(4((N-(2-(2-methoxy-ethoxy)-ethyl)-N-methylamino) -methyl) -anilino) -1-phenyl-methylenel -6-methoxycarbonyl- 2- indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-methoxy-ethoxy) ethyl) -N-methyl-amino) -methyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 9:1)
C
30
H
3 3 3 ESI mass spectrum: m/z 514 [M-Hi1 (131) 3-Z- [l-(4-((N-(tert.butoxycarbonyl-3-amino-propyl)-Nmethyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl indol inone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-tert.butoxycarbonyl- 3-amino-propyl) -N-methyl-aminomethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
33 H 8
N
4 ESI mass spectrum: m/z 571 [M+H]l 167 (132) 3-Z-[l-(4-((N-(methylcarbamoyl-methyl)-N-methyl-amino)methyl) -anilino) -1-phenyl.-methylene -6-methoxycarbonyl-2indolinane Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6methoxycarbonyl-2-indolinone and 4-((N-(methylcarbamoylmethyl) -N-methyl-amino)-methyl)-aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
28
H
28
N
4 0 4 ESI mass spectrum: m/z 483 EM-WI (133) 3-Z-[l-(4-((N-(dimethylcarbamoyl-methyl)-N-methylamino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl- 2-indolinone Prepared from l-acetyl-3-(l-ethoxy-1-phenylmethylene)-6methoxycarbonyl-2-indolinone and 4-((N-(dimethylcarbamoylmethyl) -N-methyl-amino)-methyl)-aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 10:1)
C
29
H
30
N
4 0 4 EST mass spectrum: m/z 497 EM-Hi1 (134) 3-Z-l-(4-methyl-anilino)-l-phenyl-methylene]-6methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3-(l-ethoxy-1-phenylmethylene)-6methoxycarbonyl-2-indolinone and 4-methyl-aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 9:1)
C
24
H
20 N203 ESI mass spectrum: m/z 383 EM-Hi1 (135) 3-Z-[l-(4-((N-propyl-N-methyl-amino)-methyl)-anilino)-1phenyl-methylene]-6-methoxycarbonyl-2-indolinone Prepared from i-acetyl-3-(i-ethoxy-1-phenylmethylene)-6methoxycarbonyl-2-indolinone and 4-((N-propyl-N-methyl-amino)methyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
28 29 3 03 168 ESI mass spectrum: m/z 454 EM-Hi1 (136) 3 (2 -hydroxy-ethyl) -N-methyl -amino) -methyl) anilino) -1--den'rl-me',hyIene]j -6D-metihoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-hydroxy-ethyl) -Nmethyl-amino) -methyl) -aniline Rf value: 0.5 (aluminium oxide, methylene chloride /ethanol= 40:1)
C
2 7
H
2 7
N
3 04 ESI mass spectrum: m/z 456 fM-Hi1 (137) 3-Z- II-(4-((N-(2-dimethylamino-ethyl) -N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylaminoethyl) -N-methyl-amino) -methyl) -aniline R, value: 0.5 (silica gel, methylene chloride /methanol 9:1)
C
2 9
H
32
N
4 0 3 ESI mass spectrum: m/z 483 tM-Hi1 (138) 3 (4 (3 -dimethylamino-propyl) -N-methyl -amino) methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (3-dimethylaminopropyl) -N-methyl-amino) -methyl) -aniline aniline Rf value: 0.5 (silica gel, methylene chloride /methanol 9:1) C 30 34 0 3 ESI mass spectrum: m/z 497 tM-Hi1 (139) 3-Z-[l-(4-(3-oxo-piperazin-1-yl-methyl)-anilino)-lphenyl-methylene] -6-methoxycarbonyl-2-indolinone 169 Prepared from 1-acetyl-3-(l-ethoxy-l-phenylmethylene)-6methoxycarbonyl-2-indolinone and 4-(3-oxo-piperazin-l-ylmethyl)-aniline aniline R, value: 0.46 (silica gel, methylene chloride/methanol 9:1)
C
28
H
26
N
4 04 ESI mass spectrum: m/z 481 Example 4 3-Z-[1-(4-carboxy-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone 485 mg of 3-Z-[l-(4-tert.butoxycarbonyl-anilino)-l-phenylmethylene]-6-ethoxycarbonyl-2-indolinone are dissolved in ml of methylene chloride and 6.0 ml of trifluoroacetic acid are added. The mixture is stirred for 2 hours at room temperature. Then the solvent is removed and the residue recrystallised from ether.
Yield: 375 mg (87 of theory), Rf value: 0.3 (silica gel, methylene chloride/methanol 10:1)
C
25
H
20
N
2 0O Mass spectrum: m/z 428 The following compounds are prepared analogously to Example 4: 3-Z-[1-(4-aminomethyl-anilino)-l-phenyl-methylene]-6methoxycarbonyl-2-indolinone Prepared from 3-Z-[1-(4-(N-tert.butoxycarbonyl-aminomethyl)anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01)
C
24 H,,N,03 ESI mass spectrum: m/z 398 3-Z-[1-(4-ethylaminomethyl-anilino)-1-phenyl-methylene]-6methoxycarbonyl-2-indolinone 170 Prepared from 3-Z- (N-tert.butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inane vau: .silica gel, methylene chloride /met hanolI/ammonia -10:1:0.01)
C
26
H
25
N
3 0 3 ESI mass spectrum: m/z 426 EM-Hi1 3-Z- [l-(4-carbokymethyl-anilino)-1-phenyl-methylene] -6ethoxycarbonyl indol inane Prepared from 3-Z- [1-(4-tert.butoxycarbonylmethyl-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Rf value: 0.1 (aluminium oxide, methylene chloride/ethanol/ammonia 5:1:0.01)
C
2 6
H
2 2
N
2 ESI mass spectrum: m/z 441 tM-Hi1 3-Z-[II-(4-carboxy-anilino)-1-ethyl-methylene] -6-ethoxycarbonyl indol inane Prepared from 3-Z- [1-(4-tert.butoxycarbonyl-anilino) -1-ethylmethylene] -6-ethoxycarbonyl-2-indolinone Rf value: 0.1 (aluminium oxide, methylene chloride/ethanol= 20:1)
C
2 1
H
2 0
N
2 0 ESI mass spectrum: m/z 379 tM-Hi] 3-Z- (piperazin-1-yl-methyl) -anilino) -1-phenylmethylene] -6 -methoxycarbonyl indol inane Prepared from 3-Z- (4-tert.butoxycarbonyl-piperazin-1-ylmethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone Rf value: 0.1 (silica gel, methylene chloride /methanol /ammonia 10:1:0.01)
C
28
H
28
N
4 0 3 ESI mass spectrum: m/z 469 [M+H]1 -171 3-Z- [l-(4-butylaminomethyl-anilino)-l-phenyl-methylenel -6methoxycarbonyl -2-indcl inone Prepared from 3-Z- (N-butyl-N-tert.butoxycarbonylaminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone R, value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
2 8
H
2 9
N
3 0 3 EST mass spectrum: m/z 454 EM-Hi1 3-Z- [1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6ethoxycarbonyl -2 -indol inone Prepared from 3-Z- (N-tert.butoxycarbonyl-N-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone R, value: 0.3 (silica gel, methylene chloride /methanol /ammonia 10:1:0.01)
C
2 7 2 7 3 ESI mass spectrum: m/z 442 3-Z- [1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6carbamoyl indolinone Prepared from 3-Z- (N-tert.butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone Rf value: 0.2 (silica gel, methylene chloride /methanol /ammonia 5:1:0.01)
C
2 5
H
2 4 0 2 ESI mass spectrum: m/z 411 [M-H]1 3-Z- (piperazin-l-yl-methylcarbonyl) -N-isopropylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 3-Z- ((4-tert.butoxycarbonyl-piperazin- 1-yl) -methylcarbonyl) -N-isopropyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2 -indolinone 172 Rf value: 0.35 (silica gel, methylene chloride/methanol 9:1)
C
3 2 3
N
4 ESI mass spectrum: m/z 552 EM-Hi1 3-Z-(l-(4-(N-((2-(piperazin-l-yl)-ethyl)-carbonyl)-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indolinone Prepared from 3-Z- (4-tert.butoxycarbonylpiperazin-l-yl) -eth'l) -carbonyl) -N-methyl-amino) -anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Rf value: 0.4 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01) ESI mass spectrum: m/z 540 (11) 3-Z-[l-(4-(N-propyl-aminomethyl)-anilino)-l-phenylmethylene] -6 -methoxycarbonyl-2-indolinone Prepared from 3-Z-[li- (N-propyl-N-tert.butoxycarbonylaminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone Rf value: 0.35 (silica gel, methylene chloride/methanol 9:1)
C
27
H
27
N
3 03 EST mass spectrum: m/z 440 EM-Hi1 (12) 3-Z- (N-(3-amino-propyl)-N-methyl-amino)-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 3-Z- (tert.butoxycarbonyl-3-aminopropyl) -N-methyl-amino) -methyl) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl -2 -indol inone Rf value: 0.35 (silica gel, methylene chloride/methanol 9:1)
C
28
H
3 0
N
4 03 ESI mass spectrum: m/z 471 [M+H]1 173 Example 3-Z-[l-(4-methylaminomethyl-anilino)-1-phenyl-methylene]-6ethoxvcarbonyl-2-indolinone 100 mg of 3-Z-[1-(4-(N-benzyl-N-methyl-aminomethyl)-anilino)- 1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone are dissolved in 20 ml of ethanol, 0.2 ml of IN hydrochloric acid are added and the mixture is hydrogenated for 70 minutes at room temperature and 50 psi hydrogen pressure. The reaction solution is filtered and the filtrate concentrated by rotary evaporation. The residue is dried in vacuo at 100 0
C.
Yield: 50 mg (53 of theory), Rf value: 0.3 (silica gel, methylene chloride/ethanol/ammonia 5:1:0.01)
C
26
H
25 N303 ESI mass spectrum: m/z 426 The following compounds are prepared analogously to Example 3-Z-[l-(4-methylaminomethyl-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone Prepared from 3-Z-[1-(4-(N-benzyl-N-methyl-aminomethyl)anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone Rf value: 0.2 (silica gel, methylene chloride/methanol/ammonia 10:1:0.01)
C
25
H
23
N
3 0 3 ESI mass spectrum: m/z 412 [M-H] 3-Z-[1-(4-(N-(2-methylamino-ethyl)-N-methylsulphonylamino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2indolinone Prepared from 3-Z-[1-(4-((2-(N-benzyl-N-methyl-amino)-ethyl)- N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6methoxycarbonyl-2-indolinone -174 Rf value: 0.3 (silica gel, methylene chloride/methanol/ammonia 10:1:0.01)
C
27
H-
28
N
4 0 5
S
EST mass spectrum: L/ =59[-H]1 3-Z- (N-(2-amino-ethyl)-N-methylsulphonyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 3-Z- (N-cyanomethyl-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone R, value: 0.5 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01)
C
26
H
26
N
4 0 5
S
ESI mass spectrum: m/z 505 [M-Hj1 3-Z- (3-methylamino-propyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 3-Z- [1-(4-(N-(3--(N-benzyl-N-methyl-amino) propyl) -N-methylsulphonyl-amino) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indolinone Rf value: 0.3 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01)
C
28
H
30
N
4 0 5
S
ESI mass spectrum: m/z 533 [M-HKI 3-Z- (piperazin-l-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 3-Z-[l-(4-(N-((4-benzyl-piperazin-l-yl)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indolinone Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
30
H
3
IN
5 0' ESI mass spectrum: m/z 524 [M-Hi1 175 3-Z-[1-(4-(N-(methylamino-methylcarbonyl)-N-methyl-amino)anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone Prepared from 3-Z-[1-(4-(N-((N-benzyl-N-methyl-amino)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6-methoxycarbonyl-2-indolinone Rf value: 0.3 (silica gel, methylene chloride/methanol 9:1)
C
27
H
26
N
4 0 4 ESI mass spectrum: m/z 469 3-Z-[1-(4-(N-((2-methylamino-ethyl)-carbonyl)-N-methylamino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2indolinone Prepared from 3-Z-[1-(4-(N-((2-(N-benzyl-N-methyl-amino)ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone R, value: 0.3 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01)
C
28
H
28
N
4 04 ESI mass spectrum: m/z 483 Example 6 3-Z-[1-(4-ureidomethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone 300 mg of 3-Z-[1-(4-aminomethyl-anilino)-l-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone are dissolved in 15 ml of methanol and 200 ml of triethylamine are added. Then 400 mg of potassium cyanate in 5 ml of water are added. After 2 days of stirring at room temperature the reaction solution is concentrated by rotary evaporation, the residue taken up in methylene chloride and washed once with water and once with saturated sodium chloride solution. The organic phase is dried over sodium sulphate and concentrated by rotary evaporation. The residue is dried in vacuo at 100 0
C.
Yield: 100 mg of (21 of theory), 176 Rf value: 0.7 (silica gel, methylene chloride/methanol 5:1)
C
2 H22N404 ESI mass spectrum: m/z 441 Example 7 3-Z-[1-(4-guanidinomethyl-anilino)-1-phenyl-methylene]-6methoxycarbonyl-2-indolinone 300 mg of 3-Z- [1-(4-aminomethyl-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone are dissolved in 5 ml of dimethylformamide and 300 ml of triethylamine are added. Then 700 mg of 3,5-dimethylpyrazol-l-carboxylic acid amidine in ml of dimethylformamide are added. After one day of stirring at room temperature the reaction solution is concentrated by rotary evaporation. The residue is dried at 100 0 C in vacuo.
Yield: 200 mg (87 of theory), R, value: 0.1 (Reversed phase RP 8, methanol/five percent saline solution 6:4)
C
2 sH 23 Ns0 3 Mass spectrum: m/z 441 Example 8 3-Z-[1-(4-acetylaminomethyl-anilino)-1-phenyl-methylene]-6methoxycarbonyl-2-indolinone 100 mg of 3-Z-[l-(4-aminomethyl-anilino)-l-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone are dissolved in 5 ml of glacial acetic acid, 0.1 ml of acetic anhydride is added and the mixture is stirred for 10 minutes at room temperature.
After this time the reaction solution is poured onto saturated soda solution and extracted four times with methylene chloride. The combined organic phases are washed with saturated saline solution, dried over sodium sulphate and concentrated by rotary evaporation. The residue is dried at 1000C in vacuo.
177 Yield: 20 mg (23 01 of theory), Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
2 6 2 3 3 4 £31L mass spectrum: m/z 440 [M-Hij The following compounds are prepared analogously to Example 8: 3-Z- El-(4- (N-methylsulphonyl-aminomethyl)-anilino)-lphenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 3-Z- [1-(4-aminomethyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone and methanesulphonyl chloride/triethylamine Rf value: 0.7 (silica gel, methylene chloride/methanol 5:1)
C
2 5H 23
N
3 0 5
S
ESI mass spectrum: m/z 476 EM-WI1 3-Z-E1-(4-(4-benzoyl-piperazin-1-yl-methyl)-anilino)-1phenyl-methylene] -6 -methoxycarbonyl-2-indolinone Prepared from 3-Z-[1-(4-(piperazin-l-yl-methyl) -anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone and benzoyl chloride Rf value: 0.7 (silica gel, methylene chloride/methanol 10:1)
C
3 5H 32
N
4 0 4 ESI mass spectrum: m/z 571 EM-Hi1 3-Z-El-(4- ((N-(3-acetylamino-propyl)-N-methyl-amino)methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 3-Z- El- (3-amino-propyl) -N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Rf value: 0.3 (silica gel, methylene chloride/methanol 9:1)
C
3 0
H
32
N
4 0 4 ES1 mass spectrum: m/z 511 [M-H-i 178 Example 9 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethvlene] -6--carboxy-2-indolinone 0.8 g of 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene]-6-ethoxycarbonyl-2-indolinone are dissolved in ml of ethanol, 8.3 ml of IN sodium hydroxide solution are added and the mixture is stirred for 1 hour at 80 0 C. After cooling, it is neutralised with 8.3 ml of lN hydrochloric acid. The precipitate formed is suction filtered, washed with water, ethanol and ether and dried in vacuo at 100 0
C.
Yield: 0.7 g of (89 of theory), R, value: 0.2 (silica gel, methylene chloride/methanol 5:2)
C
28
H
27 N303 Mass spectrum: m/z 453 The following compounds are prepared analogously to Example 9: 3-Z-[1-(4-bromo-anilino)-1-phenyl-methylene]-6-carboxy- 2-indolinone Prepared from 3-Z-[1-(4-bromo-anilino)-1-phenyl-methylene]- 6-ethoxycarbonyl-2-indolinone R, value: 0.4 (silica gel, toluene/ethyl acetate 5:1)
C
22
H
1 ,BrN 2 03 ESI mass spectrum: m/z 435/437 3-Z-[l-(3-(dimethylaminomethyl)-anilino)-1-phenylmethylene]-6-carboxy-2-indolinone Prepared from 3-Z-[1-(3-(dimethylaminomethyl)-anilino)- 1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone R, value: 0.7 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
25
H
23
N
3 03 ESI mass spectrum: m/z 414 -179 3-Z- (dimethylaminomethyl) -anilino)-1-phenylmethylene] -6-carboxy-2-indolinone Prepared from 3-Z- El- (dimethylaminomethyl) -anilino) 1-phenyll-methylene -6o- ethoxycarbonyl-2-indoiinone Rf value: 0.7 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
2 5
H
23
N
3 0 3 ESI mass spectrum: m/z 412 EM-Hi1 3-Z-El-(4-E(2,6-dimethyl-piperidin-1-yl)-methyl]-anilino)- 1-phenyl-methylene] -6-carboxy-2-indolinone Prepared from 3-Z- El-(4- [12,6-dimethyl-piperidin-1-yl) methyl] -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone Rf value: 0.6 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
30
H
31
N
3 0 3 ESI mass spectrum: m/z 482 EM+H]l 3-Z-El-(4-(1-methyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-carboxy-2-indolinone Prepared from 3-Z-E1-(4-(1-methyl-imidazol-2-yl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Rf value: 0.6 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
2 6
H
20
N
4 03 EST mass spectrum: m/z 435 EM-Hi1 (N-acetyl-N-dimethylaminocarbonylmethyl-amino) anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone Prepared from 3-Z- El- (N-acetyl -Ndimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Rf value: 0.3 (silica gel, methylene chloride/methanol 10:1)
C
2 8H26N40 ESI mass spectrum: m/z 497 EM-If] 180 3-Z-[li- (4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6carboxy- 2- indol inone Prepared from t- (4,-ethy'Laiiinomet-hyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Rf value: 0.6 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
2 5 2 3 3 ESI mass spectrum: r i/z 412 [M-Hi1 3-Z- (N-dimethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone Prepared from 3-Z-li- (N-dimethylaminomethylcarbonyl-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone Rf value: 0.6 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
2 7 2 6 4 ESI mass spectrum: m/z 469 EM-Hi1 3-Z- (N-tert.butoxycarbonyl-ethylaminomethyl) anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone Prepared from 3-Z-[li- (N-tert .butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
3 0
H
3 1
N
3 ESI mass spectrum: m/z 512 tM-Hi1 3-Z- ((N-carboxymethyl-N-methyl-amino) -methyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 3-Z- ((N-ethoxycarbonylmethyl-N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl indolinone 181 R, value: 0.4 (silica gel, methylene chloride/methanol 6:1)
C
27
H
2
,N
3 0 ESI mass spectrum: m/z 470 Example 3-Z-[l-(4-(piperidin-l-yl-methyl)-anilino)-1-phenylmethylene]-6-methoxycarbonyl-2-indolinone 0.9 g of 3-Z-[1-(4-(piperidin-l-yl-methyl)-anilino)-1-phenylmethylene]-6-carboxy-2-indolinone are suspended in 35 ml of dimethylformamide and 0.4 g of carbonyldiimidazole are added.
The mixture is stirred for 14 hours at 80 0 C. After this time ml of methanol are added and the mixture is stirred for another 3 hours at 50 0 C. The solvent is removed and the residue is purified over a silica gel column with methylene chloride/methanol as eluant.
Yield: 0.5 g of (49% of theory), R, value: 0.5 (aluminium oxide, methylene chloride/methanol 30:1)
C
29
H
29
N
3 0 3 ESI mass spectrum: m/z 468 The following compounds are prepared analogously to Example 3-Z-[l-(4-(piperidin-l-yl-methyl)-anilino)-1-phenylmethylene]-6-benzyloxycarbonyl-2-indolinone Prepared from 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)- 1-phenyl-methylene]-6-carboxy-2-indolinone and benzyl alcohol R, value: 0.6 (aluminium oxide, methylene chloride/methanol 30:1)
C
35
H
33
N
3 0 3 Mass spectrum: m/z 543 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene]-6-isopropyloxycarbonyl-2-indolinone -182 Prepared from 3-Z-[l-(4-(piperidin-l-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and isopropanol Rf value: 0.4 (aluminium oxide, methylene chloride/ isopropanol =30:1)
C
3 1 3303 Mass spectrum: m/z 495 [M]1 3-Z-[l-(4-(piperidin--l-yl-methyl)-anilino)-l-phenylmethylene] -6-propyloxycarbonyl-2-indolinone Prepared from 3-Z- Il- (piperidin-l-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and n-propanol Rf value: 0.7 (silica gel, methylene chloride/methanol 5:1)
C
3 1 3 3 3 Mass spectrum: m/z 495 [M*i 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-l-phenylmethylene] -6-butyloxycarbonyl-2-indolinone Prepared from 3-Z- (piperidin-l-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and n-butanol Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
3 2
H
3 5
N
3 0 3 Mass spectrum: m/z 509 3-Z- [1-(4-bromo-anilino) -1-phenyl-methylene] -6-carbamoyl- 2 -indolinone Prepared from 3-Z- [1-(4-bromo-anilino) -1-phenyl-methylene] 6 -carboxy- 2- indolinone and ammonia R, value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
22
H
16 BrN 2 03 Mass spectrum: m/z 432/434 EM-WI1 3-Z-(1-(4-(piperidin-l-yl-methyl)-anilino)-l-phenylmethylene] -6 -ethylcarbamoyl-2-indolinone Prepared from 3-Z- (piperidin-1-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and ethylamine gas Rf value: 0.6 (silica gel, methylene chloride/methanol 5:1) 183
C
3 0
H
32
N
4 02 mass spectrum: m/z 480 [M*i n, 1hr ntb' nlno' -1-phenaylmethylene] -6-[E(2-methoxy-ethoxy) -carbonyl] -2-indolinone Prepared from 3-Z- (dimethylaminomethyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and methyiglycol Rf value: 0.8 (silica gel, methylene chloride/methanol 4:1)
C
25
H
23
N
3 0 3 ESI mass spectrum: m/z 470 [M-Hi1 3-Z- [l-(4-(dimethylaminomethyl)-anilino)-l-phenylmethylene] [(2-dimethylamino-ethoxy) -carbonyl] -2-indolinone Prepared from 3-Z- (dimethylaminomethyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and 2-dimethylaminoethanol aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 5:2)
C
2 9
H
32 4 3 ESI mass spectrum: m/z 483 EM-Hi1 3-Z- [l-(4-(dimethylaminomethyl)-anilino)-l-phenylmethylene] -6-[E(2-N-tert.butoxycarbonyl-amino-ethoxy) carbonyl] -2-indolinone Prepared from 3-Z- (dimethylaminomethyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and 2-Ntert .butoxycarbonyl-amino-ethanol aniline Rf value: 0.8 (silica gel, methylene chloride/methanol 5:2)
C
3 2 3 6 4 ESI mass spectrum: m/z 412 EM-H-I 3-Z-[l-(4-(dimethylaminomethyl)-anilino)-l-phenylmethylene] ((2,2,2-trifluoroethoxy) -carbonyl] -2-indolinone 184 Prepared from 3-Z- (dimethylaminomethyl) -anilino) 1-phenyl-methylene] -6-carbaxy-2-indolinone and 2,2,2trifluoroethanol aniline R, value: 0. -t silica gemcthylene chloride/rieLhaxiol 5:1)
C
27
H
24
F
3
N
3 0 3 ESI mass spectrum: m/z 494 [M-HKI Example 11
I
3-Z- Ii- (piperidin-1-yl-methyl) -anilino) -1-phenylmethylene] -6-carbamoyl-2-indol inane 0.9 g of 3-Z-[l-(4-(piperidin-l-yl-methyl)-anilino)-l-phenylmethylenel-6-carbaxy-2-indolinane, 0.8 g of TBTU and 0.4 g of HOBT are suspended in 25 ml of dimethylformamide and 1.0 ml of triethylamine are added. The mixture is stirred for minutes at room temperature. After this time ammonia gas is introduced at 10-15 0 C over a period of 15 minutes and the mixture is stirred for 1.5 hours at room temperature. The precipitate formed is suction filtered, washed with water, ethanol and ether and dried at 100 0 C in vacua.
Yield: 0.6 g (64 0- of theory), Rf value: 0.4 (Reversed phase RP 8, methanol/five percent saline solution 6:4)
C
2 8
H
2 8
N
4 02 ESI mass spectrum: m/z 453 [M+H]l The following compounds are prepared analogously to Example 11: 3-Z-[il- (4-(piperidin-l-yl-methyl)-anilina)-1-phenylmethylene] -6-dimethylcarbamayl-2-indolinone Prepared from 3-Z- (piperidin-1-yl-methyl) -anilino) 1-phenyl-methylene] -6-carbaxy-2-indolinone and dimethylamine hydrochloride/diisopropylethylamine -185 Rf value: 0.5 (silica gel, methylene chloride/methanol 5:1)
C
30
H
32
N
4 02 ESI mass spectrum: m/z 481 [M+H+1 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene] (N-ethyl-N-methyl-carbamoyl) -2-indolinone Prepared from (piperidin-1-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and N-ethyl- N-methyl -amine Rf value: 0.5 (aluminium oxide, methylene chloride/ethanol 20:1)
C
31 H 34
N
4 0 2 ESI mass spectrum: m/z 495 [M+H]I 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene] -6-methylcarbamoyl-2-indolinone Prepared from 3-Z-[11- (piperidin-l-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and methylamine hydrochloride/di isopropylethylamine Rf value: 0.3 (aluminium oxide, methylene chloride/ethanol 20:1)
C
29
H
30
N
4 0 2 ESI mass spectrum: m/z 467 [M+H1j 3-Z- (dimethylaminomethyl)-anilino) -1-phenylmethylene] -6-methylcarbamoyl-2 -indolinone Prepared from 3-Z-[Il- (dimethylaminomethyl) -anilino) 1-phenyl-methylene] -6-carboxyl-2-indolinone and methylamine hydrochloride/triethylamine Rf value: 0.3 (silica gel, methylene chloride /ethanol 2:1)
C
26
H
26
N
4 0 2 Mass spectrum: m/z 426 3-Z- (piperidin-l-yl-methyl)-anilino) -1-phenylmethylene] (2-hydroxyethyl-carbamoyl) -2-indolinone 186 Prepared from 3-Z-[1-(4-(piperidin-1-yl-methyl) -anilino)- 1-phenyl-methylenel -6-carboxy-2-indolinone and ethanolamine/di isopropylethylamine R. value: 0. 5 (aluminium oxdmeth-'ene chl or-*de/'metharnoi 20:1)
C
30
H
32
N
4 03 ESI mass spectrum: m/z 495 EM-Hi1 3-Z-(l-(4-(pipei idin-1-yl-methyl)-anilino)-l-phenylmethylene] -6-diethylcarbamoyl-2-indolinone Prepared from 3-Z- (piperidin-1-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and diethylamine hydrochloride/diisopropylethylamine R, value: 0.8 (aluminium oxide, methylene chloride /methanol 10:1)
C
3 2 3 6 4 2 EST mass spectrum: m/z 509 [M+H]l 3-Z- (N-tert.butoxycarbonyl-ethylaminomethyl) anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone Prepared from 3-Z- (N-tert.butoxycarbonylethylaminomethyl) -anilino) -1-phenyl-methylene] -6-carboxy-2indol inone Rf value: 0.3 (silica gel, toluene/ethyl acetate/ethanol- 4:2:1)
C
3 0
H
32
N
4 04 ESI mass spectrum: m/z 511 EM-Hi1 3-Z- (N-dimethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone Prepared from 3-Z- (N-dimethylaminomethylcarbonyl-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-carboxy-2indolinone Rf value: 0.5 (silica gel, methylene chloride /methanol /ammonia 5:1:0.01) 187
C
27
H
27
N
5 03 ESI mass spectrum: m/z 468 ExamDle 12 3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone x citric acid 3.25 g of citric acid monohydrate are placed in 50 ml of methanol and 5.0 g of 3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6methoxycarbonyl-2-indolinone are added at room temperature.
The solution formed is evaporated down, the residue is washed with ether and recrystallised from ethyl acetate.
Yield: 6.3 g (90 of theory), Rf value: 0.6 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01) Melting point: 198 0
C
C
28
H
28 N4Os x C 6
H
8 0, ESI mass spectrum: m/z 483 Elemental analysis: calc.: C 60.34 H 5.37 N 8.28 found: 59.98 5.25 8.13 The following compound is prepared analogously to Example 12: 3-Z-[l-(4-(dimethylaminomethyl)-anilino)-l-phenylmethylene]-6-methoxycarbonyl-2-indolinone x methanesulphonic acid Prepared from 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1phenyl-methylene]-6-methoxycarbonyl-2-indolinone and methanesulphonic acid Rf value: 0.6 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01) Melting point: 275 0
C
C,
2
H
25
N
3 0, x CH40 3
S
ESI mass spectrum: m/z 426 188 Elemental analysis: caic. C 61.92 H 5.59 N 8.03 S 6.12 found: 61.43 5.87 7.85 5.39 The following compouinds may be prepared analogously to the foregoing Examples: 3-Z- (1-anilino-l-phenyl-methylene) -6-ethoxycarbonyl- 2-indolinone 3-Z-[l-(4-nitro-anilino)-l-phenyl-methylenej-6ethoxycarbonyl indol inone 3-Z- [l-(4-fluoro-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl indol inone 3-Z-[il- (4-chloro-anilino)-l-phenyl-methylene] -6-ethoxycarbonyl indol inone 3-Z-[1-(4-iodo-anilino)-1-phenyl-methylene]-6ethoxycarbonyl indol inone 3-Z- [1-(4-cyano-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl indolinone 3-Z-[l-(4-methoxy-anilino)-l-phenyl-methylenel-6ethoxycarbonyl indolinone 3-Z-[l-(4-ethoxy-anilino)-l-phenyl-methylene]-6ethoxycarbonyl indolinone 3-Z- [1-(4-trifluoromethyl-anilino) -1-phenyl-methylene] 6- ethoxycarbonyl indol inone 3-Z-[l-(4-methyl-anilino)-l-phenyl-methylene]-6ethoxycarbonyl indolinone -189 (11) 3-Z- II-(4-methylmercapto-anilino)-1-phenyl-methylene] 6 -ethoxycarbonyl indol inone (12) 3-Z- il- (4-aminornethvl-anilino) -1-pheny!-meithylene] -6ethaxycarbonyl indolinone (13) 3-Z- (isopropylaminomethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (14) 3-Z- [1-(4-(anilinomethyl)-anilino)-1-phenyl-methylene] 6- ethoxycarbonyl indol inane 3-Z- [1-(4-(propylaminomethyl) -anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (16) 3-Z- (butylaminomethyl) -anilino) -1-phenylmethyleie] -6-ethoxycarbonyl-2-indolinone (17) 3-Z- fl-(4-(isobutylaminomethyl)-anilino)-1-phenylmethylene] ethoxycarbonyl indolinone (18) 3-Z- [1-(4-(cyclohexylaminomethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2 -indol inane (19) 3-Z- [l-(4-(benzylaminomethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (N-ethyl-N-methyl-amino)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (21) 3-Z- (N-methyl-N-propyl-amino)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (22) 3-Z- (N-isopropyl-N-methyl-amino)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -190 (23) 3-Z--(-(4-((N-ethyl-N-propyl-amino)-methyl)-anilino)- 1-phenyl-methylenel -6-ethoxycarbonyl-2-indolinone (24) 3-Z-fl-(4-((N-ethyl,-NT-isopro---pyl -ami no) -methyl) -anilino)- 1-phenyl-methylenel -6-ethoxycarbonyl-2-indolinone 3-Z-fl-(4-(dipropylaminomethyl)--anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2--indolinone (26) 3-Z-[II-(4-(diisopropylaminomethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (27) 3-Z-[1-(4-((N-benzyl-N-ethyl-amino)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (28) 3-Z-[lI-(4-(dibenzylaminomethyl)-anilino)-1-phenylmethylene] -6 -ethoxycarbonyl-2-indolinone (29) 3-Z-[1-(4-(3,6-dihydro-2H-pyridin-1-yl-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 3-Z-[1-(4-(3,5-dimethyl-piperidin-1-yl-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (31) 3-Z-[1-(4-(azepan-1-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (32) 3-Z-[1-(4-(piperazin-1-yl-methyl)-anilino)--phelylmethylene] -6 -ethoxycarbonyl indolinone (33) 3-Z-[1-(4-(morpholin-4-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (34) 3-Z- [1-(4-(thiomorpholin-4-yl-methyl)-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone 191 3-Z-[l-(4-(1-oxo-thiomorpholin-4-yl-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (36) -ey)-anili.no) 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (37) 3-Z-[l-(4-(acetylamino-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (38) 3-Z-[l-(4-(2-amino-ethyl)-anilino)-1-phenyl-methylenel 6- ethoxycarbonyl indolinone (39) 3-Z-[1-(4-(2-methylamino-ethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone 3-Z-[1-(4-(2-ethylamino-ethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (41) 3-Z-[1-(4-(2-diethylamino-ethyl)-anilino)-1-phenylmethylene] ethoxycarbonyl indolinone (42) 3-Z-[l-(4-(2-piperidin-1-yl-ethyl)-anilino)-1-phelylmethylene] -6-ethoxycarbonyl-2 -indolinone (43) 3-Z- [l-(4-(2-acetylamino-ethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (44) 3-Z- II-(4- (3-amino-propyl) -anilino)-1-phenyl-methylene] 6 -ethoxycarbonyl indolinone 3-Z- (3-dimethylamino-propyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolilofe (46) (N-aminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 192 (47) 3-Z- (N-methylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (43) 3-Z-F- A1 (IT- ethy'aminoii-e Liycarbonyi -N-me thy! -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (49) 3-Z-[li- (N-diethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 3-Z- (piperidin-1-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (51) 3-Z- [l-(4-(N-(morpholin-4-yl-methylcarbanyl)-N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone (52) 3-Z- (piperazin-1-yIl-methylcarbonyl) -N-methylamino] -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (53) 3-Z- (2-amino-ethylcarbonyl)-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (54) 3-Z- (2-methylamino-ethylcarbanyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane 3-Z- (2-diethylamino-ethylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (56) 3-Z- [1-(4-(N-acetyl-N-(2-aminoethyl)-amino)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 193 (57) 3-Z- [1-(4-(N-acetyl-N- (2-methylamino-ethyl) -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (58) 3Z 1 4 Naey--(-ehlmn-rpl aro anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (59) 3-Z-[l-(4-(N-acetyl-N-(2-piperidin-1-yl-ethyl)-amino)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 3-Z- (N-acetyl-N- (aminocarbonylmethyl) -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (61) 3-Z- (N-acetyl-N- (dimethylaminocarbonylmethyl) amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indolinone (62) 3-Z- (N-acetyl-N- (piperidin-l-yl-carbonylmethyl) amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indolinone (63) 3-Z-[l-(4-(N-methyl-N-(aminocarbonyl)-amino)-alililo)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (64) 3-Z- (N-methyl-N- (methylaminocarbonyl) -amino) anilino) -l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 3-Z- (N-methyl-N- (dimethylaminocarbonyl) -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinole (66) 3-Z- (N-methyl-N- (piperidin-l-yl-carbonyl) -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (67) 3-Z- [l-(4-(N-(2-aminoethyl)-N-methylsulphonyl-amino)anilino) -l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 194 (68) 3-Z- (2-methylamino-ethyl) -N-methylsulphanylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (69) 3-Z- [1-(4-(N-(2-ethylamino-ethyl)-N-methylsulphonylamino) -anilina) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane 3-Z-[li- (.-diethylamino-ethy1) -N-methylsulphonylamino) -anilina) -1-phenyl-methylene] -6-ethoxycarbanyl-2ndol inane (71) 3-Z-[l-(4-(N-(2-pyrrolidin-1-yl-ethyl)-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2ndol inane (72) 3-Z- (2-piperidin-l-yl-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbanyl-2indolinane (73) 3-Z- (1-(4-(N-(2-piperazin-l-yl-ethyl)-N-methylsulphanylamino) -anilino) -1-phenyl-methylene] -6-ethaxycarbonyl-2indal inane (74) 3-Z- (marphalin-4-yl) -ethyl) -Nmethylsuiphonyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbanyl indal inane 3-Z-[li- (aminacarbanylmethyl) -N-methylsulphanylamino) -anilina) -1-phenyl-methylene] -6-ethoxycarbanyl-2ndol inane (76) 3-Z- (methylaminacarbanylmethyl) -Nmethylsuiphanyl -amino) -anilina) -1-phenyl-methylene] -6ethoxycarbonyl indalinone 195 (77) 3-Z- (ethylaminacarbanylmethyl)
-N-
methylsuiphonyl-amina) -anilino) -1-phenyl-methylene] -6ethaxycarbonyl indal inane (78) 3-Z- (N-(N-(2-dimethylamina-ethyl) -N-methyl-amino)carbonylmethyl) -N-methylsulphonyl-amina) -anilino) -1-phenylmethylene] -6-ethoxycarbanyl-2-indolinone (79) 3-Z- (diethylaminacarbanylmethyl)
-N-
methylsuiphanyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbanyl indalinane 3-Z- (pyrrolidin-1-yl-carbanylmethyl) -N-methylsuiphonyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbonyl indal inane (81) 3-Z- (piperidin-1-yl-carbonylmethyl)
-N-
methylsuiphanyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbanyl indal inane (82) 3-Z-[1-(4-(N-(piperazin-1-y1-carbonylmethy1-Nmethylsuiphanyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbanyl indal inane (83) 3-Z- 1- ((marphalin-4-yl) -carbanylmethyl) -N-methylsuiphanyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbanyl indal inane (84) (2-dimethylamin-ethxy)-anilina-i-phenylmethylene] -6-ethaxycarbanyl-2-indalinane 3-Z- (3-dimethylamina-praPaxy) -anilina) -1-phenylmethylene] -6-ethaxycarbanyl-2-indolinane (86) 3-Z- (aminacarbanylmethyl)-anilino)-J--phenylmethylene] -6 -ethaxycarbanyl-2-iridalinane -196- (87) 3-Z-[1-(4-(2-aminocarbanyl-ethyl)-anilina)-1-phenylmethylene] -6-ethoxycarbanyl-2-indolinone (88) 3-Z-[1-(4-(pyridin-2-yl)-anilina)-1-phenyl-methylene]- 6- ethaxycarbonyl indal inone (89) 3-Z-[1-(4-(pyridine-3-yl)-anilino)-1-phenyl-methylene]- 6- ethaxycarbanyl -2 indol inane 3-Z- [1-(4-(pyridin-4-yl)-anilina)-1-phenyl-methylene] 6- ethaxycarbanyl indal inane (91) 3-Z-[1-(4-(N-acetyl-N-methyl-amina)-anilino)-1-phenylmethylene] -6-ethaxycarbonyl-2-indolinane (92) 3-Z- (N-ethylcarbonyl-N- (dimethylaminacarbanylmethyl) -amino) -anilino) -1-phenyl-methylene] -6-ethaxycarbanyl- 2-indol inane (93) 3-Z- [1-(carbamoylmethyl-anilina) -1-phenyl-methylene] 6- ethaxycarbanyl indal inane (94) 3-Z- [1-(4-dimethylcarbamaylmethyl-anilina) -1-phenylmethylene] -6-ethoxycarbanyl-2-indolinone 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-methylene] 6 -ethoxycarbanyl indol inane (96) 3-Z- [1-(4-(piperidin-1-yl-methyl)-anilino)-prapylidene] 6- ethaxycarbanyl indal inane (97) 3-Z- [l-(4-(piperidin-1-yl-methyl)-anilina)-butylidene] 6 -ethaxycarbanyl-2-indalinone 197 (98) 3-Z- (3-dimethylamino-propyl) -N-acetyl-amino) anilino) -methylene] -6-ethoxycarbonyl-2-indalinone (99) 3-Z-(1-(4-(N-(3-dimethvlamino-Dropy1vl)-N-acety-aincanilino) -ethylidene] -6-ethoxycarbonyl-2-indolinone (100) 3-Z- [1-(4-(N-(3-dimethylamino-propyl) -N-acetyl-amino) anilina) -propylidene] -6-ethoxycarbonyl-2-indolinone (101) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino) anilino) -butylidene] -6-ethoxycarbonyl-2-indolinone (102) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonylamino) -anilino) -methylene] -6-ethoxycarbonyl-2-indolinone (103) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -propylidene] -6-ethoxycarbonyl-2-indolinone (104) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -butylidene] -6-ethoxycarbonyl-2-indolinone (105) 3-Z-[1-(4-tetrazol-5-yl-anilino)-methylene]-6ethoxycarbonyl -2 -indol inane (106) 3-Z- [1-(4-tetrazol-5-yl-anilino)-ethylidene] -6-ethoxycarbonyl -2-indol inane (107) 3-Z-[1-(4-tetrazol-5-yl-anilino)-propylidene]-6-ethoxycarbonyl indol inane (108) 3-Z-[l-(4-tetrazol-5-yl-anilino)-butylidene]-6ethoxycarbonyl indol inane (109) 3-Z- [1-(4-carbaxy-anilina)-methylene] -6-ethaxycarbanyl- 2- indol inane 198 (110) 3-Z-[1-(4-carboxy-anilino)-propylidene]-6ethoxycarbonyl indolinone (111) 3 (4 -carboxy-anil inn) -butylidene] 6-ehxcrc 2- indolinone (112) 3-Z-[1-(4-(N-(3-dimethylamino-propionyl) -Ndimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] ethoxy~arbony1 indol inone (113) 3-Z-[1-(4-(N-(4-dimethylamino-butyryl)-Ndimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] ethoxycarbonyl indol inane (114) 3-Z- (N-dimethylaminocarbonylmethyl-N- (2dimethylamino-ethylsulphonyl) -amino) -anilino) -1-phenylmethylene] -6 -ethoxycarbonyl-2-indol inane (115) 3-Z-[li- (N-dimethylaminocarbonylmethyl-N- (3dimethylamino-propylsulphonyl) -amino) -anilino) -1-phenylmethylene] -6 -ethoxycarbonyl-2-indolinone (116) 3-Z- (2-hydroxy-ethyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (117) 3-Z-[1-(4-((2-methoxy-ethyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (118) 3-Z-[1-(4-((2-dimethylamino-ethyl)-amino-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (119) 3-Z- [1-(4-((3-dimethylamino-propyl)-amino-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 199 (120) 3-Z- tert. butoxycarbonyl 2-amino -ethyl) -aminomethyl) -anilina) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (121) 3-Z- (N-tert.butaxycarbanyl-3-amino-propyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (122) 3-Z-[l-(4-((2-amino-ethyl)-amino-methyl)-anilino)-lphenyl-methylene] -6-ethoxycarbonyl-2-indolinone (123) 3-Z-[1-(4-((3-amino-propyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (124) 3-Z- [1-(4-((2-acetylamino-ethyl)-amino-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (125) 3-Z-[1-(4-((3-acetylamino-propyl)-amino-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (126) 3 1- (4 (2 -methylsulphonylamino- ethyl) amino-methyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (127) 3-Z- ((3-methylsulphonylamino-propyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (128) 3-Z-[l-(4-(N-(N-tert.butoxycarbonyl-2-amino-ethyl)-Nmethyl-amino-methyl) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone (129) 3-Z- [1-(4-(N-(2-amino-ethyl)-N-methyl-amino-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -200 (130) 3-Z- (2-acetylamino-ethyl) -N-methyl-aminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone (131) 3-Z- (2-methylsulphonylamino-ethyl) -N-methylamino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone (132) 3-Z-[1-(4-(ca~rboxymethy1-amino-methy1)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (133) 3-Z- El-(4-(ethoxycarbonylmethyl-amino-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (134) 3-Z-[lI-(4-(carbamoylmethyl-amino-methyl)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (135) 3-Z- (dimethylcarbamoyl-methyl-amino-methyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (136) 3-Z- (methylcarbamoyl-methyl-amino-methyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (137) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-amino-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indolinone (138) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-nitro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (139) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-acetylamino-anilino) -1-phenyl-methylene] -6ethoxycarbonyl -2 -indol inone 201 (140) (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methylsulphonylamino-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone (141) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-cyano-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (142) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-hydroxy-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (143) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methoxy-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inone (144) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-ethoxycarbonyl-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (145) 3-Z-[li- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-carboxy-anilino) -1-phenyl-methylene] -6ethoxycarbonyl -2 -indol inane (146) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-carbamoyl-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (147) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-chioro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indol inane (148) 3-Z-[li- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-f luoro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane 202 (149) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-bromo-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (150) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (151) 3-Z- (N-aimethylaminomethylcarbonyl-N-methylamino) -3-trifluoromethyl-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone (152) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino)-3,5-dibromo-anilino)-1-phenyl-methylene] -6ethoxycarbonyl indolinone (153) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) 5-dichioro-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inone (154) 3-Z-(1-(4-(dimethylaminomethyl)-3-amino-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (155) 3-Z-[1-(4-(dimethylaminomethyl)-3-nitro-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (156) 3-Z- (dimethylaminomethyl) -3-acetylamino-anilino) 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (157) 3-Z-[Il- (dimethylaminomethyl) -3- (methylsuiphonylamino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inone (158) 3-Z-[1-(4-(dimethylaminomethyl)-3-cyano-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -203 (159) 3-Z-tl-(4-(dimethylaminomethyl)-3-hydroxy-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (160) 3-Z- (dimethyiauiinomiDiethyiL) -3-meth'oxy-anilin'-O) phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (161) 3-Z- (dimethylaminomethyl)-3- (ethoxycarbonyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (162) 3-Z- [1-(4-(dimethylaminomethyl)-3-carboxy-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (163) (4-(dimethylaminomethyl)-3-carbamoyl-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (164) 3-Z- [1-(4-(dimethylaminomethyl)-3-chloro-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (165) 3-Z- [1-(4-(dimethylaminomethyl) -3-fluoro-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (166) 3-Z- [1-(4-(dimethylaminomethyl)-3-bromo-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (167) 3-Z- [l-(4-(dimethylaminomethyl)-3-methyl-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (168) 3-Z- (dimethylaminomethyl) -3-trifluoromethylanilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (169) 3-Z- II-(4-(dimethylaminomethyl)-3,5-dibromo-aliliflo)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (170) 3-Z- [1-(4-(dimethylaminomethyl)-3,5-dichloro-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 204 (171) (4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)- N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indolinone (172) 3-Z- [1-(4-(N-(imidazo-1-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone (173) 3-Z-[li- (N-.(phthalimido-2-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2ndcl inone (174) 3-Z- Ii- (N-aminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (175) 3-Z- (N-acetylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (176) 3-Z-[li- (N-methylsulphonylaminomethylcarbonyl-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indolinone (177) 3-Z- [1-(4-(N-((N-(2-methoxyethyl)-N-methyl-amino)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6- ethoxycarbonyl -2 -indol inone (178) 3-Z- (2-dimethylaminoethyl) -N-methyl-amino) methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -ethoxycarbonyl indolinone (179) 3-Z-[1-(4-(N-((di-(2-hydroxyethyl)-amino)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6- ethoxycarbonyl indol inone (180) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -methylene] -6-ethoxycarbonyl-2-indolinone 205 (181) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -ethylidene] -6-ethoxycarbonyl-2-indolinone (182) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -propylidene] -6-ethoxycarbonyl-2-indolinone (183) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -butylidene] -6-ethoxycarbonyl-2-indolinone (184) 3-Z-[l1-(4-(dimethylaminomethyl)-anilino)-methylene] -6ethoxycarbonyl indolinone (185) 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-ethylidene]-6ethoxycarbonyl -2 -indol inane (186) 3-Z- [1-(4-(dimethylaminomethyl) -anilino) -propylidene] -6ethoxycarbonyl indolinone (187) 3-Z- [1-(4-(dimethylaminomethyl)-anilino)-butylidene]-6ethoxycarbonyl -2 -indol inane (188) 3-Z- (N-dimethylaminocarbonylmethyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (189) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (190) 3-Z-[1-(4-((imidazolidin-2,4-dion-5-ylidene)-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (191) 3-Z- [1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane 206 (192) 3-Z- El- (4-(N-tert.butoxycarbonyl-aminomethyl) -anilino) 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (193) 3-Z- (2-oxo-pyrrolidinr-1 -y 1 -methyl -a-41inolphenyl-methylene] -6-ethoxycarbonyl-2-indolinone (194) 3-Z- CN-aminocarbonylmethyl-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone (195) 3-Z- (N-cyanomethyl-N-methylsulphonyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (196) 3-Z-[1-(4-(2-(imidazol-4-yl)-ethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (197) 3-Z-(1-(4-((2-(N-benzyl-N-methyl-amino)-ethyl)-Nmethylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (198) 3-Z-[1-(4-cyclohexylamino-anilino)-1-phenyl-methylene] 6 -ethoxycarbonyl indol inane (199) 3-Z-[l-(4-(imidazol-1-yl-methyl)-anilino)-1-phenylmethylene] -6 -ethoxycarbonyl-2-indolinone (200) 3-Z-(1-(4-(imidazol-1-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (201) 3-Z- [1-(N-methyl-piperidine-4-yl-amino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (202) 3-Z-(1-(4-(imidazol-4-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbony1-2-indolinone -207 (203) 3-Z-[l-(4-((4-hydroxy-piperidin-1-yl)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (204) 3-Z- ((4-rm-ethoxy-piLperiLdi'n-I,-yl), -Me-thyl) -mni Iin',) 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (205) 3-Z-(1-(4-benzyl-anilino)-l-phenyl-methylene]-6ethoxycarbonyl -2-indol inane (206) (N-(3-trifluoroacetylamino-propyl)-Nmethylsuiphonyl-amino) -anilino) -1-phenyl-methylenel -6ethoxycarbonyl -2-indol inane (207) 3-Z-[l-(4-(4-tert.butoxycarbonyl-piperazin-1-yl-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (208) 3-Z-[1-(4-(l-methyl-imidazol-2-yl)-anilino)-l-phelylmethylene] -6-ethoxycarbonyl-2-indolinone (209) 3-Z-[1-(4-(1-methyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (210) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -3-amino-aniline) -1-phenyl-methylenel -6-ethoxycarbenyl- 2 -indelinone (211) ((3-(N-benzyl-N-methyl-amino)-propyl)-Nmethylsuiphenyl-amine) -aniline) -1-phenyl-methylene] -6ethexycarbenyl indelinene (212) 3-Z- [l-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amie) aniline) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (213) 3-Z- [1-(4-(N-(2-dimethylamine-ethyl)-N-butyryl-amine) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -208 (214) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl)--N-isobutyrylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inone (215) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl) -N-benzoyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (216) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-3amino-anilino) -1-ph~ny1-methylene] -6-ethoxycarbonyl- 2-indol inane (217) (4-(4-hydroxymethyl-piperidin-1-yl-methyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (218) 3-Z-[1-(4-(2-(4-hydroxy-piperidin-1-yl)--ethyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (219) 3-Z- (2-dimethylamino-ethyl) -N-propylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indol inane (220) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl) -N-butylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indol inane (221) 3-Z- (2-dimethylamino-ethyl) -N-phenylsulphonylamino) -aniline) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (222) 3-Z- (2-dimethylamino-ethyl) -N-benzylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indol inane (223) 3-Z-[1-(4-((imidazolidin-2,4-dion-5-yl)-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinane 0 209 (224) 3-Z-[1-(4-((3-hydroxy-pyrrolidin-1-yl)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (cylol1 xly-methyl) -anilin-l-1-pheny-,, methylene] -6-ethoxycarbonyl-2-indolinone (226) 3-Z-[1-(4-(cyclohexyl-carbonyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (227) 3-Z- [1-(4-diethylaminomethyl-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (228) 3-Z-[1-(4-(N-(n-hexyl)-N-methyl-aminomethyl)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (229) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(furan-2carbonyl) -amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl -2 -indolinone (230) 3-Z-[l-(4-(N-(2-dimethylamino-ethyl)-N-(2-methoxybenzoyl) -amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indol inane (231) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(pyridine-3carbonyl) -amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone (232) 3-Z-[l-(4-(N-(2-dimethylamino-ethyl)-N-(phenyl-acetyl)amino) -aniline) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone (233) 3-Z-[1-(4-(imidazol-2-yl)-anilino)-l-phenyl-methylene]- 6- ethoxycarbonyl indolinone (234) 3-Z-[l-(4-(l-ethyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2 -indolinone -210 (235) 3-Z-[l-(4-(l-benzyl-imidazol-2-yl)-anilino)-l-phenylmethylenel -6-ethaxycarbonyl-2-indolinone (236) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-Nisoprapylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (237) 3-Z- [l-(4-(N-.(4-benzy1-piperazin-1-y1)-methylcarbonyl)- N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (238) 3-Z- (pyrrolidin-1-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (239) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl) -N-acetyl-amino) -3broma-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinane (240) 3-Z-[l-(4-(5-methyl-imidazol-4-yl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2--indolinone (241) 3-Z-[lI-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-Nisopropyl-amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (242) 3-Z- (2-dimethylamino-ethyl)-carbonyl)-Nbenzyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbanyl- 2- indol inane (243) 3-Z- (N-butyl-N-tert.butoxycarbonyl-aminomethyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -211 (244) (N-((N-aminocarbonylmethyl-N-methyl-amino) methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -ethoxycarbonyl indolinone (245) 3-Z- ((N-benzyl-N-methyl-amino) -methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (246) 3-Z- [1-(4-(N-(di-(2-methoxyethyl)-amino-methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indcl inone (247) 3-Z-[l-(4-(N-((2-(4-tert.butoxycarbonyl-piperazin-1-yl)ethyl) -carbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6- ethoxycarbonyl indol inone (248) 3-Z-[l-(4-(N-((2-(piperidin-l-yl)-ethyl)-carboflyl)-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inone (249) 3-Z-[1-(4-(N-((2-(N-benzyl-N-methyl-amino)-ethyl)carbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone (250) 3-Z- (N-dimethylaminomethylcarbonyl-N-isopropylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inone (251) 3-Z- (piperidin-l-yl-methylcarbonyl) -Nisopropyl -amino) -anilino) -l-phenyl -methylene] -6ethoxycarbonyl indolinone (252) 3-Z-[l-(4-(N-((4-tert.butoxycarbonyl-piperazifl-l-yl)V methylcarbonyl) -N-isopropyl-amino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone -212 (253) 3-Z- (N-benzyl-N-methyl-amino) -methylcarbonyl) N-benzyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone (254) 3-Z- (N-dimethylaminomethylcarbonyl-N-benzylamino) -anilino) -1-phenyl-methylenel-6-ethoxycarbonyl- 2- indolinone (255) 3-Z- piperidin-1-y1-methylcarbonyl) -N-benzylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (256) 3-Z-[1-(4-(1,2,4-triazol-2-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (257) 3-Z-[1-(4-(1,2,3-triazol-2-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (258) 3-Z-[1-(4-(1,2,3-triazol-1-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (259) 3-Z- ((N-aminocarbonylmethyl-N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indol inane (260) 3-Z-[1-(4-((di-(2-methoxy-ethyl)-amino)-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (261) 3-Z-[l-(4-((di-(2-hydroxy-ethyl)-amino)-methyl)aniline) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (262) 3-Z- 1- ((N-ethoxycarbonylmethyl-N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane S 213 (263) 3-Z-[l-(4-(azetidin-1-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (24)3-r7 rI (4 (N -propyl tert. but xycarbcny1 -ami 1-met hy I~ anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (265) 3-Z-[l-(4-((N-(2-(2-methoxy-ethoxy)-ethyl)-N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (266) 3-Z-[1-(4-((N-(tert.butoxycarbonyl-3-amino-propyl)-Nmethyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (267) 3-Z- (methylcarbamoyl-methyl) -N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indol inane (268) 3-Z- (dimethylcarbamoyl-methyl) -N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indolinone (269) 3-Z-[l-(4-((N-propyl-N-methyl-amino)-methyl)-anilino)phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (270) 3-Z-[l-(4-((N-(2-dimethylamino-ethyl)-N-methyl-amino)-_ methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (271) 3-Z-[Il-(4-((N-(3-dimethylamino-propyl)-N-methyl-amino)methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (272) 3-Z- (l-(4-((N-(2-methoxy-ethyl)-N-methyl-amino)-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -214 (273) 3-Z-[1-(4-((N-(2-hydroxy-ethyl)-N-methyl-amino)-methyl)anilino) -1-phenyl-methylenel -6-ethoxycarbonyl-2-indolinone (274) 3 (4 (dioxolan-2-yl-methyi) -N-methyl -amino) methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (275) 3-Z-[l-(4-(3-oxo-piperazin-1-yl-methyl)-anilino)-lphenyl-methylene] -G.'thoxycarbonyl-2-indolinone (276) 3-Z- E1-(4-(N-(piperazin-1-yl-methylcarbonyl)-Nisopropyl-amina) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (277) 3-Z-[l-(4-(N-((2-(piperazin-l-yl)-ethyl)-carbonyl)-Nmethyl-amino) -anilino) -1-phenyl-methylenel -6-ethoxycarbonyl- 2-indcl inane (278) 3 [1 (3 -amino-propyl) -N-methyl -amino) -methyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (279) 3-Z- (3-methylamina-propyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indol inane (280) 3-Z- [1-(4-Ureidomethyl-anilino)-l-phenyl-methylene]-6ethoxycarbonyl indol inane (281) (4-guanidinomethyl-anilina) -1-phenyl-methylene] 6- ethoxycarbonyl -2 -indol inane (282) 3-Z-[1-(4-(N-methylsulphonyl-aminomethyl)-anilina)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (283) 3-Z-[l-(4-(4-benzoyl-piperazin-1-yl-methyl)-anilino)-lphenyl-methylene] -6-ethoxycarbonyl-2-indolinone 215 (284) 3-Z-[1-(4-((N-(3-acetylamino-propyl)-N-methyl-amino)methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- (285) 3-Z- (3-methylsulphonylamino-propyl) -N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (286) 3-Z- [1-(4-((N-carbaxymethyl-N-methyl-amino)-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (287)3-Z- (l-anilino-1-phenyl-methylene) -6-methoxycarbonyl- 2-indolinone (288) 3-Z- [1-(4-nitro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl indolinone (289) 3-Z- [1-(4-fluoro-anilino)-1-phenyl-methylene] -6-methoxycarbonyl indolinone (290) 3-Z- [l-(4-chloro-anilina)-l-phenyl-methylene] -6-methoxycarbonyl -2 -indolinone (291) 3-Z- [1-(4-bromo-anilino)-l-phenyl-methylene] -6-methoxycarbonyl indol inane (292) 3-Z-[l-(4-iodo-anilino)-1-phenyl-methylene]-6methoxycarbonyl -2 -indol inane (293) 3-Z- Ll-(4-cyano-anilino)-1-phenyl-methylene] -6-methoxycarbonyl -2-indol inane (294) 3-Z- El- (4-carboxy-anilino)-1-phenyl-methylene]-6methoxycarbonyl indol inane 216 (295) 3-Z-[1-(4-methoxy-anilino)-1-phenyl-methylene]-6methoxycarbonyl -2-indol inane (296) 3-.F-(-toyanln)i pey-mae-thy-lenel -6-raetfioxycarbonyl indol inone (297) 3-Z- [1-(4-trifluoromethyl-anilino)-1-phenyl-methylene] 6 -methoxycarbonyl indolinone (298) 3-Z- [1-(4-methylmercapto-anilino) -1-phenyl-methylene] 6 -methoxycarbonyl -2-indol inane (299) 3-Z- [l-(4-(isopropylaminomethyl)-anilino)-i-phenylmethylene] -6 -methoxycarbonyl indolinone (300) 3-Z- [1-(4-(anilinomethyl)-anilino)-1-phenyl-methylene] 6 -methoxycarbonyl -2-indol inane (301) 3-Z- (isobutylaminomethyl)-anilino)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone (302) (cyclohexylaminomethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (303) (benzylaminomethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2 -indolinone (304) 3-Z- 11- ((N-methyl-N-propyl-amino)-methyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (305) 3-Z- (N-isopropyl-N-methyl-amino) -methyl) aniline) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (306) (N-ethyl-N-propyl-amino)-methyl)-aniiino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone -217- (307) 3-Z-[1-(4-((N-ethyl-N-isopropyl-amino)-methyl)-anilino)- 1-phenyl--methylene] -6-methoxycarbonyl-2-indolinone (308) methylene] -6-methoxycarbonyl-2-indolinone (309) 3-Z- [1-(4-(diisopropylaminomethyl)-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (310) 3-Z- (N-benzyl-N-ethyl-amino) -methyl) -anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (311) 3-Z-[l-(4-(dibenzylaminomethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl -2-indolinone (312) 3-Z-[l-(4-(3,6-dihydro-2H--pyridin-1-yl-methyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (313) 3-Z-[1-(4-(3,5-dimethyl-piperidin-1-yl-methyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (314) 3-Z-[1-(4-(azepan-1-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (315) 3-Z-[1-(4-(2-amino-ethyl)-anilino)-1-phenyl-methylene]- 6 -methoxycarbonyl -2-indolinone (316) 3-Z-(1-(4-(2-methylamino-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbony1-2-indolinone (317) 3-Z-[1-(4-(2-ethylamino-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (318) 3-Z- [1-(4-(2-dimethylamino-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone -218 (319) 3-Z-[1-(4-(2-diethylamino-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (320) 3-Z- (2-piperidin-1-yl-ethyi,-) -anilino)l- I-phlenylmethylene] -6-methoxycarbonyl-2-indolinone (321) 3-Z-[1-(4-(2-acetylamino-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (322) 3-Z- E1-(4-(3-amino-propyl)-anilino)-1-phenyl-methylene 6 -methoxycarbonyl indolinone (323) 3-Z-[1-(4-(3-dimethylamino-propyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (324) 3-Z- El- (4-(N-aminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (325) 3-Z- (N-ethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (326) (N-diethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (327) (N-dipropylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2ndol inane (328) 3-Z- ((N-ethyl-N-methyl-amino) -methylcarbonyl) N-methyl-amino) -aniline) -1-phenyl-methylene] -6methoxycarbonyl indol inone (329) 3-Z- (N-ethyl-N-propyl-amino) -methylcarbonyl)- N-methyl-amino) -anilino) -1-phenyl-methylenel -6methoxycarbonyl -2-indol inane -219 (330) 3-Z- (N-methyl-N-propyl-amino)-methylcarbonyl)- N-methyl-amino) -anilino) -1-phenyl-methylene] -6met hoxycarbonyl -2-indcl inane (331) 3-Z- I (N-dimethylaminomethylcarbonyl-N-ethyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (332) 3-Z- (N-dimethylaminomethylcarbonyl-N-propylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inane (333) 3-Z- 1- (N-dimethylaminomethylcarbonyl-N-butyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (334) 3-Z- (N-(2-amino-ethylcarbonyl)-N-methyl-amino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (335) 3-Z- (2-diethylamino-ethylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2indol inane (336) 3-Z-[l-(4-(N-acetyl-N-(2-aminoethyl)-amino)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (337) 3-Z-[l-(4-(N-acetyl-N-(2-methylamino-ethyl)-amino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (338) 3-Z-[l-(4-(N-acetyl-N-(3-methylamino-propyl)-amino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (339) 3-Z-[1-(4-(N-acetyl-N-(2-piperidin-1-yl-ethyl)-amino)aniline) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (340) 3-Z-[II-(4-(N-acetyl-N-(aminocarbonylmethyl)-amino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone -220 (341) 3-Z- E1-(4-(N-acetyl-N- (piperidin-1-yl-carbonylmethyl) amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone (342) 3-Z-[1-(4-(N-methyl-N-(aminocarbonyl)-amino)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (343) 3-Z- 11- (N-methyl-N- (methylaminocarbonyl) -amino) anilino) -l-phenyl-m6thylene] -6-methoxycarbonyl-2-indolinone (344) 3-Z- (N-methyl-N- (dimethylaminocarbonyl) -amino) anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2-indolinone (345) 3-Z-[1-(4-(N-methyl-N-(piperidin-l-yl-carbonyl)-amino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (346) 3-Z-[Il-(4-(N-(2-ethylamino-ethyl)-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone (347) 3-Z- (2-diethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone (348) 3-Z-[l-(4-(N-(2-pyrrolidin-1-yl-ethyl)-Nmethylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone (349) 3-Z- Ii- (2-piperidin-1-yl-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone (350) 3-Z- (2-piperazin-1-yl-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone 221 (351) 3-Z-[1-(4-(N-(2-(4-morpholin-1-yl)-ethyl)-Nmethylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone (352) 3-Z- [1-(4-(N-(ethylaminocarbonylmethyl)-Nmethylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone (353) 3-Z- (diethylaminocarbonylmethyl)
-N-
methylsuiphonyl-amino) -anilino) -1-phenyl-methylenel -6methoxycarbonyl indol inone (354) 3-Z- (pyriolidin-1-yl-carbonylmethyl) -N-methylsuiphonyl -amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone (355) 3-Z- (piperidin-1-yl-carbonylmethyl) -N-methylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6iethoxycarbonyl indolinone (356) (piperazin-1-yl-carbonylmethyl) -N-methylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inane (357) 3-Z- [1-(4-(N-((morpholin-4-yl)-carbonylmethyl)-N-methylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone (358) 3-Z- [1-(4-(2-dimethylamino-ethoxy)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (359) 3-Z- [l-(4-(3-dimethylamino-propoxy)-anilino)-1-phenylmethylene] -6 -methoxycarbonyl indolinone (360) 3-Z-[II-(4-(aminocarbonylmethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone 222 (361) 3 -Z-[l-(4-(2-aminocarbonyl-ethyl).anilino)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone (362) 3-Z- [1-(4-(pyridin-2-yl)-anilino)-1-phenyl-methylene] 6-me thoxycarbonyl indol inane (363) 3-Z- (pyridine-3-yl)-anilino) -1-phenyl-methylene] 6 -methoxycarbonyl -2.k -indol inane (364) 3-Z- ((N-phenethyl-N-methyl-amino) -methyl) -anilino) 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (365) 3-Z-[lI-(4-(N-acetyl-N-methyl-amino)-anilino-l-phenylmethylene] -6-methoxycarbonyl-2-indalinone (366) 3-Z- (N-ethylcarbonyl-N- (dimethylaminocarbanylmethyl) -amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indolinone (367) 3-Z- (N-methyl-N-methylsulphonyl-amino) -anilino) 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (368) 3-Z- [1-(4-carboxymethyl-anilino)-1-phenyl-methylene].6methoxycarbonyl indolinone (369) 3-Z- [1-(4-carbamoylmethyl-anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indolinone (370) 3-Z- [1-(4-dimethylcarbamoylmethyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (371) 3-Z-[1-(4-tetrazol-5-yl-anilino)-1-phenyl-methylene]- 6 -methoxycarbonyl indol inane -223 (372) 3-Z- (piperidin-1-yl-methyl) -anilino) -methylene] 6 -methoxycarbonyl indol inane (373) 3-Z-[1.-(4-(piperidin-1-l-rnethl,)-anilino)-eth,,licien-,-jl 6 -methoxycarbonyl indolinone (374) 3-Z- II-(4-(piperidin-1-yl-methyl)-anilino) -propylidenel 6 -methoxycarbonyl indolinone (375) 3-Z- [l-(4-(piperidin-1-yl-methyl)-anilino)-butylidene] 6 -methoxycarbonyl indol inane (376) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino) anilino) -methylene] -6-methoxycarbonyl-2-indolinone (377) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino) anilino) -ethylidenel -6-methoxycarbonyl-2-indolinone (378) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)anilino) -propylidene] -6-methoxycarbonyl-2-indolinone (379) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)anilino) -butylidene] -6-methoxycarbonyl-2-indolinone (380) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -methylene] -6-methoxycarbonyl-2-indolinone (381) 3-Z- (N-(2-dimethylamino-ethyl)-N-methylsulphonylamino) -anilino) -ethylidene] -6-methoxycarbonyl-2-indolinone (382) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -propylidene] -6-methoxycarbonyl-2-indolinone (383) 3-Z-[li- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -butylidene] -6-methoxycarbonyl-2-indolinone -224 (384) 3-Z-[l-(4-tetrazol-5-yl-anilino)-methylene]-6-methoxycarbonyl indol inone (385 3-Z [1-(4-ttraz~1-~"l e-y'iaene'-6-methoxycarbonyl indolinone (386) 3-Z-[l-(4-tetrazol-5-yl-anilino)-propylidenel-6-methoxycarbonyl indol inane (387) 3-Z-[1-(4-tetrazol-5-yl-anilino)-butylidene]-6-methoxycarbonyl -2-indol inane (388) 3-Z- [1-(4-carboxy-anilino) -methylene] -6-methoxycarbonyl- 2- indolinone (389) 3-Z-[1-(4-carboxy-anilino)-ethylidene]-6methoxycarbonyl indol inane (390) 3-Z- [1-(4-carboxy-anilino)-propylidene]-6-methoxycarbonyl indolinone (391) 3-Z- [1-(4-carboxy-anilino) -butylidene] -6methoxycarbonyl -2 -indal inane (392) 3-Z-[l-(4-(N-benzyl-N-methyl-aminomethyl)-anilino)-1methyl-methylene] -6-methoxycarbonyl-2-indolinone (393) 3-Z-[1-(4-(2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl-2ndol inane (394) 3-Z-[l-(4-((benzo(1,3)dioxol-5-yl-methyl)-methyl-aminomethyl) -anilino) -1-methyl-methylene] -6-methoxycarbanyl-2ndol inone 0 225 (395) 3-Z- [1-(4-(N-phenethyl-N-methyl-aminomethyl) -anilino) -1methyl-methylene] -6-methoxycarbonyl-2-indolinone (396) 3-Z- (3.,4-dimethoxv-benzvl) -N-methyl-aminomethyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl-2indol inane (397) 3-Z-[1-(4-(N-(4-Chloro-benzyl)-N-methyl-amino-methyl)anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone (398) 3-Z-[l-(4-(N--(4-methylbenzyl)-N-methyl-amino-methyl)anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone (399) 3-Z-[l-(4-(N-(4-fluoro-benzyl)-N-methyl-amino-methyl)anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone (400) 3-Z-[l-(4-(N-(4-bromo-benzyl)-N-methyl-amino-methyl)anilino) -1-methyl-methylenel-6-methoxycarbonyl-2-indolinone (401) 3-Z-[l-(4-(N-(3-dimethylamino-propionyl)-Ndimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (402) 3-Z-[1-(4-(N-(4-dimethylamino-butyryl)-Ndimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (403) 3-Z- (N-dimethylaminocarbonylmethyl-N- (2dimethylamino-ethylsulphonyl) -amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2 -indolinone (404) 3-Z- (N-dimethylaminocarbonylmethyl-N- (3dimethylamino-propylsulphonyl) -amino) -anilino) -1-phenylmethylene] -6 -methoxycarbonyl indolinone 0 226 (405) 3-Z-[1-(4-((2-hydroxy-ethyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (406) 3-Z-[l-(4-((2-methoxy-ethyl)-amino-meth1)-anilinphenyl-methylene] -6-methoxycarbonyl-2-indolinone (407) 3-Z- [1-(4-((2-dimethylamino-ethyl) -amino-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (408) 3-Z-[l-(4-((3-dimethylamino-propyl)-amino-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (409) 3-Z- (N-tert.butoxycarbonyl-2-amino-ethyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone (410) (N-tert.butoxycarbonyl-3--amino-propyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2ndcl inane (411) 3-Z-[1-(4-((2-amino-ethyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (412) 3-Z-[l-(4-((3-amino-propyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (413) 3-Z- [1-(4-((2-acetylamino-ethyl)-amino-methyl) -anilino) 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (414) 3-Z- [1-(4-((3-acetylamino-propyl)-amino-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (415) ((2-methylsulphonylamino-ethyl) -amino-methyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone 0 227 (416) 3-Z- (3-methylsulphonylamino-propyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone (417) 3-Z-(l-(4-(N-(N-tert.butoxycarbonyl-2-amino-ethyl)-Nmethyl-amino-methyl) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone (418) 3-Z-[1-(4-(N-(2-amino-ethyl)-N-methyl-amino-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (419) 3-Z-[1-(4-(N-(2-acetylamino-ethyl)-N-methyl-aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone (420) 3-Z- (2-methylsulphonylamino-ethyl) -N-methylamino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indcl inone (421) 3-Z-[1-(4-(carboxymethyl-amino-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (422) 3-Z- [1-(4-(ethoxycarbonylmethyl-amino-methyl) -anilino) 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (423) 3-Z-[Il-(4-(carbamoylmethyl-amino-methyl) -anilino) -1phenyl-methylene] -6 -methoxycarbonyl-2 -indolinone (424) 3-Z- (dimethylcarbamoyl-methyl-amino-methyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (425) 3-Z- (methylcarbamoyl-methyl-amino-methyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone 228 (426) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-amino-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone (427) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-nitro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone (428) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-acetylamino-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inone (429) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methylsuiphonylamino-anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone (430) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-cyano-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indol inone (431) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-hydroxy-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inone (432) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methoxy-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inone (433) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-ethoxycarbonyl-anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone (434) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-carboxy-anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone 0 229 (435) (N-dimethylaminomethylcarbonyl-N-methylamino) -3-carbamayl-anilina) -1-phenyl-methylene] -6methoxycarbonyl indol inane (436) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-chiara-anilina) -1-phenyl-methylene] -6methoxycarbonyl indol inane (437) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-f luoro-anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inane (438) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-bromo-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indolinone (439) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methyl-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2-indol inane (440) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-trifluoromethyl-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inane (441) 3-Z-[li- (N-dimethylaminomethylcarbonyl-N-methylamino) -3,5-dibromo-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inane (442) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3,5-dichioro-anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inane (443) 3-Z- (dimethylaminomethyl)-3-amino-anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone 230 (444) 3-Z-[1-(4-(dimethylaminomethyl)-3-nitro-anilino)-iphenyl-methylene] -6-methoxycarbonyl-2-indolinone (445) -[1(-dehyaiimhy)--etlin-riic 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (446) 3-Z- (dimethylaminomethyl) -3-methylsuiphonylaminoanilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (447) 3-Z- [1-(4-(dimethylaminomethyl)-3-cyano-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (448) 3-Z-(1-(4-(dimethylaminomethyl)-3-hydroxy-anilino)-iphenyl-methylene] -6-methoxycarbonyl-2-indolinone (449) 3-Z- [l-(4-(dimethylaminomethyl)-3-methoxy-anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (450) 3-Z- (dimethylaminomethyl) -3-ethoxycarbonylanilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (451) 3-Z-[1-(4-(dimethylaminomethyl)-3-carboxy-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (452) 3-Z-[lI-(4-(dimethylaminomethyl)-3-carbamoyl-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (453) 3-Z- [1-(4-(dimethylaminomethyl)-3-chloro-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (454) 3-Z- [l-(4-(dimethylaminomethyl)-3-fluoro-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (455) 3-Z- [l-(4-(dimethylaminomethyl)-3-bromo-anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone S 231 (456) 3-Z-[1-(4-(dimethylaminomethyl)-3-methyl-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (457) 3-Z- (dimethyl;a=mintnethvl) -3-trifluro--me-t-tylanilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (458) 3-Z-[1-(4-dimethylaminomethyl-3,5-dibromo-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (459) 3-Z- E1-(4-(dimethylaminomethyl)-3,5-dichloro-anilino)-iphenyl-methylene] -6-methoxycarbonyl-2-indolinone (460) 3-Z-t1-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] [(2-hydroxy-ethoxy) -carbonyl] -2-indolinone (461) 3-Z-[l-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] [(ethoxycarbonyl-methoxy) -carbonyll -2-indolinone (462) 3-Z- [1-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] [(carboxy-methoxy) -carbonyl] -2-indolinone (463) 3-Z- [l-(4-(dimethylaminomethyl)-anilino) -1-phenylmethylene] [(carbamoyl-methoxy) -carbonyl] -2-indolinone (464) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] Ii(2-hydroxy-ethoxy) carbonyl] -2 -indolinone (465) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] [(ethoxycarbonylmethoxy) -carbonyl] -2-indolinone (466) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] [(carboxy-methoxy) carbonyl] indol inane 232 (467) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] [(carbamoyl-methoxy) carbonyl] -2 -indol inane (468) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] [(2-methoxy-ethoxy) carbonyl] -2-indolinone (469) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] [(2-dimethylaminoethoxy) -carbonyl] -2-indolinone (470) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] 1(2- (Ntert .butoxycarbonyl-amino) -ethoxy) -carbonyl] -2-indolinone (471) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] -6-[(2-amino-ethoxy) carbonyl] -2-indolinone (472) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] trifluoroethoxy) -carbonyl] -2-indolinone (473) 3-Z- ((4-methyl-piperazin-1-yl) -methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone (474) 3-Z- (imidazo-1-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inane (475) 3-Z- (phthalimido-2-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inane 233 (476) 3-Z- (N-aminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (477) 3-Z -L -1 %I N ac t T m -1-1r -a-ino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (478) 3-Z- (N-methylsulphonylaminomethylcarbonyl-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone (479) 3-Z-[l-(4-(N-((N-(2-methoxyethyl)-N-methyl-amino)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] *6 -methoxycarbonyl indolinone (480) 3-Z- [l-(4-(N-((N-(2-dimethylaminoethyl)-N-methyl-amino) methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indol inane (481) 3-Z-[1-(4-(N-((di-(2-hydroxyethyl)-amino)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indol inane (482) 3-Z-[l-(4-tert.butoxycarbonylmethyl-anilino)-1-phenylmethylene] -6 -methoxycarbonyl -2-indol inane (483) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -methylene] -6-methoxycarbonyl-2-indolinone (484) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -aniline) -ethylidene] -6-methoxycarbonyl-2-indolinone (485) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -aniline) -propylidene] -6-methoxycarbonyl-2-indolinone (486) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -butylidene] -6-methoxycarbonyl-2-indolinone 0 234 (487) 3-Z- [l-(4-(dimethylaminomethyl)-anilino)-methylene] -6methoxycarbonyl indol inane (488) 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-ethylidene]-6methoxycarbonyl indol inane (489) 3-Z- [1-(4-(dimethylaminomethyl)-anilino)-propylidene] -6methoxycarbonyl ijdo1 inone (490) 3-Z- [1-(4-(dimethylaminomethylL)-anilino)-butylidene] -6methoxycarbonyl -2 -indol inane (491) 3-Z-[1-(4-tert.butyloxycarbonyl-anilino)-1-phenylmethylene] -6 -methoxycarbonyl indolinone (492) 3-Z- [l-(4-(N-(2-dimethylamino-ethyl)-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (493) 3-Z- (3-dimethylamino-propyl) -N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (494) 3-Z- [1-(4-(N-methyl-acetylamino)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (495) 3-Z-[1-(4-(imidazol-4-yl)-anilino)-1-phenyl-methylene]- 6 -methoxycarbonyl-2-indolinone (496) 3-Z-[1-(4-((N-(dioxolan-2-yl-methyl)-N-methyl-amino)methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2 -indol inane (497) 3-Z-[l-(4-(N-benzyl-N-methyl-amino-methyl)-anilino)-lmethyl-methylene] -6-carbamoyl-2-indolinone 0 235 (498) 3-Z-[1-(4-(2,3,4,5-tetrahydro-benzo(d)azepin-3-yl.
methyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (499) -3-Z-[1I-(4-((benzo(l,3)dioxol-5-vl-methvl) -methyl-arn-no methyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (500) 3-Z- El-(4-(N-phenethyl-N-methyl-amino-methyl)-anilino) 1-methyl-methylene] -6-carbamoyl-2-indolinone (501) 3-Z-[l-(4-(N-(3,4-dimethoxy-benzyl)-N-methyl-aminomethyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (502) 3-Z- [1-(4-(N-(4-Chloro-benzyl)-N-methyl-amino-methyl) anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (503) 3-Z- (4-methyl-benzyl) -N-methyl-amino-methyl) anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (504) (4-fluoro-benzyl) -N-methyl-amino-methyl)anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (505) (4-(N-(4-bromo-benzyl)-N-methyl-amino-methyl)anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (506) 3-Z-[1-(4-((N-(2-methoxy-ethyl)-N-methyl-amino)-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (507) 3-Z-[lI-(4-(dimethylaminomethyl)-anilino) -1-phenylmethylene] [(2-amino-ethoxy) -carbonyl] -2-indolinone (508) 3-Z- (3-methylsulfonylamino-propyl) -N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone 0 236 Example 13 Dry ampoule containing 75 mg of active substance per 10 ml Composition: Active substance Mannitol water for injections 75.0 mg 50.0 mg ad 10.0 ml Preparation: Active substance and mannitol are dissolved in water. After packaging the solution is freeze-dried. To produce the solution ready for use, the product is dissolved in water for injections.
Example 14 Dry ampoule containing 35 mg of active substance per 2 ml Composition: Active substance Mannitol water for injections 35.0 mg 100.0 mg ad 2.0 ml Preparation: Active substance and mannitol are dissolved in water. After packaging, the solution is freeze-dried.
To produce the solution ready for use, the product is dissolved in water for injections.
0 237 Example Tablet containing 50 mg of active substance Composition: Active substance Lactose Maize starch Polyvinylpyrrolidone Magnesium stearate 50.0 mg 98.0 mg 50.0 mg 15.0 mg 2.0 mq 215.0 mg Preparation: and are mixed together and granulated with an aqueous solution of is added to the dried granulated material. From this mixture tablets are pressed, biplanar, faceted on both sides and with a dividing notch on one side.
Diameter of the tablets: 9 mm.
Example 16 Tablet containing 350 mg of active substance Composition: Active substance Lactose Maize starch Polyvinylpyrrolidone Magnesium stearate 350.0 mg 136.0 mg 80.0 mg 30.0 mg 4.0 mq 600.0 mg 238 Preparation: and are mixed together and granulated with an aqueous solution of is added to the dried granulated material. From this mixture tablets are pressed, biplanar, faceted on both sides and with a dividing notch on one side.
Diameter of the tablets: 12 mm.
Example 17 Capsules containing 50 mg of active substance Composition: Active substance Dried maize starch Powdered lactose Magnesium stearate 50.0 mg 58.0 mg 50.0 mg 2.0 mg 160.0 mg Preparation: is triturated with This trituration is added to the mixture of and with vigorous mixing.
This powder mixture is packed into size 3 hard gelatine capsules in a capsule filling machine.
Example 18 Capsules containing 350 mg of active substance 239 Composition: Active substance Dried maize starch Powdered lactose Magnesium stearate 350.0 mg 46.0 mg 30.0 mg 4.0 mg 430.0 mg Preparation: is triturated with This trituration is added to the mixture of and with vigorous mixing.
This powder mixture is packed into size 0 hard gelatine capsules in a capsule filling machine.
Example 19 Suppositories containing 100 mg of active substance 1 suppository contains: Active substance 100.0 mg Polyethyleneglycol 1500) 600.0 mg Polyethyleneglycol 6000) 460.0 mg Polyethylenesorbitan monostearate 840.0 mg 2,000.0 mg Preparation: The polyethyleneglycol is melted together with polyethylene sorbitan monostearate. At 40 0 C the ground active substance is homogeneously dispersed in the melt. It is cooled to 38 0 C and poured into slightly chilled suppository moulds.
PAOPER'JgOIO233Ol- dcImsdmc.I14J4 -239A- Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form or suggestion that that prior art forms part of the common general knowledge in Australia.
boo.
S
S.
S
Claims (7)
1. Indolinones of general formula R 3 R 4 -N X R2 I Rz substituted in the 6 position, wherein X denotes an oxygen or sulphur atom, RI denotes a hydrogen atom or a C 1 4 -alkoxycarbonyl or C 2 4 alkanoyl group, R 2 denotes a carboxy group, a straight-chain or branched C 1 -6-alkoxy-carbonyl group, a C 4 7 -cycloalkoxy-carbonyl or an aryloxycarbonyl group, a straight-chain or branched Cl-6-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a 15 phenyl, heteroaryl, carboxy, C1- 3 -alkoxy-carbonyl, aminocarbonyl, C 1 3 -alkylamino-carbonyl or di-(Cz- 3 -alkyl) aminocarbonyl group, a straight-chain or branched C 2 6 -alkoxy-carbonyl group, **which is terminally substituted in the alkyl moiety by a 20 chlorine atom or a hydroxy, C 1 -3-alkoxy, amino, C 1 3 -alkylamino or di-(C 1 3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 241 position of the ethyl group by a hydroxy or C 13 ,-alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or N-(C 1-alkyl) -C,-,-alkylaminocarbonyl-phenyl group, it may also denote a di- 1- 2 -alkYl -aminocarbonyl gop R 3 denotes a hydrogen atom, a C 1 6 -al kyl, C 37 ,-cycloalkyl, trifluoromethyl or heteroaryl group, a phenyl or naphthyl group, a phenyl or naphthyl group mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, C 1 3 -alkyl or C 13 ,-alkoxy group, whilst in the event of disubstitution the substituents may be identical or different and wherein the abovementioned unsubstituted as well as the mono- and disubstituted phenyl and naphthyl groups may additionally be substituted by a hydroxy, hydroxy-C- 3 -alkyl or C- alkoxy- C 1 3 -al kyl group, by a cyano, carboxy, carboxy- C- 3 -alkyl, C- 3 -alkoxycarbonyl, aminocarbonyl, C'3 alkylamino-carbonyl or di- (C- 3 alkyl) -aminocarbonyl group, by a nitro group, by an amino, C1--alkylamino, di- 3 -alkyl) -amino or amino-C 13 ,-alkyl group, by a C1- -alkylcarbonylamino, N- (Cl- -alkyl) -C- 3 -alkyl- carbonylamino, C 1 3 -alkylcarbonylamino-C 13 ,-alkyl, N- (C 1 3 -alkyl) -Cl- 3 -alkylcarbonylamino-C 1 3 -alkyl, C 1 3 -alkyl- sulphonylamino, C- 3 -alkylsulphonylamino-Cl 1 3 -alkyl, N- (C- 3 alkyl) -C 13 -alkylsulphonylamino-Cl 1 3 -alkyl or aryl -Cl- 3 -alkylsulphonylamino group, 242 by a cycloalkylamino, cycloalkyleneimino, cyclo- alkyleneiminocarbonyl, cycloalkyleneimino-C 1 3 -alkyl, cycloalkyleneiminocarbonyl-C 1 3 -alkyl or cycloalkyleneiminosulphonyl-C, 3 -alkyl group having 4 to 7 ring members in each case, whilst in each case the methylene group in position 4 of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or -N(C- 3 -alkyl) group, or by a heteroaryl or heteroaryl-C,_ 3 -alkyl group, R 4 denotes a C 3 _.-cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7- membered cycloalkyl group may be substituted by an amino, C, 3 alkylamino or di-(C_3-alkyl)-amino group or replaced by an -NH or -N(CI 3 -alkyl) group, or a phenyl group substituted by the group Rg, which may additionally be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C,_ 5 -alkyl, trifluoromethyl, hydroxy, C 1 3 -alkoxy, carboxy, C13_-alkoxycarbonyl, amino, acetylamino, C 1 3 -alkyl-sulphonylamino, aminocarbonyl, C_ 1 3 -alkyl-aminocarbonyl, di-(C 3 -alkyl)-aminocarbonyl, aminosulphonyl, C 1 _3-alkyl-aminosulphonyl, di-(C_3-alkyl)-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different and wherein R denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, amino, C_-s-alkyl, C3_,-cycloalkyl, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group, the group of formula 0 243 0 NH wherein the hydrogen atoms bound to a nitrogen atom may in each case be replaced independently of one another by a C 1 3 -alkyl group, a C- 3 -alkoxy group, a C 1 3 -alkoxy-C 1 I 3 -alkoxy, phenyl-C- 3 -alkoxy, amino- C 2 3 -alkoxy, C 1-3-a lkylamino-C 2 3 -alkoxy, di- (CI- 3 -alkyl) amino- C 2 alkoxy, phenyl-C 1 3 ,-alkylamino- C 2 3 -alkoxy, N- (Cl- 3 -alkyl) -phenyl-C 1 3 -alkylamino-C 2 3 -alkoxy, C 5 -,-cycloalkyleneimino-C 2 3 -alkoxy or CI-3-al kylmercapto group, a carboxy, C, 4 -alkoxycarbonyl, aminocarbonyl, C 1 3 -alkyl- amino-carbonyl, N- (C,-,-alkyl) -C,-,-alkylaminocarbonyl, phenyl-Cl- 3 -alkylamino-carbonyl, N-(C- 3 -alkyl) -phenyl-Cl- 3 -alkylamino-carbonyl, piperazinocarbonyl or N- (Cl 1 3 -alkyl) -piperazinocarbonyl group, a C 1 3 -alkylaminocarbonyl or N- (C 1 -5-alkyl) Cl- 3 -alkylaminocarbonyl group wherein an alkyl moiety is substituted by a carboxy or C 1 3 -alkoxycarbonyl group or in the 2 or 3 position by a di- (Cl 1 3 -alkyl) -amino, piperazino, N-(C- 3 -alkyl) -piperazino or a 4- to 7-membered cycloalkyleneimino group, a C 3 7 -cycloalkyl-carbonyl group, wherein the methylene group in the 4 position of the 6- or
7-membered cycloalkyl moiety may be substituted by an *amino, Cl- 3 -alkylamino or di- (Cl 1 3 -alkyl) -amino group or replaced by an -NH or -N(C. 3 -alkyl) group, a 4- to 7-membered cycloalkyleneimino group wherein 244 a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or the cycloalkylene moiety may be fused to a phenyl ring or one or two hydrogen atoms may each be replaced by a C,_3- alkyl group and/or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C 1 3 ,-alkoxycarbonyl, aminocarbonyl, Cl. 3 -alkylaminocarbonyl, di- (C 1 3 -alkyl) -aminocarbonyl, phenyl-C 1 -3-alkylamino or N-(C- 3 -alkyl)- phenyl-C, 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 .3-alkyl), -N(phenyl), -N(C- 3 -alkyl-carbonyl) or -N(benzoyl) group, a C- 4 -alkyl group substituted by the group R 7 wherein R, denotes a C 3 7 -cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be substituted by an amino, C 1 3 -alkylamino or di-(C,~-alkyl)-amino group or replaced by an -NH or -N(C 1 3 -alkyl) group or in a 5- to 7-membered cycloalkyl group a 2 group may be replaced by a -CO-NH group, a -(CH 2 3 group may be replaced by a -NH-CO-NH or -CO-NH-CO group or a -(CH 2 4 group may be replaced by a -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C1-3-alkyl group, 245 an aryl or heteroaryl group, a hydroxy or C,- 3 -al koxy group, an amino, Cl- 7 -alkylamino, di- 7 -alkyl) -amino, phenylamino, N-phenyl-C 13 ,-alkyl-amino, phenyl-C,- -alkyl- amino, N- (Cl-3-alkyl) -phenyl-C,,3-alkylamino or di- (phenyl-Cl-3-alkyl) -amino group, an o-hydroxy-C 2 -3-alkyl-amino, N- 3 -alkyl) -aw-hydroxy- C 2 -3-al kyl-amino, di- (&-hydroxy-C 2 3 -alkyl) -amino, di- (Cl-3-alkoxy) -C2- 3 -alkyl) -amino or N- (dioxolan- 2-yl) 3 -alkyl-amino group, a C -alkylcarbonylamino-C2- -alkylaioo C,-3-al kylcarbonylamino-C 2 -3-alkyl-N- (C,-,-alkyl) -amino group, aC,-3 alkylsuiphonylamino, N- (C,,3-alkyl) -C,,3-alkyl- suiphonylamino, C,,3-alkylsulphonylamino-C2- 3 -alkyl-amino or Cl-3-alkylsulphonylamino-C2-3-alkyl-N- (C,,3-alkyl) -amino group, a hydroxycarbonyl-C,-,-alkylamino or N- (C- 3 -alkyl)- hydroxycarbonyl -C,-,-alkyl-amino group, a guanidino group wherein one or two hydrogen atoms may each be replaced by a C1- alkyl group, a group of formula N(R 8 )-C0(CH 2 )n-R 9 I) wherein R. denotes a hydrogen atom or a C 1 3 alkyl group, 246 n denotes one of the numbers 0, 1, 2 or 3 and R9 denotes an amino, C, 4 -alkylamino, di- (C 14 -alkyl)-amino, phenylamino, N- (C- 4 -alkyl) -phenylamino, benzylamino, N-(C. 4 -alkyl)-benzylamino or C 1 4 -alkoxy group, a 4- to 7-membered cycloalkyleneimino group, whilst in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C.3-alkyl), -N(phenyl), -N(C_ 3 -alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula -N(Rio)-(CH 2 )m-(CO)o-R11 (III), wherein Rio denotes a hydrogen atom, a C,_3-alkyl group, a C_.3-alkylcarbonyl, arylcarbonyl, phenyl-C 1 3 -alkyl- carbonyl, C_3-alkylsulphonyl, arylsulphonyl or phenyl-C_ 3 -alkylsulphonyl group, m denotes one of the numbers 1, 2, 3 or 4, o denotes the number 1 or, if m denotes one of the numbers 2, 3 or 4, o may also denote the number 0 and R 1 denotes an amino, C, 4 -alkylamino, di-(Cl_ 4 -alkyl)-amino, phenylamino, N-(Cl. 4 -alkyl)-phenylamino, benzylamino, N- (C- 4 -alkyl) -benzylamino, C-. 4 -alkoxy or C,.3-alkoxy-C_ 3 -alkoxy group, a di-(C,--alkyl)-amino-C_- 3 247 alkylamino group optionally substituted in the 1 position by a C 1 3 -alkyl group or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7- membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, 3 -alkyl), -N(phenyl), -N(C_ 3 -alkyl-carbonyl) or -N(benzoyl) group, a C 4 7 -cycloalkylamino, C 4 cycloalkyl-CI_3-alkylamino or C 4 7 -cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a Cs,-cycloalkyl, C 2 -4-alkenyl or C, 4 -alkyl group, a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C 1 3 -alkyl, C 1 _3-alkoxy or amino group, and/or one or two hydrogen atoms may each be replaced by a C_.3-alkyl, Cs-7-cycloalkyl or phenyl group and/or the methylene group in the 3 position of a cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C. 3 -alkyl, Ci-3-alkoxy or C 1 .3-alkoxy-C 1 .3-alkyl group, the methylene group in the 3 or 4 position of a 6- or 7-membered cycloalkyleneimino group may in each case be substituted by a hydroxy, hydroxy-C 1 3 -alkyl, 248 C,- 3 -alkoxy, C 1 3 -alkoxy-C. 3 -alkyl, carboxy, C- 4 -alkoxycarbonyl, aminocarbonyl, C,- 3 -alkylaminocarbonyl, di- (CI- 3 -alkyl) -aminocarbonyl, phenyl-C 1 3 -aikyiamino or N4- (C -alkyl) -pril -C- 1 3 -alkyl amino group or may be replaced by an oxygen or sulphur atom, by a suiphinyl, suiphonyl, -NH, -N(C 1 3 -alkyl-), -N(phenyl), -N(phenyl-Cj -alkyl-) -N(Cl 1 3 -alkyl-carbonyl-) -N(Cl- 4 -hydroxy-carbonyl-) -N(Cl 1 4 -alkoxy-carbonyl-), -N(benzoyl-) or -N(phenyl-C 1 3 -alkyl-carbonyl-) group, wherein a methylene group linked to an imino- nitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the imino- nitrogen atom may each be replaced by a carbonyl group, or R 6 denotes a C 1 4 -alkyl group which is substituted by a carboxy, C- 3 -alkoxycarbonyl, aminocarbonyl, C- 3 -alkylaminocarbonyl or di-(CI- 3 -alkyl) -aminocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group, an N-(Cl- 3 -alkyl)-C,.-alkanoylamino group which is additionally substituted in the alkyl moiety by a carboxy or C -3-alkoxycarbonyl group, a group of formula -N(R2)-CO-(CH2)p- R13 (IV), wherein 249 R 12 denotes a hydrogen atom, a C 1 6 -alkyl or C 3 .,-cycloalkyl group or a C 1 _-alkyl group terminally substituted by a phenyl, heteroaryl, triflucromethyl, hydroxy, C- 3 arlkoxy, aminocarbonyl, C 1 4 -alkylamino-carbonyl, di-(C,--alkyl)- amino-carbonyl, Ci. 3 -alkyl-carbonyl, C. 3 -alkyl-sulphonyl- amino, N- (C, 3 -alkyl)-C~ 3 -alkyl-sulphonylamino, Cl- 3 -alkyl-aminosulphonyl or di- (Ci.3-alkyl) -aminosulphonyl group and p denotes one of the numbers 0, 1, 2 or 3 and R, 3 assumes the meanings of the abovementioned group R,, or, if p denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula -N(R 4 -(CH2)q-(CO)r-Rl5 wherein R, 4 denotes a hydrogen atom, a C 1 4-alkyl group, a Cl. 3 -alkylcarbonyl, arylcarbonyl, phenyl-C_-3-alkylcarbonyl, heteroarylcarbonyl, heteroaryl-C,~ 3 -alkylcarbonyl, C,. 4 -alkylsulphonyl, arylsulphonyl, phenyl-Ci.3-alkylsulphonyl, heteroarylsulphonyl or heteroaryl-C 1 3 -alkyl-sulphonyl group, q denotes one of the numbers 1, 2, 3 or 4, r denotes the number 1 or, if q is one of the numbers 2, 3 or 4, it may also denote the number 0 and Ri 5 assumes the meanings of the abovementioned group R,, 250 a group of formula -N(Ri6)-SO2-R17 (VI), wherein R16 denotes a hydrogen atom or a C 1 _4-alkyl group optionally terminally substituted by a cyano, trifluoromethyl-carbonylamino or N-(C 1 3 -alkyl)-trifluoromethyl-carbonyl-amino group and R 1 denotes a C 1 3 -alkyl group, an amino group substituted by a di-(C_3-alkyl)- amino-C_-3-alkyl-carbonyl or di-(C_3-alkyl)- amino-C-_3-alkyl-sulphonyl group and a di-(C, 3 -alkyl)- aminocarbonyl-C_3-alkyl group, or an 3 -alkyl)-C 15 s-alkylsulphonylamino or N-(C 1 3 -alkyl)-phenylsulphonylamino group wherein the alkyl moiety is additionally substituted by a cyano or carboxy group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R, may be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C,_-alkyl, trifluoromethyl, hydroxy, C _3-alkoxy, carboxy, C, 3 -alkoxycarbonyl, aminocarbonyl, C,_4-alkylamino-carbonyl, di-(C-_4-alkyl)-amino-carbonyl, aminosulphonyl, C_3-alkyl-aminosulphonyl, di-(Cl--alkyl)-aminosulphonyl, C-_-alkyl-sulphonylamino, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, 251 and R, denotes a hydrogen atom or a C,.3-alkyl group, wherein by an aryl group is meant a phenyl or naphthyl group optionally mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a cyano, trifluoromethyl, nitro, carboxy, aminocarbonyl, C_3-alkyl or C 13 -alkoxy group and by a heteroaryl group is meant a monocyclic 5- or 6-membered heteroaryl group optionally substituted by a C 1,-alkyl group in the carbon skeleton, wherein the 6-membered heteroaryl group contains one, two or three nitrogen atoms and the 5-membered heteroaryl group contains an imino group optionally substituted by a C 1 3-alkyl or phenyl-C 1 -alkyl group, an oxygen or sulphur atom or an imino group optionally substituted by a Ci. 3 -alkyl or phenyl-C_-3-alkyl group or an oxygen or sulphur atom and additionally a nitrogen atom or an imino group optionally substituted by a C 1 3 -alkyl or phenyl-C 1 3 -alkyl group and two nitrogen atoms, and moreover a phenyl ring may be fused to the abovementioned monocyclic heterocyclic groups via two adjacent carbon atoms and the bonding takes place via a nitrogen atom or via a carbon atom of the heterocyclic moiety or a fused phenyl ring, some or all of the hydrogen atoms in the abovementioned alkyl and alkoxy groups or in the alkyl moieties contained in the P.OPERVg\IO033.41 -252- above-defined groups of formula I may be replaced by fluorine atoms, and the hydrogen atom of any carboxy group present or a hydrogen atom bound to a nitrogen atom may each be replaced by a hydroxy group, an acyl group, an allyloxycarbonyl group, a C 1 16 -alkoxycarbonyl group, a phenyl-Ci- 6 alkoxycarbonyl group, a Ci- 3 -alkylsulfonyl-C 2 4 alkoxycarbonyl, C 1 -3-alkoxy-C 2 4 -alkoxy-C 2 -4-alkoxycarbonyl or RcCO-O-RfCRg) CO-group wherein Re denotes a Ci- 8 -alkyl, C5- 7 -cycloalkyl, phenyl or phenyl-C1- 3 alkyl group, Rf denotes a hydrogen atom, a Cj- 3 -alkyl, C5-7-cycloalkyl or phenyl group, and Rg denotes a hydrogen atom, a C 1 3 alkyl, or Re-CO-O-(RfCRh)-O- group, wherein Re and Rf are as hereinbefore defined and Rh is a hydrogen atom or a C1- 3 alkyl group, 20 the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof. 2. Indolinones of general formula I according to claim 1, wherein S RI and R 3 are as hereinbefore defined and X denotes an oxygen atom, R 2 denotes a carboxy group, a straight-chain or branched C 1 -6-alkoxy-carbonyl group, a C5- 7 -cycloalkoxycarbonyl or a phenoxycarbonyl group, P.OPER VJc0233.O1 cltmidoc.1404A5 -252A- a straight-chain or branched C 1 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, Cl- 3 -alkoxycarbonyl, aminocarbonyl, C 1 3 -alkylaminocarbonyl or di-(C 1 3 -alkyl)-aminocarbonyl group, a straight-chain or branched C2-3-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom, by a hydroxy, C 1 3 -alkoxy, amino, C 1 3 -alkylamino or di-(Ci- 3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C1- 3 -alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or **o o•* *oo oooo* *oo 253 N- (C-s-alkyl)-C 1 3 -alkylaminocarbonyl-phenyl group, it may also denote a di-(C 1 -2-alkyl)-aminocarbonyl group, R denotes a C, ,-cycloalkl group, whilst the methylene group in the 4 position of a 6- or 7- membered cycloalkyl group may be substituted by an amino, C 1 3 alkylamino or di- 3-alkyl)-amino group or replaced by an -NH or -N(CI--alkyl) group, or a phenyl group substituted by the group which may additionally be mono- or disubstituted by fluorine, chlorine or bromine atoms, by C. 3-alkyl, trifluoromethyl, hydroxy, C 1 3 -alkoxy, carboxy, C_ 3 -alkoxycarbonyl, amino, acetylamino, aminocarbonyl, Ci.3-alkyl-aminocarbonyl, di-(C 1 3 -alkyl)-aminocarbonyl, nitro or cyano groups, wherein the substituents may be identical or different and wherein R 6 denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, amino, C 1 _s-alkyl, C 3 _,-cycloalkyl, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group, the group of formula 0 NH -CH N O H wherein a hydrogen atom bound to the nitrogen atom may be replaced by a C I3-alkyl group, a C 1 3-alkoxy group, an amino-C 2 3 -alkoxy, C 1 _3-alkylamino- C 2 3 -alkoxy, di-(C_-3-alkyl)-amino-C 2 -3-alkoxy, phenyl- C 3 -alkylamino-C 2 ,3-alkoxy, N-(Cl 3 -alkyl)-phenyl- 254 CI 3 -alkylamino-C2-3-alkoxy, pyrrolidino-C 2 3 -alkoxy, piperidino-C 2 3 -alkoxy or C,_3-alkylmercapto group, a carboxy, C _--alkoxycarbonyl, aminocarbonyl, C 1 _3-alkyl- amino-carbonyl, phenyl-C 1 _3-alkylamino-carbonyl or N-(C 1 3 -alkyl) -phenyl-C, 3 -alkylamino-carbonyl group, a C 3 ,_-cycloalkyl-carbonyl group, wherein the methylene group in the 4 position of the 6- or 7-membered cycloalkyl moiety may be replaced by an -NH or -N(C 1 3 -alkyl) group, a 4- to 7-membered cycloalkyleneimino group, wherein a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or one or two hydrogen atoms may each be replaced by a C 1 -3-alkyl group and/or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a carboxy, Cl_ 3 -alkoxycarbonyl, aminocarbonyl, C 1 3 -alkylaminocarbonyl, di-( CC 3 -alkyl) -aminocarbonyl, phenyl-C 1 _3-alkylamino or N-(C 1 3 -alkyl)- phenyl-C,_,-alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or -N(C,_3-alkyl) group, a C,_ 4 -alkyl group terminally substituted by the group R,, wherein R, denotes a Cs,_-cycloalkyl group, 255 whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be replaced by an -NH or -N(C 1 3 -alkyl) group or in a 5 to 7 -membered cycloalkyl group a (CH 2 2 group may be replaced by a -CO-NH group, a (CH 2 3 group may be replaced by a -NH-CO-NH- or a (CH 2 4 group may be replaced by a -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 -alkyl group, a phenyl or heteroaryl group, a hydroxy or C 1 3 -al koxy group, an amino, Cl- 6 -alkylamino, di- (Cl 1 6 -alkyl) -amino, phenylamino, N-phenyl -C 1 3 -alkyl -amino, phenyl-C 1 3 -alkylamino, N- (C 1 3 -alkyl) -phenyl-C 1 3 -alkylamino or di- (phenyl-C 1 3 -alkyl) -amino group, a co-hydroxy-C 2 3 -alkyl -amino, N- (C- 3 -alkyl) -co-hydroxy- -C 2 3 -alkyl -amino, di- ((o-hydroxy-C 2 3 -alkyl) -amino, di- (Cl- 3 -alkoxy) -C 2 3 -alkyl) -amino or N- (dioxolan-2-yl) -Cl 1 3 -alkyl-amino group, a Cl- 3 -alkylcarbonylamino-C 2 -alkyl -amino or C 1 3 -al kylcarbonylamino-C 2 3 -alkyl-N- (C 1 3 -alkyl) -amino group, a C 1 3 -al kyl sulphonyl amino, N- (C 1 3 -alkyl) Cl- 3 -al kylsulphonylamino, CI- 3 -alkylsulphonylamino- -C 2 3 -alkyl -amino or C,- 3 -alkylsulphonylamino-C 2 3 -alkyl- (Cl- 3 -alkyl) -amino group, a hydroxycarbonyl-C 1 3 -alkylamino or N- (Cl- 3 -alkyl) -hydroxycarbonyl -C 1 3 -alkyl -amino group -256 a guanidino group wherein a hydrogen atom may be replaced by a C .3-alkyl group, a group of formula -N(R8)-CO-(CH 2 )n-R 9 (II), wherein R, denotes a hydrogen atom or a C,13-alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and R 9 denotes an amino, C, 3 -alkylamino, di-(C 1 3 -alkyl)- amino, phenylamino, benzylamino or C 14 -alkoxy group, a to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH, -N(C 1 3 -alkyl), -N(phenyl), -N(Cl_ 3 -alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula -N(R 1 0 )-(CH2)m-(CO)o-R 11 (III), wherein Rio denotes a hydrogen atom, a C,3-alkyl group, a C 1 .3-alkylcarbonyl or C_ 3 -alkylsulphonyl group, m denotes one of the numbers 1, 2 or 3, o denotes the number 1 or, if m is one of the numbers 2 or 3, o may also denote the number 0 and 257 R11 denotes an amino, C 1 3 -alkylamino, di- (C- 3 -alkyl)-amino, C. 4 -alkoxy or C 1 3 -alkoxy-C_ 3 -alkoxy group or a 5- to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH, -N(C 1 3 -alkyl), -N(phenyl), -N(C_ 3 -alkyl-carbonyl) or -N(benzoyl) group, a C 4 .,-cycloalkylamino or C,,-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond, a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or one or two hydrogen atoms may each be replaced by a C, _-alkyl group and/or the methylene group in position 3 of the pyrrolidino group may be substituted by a hydroxy or C_3-alkoxy group, in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl, C 1 .3-alkoxy, carboxy, C 1 3 -alkoxycarbonyl, aminocarbonyl, C_ 3 -alkylaminocarbonyl, di-(C 1 3 -alkyl)-aminocarbonyl, phenyl-C_.3-alkylamino or N-(Ci_ 3 -alkyl)-phenyl-C_ 3 -alkyl- amino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 .3-alkyl), -N(phenyl), 258 -N(phenyl-C 1 3 -alkyl), -N(C, 1 3 -alkyl-carbonyl), -N(C 1 4 -alkoxy-carbonyl), -N(benzoyl) or -N(phenyl-C 1 3-alkyl-carbonyl) group, wherein a methylene group linked to an imino- nitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a to 6-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the imino- nitrogen atom may each be replaced by a carbonyl group, or R, denotes a C 1 4 -alkyl group which is terminally substituted by a carboxy, C 1 _3-alkoxycarbonyl, aminocarbonyl, C 1 3 -alkylaminocarbonyl or di-(CI- 3 -alkyl)-aminocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group, a group of formula -N(RI 2 )-CO-(CH 2 )p-R 1 3 (IV), wherein R 12 denotes a hydrogen atom, a C 1 _-alkyl, Cs,_-cycloalkyl, phenyl-C 1 3 -alkyl or heteroaryl-Cl_ 3 -alkyl group and p denotes one of the numbers 0, 1, 2 or 3 and R, 3 assumes the meanings of the abovementioned group R,, or, if p denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula 259 -N(R 1 4 )-(CH2)q-(CO)r-R15 wherein R 14 denotes a hydrogen atom, a C 1 4 -alkyl group, a C 1 _3-alkylcarbonyl, phenylcarbonyl, phenyl-C 1 3 -alkyl- carbonyl, heteroarylcarbonyl, heteroaryl-C 1 .3-alkylcarbonyl, C 4 -alkylsulphonyl, phenylsulphonyl, phenyl-C 1 -_-alkylsulphonyl- heteroarylsulphonyl or heteroaryl-C 1 3 -alkyl-sulphonyl group, q denotes one of the numbers 1, 2, 3 or 4, r denotes the number 1 or, if q is one of the numbers 2, 3 or 4, it may also denote the number 0 and RIs assumes the meanings of the abovementioned group R,, a group of formula -N(R 1 6 )-S0 2 -R 17 (VI), wherein R 16 denotes a hydrogen atom or a C, 4 -alkyl group optionally terminally substituted by a cyano, trifluoromethyl- carbonylamino or N-(C 1 3 -alkyl)-trifluoromethyl- -carbonyl-amino group and denotes a C-_3-alkyl group, an amino group substituted by a di-(C 1 3 -alkyl)- amino-C 1 3 -alkyl-carbonyl or di-(Cl_ 3 -alkyl)- amino-C,.3-alkyl-sulphonyl group and a di-(C 1 -3-alkyl)- aminocarbonyl-Cl--alkyl group, P.AOPERUliO0233.41 dimdoc-I 15A4S -260- wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R 6 may be mono- or disubstituted by fluorine, chlorine or bromine atoms, by C 1 3 -alkyl, trifluoromethyl, hydroxy, C 1 3 -alkoxy, carboxy, C1- 3 -alkoxycarbonyl, aminocarbonyl, C 1 3 -alkyl-aminocarbonyl, aminosulphonyl, C 1 3 -alkyl-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, and R 5 denotes a hydrogen atom or a C 1 3 -alkyl group, whilst by a heteroaryl group as mentioned above is meant a pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, pyrrolyl, furyl, thienyl, oxazolyl, thiazolyl, pyrazolyl, imidazolyl or triazolyl group optionally substituted in the carbon skeleton by a C 1 3 -alkyl group wherein a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 -alkyl or phenyl-C 1 3 -alkyl group and wherein the 5-membered heteroaryl groups containing at least one imino group are bound via a carbon or nitrogen atom, S 25 a hydrogen atom bound to a nitrogen atom in the **0 abovementioned groups may each be replaced by a hydroxy group, an acyl group, an allyloxycarbonyl group, a C 1 16 ***alkoxycarbonyl group, a phenyl-C 1 6 -alkoxycarbonyl group, a C 1 3 -alkylsulfonyl-C 2 -4-alkoxycarbonyl, C 1 3 -alkoxy-C 2 -4-alkoxy- C2-4-alkoxycarbonyl or RcCO-O-RfCR,) -O-CO-group wherein P.OPERU\Jl0233.01 clims doc-14/4M 260A Rc denotes a C 1 i--alkyl, Cs- 7 -cycloalkyl, phenyl or phenyl-Ci- 3 alkyl group, Rf denotes a hydrogen atom, a Cj- 3 -alkyl, C 5 -7-cycloalkyl or phenyl group, and Rg denotes a hydrogen atom, a C1- 3 alkyl, or Re-CO-O-(RfCRh)-O- group, wherein Re and Rf are as hereinbefore defined and Rh is a hydrogen atom or a C1- 3 alkyl group, the carboxy groups contained in the abovementioned groups may each be replaced by a tert.butoxycarbonyl precursor group, some or all of the hydrogen atoms in the abovementioned alkyl and alkoxy groups or in the alkyl moieties contained in the above-defined groups of formula I may be replaced by fluorine atoms and 261 the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof. 3. Indolinones of general formula I according to claim 1, wherein X denotes an oxygen atom, RI denotes a hydrogen atom, R 2 denotes a carboxy group, a straight-chain or branched C, 4 -alkoxycarbonyl group or a phenoxycarbonyl group, a straight-chain or branched C _3-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, carboxy, C 1 3 -alkoxycarbonyl, aminocarbonyl, C_3-alkylaminocarbonyl or di- (C_3-alkyl)-aminocarbonyl group, a straight-chain or branched C2-3-alkoxy-carbonyl group which is terminally substituted in the alkyl moiety by a hydroxy, C 1 _3-alkoxy, amino, C 1 3 -alkylamino or di-(C 1 3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C 1 3 -alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or N-(Cis-alkyl)-C_ 3 -alkylaminocarbonyl-phenyl group, it may also denote a di-(C 1 2 -alkyl)-aminocarbonyl group, R 3 denotes a C 1 _4-alkyl group or a phenyl group which may be substituted by a fluorine, chlorine or bromine atom, by a trifluoromethyl, C,_ 3 -alkyl, hydroxy or Ci.3-alkoxy group, R 4 denotes a C 5 s 6 -cycloalkyl group, 262 wherein the methylene group in position 4 of the cyclohexyl group may be substituted by an amino, C_3-alkylanino or di- tC-alky)-amino group or replaced by an -NH or -N(C 1 _3-alkyl) group, a phenyl group, a phenyl group disubstituted by C 1 _3-alkyl, C 1 .3-alkoxy or nitro groups, wherein the substituents may be identical or different, or a phenyl group substituted by the group R 6 which may additionally be substituted by a fluorine, chlorine or bromine atom or by an amino or nitro group, wherein R 6 denotes a fluorine, chlorine or bromine atom, a C, 1 3 -alkyl, Cl-alkoxy, nitro, amino or C,_ 6 -cycloalkyl group, a pyrrolyl, pyrazolyl, imidazolyl, triazolyl or tetrazolyl group bound via a carbon atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be substituted by a C _3-alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 _3-alkyl or phenyl-C 1 _3-alkyl group, the group of formula O 0 NH CH N H a carboxy, C,- 4 alkoxycarbonyl, phenyl-C, 3 -alkylamino-carbonyl or C,,-cycloalkyl-carbonyl group, a 5 or 6-membered cycloalkyleneimino group, wherein 263 the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH or -N(C 1 3 -alkyl) group, an unbranched C 1 3 -alkyl group terminally substituted by the group wherein R 7 denotes a Cs,_-cycloalkyl group, wherein in a 5 or 6-membered cycloalkyl group a -(CH 2 2 group may be replaced by a -CO-NH group, a -(CH 2 3 group may be replaced by an -NH-CO-NH- or a group may be replaced by an -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 -alkyl group, a phenyl or pyridinyl group or a pyrrolyl, pyrazolyl, imidazolyl or triazolyl group bound via a carbon or nitrogen atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be substituted by a C 1 3 -alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a C_ 3 -alkyl group, a hydroxy or C1.3-alkoxy group, an amino, C 1 6 -alkylamino, di-(C. 6 -alkyl)-amino, phenylamino, N-phenyl-C 1 3 -alkylamino, phenyl-Ci_,-alkylamino or N-(C_-3-alkyl)-phenyl- C 1 3 -alkylamino group, a o-hydroxy-C 2 3 -alkyl-amino, N-(C 3 -alkyl) -o-hydroxy-C2- 3 -alkylamino, di- (o-hydroxy-C 2 3 -alkyl)-amino or di- 3 -alkoxy)-C 2 3 alkyl)-amino group, 0 264 a C 3 -alkylcarbonylamino-C 2 3 -alkyl-amino or C 3 -alkylcarbonylamino-C 2 3 -alkyl-N- (C 13 -alkyl) -amino group, a C.,--alkylsulphonylamino, N- (C,-,-alkyl) C- 3 -a lkylsulphonylamino, -alkylsulphonylamino- -C 2 3 -alkylamino or C- 3 -al kylsuiphonylamino- -C 23 -alkyl-N- (C 13 -alkyl) -amino group, a hydroxycarbony1-C,-,-alkylamino or N- (Cl. 3 -alkyl) -hydroxycarbonyl-C 1 3 -alkyl-amino group, a guanidino group wherein a hydrogen atom may be replaced by a -alkyl group, a group of formula 2 )n-R 9 (II), wherein R 8 denotes a hydrogen atom or a -alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and R 9 denotes an amino, C 1 3 -alkylamino, di-(CI- 3 -alkyl) -amino or Cl-, lkoxy group, a 5- or 6- membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH, -N(Cl 1 3 -alkyl) or -N(C 1 3 -alkyl-carbonyl) group, or, if n denotes one of the numbers 1, 2 or 3, R 9 may also denote a hydrogen atom, a group of formula -N(R 0 (CH2)m-(CO) 0 -Rjj (II (III) 265 wherein R, 0 denotes a hydrogen atom or a C,..-alkyl group, m denotes one of the numbers 1, 2 or 3, o denotes the number 1 or, if m is one of the numbers 2 or 3, o may also denote the number 0 and RI, denotes an amino, C 1 3 -alkylamino, di-(C 1 3 -alkyl)-amino, C 1 4 -alkoxy or methoxy-C 1 -alkoxy group or a 5- or 6-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH, -N(C 1 _3-alkyl) or -N(C 1 3 -alkyl-carbonyl) group, an azetidino, pyrrolidino, piperidino, 2,6-dimethyl-piperidino, 3,5-dimethyl-piperidino or azepino group, wherein the methylene group in position 3 of the pyrrolidino group may be substituted by a hydroxy group, the methylene group in position 4 of the piperidino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl or C 1 3 -alkoxy group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl), -N(C 1 .3-alkyl- carbonyl), -N(benzoyl) or -N(phenyl-C 1 3 -alkyl-carbonyl) group, wherein a methylene group linked to an imino- nitrogen atom of the pyrrolidino, piperidino or 266 piperazino group may be replaced by a carbonyl group, or RG denotes a straight-chain C 1 _-alkyl group which is terminally substituted by a carboxy or C_ 3 -alkoxy-carbonyl group, a group of formula -N(RI2)-CO-(CH2)p-R13 (IV), wherein R 12 denotes a hydrogen atom, a C,- 3 -alkyl or phenyl- C 1 3 -alkyl group, p denotes one of the numbers 0, 1 or 2 and Ri 3 denotes an amino, C, 4 -alkylamino, di-(C 1 _4-alkyl)-amino, benzylamino, N- (C_.3-alkyl) -benzylamino, C_ 3 -alkoxy-C_ 3 -alkylamino, N- (C_.3-alkyl)- C~ 3-alkoxy-Cl. 3 -alkylamino, di- (2-methoxy-ethyl) -amino, di- (o-hydroxy-C2-3-alkyl) -amino or aminocarbonyl-methyl-N- (methyl)-amino group, a pyrrolyl, pyrazolyl or imidazolyl group bound via a nitrogen atom and optionally substituted by a C,_ 3 -alkyl group, a pyrrolidino, piperidino, morpholino, thiomorpholino or a piperazino group optionally substituted in the 4 position by a C_.3-alkyl, phenyl-C 1 3 -alkyl, C_.3-alkylcarbonyl or C -4-alkoxycarbonyl group or, if n denotes the number 1 or 2, it may also denote a hydrogen atom, 267 a group of formula -N(RI 4 -(CH2)q-(CO)r-R5 wherein R, 4 denotes a hydrogen atom, a C 1 _-alkyl, C. 3 -alkyl- carbonyl, phenylcarbonyl, phenyl-C 1 3 -alkylcarbonyl, furyl- carbonyl, pyridinyl-carbonyl, furyl-C, 3 -alkylcarbonyl, pyridinyl-C 1 3 -alkylcarbonyl, C 1 4 -alkylsulphonyl, phenylsulphonyl or phenyl-CI 3 -alkylsulphonyl group, q denotes one of the numbers 1, 2 or 3, r denotes the number 1 or, if q is one of the numbers 2 or 3, it may also denote the number 0 and Rs denotes an amino, C 1 -4-alkylamino, di-(C 1 4 -alkyl)-amino, phenylamino, N-(C 14 -alkyl)-phenylamino, benzylamino or N-(CI.4-alkyl)-benzylamino group, or a group of formula -N(R 16 )-S0 2 -R 1 7 (VI), wherein R 16 denotes a hydrogen atom or a C_, 3 -alkyl group optionally terminally substituted by a cyano, trifluoromethyl-carbonylamino or 3 -alkyl)-trifluoromethyl-carbonyl-amino group and R 1 denotes a C,13-alkyl group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R, may be substituted by a fluorine, chlorine or bromine atom, by 268 a methyl, trifluoromethyl, methoxy, nitro or cyano group and R 5 denotes a hydrogen atom, wherein a hydrogen atom bound to a nitrogen atom in the abovementioned groups may be replaced by an acetyl or tert.butoxycarbonyl group, the carboxy groups contained in the abovementioned groups may also be present in the form of the tert.butoxycarbonyl precursor group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof. 4. Indolinones of general formula I according to claim 1, wherein X denotes an oxygen atom, Ri and R 5 each denote a hydrogen atom, R 2 denotes a methoxycarbonyl, ethoxycarbonyl or aminocarbonyl group, R 3 denotes a phenyl group and R 4 denotes a phenyl group monosubstituted by the group R,, wherein R 6 denotes an N-methyl-imidazol-2-yl group, an unbranched C 1 3 -alkyl group which is terminally substituted by a C_.4-alkylamino, di-(C 1 4 -alkyl)-amino, piperidino or 2,6-dimethyl-piperidino group, 269 a group of formula -N(R!2)-CO-(CH2)p-Ri3 (IV); wherein R 12 denotes a C_ 3 -alkyl group, p denotes one of the numbers 1 or 2 and R 13 denotes a di-(C 1 3 -alkyl)-amino group, or a group of formula -N(R 1 4 (CH2)q-(CO)r-R15 wherein R, 4 denotes a C 1 3 -alkyl-carbonyl or C-3-alkylsulphonyl group, q denotes one of the numbers 1, 2 or 3, r denotes the number 1 or, if q is one of the numbers 2 or 3, r may also denote the number 0 and R 15 denotes a di-(C 1 alkyl)-amino group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof. 270 The following substituted indolinones of general formula I according to claim 1: 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- [(1-(4-(piperidin-l-yl-methyl)-anilino)---phenyl- methylene] -6-carbamoyl-2-indolinone, 3-Z- (pipe ridin-1-yl--methyl) -anilino) -1-phenyl- methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- [l-(4-(dimethylaminomethyl)-anilino) -1-phenyl- methylene] ethoxycarbonyl indol inone, 3-Z- [1-(4-((2,6-dimethyl-piperidin-1-yl) -methyl) -anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-ani- lino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-ani- lino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonyl- amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2- indolinone, 3-Z- [1-(4-(dimethylaminomethyl)-anilino)-1-phenyl- methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- (N-acetyl-N-dimethylaminocarbonylmethyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- [1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6- methoxycarbonyl indol inone, PAOPER~gc~l0233-0l claims dcc.l VAMS -271 3-Z-[1-(4-(l-methyl-imidazol-2-yl)-anilino)--phenyl- methylenel -6-methoxycarbonyl-2-inlolinone, (in) 3-Z- (N-dimethylaminomethylcarbonyl-N-methyl- amino) -anhlino) -1-phenyl-methylene] -6-methoxycarbonyl-2- indolinone, (2-cimethylamino-ethyl)-N-methylsulphonyl- amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2- inclolinone, 3-Z-I1- (3-cimethylamino-propyl) -N- methylsulphonyl-amino) -anilino) -1-phenyl-methylene]-6- methoxycarbonyl-2-indolinone, (q*--l(-N(2dmtylmn-ty)croy) (N-(2dimethylaminoaronyyl-N-eyamn) ()3[-4methyl- amino hy-anilino) 1 -phenyl-e]-- mtee-6-m etoxycarbonyl-2-inciolinone MOPER\JgcIO233- caimd-IA44V -271A- 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)- methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl- methylene]-6-methoxycarbonyl-2-indolinone the tautomers, the mixtures and the salts thereof. 6. 3-Z-[1-(4-(N-((4-methyl-piperazin-l-yl)- methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl- methylene]-6-methoxycarbonyl-2-indolinone a tautomer or a salt thereof. 7. Physiologically acceptable salts of the compounds according to claims 1 to 6. 15 8. Pharmaceutical compositions containing a compound according to any one of claims 1 to 6 or a salt according to o claim 7 optionally together with one or more inert carriers and/or diluents. o. 20 9. Use of a compound according to any one of claims 1 to 6 or a salt according to claim 7 for preparing a pharmaceutical composition which is suitable for treating excessive or anomalous cell proliferation.
10. Process for preparing a pharmaceutical composition according to claim 8, wherein a compound according to at least one of claims 1 to 6 or a salt according to claim 7 is incorporated in one or more inert carriers and/or diluents by a non-chemical method. PAOPERJgcL102331 claims dc-.IA4ffi -272-
11. Process for preparing the compounds according to claims 1 to 7, wherein a. a compound of general formula R3 X (VII), R 2 I R18 wherein X and R 3 are defined as in claims 1 to R 2 has the meanings given for R 2 in claims 1 to 10 R 18 denotes a hydrogen atom or a protecting group for the nitrogen atom of the lactam group, wherein one of the groups R 2 and R 18 may also denote a bond to a solid phase optionally formed via a spacer and the other one of the groups R 2 and R 1 8 273 has the abovementioned meanings, and Z, denotes a halogen atom, a hydroxy, alkoxy or aryl-alkoxy group, is reacted with an amine of general formula H N (VIII), R4 wherein R 4 and R 5 are defined as in claims 1 to and subsequently, if required, any protecting group used for the nitrogen atom of the lactam group is cleaved or a compound thus obtained is cleaved from a solid phase, or b. in order to prepare a compound of general formula I wherein R 2 has the meanings given in claims 1 to 5, with the exception of the carboxy group, a compound of general formula R 3 R4 N O (IX), HOOC N RI wherein RI and R 3 to R 5 are defined as in claims 1 to or a reactive derivative thereof, is reacted with a compound of general formula 0 274 H R 19 WX) wherein R, 9 deniotes a C- 1 6 -alkanGL1O1, a C 4 7 -Ycloalkanol o~r an aromatic alcohol, a C 1-6-alkanol which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C 13 ,-alkoxy-carbonyl, aminocarbonyl, C 13 ,-alkylamino-carbonyl or di- (Cl- 3 -alkyl) -aminocarbonyl group, a C_ 6 -alkanol which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, C 1 3 -alkoxy, amino, C 1 3 -alkylamino or di- (C- 3 -alkyl) -amino group, an amino or methylamino group, an ethylamino group optionally substituted in the 2 position of the ethyl group by a hydroxy or C 1 3 -al koxy group or a di- (C 12 -alkyl) -amino group, or C. in order to prepare a compound of general formula I, wherein R 4 denotes a Cl- 4 -alkyl group substituted by the group R 7 wherein R, denotes an amino, C,-,-alkylamino, di- (C 1 7 -alkyl) -amino, phenylamino, N-phenyl-C 1 3 -alkyl -amino, phenyl-C- 3 -alkyl- amino, N- (Cl- 3 -alkyl) -phenyl-C 1 3 ,-alkylamino or di- (phenyl-Cl- 3 -alkyl) -amino group, a wo-hydroxy-C 2 3 -alkyl -amino, N- (Cl- 3 -alkyl) -o-hydroxy-C 2 3 -alkyl -amino, di- ((o-hydroxy-C 2 3 -alkyl) -amino, di- (co- (Cl- 3 -alkoxy) -C 2 3 -alkyl) -amino or N- (dioxolan-2-yl) -C 1 3 -alkyl-amino group, 275 a C, -alkylcarbonylamiio-C 23 -alkyl-amino or C- 3 -al kylcarbonylamino-C 2 alkyl-N- (C,-,-alkyl) -amino group, a C 1 3 alkylsulphonyl ari non N- (Cr_ 3 -alkyl.)- C 1 3 -al kylsuiphonylamino, C- 3 -al kylsulphonylamino-C 2 3 -alkyl -aminlo or C- 3 -al kylsulphonylamino-C 23 -alkyl-N- (C 1 3 -alkyl) -amino group, a group of formula N(R 0 (CH2)m-(CO) 0 -Rjj (II wherein Rio denotes a hydrogen atom, a CI-3-al kyl group, a C 1 3 -alkylcarbonyl, arylcarbonyl, phenyl-Cl- 3 -alkyl- carbonyl, C,- 3 -alkylsulphonyl, arylsuiphonyl or phenyl- Cl- 3 -alkylsulphonyl group, m denote's one of the numbers 1, 2, 3 or 4, o denotes the number 1 and denotes an amino, Cl- 4 -alkylamino, di- (Cl- 4 -alkyl) -amino, phenylarnino, N- (C, 4 -alkyl) -phenylamino, benzylamino, N- (C 1 4 -alkyl) -benzylamino, C 1 4 ,-alkoxy or C- 3 -alkoxy-Cl- 3 -alkoxy group, a di- (Cl 1 4 -alkyl) -amino-Cl- 3 alkylamino group optionally substituted in the 1 position by a C 1 3 -alkyl group, or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7- membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a suiphinyl, sulphonyl, -NH, 276 -N(C 1 3 -alkyl), -N(phenyl), -N(C 1 3 -alkyl-carbonyl) or -N(benzoyl) group, aC n-cycloalkylamino, C 4 -iycalkyl-C. 3 -alkylamino or 17 4 _jI C 4 ,-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a C,,-cycloalkyl, C, 2 4 -alkenyl or C' 1 4 -alkyl group, or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, Cl- 3 -alkyl, C 1 3 -alkoxy or amino group, and/or one or two hydrogen atoms may each be replaced by a C 1 3 -alkyl, C, 7 -cycloalkyl or phenyl group and/or the methylene group in the 3 position of a cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl, Cl-3-alkoxy or C1- 3 -alkoxy-C, 3 -alkyl group, in each case the methylene group in the 3 or 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C 3 -alkyl, Cl- 3 -alkoxy, C 1 3 -alkoxy-Cl -alkyl, C 1 4 -alkoxycarbonyl, aminocarbonyl, Cl_3-alkylaminocarbonyl, di-(C, 3 -alkyl)- aminocarbonyl, phenyl-Cl_ 3 -alkylamino or N-(C, 3 -alkyl)- phenyl-Cl- 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl-), -N(phenyl), 277 -N(phenyl-C 1 3 -alkyl-) -N(C 1 3 -alkyl-carbonyl-), -N(Ci, 4 -alkoxy-carbonyl-), -N(benzoyl-) or -N(phenyl-C, 3 -alkyl-carbonyl-) group, wherein a methylene group linked to an imino- nitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the imino- nitrogen atom may each be replaced by a carbonyl group, a compound of general formula R 3 R I A-Z2 N x (XI), N R2' I R 1 8 wherein R 3 R s and X are defined as in claims 1 to R 2 has the meanings given for R 2 in claims 1 to Ri 8 denotes a hydrogen atom or a protecting group for the nitrogen atom of the lactam group, wherein one of the groups R 2 and Ri 8 may also denote a bond to a solid phase optionally formed via a spacer and the other one of the groups R 2 and R, 1 has the abovementioned meanings, A denotes a C 1 -alkyl group and Z 2 denotes a leaving group, 278 is reacted with an amine of general formula (XII), wherein R 7 has the meanings given for R 7 hereinbefore, and subsequently, if necessary, any protecting group used for the nitrogen atom of the lactam group is cleaved, or a compound thus obtained is cleaved from a solid phase, and subsequently, if desired, a compound of general formula I thus obtained which contains an alkoxycarbonyl group is converted by hydrolysis into a corresponding carboxy compound, or a compound of general formula I thus obtained which contains an amino or alkylamino group is converted by reductive alkylation into a corresponding alkylamino or dialkylamino compound, or a compound of general formula I thus obtained which contains an amino or alkylamino group is converted by acylation or sulphonation into a corresponding acyl or sulphonyl compound or a compound of general formula I thus obtained which contains a carboxy group is converted by esterification or amidation into a corresponding ester or aminocarbonyl compound or a compound of general formula I thus obtained which contains a cycloalkyleneimino group wherein a methylene group is replaced by a sulphur atom is converted by oxidation into a corresponding sulphinyl or sulphonyl compound, or 279 a compound of general formula I thus obtained which contains a nitro group is converted by reduction into a corresponding amino compound, or a compound of general formula I thus obtained wherein R 4 denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group is converted, by reaction with a corresponding cyanate, isocyanate or carbamoyl halide, into a corresponding urea compound of general formula I or a compound of general formula I thus obtained wherein R, denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group is converted, by reaction with a corresponding compound which transfers the amidino group or by reaction with a corresponding nitrile, into a corresponding guanidino compound of general formula I, or if necessary any protecting group used during the reactions to protect reactive groups is cleaved or subsequently, if desired, a compound of general formula I thus obtained is resolved into the stereoisomers thereof or a compound of general formula I thus obtained is converted into the salts thereof, particularly, for pharmaceutical use, into the physiologically acceptable salts thereof with an inorganic or organic acid or base. PAOPER~geOZ233-I d.amsdocm-4i)4MV5 -280-
12. Use of a compound according to any one of claims 1 to 6 or a salt according to claim 7 for treating excessive or an anomalous cell proliferation.
13. Method of treating excessive or an anomalous cell proliferation in a patient by administering a compound according to any one of claims 1 to 6 or a salt according to claim 7 to a patient in need of treatment.
14. Indolinones of general formula I according to claim 1 substantially as hereinbefore described with reference to the Examples. 15 DATED this 15 th day of April, 2005 Boehringer Ingelheim Pharma GmbH Co. KG by DAVIES COLLISON CAVE S: 2 *o
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19949208A DE19949208A1 (en) | 1999-10-13 | 1999-10-13 | New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis |
DE19949208 | 1999-10-13 | ||
DE2000142696 DE10042696A1 (en) | 2000-08-31 | 2000-08-31 | New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis |
DE10042696 | 2000-08-31 | ||
PCT/EP2000/009867 WO2001027081A1 (en) | 1999-10-13 | 2000-10-09 | 6-position substituted indoline, production and use thereof as a medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1023301A AU1023301A (en) | 2001-04-23 |
AU781939B2 true AU781939B2 (en) | 2005-06-23 |
Family
ID=26006858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU10233/01A Active 2025-10-09 AU781939B2 (en) | 1999-10-13 | 2000-10-09 | 6-position substituted indoline, production and use thereof as a medicament |
Country Status (42)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9642851B2 (en) | 2012-12-06 | 2017-05-09 | Kbp Biosciences Co., Ltd. | Indolinone derivative as tyrosine kinase inhibitor |
Families Citing this family (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19816624A1 (en) * | 1998-04-15 | 1999-10-21 | Boehringer Ingelheim Pharma | Novel substituted indolinones, their preparation and their use as pharmaceuticals |
KR100589032B1 (en) | 2000-10-20 | 2006-06-14 | 에자이 가부시키가이샤 | Nitrogenous aromatic ring compounds |
US6638965B2 (en) | 2000-11-01 | 2003-10-28 | Boehringer Ingelheim Pharma Kg | Substituted indolinones, preparation thereof and their use as pharmaceutical compositions |
DE10117204A1 (en) | 2001-04-06 | 2002-10-10 | Boehringer Ingelheim Pharma | Indolinones substituted in the 6-position, their preparation and their use as medicaments |
US20030091974A1 (en) * | 2001-06-29 | 2003-05-15 | Alain Moussy | Method for screening compounds capable of depleting mast cells |
JP2004537537A (en) | 2001-06-29 | 2004-12-16 | アブ サイエンス | Uses of tyrosine kinase inhibitors to treat inflammatory diseases |
WO2003002106A2 (en) | 2001-06-29 | 2003-01-09 | Ab Science | Use of tyrosine kinase inhibitions for treating allergic diseases |
ATE343415T1 (en) | 2001-06-29 | 2006-11-15 | Ab Science | THE USE OF C-KIT INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE |
DE60227709D1 (en) * | 2001-06-29 | 2008-08-28 | Ab Science | THE USE OF C-CRITERIA FOR THE TREATMENT OF AUTOIMMUNE DISEASES |
US7727731B2 (en) | 2001-06-29 | 2010-06-01 | Ab Science | Potent, selective and non toxic c-kit inhibitors |
CA2461812C (en) * | 2001-09-27 | 2011-09-20 | Allergan, Inc. | 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
US6797825B2 (en) | 2001-12-13 | 2004-09-28 | Abbott Laboratories | Protein kinase inhibitors |
US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
EP1458713B1 (en) | 2001-12-27 | 2005-08-24 | Theravance, Inc. | Indolinone derivatives useful as protein kinase inhibitors |
SE0302546D0 (en) | 2003-09-24 | 2003-09-24 | Astrazeneca Ab | New compounds |
ITBO20020198A1 (en) * | 2002-04-12 | 2003-10-13 | Univ Bologna | DERIVATIVES 2, 5 BIS DIAMMINO 1, 4 BENZOCHENIONIC USEFUL FOR THE TREATMENT OF ALZHEIMER DISEASE, METHOD FOR THEIR PREPARATION AND |
US7169936B2 (en) | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
US7514468B2 (en) | 2002-07-23 | 2009-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions |
DE10233500A1 (en) * | 2002-07-24 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-Z- [1- (4- (N - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone monoethanesulfonate and its use as a medicament |
US20040204458A1 (en) | 2002-08-16 | 2004-10-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of Lck inhibitors for treatment of immunologic diseases |
DE10237423A1 (en) | 2002-08-16 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Treating immunological (or related) diseases, e.g. inflammatory bowel disease, rheumatoid arthritis or psoriasis, comprises administration of 3-methylene-2-indolinone derivative or quinazoline compound |
US7148249B2 (en) * | 2002-09-12 | 2006-12-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments |
JP4879492B2 (en) * | 2002-11-27 | 2012-02-22 | アラーガン、インコーポレイテッド | Kinase inhibitors for the treatment of diseases |
US20050043233A1 (en) * | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
WO2005044788A1 (en) | 2003-11-11 | 2005-05-19 | Eisai Co., Ltd. | Urea derivative and process for producing the same |
SE0401790D0 (en) * | 2004-07-07 | 2004-07-07 | Forskarpatent I Syd Ab | Tamoxifen response in pre- and postmenopausal breast cancer patients |
US20060058311A1 (en) * | 2004-08-14 | 2006-03-16 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation |
EP2364699A1 (en) | 2004-09-13 | 2011-09-14 | Eisai R&D Management Co., Ltd. | Joint use of sulfonamide based compound with angiogenesis inhibitor |
US8772269B2 (en) | 2004-09-13 | 2014-07-08 | Eisai R&D Management Co., Ltd. | Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
AU2005283422C1 (en) | 2004-09-17 | 2017-02-02 | Eisai R & D Management Co., Ltd. | Medicinal composition |
PE20060777A1 (en) * | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES |
EP2281901B1 (en) | 2005-08-02 | 2013-11-27 | Eisai R&D Management Co., Ltd. | Anti-tumour pharmaceutical composition with angiogenesis inhibitors |
WO2007057397A1 (en) * | 2005-11-15 | 2007-05-24 | Boehringer Ingelheim International Gmbh | Treatment of cancer |
CN104706637A (en) | 2006-05-18 | 2015-06-17 | 卫材R&D管理有限公司 | Antitumor agent for thyroid cancer |
EP1870400A1 (en) * | 2006-06-08 | 2007-12-26 | Boehringer Ingelheim Pharma GmbH & Co. KG | Salts and crystalline salt forms of an 2-indolinone derivative |
KR101472600B1 (en) | 2006-08-28 | 2014-12-15 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Antitumor agent for undifferentiated gastric cancer |
JP5319306B2 (en) | 2007-01-29 | 2013-10-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Composition for treatment of undifferentiated gastric cancer |
WO2008152013A1 (en) * | 2007-06-12 | 2008-12-18 | Boehringer Ingelheim International Gmbh | Indolinone derivatives and their use in treating disease-states such as cancer |
ES2435454T3 (en) | 2007-06-21 | 2013-12-19 | Janssen Pharmaceutica, N.V. | Indolin-2-one and aza-indolin-2-one |
KR101513326B1 (en) | 2007-11-09 | 2015-04-17 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Combination of anti-angiogenic substance and anti-tumor platinum complex |
PE20091445A1 (en) * | 2007-12-03 | 2009-10-19 | Boehringer Ingelheim Int | INDOLINONE DERIVATIVES AND PROCEDURE FOR ITS MANUFACTURE |
CN101883756A (en) | 2007-12-03 | 2010-11-10 | 贝林格尔.英格海姆国际有限公司 | Process for preparing indolinone derivatives |
ES2662824T3 (en) | 2008-06-06 | 2018-04-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical combination |
EP2471787A1 (en) | 2008-07-29 | 2012-07-04 | Boehringer Ingelheim International GmbH | New compounds |
JP2012515184A (en) | 2009-01-14 | 2012-07-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | How to treat colorectal cancer |
US8802384B2 (en) | 2009-03-12 | 2014-08-12 | Boehringer Ingelheim International Gmbh | Method or system using biomarkers for the monitoring of a treatment |
WO2010108503A1 (en) | 2009-03-24 | 2010-09-30 | Life & Brain Gmbh | Promotion of neuronal integration in neural stem cell grafts |
EP2429520A1 (en) | 2009-05-14 | 2012-03-21 | Boehringer Ingelheim International GmbH | New combination therapy in treatment of oncological and fibrotic diseases |
US20120107304A1 (en) | 2010-04-27 | 2012-05-03 | Boehringer Ingelheim International Gmbh | Combination therapy in treatment of oncological and fibrotic diseases |
JP5898074B2 (en) | 2010-06-25 | 2016-04-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Antitumor agent by combined use of compounds having kinase inhibitory action |
WO2012068441A2 (en) | 2010-11-19 | 2012-05-24 | Ratiopharm Gmbh | Intedanib salts and solid state forms thereof |
KR101762999B1 (en) | 2011-04-18 | 2017-07-28 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Therapeutic agent for tumor |
EP3444363B1 (en) | 2011-06-03 | 2020-11-25 | Eisai R&D Management Co., Ltd. | Biomarkers for prediciting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
WO2013059740A1 (en) | 2011-10-21 | 2013-04-25 | Foundation Medicine, Inc. | Novel alk and ntrk1 fusion molecules and uses thereof |
EP3604307A1 (en) | 2012-01-26 | 2020-02-05 | Angion Biomedica Corp. | Anti-fibrotic compounds and uses thereof |
CA2890346A1 (en) | 2012-11-05 | 2014-05-08 | Foundation Medicine, Inc. | Novel fusion molecules and uses thereof |
EP2914621B1 (en) | 2012-11-05 | 2023-06-07 | Foundation Medicine, Inc. | Novel ntrk1 fusion molecules and uses thereof |
MX2015004979A (en) | 2012-12-21 | 2015-07-17 | Eisai R&D Man Co Ltd | Amorphous form of quinoline derivative, and method for producing same. |
WO2014113729A2 (en) | 2013-01-18 | 2014-07-24 | Foundation Mecicine, Inc. | Methods of treating cholangiocarcinoma |
US20140350022A1 (en) | 2013-05-10 | 2014-11-27 | Boehringer Ingelheim International Gmbh | Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment |
SG11201509278XA (en) | 2013-05-14 | 2015-12-30 | Eisai R&D Man Co Ltd | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds |
CN104003925B (en) * | 2013-06-05 | 2016-03-30 | 四川大学 | Indolinone compound or its derivative and use thereof |
WO2015009889A1 (en) * | 2013-07-18 | 2015-01-22 | Concert Pharmaceuticals, Inc. | Deuterated intedanib derivatives and their use for the treatment of proliferative disorders |
WO2015017728A1 (en) | 2013-07-31 | 2015-02-05 | Windward Pharma, Inc. | Aerosol tyrosine kinase inhibitor compounds and uses thereof |
RS63559B1 (en) | 2014-08-28 | 2022-10-31 | Eisai R&D Man Co Ltd | High-purity quinoline derivative and method for manufacturing same |
CN104262232B (en) * | 2014-09-09 | 2016-05-04 | 苏州明锐医药科技有限公司 | The preparation method of Ni Taidani |
SG11201706630UA (en) | 2015-02-25 | 2017-09-28 | Eisai R&D Man Co Ltd | Method for suppressing bitterness of quinoline derivative |
AU2015384801B2 (en) | 2015-03-04 | 2022-01-06 | Eisai R&D Management Co., Ltd. | Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer |
WO2016178064A1 (en) | 2015-05-06 | 2016-11-10 | Suven Life Sciences Limited | Polymorph of nintedanib ethanesulphonate, processes and intermediates thereof |
CN104844499B (en) * | 2015-06-05 | 2017-03-08 | 北京康立生医药技术开发有限公司 | One kettle way prepares the synthetic method of Nintedanib |
EP4335418A3 (en) | 2015-06-06 | 2024-05-22 | Cloudbreak Therapeutics, LLC | Compositions and methods for treating pterygium |
CA2988707C (en) | 2015-06-16 | 2023-10-10 | Eisai R&D Management Co., Ltd. | Combination of cbp/catenin inhibitor and immune checkpoint inhibitor for treating cancer |
CN105126909B (en) * | 2015-07-13 | 2018-01-23 | 淮海工学院 | Application of the immobilized palladium catalyst in the synthesis of the nitrobenzene methyl of 4 phenylacetylene base 3 |
CZ308695B6 (en) | 2015-07-29 | 2021-03-03 | Zentiva, K.S. | Process for preparing methyl (Z) -3 - [[4- [methyl [2- (4-methyl-1-piperazinyl) acetyl] amino] phenyl] amino] phenylmethylene) -oxindole-6-carboxylate (intedanib, nintedanib) |
CN106467500A (en) * | 2015-08-14 | 2017-03-01 | 廊坊百瑞化工有限公司 | A kind of one pot synthesis synthesize the new method of Nintedanib key intermediate |
RU2718048C2 (en) | 2015-08-20 | 2020-03-30 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Antitumour therapeutic agent |
CN109302846B (en) | 2015-12-24 | 2021-05-11 | 莱斯彼维特有限公司 | Indolinone compounds and their use in the treatment of fibrotic diseases |
CZ2016104A3 (en) | 2016-02-24 | 2017-09-06 | Zentiva, K.S. | Crystalline modifications of methyl (3Z)-3- {[(4-{methyl[(4-methylpiperazin-1yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2oxo-2,3-dihydro-1H-indole-6-carboxylate and the methods of their preparation |
AU2017231860C1 (en) | 2016-03-08 | 2022-01-20 | Respivert Limited | Indole derivatives and their use as protein kinase inhibitors |
WO2017178428A1 (en) | 2016-04-13 | 2017-10-19 | Boehringer Ingelheim International Gmbh | Pharmaceutical combination of nintedanib, trifluridine and tipiracil for treating colorectal cancer |
EP3246029A1 (en) | 2016-05-19 | 2017-11-22 | Boehringer Ingelheim International Gmbh | Pharmaceutical combination of nintedanib and capecitabine for the treatment of colorectal cancer |
US20190275032A1 (en) | 2016-05-27 | 2019-09-12 | Boehringer Ingelheim International Gmbh | Use of ecm biomarkers for determining the treatment onset with nintedanib and pirfenidone |
WO2017207643A1 (en) | 2016-06-01 | 2017-12-07 | Boehringer Ingelheim International Gmbh | Use of ecm biomarkers for the determining the treatment onset with nintedanib and pirfenidone |
AU2017274195B2 (en) | 2016-06-02 | 2022-04-07 | Ads Therapeutics Llc | Compositions and methods of using nintedanib for improving glaucoma surgery success |
CN109789127B (en) | 2016-07-29 | 2022-03-25 | 英克特诺治疗公司 | Use of indolinone compounds |
CN106748961A (en) * | 2016-11-30 | 2017-05-31 | 瑞阳制药有限公司 | The impurity compound of Nintedanib, preparation method, using and its detection method |
CN106748960A (en) * | 2016-11-30 | 2017-05-31 | 瑞阳制药有限公司 | The potential impurity compound of Nintedanib, preparation method, using and its detection method |
WO2018108669A1 (en) | 2016-12-12 | 2018-06-21 | Boehringer Ingelheim International Gmbh | Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol |
EP3600322A1 (en) | 2017-03-28 | 2020-02-05 | Boehringer Ingelheim International GmbH | Nintedanib for use in methods for the treatment of muscular dystrophy |
MA50441A (en) | 2017-10-23 | 2020-09-02 | Boehringer Ingelheim Int | NEW ASSOCIATION OF ACTIVE AGENTS FOR THE TREATMENT OF PROGRESSIVE INTERSTITIAL FIBROSAN PNEUMOPATHIES (PF-ILD) |
US11261158B2 (en) | 2017-11-17 | 2022-03-01 | Fermion Oy | Synthesis of 2-indolinone derivatives |
JP7061310B2 (en) * | 2018-04-05 | 2022-04-28 | 国立大学法人 大分大学 | Pharmaceuticals for the prevention and treatment of chronic fatty diseases |
CN108358827A (en) * | 2018-05-07 | 2018-08-03 | 日照市普达医药科技有限公司 | It is a kind of to treat psoriasic 2- oxo-indoles analog derivative and preparation method thereof |
US12156873B2 (en) | 2018-05-25 | 2024-12-03 | Ads Therapeutics Llc | Composition for treating ocular hyperemia and a method for treating ocular hyperemia with the same |
MX2021003945A (en) * | 2018-10-05 | 2021-05-27 | Ichnos Sciences S A | Indolinone compounds for use as map4k1 inhibitors. |
CN115361950A (en) | 2020-04-01 | 2022-11-18 | 勃林格殷格翰国际有限公司 | Use of biomarkers in the treatment of fibrotic disorders |
CN111848490B (en) * | 2020-08-24 | 2021-09-24 | 江西国药有限责任公司 | Preparation method of high-purity ethanesulfonic acid nintedanib |
CN112574094B (en) * | 2020-12-14 | 2022-07-01 | 成都大学 | Indolinone derivatives and their pharmaceutical uses |
WO2022158956A1 (en) | 2021-01-25 | 2022-07-28 | 주식회사 나이벡 | Peptide for preventing and treating fibrosis |
EP4098246A1 (en) | 2021-05-31 | 2022-12-07 | Lotus Pharmaceutical Co., Ltd. | Formulation of nintedanib |
CN115703758B (en) * | 2021-08-12 | 2024-03-26 | 中国医学科学院药物研究所 | A class of compounds used as kinase inhibitors and preparation methods and uses thereof |
WO2024037982A1 (en) | 2022-08-16 | 2024-02-22 | Boehringer Ingelheim International Gmbh | Pharmaceutical formulations of nintedanib for intraocular use |
TWI857798B (en) * | 2023-09-28 | 2024-10-01 | 國立臺灣大學 | Indoline derivatives for treatment and/or prevention of tumor or cell proliferative and fibrosis diseases |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015500A1 (en) * | 1997-09-05 | 1999-04-01 | Glaxo Group Limited | Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL96047C (en) * | 1956-06-08 | |||
WO1995030420A1 (en) * | 1994-05-06 | 1995-11-16 | Alcon Laboratories, Inc. | Use of vitamin e tocopheryl derivatives in ophthalmic compositions |
US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
ATE243034T1 (en) * | 1996-01-17 | 2003-07-15 | Taiho Pharmaceutical Co Ltd | INTIMAL THICKENING INHIBITORS |
DE19815020A1 (en) * | 1998-04-03 | 1999-10-07 | Boehringer Ingelheim Pharma | New substituted indolinones, their production and their use as medicines |
DE19816624A1 (en) * | 1998-04-15 | 1999-10-21 | Boehringer Ingelheim Pharma | Novel substituted indolinones, their preparation and their use as pharmaceuticals |
DE19824922A1 (en) * | 1998-06-04 | 1999-12-09 | Boehringer Ingelheim Pharma | Novel substituted indolinones, their preparation and their use as pharmaceuticals |
GB9904933D0 (en) * | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Compounds |
-
2000
- 2000-09-10 UA UA2002053890A patent/UA75054C2/en unknown
- 2000-10-09 HU HU0204587A patent/HU230416B1/en active Protection Beyond IP Right Term
- 2000-10-09 EE EEP200200197A patent/EE05427B1/en active Protection Beyond IP Right Term
- 2000-10-09 MX MXPA02002799A patent/MXPA02002799A/en active IP Right Grant
- 2000-10-09 DK DK00971347.0T patent/DK1224170T5/en active
- 2000-10-09 RS YUP-266/02A patent/RS51013B/en unknown
- 2000-10-09 AU AU10233/01A patent/AU781939B2/en active Active
- 2000-10-09 SK SK646-2002A patent/SK287312B6/en not_active IP Right Cessation
- 2000-10-09 ES ES00971347T patent/ES2331459T3/en not_active Expired - Lifetime
- 2000-10-09 CZ CZ20021410A patent/CZ301073B6/en unknown
- 2000-10-09 CN CNB008158681A patent/CN100455568C/en not_active Expired - Lifetime
- 2000-10-09 BR BRPI0014735 patent/BRPI0014735B8/en active IP Right Grant
- 2000-10-09 EP EP00971347.0A patent/EP1224170B9/en not_active Expired - Lifetime
- 2000-10-09 SI SI200031039T patent/SI1224170T1/en unknown
- 2000-10-09 AT AT00971347T patent/ATE439342T1/en active
- 2000-10-09 PT PT00971347T patent/PT1224170E/en unknown
- 2000-10-09 EA EA200200380A patent/EA006080B1/en not_active IP Right Cessation
- 2000-10-09 EP EP09164507A patent/EP2157081A1/en not_active Withdrawn
- 2000-10-09 CA CA002387013A patent/CA2387013C/en not_active Expired - Lifetime
- 2000-10-09 KR KR1020077017807A patent/KR100857734B1/en active IP Right Grant
- 2000-10-09 NZ NZ518489A patent/NZ518489A/en not_active IP Right Cessation
- 2000-10-09 IL IL14875600A patent/IL148756A0/en active IP Right Grant
- 2000-10-09 ME MEP-454/08A patent/MEP45408A/en unknown
- 2000-10-09 JP JP2001530102A patent/JP4021664B2/en not_active Expired - Lifetime
- 2000-10-09 DE DE50015711T patent/DE50015711D1/en not_active Expired - Lifetime
- 2000-10-09 WO PCT/EP2000/009867 patent/WO2001027081A1/en active IP Right Grant
- 2000-10-09 KR KR1020027004701A patent/KR100835546B1/en active IP Right Grant
- 2000-10-09 PL PL355433A patent/PL207445B1/en not_active IP Right Cessation
- 2000-10-11 PE PE2000001088A patent/PE20010671A1/en not_active IP Right Cessation
- 2000-10-11 EG EG2000101293A patent/EG25931A/en active
- 2000-10-11 MY MYPI20004762A patent/MY127956A/en unknown
- 2000-10-12 TW TW089121320A patent/TWI268922B/en active
- 2000-10-12 CO CO00077925A patent/CO5261488A1/en not_active Application Discontinuation
- 2000-10-13 AR ARP000105394A patent/AR026036A1/en active Pending
-
2001
- 2001-02-06 SA SA01210704A patent/SA01210704B1/en unknown
-
2002
- 2002-03-19 IL IL148756A patent/IL148756A/en active Protection Beyond IP Right Term
- 2002-04-05 BG BG106587A patent/BG65983B1/en active Active
- 2002-04-10 HR HR20020306A patent/HRP20020306B1/en not_active IP Right Cessation
- 2002-04-11 NO NO20021719A patent/NO322746B1/en active Protection Beyond IP Right Term
-
2003
- 2003-06-30 HK HK03104649.4A patent/HK1052505B/en not_active IP Right Cessation
-
2007
- 2007-08-15 JP JP2007211755A patent/JP2007302697A/en active Pending
-
2009
- 2009-11-06 CY CY20091101152T patent/CY1110067T1/en unknown
-
2015
- 2015-03-13 CY CY2015009C patent/CY2015009PI2/en unknown
- 2015-03-16 FR FR15C0024C patent/FR15C0024I2/en active Active
- 2015-03-16 LU LU92681C patent/LU92681I2/en unknown
- 2015-03-16 BE BE2015C018C patent/BE2015C018I2/fr unknown
- 2015-03-16 NL NL300725C patent/NL300725I2/en unknown
- 2015-03-18 NO NO2015009C patent/NO2015009I1/en unknown
-
2016
- 2016-05-13 HU HUS1600022C patent/HUS1600022I1/en unknown
-
2023
- 2023-09-05 NO NO2023033C patent/NO2023033I1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015500A1 (en) * | 1997-09-05 | 1999-04-01 | Glaxo Group Limited | Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9642851B2 (en) | 2012-12-06 | 2017-05-09 | Kbp Biosciences Co., Ltd. | Indolinone derivative as tyrosine kinase inhibitor |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU781939B2 (en) | 6-position substituted indoline, production and use thereof as a medicament | |
US6762180B1 (en) | Substituted indolines which inhibit receptor tyrosine kinases | |
US6794395B1 (en) | Substituted indolinones, their manufacture and their use as medicaments | |
US7148249B2 (en) | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments | |
AU6086399A (en) | Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes | |
US20030092756A1 (en) | Substituted indolinones | |
MXPA04012937A (en) | Indoline derivatives substituted in position 6, production and use thereof as medicaments. | |
JP2005537276A (en) | 6-substituted indolinone derivatives, their preparation and use as pharmaceutical compositions | |
US7514468B2 (en) | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions | |
DE10042696A1 (en) | New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis | |
DE19949208A1 (en) | New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TC | Change of applicant's name (sec. 104) |
Owner name: BOEHRINGER INGELHEIM PHARMA GMBH AND CO. KG Free format text: FORMER NAME: BOEHRINGER INGELHEIM PHARMA KG |